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1. Overview – Organometallic Chemistry 
Synthetic organic chemistry targets the construction and alteration of carbon based chemical 
compounds. Therein, keeping the right balance between selectivity and chemical reactivity is 
one of the most important challenges. This applies especially for organometallic compounds, 
which contain at least one chemical bond between a metal or metalloid and carbon.1 This 
sensitive harmony between selectivity and reactivity of an organometallic has a long history, 
reaching back to the first half of the 19th century, when this chapter of organic chemistry was 
opened with the discovery of cacodyl ((Me2As)2) and cacodyl oxide (Me2AsOAsMe2) by 
Cadet2, and later potassium trichloro(ethylene)platinate(II) by Zeise3 (Scheme 1A). These 
reagents, however, suffered from low stability and significant toxicity and thus found no further 
application in organic synthesis. Later, Frankland discovered the first organozinc species with 
the development of diethylzinc (Et2Zn, Scheme 1B).
4 This highly pyrophoric liquid, which 
reacts violently with air or oxygen, proved to be a reasonable nucleophile adding readily to 
ethyl oxalate, producing the tertiary alcohol.5 Nevertheless, drawn back by its difficult and 
dangerous handling, these reagents attracted only little attention. 
 
Scheme 1. A. Structures of cacodyl ((Me2As)2), cacodyl oxide (Me2AsOAsMe2) and potassium 
trichloro(ethene)platinate(II); B. Frankland’s preparation of diethylzinc and its addition to ethyl 
oxalate.2,3,4,5 
                                                          
1  M. H. Crabtree, The Organometallic Chemistry of the Transition Metals (5th ed.), John Wiley and Sons, New 
York, 2009. 
2  a) D. Seyferth, Organometallics 2001, 20, 1488–1498; b) L. C. Cadet de Gassicourt, “Suite d’Experiences 
nouvelles sur l’Encre sympathique de M. Hellot qui peuvent servir a` l’analyse du Cobolt; et Histoire d′une 
liqueur fumante, tire de l’Arsenic” Memoires de Mathematique et de Physique. Presentes a` l’Academie 
Royale des Sciences par diverse Savans et lus dans ses Assembles. Tome Troisieme, MDCCLX, 1760. These 
results were communicated to the Royal Academy of Sciences in 1757, reported on favorably by two 
academicians, Bourdelin and Lassone, in January 1758, and finally published in 1760. 
3  W. C. Zeise, Ann. Phys. (Berl.) 1831, 97, 497–541. 
4  E. Frankland, Justus Liebigs Ann. Chem. 1849, 71, 171–213. 
5  E. Frankland, Justus Liebigs Ann. Chem. 1863, 126, 109–113. 
A. Introduction 
3 
A substantial milestone was set by Grignard at the beginning of the 20th century with the 
preparation of methylmagnesium chloride as the first stabilized organomagnesium reagent.6 He 
established the use of coordinative solvents, such as diethyl ether, which break through 
coordination the highly aggregated organometallic clusters and lead to more reactive but stable 
monomeric organometallic species.7 These Grignard reagents showed excellent behaviour in 
addition reactions to aldehydes, ketones and carbon dioxide, leading to secondary alcohols, 
tertiary alcohols and carboxylic acids, respectively (Scheme 2).8 The reactions smoothly 
proceeded at room temperature and under atmospheric pressure. This provided the first rapid 
and highly versatile method for the synthesis of numerous organic compounds of different 
types, using organometallic reagents. 
 
Scheme 2. Preparation of MeMgI and addition to a ketone, leading to the corresponding tertiary 
alcohol.9 
In the following years, the synthesis of such reagents has been further investigated and 
optimized.10 This resulted in a wide range of main-group or transition metal based 
organometallics, which have been successfully applied as nucleophiles in various organic 
syntheses.8 Based on these discoveries it was found, that the reactivity of organometallic 
reagents can be fine-tuned by the choice of the metal. Reagents with a strongly polarized 
carbon-metal bond (high ionic character), like carbon-lithium and carbon-magnesium bonds 
are closely connected to a high reactivity towards electrophiles accompanied by low chemical 
selectivity and often lowered stability. However, reagents with more covalent carbon-metal 
bonds, such as carbon-copper or carbon-boron bonds show a reversed behaviour. In general, 
the reactivity of an organometallic species depends on the character of the carbon-metal bond: 
the more ionic, the more reactive. Thus, the lower the electronegativity of the metal the more 
reactive is the corresponding organometallic (Figure 1).8 
                                                          
6  V. Grignard, C. R. Acad. Sci. 1900, 130, 1322–1324. 
7  F. W. Walker, E. C. Ashby, J. Am. Chem. Soc. 1969, 91, 3845–3850. 
8  a) H. G. Richey, Grignard reagents: new developments, Wiley, 2000; b) G. S. Silverman, P. E. Rakita, 
Handbook of Grignard Reagents, Taylor & Francis, 1996; c) B. J. Wakefield, Organomagnesium Methods in 
Organic Chemistry, Elsevier Science, 1995. 
9  P. Barbier, Compt. Rend. 1899, 128, 110–112. 
10  P. Knochel, Handbook of Functionalized Organometallics, Vol. 1 and 2, Wiley-VCH, Weinheim, 2005. 
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Figure 1. Electronegativity difference of selected metals relative to carbon (Pauling electronegativity 
scale).11 
In modern synthetic organic chemistry, organometallics play an important role in numerous 
methodologies and the synthesis of complex molecules. Their well tuneable reactivity and 
selectivity as well as their broad and ready availability made them an indispensable tool for the 
preparation of pharmaceutical and agrochemical molecules.12 
One outstanding class of organometallics, despite not yet fully included in industrial 
applications, are organozinc reagents. Their history, preparation, and their potential in organic 
synthesis will be discussed in the following. 
  
                                                          
11  A. Boudier, L. O. Bromm, M. Lotz, P. Knochel, Angew. Chem. Int. Ed. 2009, 39, 4414–4435. 
12  K. C. Nicolaou, J. S. Chen, in Classics in Total Synthesis III, Wiley-VCH Verlag GmbH, 2011. 
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2. Organozinc Chemistry 
2.1 Overview 
Organozinc reagents play an important role in modern organic chemistry and have proved to 
be valuable synthetic tools in carbon-carbon bond formation reactions. Their chemistry dates 
back to 1849, when Frankland discovered diethylzinc as the first organozinc reagent 
(Scheme 1B).4 Although their potential as nucleophiles using the polarized carbon-metal bond 
was quickly recognized, Grignard’s discovery of the organomagnesium species in 1900 was 
dedicated most attention at that time.8 Nevertheless, a few important reactions using organozinc 
chemistry, such as the Reformatsky reaction13 (Scheme 3A) or the Simmons-Smith14 
cyclopropanation (Scheme 3B), have been developed in the meanwhile. 
 
Scheme 3. A. Reformatsky reaction – zinc insertion into carbon-iodine bond of α-iodo ethyl acetate, 
providing, after addition to acetone, the corresponding tertiary alcohol.13 B. Simmons-Smith 
cyclopropanation using diiodomethane and elementary zinc (activated with copper or sonication).14 
It was only after several decades that the full potential of organozinc reagents was discovered.10 
Compared to other organometallics, organozinc reagents have a very high compatibility with a 
large number of sensitive functional groups. Unfortunately, this results in a low reactivity 
towards electrophiles, which makes a broad synthetic application difficult. However, the 
presence of empty p-orbitals of suitable energy allows fast and smooth transmetalations to 
many other transition metals, such as copper. 
  
                                                          
13  S. Reformatsky, Ber. Dtsch. Chem. Ges. 1887, 20, 1210–1211. 
14  H. E. Simmons, R. D. Smith, J. Am. Chem. Soc. 1958, 80, 5323–5324. 
A. Introduction 
6 
 
Scheme 4. Preparation of BuZnI via oxidative insertion of activated zinc into the carbon-iodine bond, 
transmetalation with CuCN·2LiCl and subsequent acylation using benzoyl chloride.15 
In the case of a transmetalation with CuCN·2LiCl, the resulting reagents are 
thermodynamically more stable (more covalent carbon-copper bond). However, they are also 
more reactive due to the presence of nucleophilic, non-binding d-electrons, which interact with 
the electrophile in an oxidative process and mediate the formation of the new carbon-carbon 
bonds, such as an acylation (Scheme 4).10 This extraordinary ability of committing 
transmetalation gained new importance when the power of palladium-catalyzed cross-coupling 
reactions was recognized in the 1960s due to the findings of Heck.16 With the help of palladium 
complexes, an efficient way of forming C-C bonds between less reactive organic aryl halides 
and various carbon nucleophiles was found. By now, these palladium-catalyzed cross-coupling 
reactions (especially using organozinc and organoboron reagents) have become powerful and 
indispensable tools in organic synthesis (Scheme 5).17 This rewarded Richard F. Heck, Ei-ichi 
Negishi and Akira Suzuki with the Nobel Prize in Chemistry in 2010 for their work on this new 
type of C-C bond formation. 
 
Scheme 5. Selected example of a Negishi cross coupling reaction.18 
  
                                                          
15  P. Knochel, M. C. P. Yeh, S. C. Berk, J. Talbert, J. Org. Chem. 1988, 53, 2392–2394. 
16  K. F. Heck, J. P. Nolley, J. Org. Chem. 1972 87, 2320–2322. 
17  K. C. Nicolaou, P. G. Bulger, D. Sarlah, Angew. Chem. Int. Ed. 2005, 44, 4442–4489; b) J. Zhou, G. C. Fu, J. 
Am. Chem. Soc. 2003, 125, 12527–12530; c) N. Miyaura, A. Suzuki, Chem. Rev.1995, 95, 2457–2483. 
18  E.-i. Negishi, A. O. King, N. Okukado J. Org. Chem. 1977, 42, 1821–1823. 
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2.2 Preparation of Organozinc Compounds 
The choice of method for the preparation of an organozinc reagent depends on the nature of 
the starting substrate. However, the most common approaches utilize organic halides, but also 
direct C-H activation or transmetalation from other organometallics are possible. The method 
of preparation can also depend on the presence of certain functional groups. 
 
2.2.1 Oxidative Insertion 
The most common approach for the direct synthesis of organozinc reagents is the insertion of 
zinc powder into organic halides. In many cases, however, expensive organic iodides must be 
used and elevated reaction temperatures are required.1,19 To overcome these disadvantages, 
Rieke and co-workers developed a procedure to activate metal atoms by reduction of the 
corresponding metal salt with lithium naphthalide. Thus, functionalized organozinc reagents 
from less reactive aryl or alkyl bromides can be obtained, using this highly active zinc (Zn*) 
produced by reduction of ZnCl2 (Scheme 6).
20 Therefore, starting from ethyl 4-bromobutyrate, 
the corresponding organozinc bromide was obtained using Rieke zinc. A subsequent 
palladium-catalyzed cross-coupling with 1-bromo-4-nitrobenzene, led to the desired ethyl 4-
(4-nitrophenyl)butanoate in 90% yield over two steps. 
 
Scheme 6. Oxidative zinc insertion into a carbon-halide bond using highly activated Rieke zinc, and 
subsequent palladium-catalyzed cross-coupling.20a 
This method of activation, however, produces a lot of sideproducts and proved to be 
inconvenient to use. Knochel and co-workers were able to utilize commercially available zinc 
powder as suitable reagent for the insertion into highly functionalized halides under mild 
                                                          
19  P. Knochel, N. Millot, A. L. Rodriguez, in Organic Reactions 58, Wiley–VCH: Weinheim, Germany, 2004, 
417–759 c) P. Knochel, R. D. Singer, Chem. Rev. 1993, 93, 2117–2188. 
20  a) L. Zhu, R. M. Wehmeyer, R. D. Rieke, J. Org. Chem. 1991, 56, 1445–1453; b) R. D. Rieke, Science 1989, 
246, 1260–1264; c) T. P. Burns, R. D. Rieke, J. Org. Chem. 1983, 48, 4141–4143. 
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conditions in the presence of LiCl (Scheme 7).21 This enabled the preparation of aromatic, 
heteroaromatic, alkylic and benzylic zinc reagents in the presence of a variety of functional 
groups such as esters, nitriles and aldehydes. Based on experimental, computational and 
analytical studies, the origin of this behaviour was revealed.22 First, LiCl increases the 
solubility of the organometallic reagent in THF solution, which enables the regeneration of a 
free metal surface during the insertion reaction.22 Thus, the heteroaromatic bromide was 
converted into the corresponding organozinc compound and subsequently exposed into a 
palladium-catalyzed cross-coupling to form the arylated product. 21a 
 
Scheme 7. Zinc insertion in the presence of LiCl, and subsequent palladium-catalyzed cross-
coupling.21a 
 
2.2.2 Halogen-Zinc Exchange 
Starting from organic halides, an alternative approach to access organozinc reagents is the 
exchange reaction with another organozinc reagent. The halogen-metal exchange represents 
one of the most efficient methods for the preparation of functionalized organometallics. The 
reaction of an organic halide R1–X with an organometallic R2–Met produce a halogenate 
complex (R1R2X− Met+).23 Subsequent decomposition forms the most stable organometallic 
species, meaning it has the carbon skeleton with the lowest electron density and/or the highest 
ability to stabilize the excess negative charge (Scheme 8A). Therefore, the exchange reagent 
(R2–Met) must be less stable than the organometallic species formed (R1–Met). The speed of 
the halogen-zinc exchange can be catalyzed by the addition of a carboxylate such as Li(acac)24 
                                                          
21  a) A. Metzger, M. A. Schade, P. Knochel, Org. Lett. 2008, 10, 1107–1110; b) N. Boudet, S. Sase, P. Sinha, 
C.-Y. Liu, A. Krasovskiy, P. Knochel, J. Am. Chem. Soc. 2007, 129, 12358–12359; c) A. Krasovskiy, V. 
Malakhov, A. Gavryushin, P. Knochel, Angew. Chem. Int. Ed. 2006, 45, 6040–6044. 
22  a) J. E. Fleckenstein, K. Koszinowski, Organometallics 2011, 30, 5018–5026; b) C.-Y. Liu, X. Wang, T. 
Furuyama, S. Yasuike, A. Muranaka, K. Morokuma, M. Uchiyama, Chem. Eur. J. 2010, 16, 1780–1784; c) K. 
Koszinowski, P. Böhrer, Organometallics 2009, 28, 771–779; d) C. Feng, D. W. Cunningham, Q. T. Easter, 
S. A. Blum, J. Am. Chem. Soc. 2016, 138, 11156–; e) 11159A. Krasovskiy, B. F. Straub, P. Knochel, Angew. 
Chem. Int. Ed. 2006, 45, 159–162. 
23  H. J. Reich, A. W. Sanders, A. T. Fiedler, M. J. Bevan, J. Am. Chem. Soc. 2002, 124, 13386–13387. 
24  F. F. Kneisel, M. Dochnahl, P. Knochel, Angew. Chem. Int. Ed 2004, 43, 1017–1021. 
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or a lithium alcoholate25. Thus, the treatment of 4-formyl-2-iodo-6-methoxyphenyl acetate with 
iPr2Zn in NMP, accelerated by the addition of Li(acac) (10 mol%), led to the corresponding 
diarylzinc species. After acylation in the presence of tfp26 (5 mol%) and Pd(dba)2 (2.5 mol%), 
2-(cyclohexanecarbonyl)-4-formyl-6-methoxyphenyl acetate is obtained in 75% yield 
(Scheme 8B).24 
 
Scheme 8. A. General equation for the halogen-metal exchange; B. Li(acac)-catalyzed I/Zn-exchange 
for the preparation of polyfunctional diarylzinc species.24 
The use of stronger electron donors, such as an alcoholate, allows for the performance of a 
Br/Zn exchange under mild conditions. Thus, treatment of 2-((2-
(dimethylamino)ethyl)(methyl)amino)ethan-1-ol with Et2Zn and sBuLi produces the 
dialkylzinc lithium alkoxide complex [sBu2Zn(OR)2]
2−·2Li+ in toluene.25 Subsequent treatment 
of 5-bromo-2-chlorobenzonitrile with this diorganozinc complex (0.8 equiv) in toluene at 
25 °C produces the corresponding diaryl zinc species within 1 h, which after allylation yields 
the desired product in 79% yield (Scheme 9).25 
 
Scheme 9. Br/Zn exchange using the highly reactive alkoxide exchange reagent [sBu2Zn(OR)2]2Li, 
leading to the corresponding diorganozinc species.25 
 
                                                          
25  M. Balkenhohl, D. S. Ziegler, A. Desaintjean, L. J. Bole, A. R. Kennedy, E. Hevia, P. Knochel, Angew. Chem. 
Int. Ed. 2019, 58, 12898–12902. 
26  V. Farina, B. Krishnan, J. Am. Chem. Soc. 1991, 113, 9585–9595. 
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2.2.3 Directed Metalation 
Another approach to access functionalized organometallics is the directed metalation with 
metal bases. Therein, thermodynamic and kinetic parameters have a strong influence on the 
speed of metalation as well as on the regioselectivity. The base selected for directional 
metalation (R2–Met or R22N–Met) must be stronger than the produced metalated species R1–
Met.10 Traditionally, strong bases such as alkyllithium reagents and lithium amides (R2NLi; 
e.g. LDA) are widely used for this purpose. However, due to their high reactivity and low 
tolerance to functional groups, organolithium reagents often suffer from undesired side 
reactions. Another serious disadvantage is their low stability in THF at ambient temperature, 
requiring often low temperatures of −78 to −100 °C.27 A significant improvement, in this 
respect, was the development of the highly active mixed Mg/Li bases of the type 
R22NMgCl·LiCl, reported by Knochel and co-workers.
28 TMP based magnesium bases, such 
as TMPMgCl·LiCl, have been extensively used for the metalation of various substrates.29 To 
elaborate TMP bases, that exhibit a higher tolerance towards functional groups, Knochel and 
co-workers developed the highly chemoselective TMP-derived bases TMPZnCl·MgCl2·LiCl
30 
TMP2Zn·2MgCl2·2LiCl
31, TMPZnCl·LiCl32 and TMP2Zn·2LiCl
30 for the metalation of 
sensitive aromatics and heterocycles under mild conditions (Scheme 10). 
 
Scheme 10. Preparation of different TMP-zinc bases, starting from TMPMgCl·LiCl or TMPLi.30,31,32 
                                                          
27  a) J. Skotnitzki, A. Kremsmair, P. Knochel, Synthesis 2020, 52, 189–196; b) G. Wu, M. Huang, Chem. Rev. 
2006, 106, 2596–2616; c) R. G. Jones, H. Gilman, Organic Reactions 2004, 6, 339–366. 
28  a) T. Kunz, P. Knochel, Angew. Chem. Int. Ed. 2012, 51, 1958–1961; b) A. Krasovskiy, V. Krasovskaya, P. 
Knochel, Angew. Chem. Int. Ed. 2006, 45, 2958–2961. 
29  a) T. Klatt, J. T. Markiewicz, C. Sämann, P. Knochel, J. Org. Chem. 2014, 79, 4253–4269; b) B. Haag, M. 
Mosrin, H. Ila, V. Malakhov, P. Knochel, Angew. Chem. Int. Ed. 2011, 50, 9794–9824. 
30  K. Schwärzer, C. P. Tüllmann, S. Graßl, B. Górski, C. E. Brocklehurst, P. Knochel, Org. Lett. 2020, DOI: 
10.1021/acs.orglett.0c00238. 
31  M. Mosrin, P. Knochel, Org. Lett. 2009, 11, 1837–1840. 
32  S. Wunderlich, P. Knochel, Angew. Chem. Int. Ed. 2007, 46, 7685–7688. 
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Thus, 2-nitrobenzofuran is readily metalated using TMP2Zn·2MgCl2·2LiCl, providing after 
copper-catalyzed allylation the functionalized heteroarene in 80% yield (Scheme 11).32 Also, 
caffeine and 1,3,4-oxadiazole are smoothly functionalized using TMPZnCl·LiCl and 
TMP2Zn·2LiCl, respectively, to afford after allylation or palladium-catalyzed cross-coupling 
the corresponding heteroarenes in 69–98% yield.30,31 
 
Scheme 11. Metalation of various heteroarenes using TMP-zinc bases.30,31,32 
 
2.2.4 Transmetalation 
Transmetalation reactions are key transformations in synthetic organic chemistry, as they allow 
the reactivity of organometallic reagents to be adjusted to the electrophile and avoid side 
reactions. The most common method of transmetalation is the treatment of an organometallic 
R1–Met1 with a metal salt Met2–Xn, providing a new organometallic species R1–Met2. As 
mentioned for the directed metalation and the halogen/metal exchange, the driving force is the 
formation of the stronger carbon-metal bond, possessing the more covalent character. 
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Therefore, it is crucial for the process of transmetalation, that the C–Met2 bond is energetically 
more favourable than the C–Met1 bond. Since organozinc reagents are very stable, possesing a 
highly covalent C–Met bond, the transformation starting from various reactive 
organometallics, such as organolithium or organomagnesium reagents, is possible.10 Therefore, 
most organomagnesium species can be transmetalated to the corresponding organozinc reagent 
by treatment with a suitable zinc-salt. To maintain the key advantage of organozincs, namely 
its functional group tolerance, Knochel and co-workers developed an oxidative magnesium 
insertion into aryl-halide bonds in the presence of ZnCl2.
33 Using this method, various 
functional groups like esters or nitriles can be tolerated in this magnesium insertion, since the 
transmetalation proceeds faster than a possible attack of the formed organomagnesium reagent. 
The oxidative insertion of magnesium proceeds faster than the insertion of zinc. This allows to 
use rather unreactive halides with would not undergo a zinc insertion and thus drastically 
enlargens the scope of organozinc reagents. Thus, ethyl 4-chloro-2,6-dimethoxypyrimidine-5-
carboxylate and 3-(chloromethyl)benzonitrile are smoothly converted to their organozinc 
species, allowing further functionalizations to give the corresponding functionalized 
compounds (Scheme 12).33 
 
Scheme. 12. Preparation and subsequent trapping of organozinc reagents via oxidative magnesium 
insertion in the presence of ZnCl2.33  
                                                          
33  F. M. Piller, A. Metzger, M. A. Schade, B. A. Haag, A. Gavryushin, P. Knochel, Chem. Eur. J. 2009, 15, 
7192–7202. 
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3. C-N Bond Forming reactions using Organometallic Reagents 
3.1 Overview 
The elaboration of carbon-heteroatom bonds is of one of the most important challenges in 
synthetic organic chemistry. Therein, the formation of carbon-nitrogen bonds is especially 
worth mentioning, since over 80% among the FDA approved pharmaceuticals contain at least 
one nitrogen atom.34 Typically, such C-N bonds are formed by a nucleophilic attack (SN-attack) 
of a nitrogen35 on an electrophilic carbon (Scheme 13A) or via reductive amination36 (Scheme 
13B). These methods have found broad application in various organic synthetic processes, 
however, entail undesireable limitations, such as restricted tolerance towards functional groups 
or unselectivtity (e.g. overalkylation). Thus, over the last decades, various new methods to 
furnish carbon-nitrogen bonds have been developed. A few selected examples will be discussed 
in the following. 
 
Scheme 13. A. General amination through a SN-attack of an amine; B. General reductive amination 
procedure, using an aldehyde and a reducing agent, such as NaBH4.35,36 
  
                                                          
34  E. Vitaku, D. T. Smith, J. T. Njardarson, J. Med. Chem. 2014, 57, 10257–10274. 
35  J. March “Advanced organic chemistry: reactions, mechanisms, and structure” John Wiley & Sons, Weinheim, 
1992. 
36  E. W. Baxter, A. B. Reitz, "Reductive aminations of carbonyl compounds with borohydride and borane 
reducing agents" Organic reactions 2004, 59, 1–714. 
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3.2 Nucleophilic Aminations Using Transition Metal Catalyst 
After the discovery of palladium-catalyzed carbon-carbon cross-coupling reactions in the 
1960s, the potential of these transformations for bond forming reactions in general has been 
revealed. Nowadays, one of the most common methods for the construction of carbon-nitrogen 
bonds is the transition metal catalyzed nucleophilic amination.37 Most frequently palladium 
complexes are used for these transformation, as developed by Buchwald and Hartwig in 1994.38 
Although these haven’t been the first examples of palladium-catalyzed C-N bond forming 
reactions,39 the tremendous scope and utility of the Buchwald-Hartwig amination protocol led 
to the development of various optimized procedures and it has become one of the most 
powerful tools to construct carbon-nitrogen bonds. It combines the usage of easily available 
starting materials (amines and halides or pseudohalides) with an excellent orthogonality 
towards functional groups. This enabled applications in numerous syntheses of biologically 
active molecules.37 One examples is the synthesis of the carbazole alkaloide dictyodendrine B, 
reported by Jia and co-workers.40 Therein, the key-step to furnish the carbazole scaffold is 
achieved using a Buchwald-Hartwig type cross-coupling. Thus, the 5-bromoindole is aminated 
using a 2-chloro aniline derivative in the presence of a palladium-catalyst, providing after a 
subsequent oxidative ring closure the desired carbazole derivative in 71% yield (Scheme 14). 
 
Scheme 14. Application of nucleophilic palladium-catalyzed amination in the synthesis of 
dictyodendrine B.40  
                                                          
37  P. Ruiz-Castillio, S. L. Buchwald, Chem. Rev. 2016, 116, 12564–12649. 
38  a) F. Paul, J. Patt; J. F. Hartwig, J. Am. Chem. Soc. 1994, 116, 5969–5970; b) A. S. Guram, S. L. Buchwald J. 
Am. Chem. Soc. 1994, 116, 7901–7902. 
39  a) J. P. Genêt, M. Balabane, J. Bäckvall, J. E. Nyström, Tetrahedron Lett. 1983, 24, 2745–2748; b) J.-E. 
Báckvall, R. E. Nordberg, J.-E. Nyström, J. Org. Chem. 1981, 46, 3479–3483. 
40  J. Liang, W. Hu, P. Tao, Y. Jia, J. Org. Chem. 2013, 78, 5810–8515. 
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3.3 Electrophilic Aminations 
These methods proved to be succesful in most cases, therefore representing an extremely 
valuable tool for synthetic chemistry. Nevertheless, all procedures mentioned so far, are based 
on a nucleophilic nitrogen source. Given the high electronegativity of nitrogen such a 
behaviour appears to be obvious, though limits the scope of all these reactions, since many 
amines have only limited nucleophilic character. This could either originate from aromatic 
residues, which delocalize the electron density of the nitrogen into the ring-system, or simply 
from sterical hinderance. These difficulties may be overcome with the aid of an “umpolung 
strategy”, utilizing an electrophilic nitrogen source of type [NR2]+. There are different 
approaches to change the electronic character of a nitrogen atom, of which the usage of 
nitrenoid intermediates for C-N bond forming reactions is rather less explored.41 The following 
chapter will focus on various examples of transition-metal catalyzed reactions using an 
electrophilic nitrogen source containing a weak N-X bond (X is an equally or more 
electronegative atom than nitrogen) and an organometallic species. 
 
3.3.1 Early Examples 
The first example of a transition metal catalyzed electrophilic amination of an organometallic 
species was reported by Narasaka in 1997.42 O-Methylsulfonyloximes were utilized as 
electrophilic nitrogen source, which after treatment with an alkyl Grignard reagent in the 
presence of a copper-catalyst reacted to the corresponding substituted imine. After hydrolysis 
and benzoylation the desired amide was obtained in 96% yield (Scheme 15). This method was 
succesful for primary as well as for secondary and tertiary magnesium reagents. The presence 
of the copper catalyst proved to be essential for this transformation, as without this transition 
metal, no product formation was observed. 
 
Scheme 15. Electrophilic amination of alkyl Grignard reagents in the presence of a copper-catalyst, 
using O-methylsulfonyloximes.42  
                                                          
41  a) H. M. L. Davies, J. R. Manning, Nature 2008, 451, 417–424; b) P. Mueller, C. Fruit, Chem. Rev. 2003, 103, 
2905–2920; c) I. D. G. Watson, A. K. Yudin, Curr. Opin. Drug Discovery Dev. 2002, 5, 906–917.  
42  T. Hironori, Y. Hayashi, K. Narasaka, Chem. Lett. 1997, 26, 317–318. 
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3.3.2 Electrophilic Aminations Using N-Hydroxylamine Benzoates 
A frequently used electrophilic nitrogen source are N-hydroxylamine benzoates, which have 
been introduced by Johnson and co-workers.43 Similar to the oximes mentioned above, the 
electronegativity difference between nitrogen and oxygen leads to a positively polarized 
nitrogen atom. In addition to this electronic umpolung on the nitrogen atom, the N-O bond is 
rather weak and OCOPh an excellent leaving group. This combination enabled a smooth 
transformation with various diorganozinc reagents in the presence of a copper-catalyst. Thus, 
dipyridylzinc (0.6 equiv) is readily aminated using morpholino benzoate and [Cu(OTf)]2·C6H6 
(1.25 mol%) under mild conditions (25 °C, 1 h), providing the 4-(pyridin-2-yl)morpholine in 
71% yield (Scheme 16).43 
 
Scheme 16. Copper-catalyzed electrophilic amination of diarylzincs using N-hydroxylamine 
benzoates.43 
The scope and the mechanism of this transformation was further investiagted in the following 
years.44 Due to the usage of a mild organozinc species, various functional groups, such as esters 
were tolerated. However, the limited scope of diorganozinc reagents as well as of 
polyfunctionalized hydroxylamine benzoates still represented major drawbacks. Later, this 
method was extended to secondary hydroxylamine benzoates and Grignard reagents (Scheme 
17).44,45 Interstingly, the attack of the Grignard reagent at the carbonyl position of the benzoate 
was easily suppressed by employing a slow addition of the metallic species.  
                                                          
43  a) A. M. Berman, J. S. Johnson, J. Org. Chem. 2005, 70, 364–366; b) A. M. Berman, J. S. Johnson, J. Am. 
Chem. Soc. 2004, 126, 5680–5681. 
44  M. Campbell, J. S. Johnson, Org. Lett. 2007, 9, 1521–1524. 
45  A. M. Berman, J. S. Johnson, J. Org. Chem. 2006, 71, 219–224. 
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Scheme 17. Electrophilic amination of Grignard reagents in the presence of a copper-catalyst.44 
To enhance the scope of suitable nucleophiles, Wang and co workers showed that using a 
slightly alterated procedure, highly functionalized aryl and heteroaryl diorganozinc reagents 
obtained from directed metalation with TMP2Zn can engage in electrophilic amination.
46 
Therefore, various heterocyclic scaffolds, such as caffeine or 1,3,4-oxadiazole have been 
metalated using the bis-base TMP2Zn (0.6 equiv, 25 °C) and subsequently aminated using 
morpholino benzoate in the presence of Cu(OAc)2 (10 mol%) affording the corresponding 
aminated products in 82–91% yield (Scheme 18).46 
 
Scheme 18. Metalation of caffeine and substituted 1,3,4-oxadiazole using TMP2Zn and subsequent 
electrophilic amination using morpholino benzoate.46  
                                                          
46 S. L. McDonald, C. E. Hendrick, Q. Wang, Angew. Chem. Int. Ed. 2014, 53, 4667–4670. 
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3.3.3 Electrophilic Aminations Using N-Chloroamines 
Another widely used source of electrophilic nitrogen are N-chloroamines. In the past, these 
rather labile substrates have been used to generate aminyl radicals, which then undergo for 
example cyclization reactions.47 These radical based reactions, however, lack of selectivity due 
to the high reactivity of the aminyl radicals. Nevertheless, the basic prerequisite for a transition 
metal-catalyzed electrophilic amination with an organometallic reagent is given. Although the 
electronegativity of chlorine and nitrogen is almost identical, the slight polarization engaged 
with the weak N-Cl bond and chloride as a good leaving group, provides a highly suitable 
precursor. Lei and co-workers showed the utility of N-chloroamines in the copper-catalyzed 
coupling with boronic acids.48 A wide range of arylboronic acids was successfully amidated 
with acetylated aniline derivatives, providing the corresponding teriary amides in high yields 
(Scheme 19). Suprisingly, a radical mechanism was ruled out by experimental studies. The 
proposed mechanism is based on an oxidative insertion into the N-Cl bond followed by 
transmetalation with the boronic acid. 
 
Scheme 19. Amidation of boronic acids using N-chloroamines in the presence of a copper-catalyst.48 
This method, however, was limited to acetylated substrates, therefore leading to amides only. 
Later, Jarvo and co-workers extended this method and developed a nickel-catalyzed 
cross-coupling between N-chloroamines and diphenylzinc.49 Thus, the diarylzinc species 
(2.0 equiv) was readily aminated in the presence of Ni(cod)2 (5.0 mol%) and bipyridine 
(10 mol%) using N-chloro dibutylamine, leading to the corresponding tertiary amine in 60% 
yield (Scheme 20). Remarkably, electron-donating as well as electron-withdrawing 
substituents were tolerated. This method was further extended to a one-pot procedure, 
generating the N-chloroamine in-situ using NCS (1.1 equiv).  
                                                          
47  a) R. Göttlich, M. Noack, Tetrahedron Lett. 2001, 42, 7771–7774; b) L. Stella, Angew. Chem. Int. Ed. 1983, 
22, 337–350. 
48  C. He, C. Chen, J. Cheng, C. Liu, W. Liu, Q. Li, A. Lei, Angew. Chem. Int. Ed. 2008 , 47 , 6414–6417. 
49  T. J. Barker, E. R. Jarvo, J. Am. Chem. Soc. 2009, 131, 15598–15599. 
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Scheme 20. In-situ generation of N-chloroamines and subsequent electrophilic amination of 
diorganozinc reagents in the presence of a nickel-catalyst.49 
Another development of this protocol was reported by Gosmini and co-workers.50 They 
showed, that this transformation is also efficiently achieved using a cobalt-catalyst. 
Interstingly, the cobalt-catalyst was used prior to generate the organozinc species by a radical 
cobalt-catalyzed insertion,51 and then reused for the electrophilic amination reaction. Thus, 1-
bromo-3,5-bis(trifluoromethyl)benzene was smoothly converted into the corresponding 
organozinc reagent using this CoBr2-catalyzed insertion, and subsequently aminated with 3-
(benzylchloroamino)propanenitrile, leading to the desired tertiary amine in 61% yield 
(Scheme 21). 
 
Scheme 21. Cobalt-catalyzed zinc insertion into a carbon-bromine bond and subsequent amination with 
a N-chloramine, reusing the cobalt-catalyst.50  
                                                          
50  X. Qian, Z. Yu, A. Auffrant, C. Gosmini, Chem. Eur. J. 2013, 19, 6225–6229. 
51  a) H. Fillon, C. Gosmini, J. Perichon, J. Am. Chem. Soc. 2003, 125, 3867–3870; b) I. Kazmierski, C. Gosmini, 
J.-M. Paris, J. Perichon, Tetrahedron Lett. 2003, 44, 6417–6420. 
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3.3.4 Electrophilic Aminations Using other Nitrogen Sources 
The basic idea of utilizing a polarized, weak nitrogen-heteroatom bond for electrophilic 
aminations has been further developed by Kürti and co-workers. So far, no direct synthesis of 
primary amines using an electrophilic amination has been developed. The difficulty presented 
by this task, is to find a suitable aminating agent, which can transfer the electrophilic nitrogen, 
yet will not undergo deprotonation by the basic organometallic species. The approach to 
overcome this undesired sidereaction, was to utilize a sterically hindered nitrogen source.52 
Thus, bulky NH-oxaziridines represent excellent electrophilic nitrogen transfer reagents, which 
after ring-opening provide the desired primary amines in excellent yields (Scheme 22).53 
 
Scheme 22. Electrophilic amination of aryl and heteroaryl Grignard reagents using NH-oxaziridine, 
leading to primary aniline derivatives.53 
This reaction utilizes aryl and heteroaryl Grignard reagents and proceeds smoothly without the 
presence of a transition metal. Remarkably, strained oxaziridines could also be used to prepare 
phenoles derivatives under similar conditions. For unprotected NH-oxaziridines, exclusively 
the attack on the nitrogen atom was observed. However, when attaching a sterically hindered 
group, such as a benzyl moiety, the attack on the nitrogen is blocked and a selective 
oxygenation of the magnesium reagent was observed (Scheme 23).53 
                                                          
52  E. J. Corey, A. W. Gross, J. Org. Chem. 1985, 50, 5391–5393. 
53  a) H. Gao, Z. Zhou, D.-H. Kwon, J. Coombs, S. Jones, N. E. Behnke, D. H. Ess, L. Kürti, Nat. Chem. 2017, 
9, 681–688; b) Z. Zhou, Z. Ma, N. E. Behnke, H. Gao, L. Kürti, J. Am. Chem. Soc. 2017, 139, 115–118. 
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Scheme 23. Electrophilic oxygenation of arylmagnesium halides with N–benzyl oxaziridine.53  
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4. Objectives 
The importance of carbon-heteratom bond forming reactions has been displayed above. 
However, most literature known procedures utilize nucleophilic sources of e.g. nitrogen or 
sulphur. As shown in previous procedures, the usage of a N/S–X bond, where X equals an even 
more electrophilic atom, can lead to electrophilic sources of e.g. nitrogen or sulphur. These 
react with suitable nucleophile to the desired products. We envisioned, that organozinc halides 
of type 1 would be especially attractive nucleophiles, since these organometallics are 
compatible with the presence of various functional groups. This high tolerance towards 
functional groups correlates with a low reactivity of organozinc reagents. Therefore, we 
anticipated, that a transition metal catalyst will be required for achieving the desired 
transformations. 
Thus, we planned to elaborate the preparation of suitable electrophilic sources of nitrogen and 
sulphur, using a more electronegative leaving group. These will be tasked for their activity in 
transition metal-catalyzed reactions with various alkyl-, benzyl-, aryl- and hetereoarylzinc 
reagents 1, aiming for tertiary amines 2, secondary amines 3 or thioethers 4 (Scheme 24).  
 
Scheme 24. Envisioned new procedures to construct carbon-heteroatom bonds using organozinc 
reagents and electrophilic nitrogen and sulphur sources in the presence of a transition metal catalyst.  
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1. Cobalt-Catalyzed Electrophilic Amination of Aryl- and 
Heteroaryl-Zinc Pivalates with N-Hydroxylamine Benzoates 
1.1 Introduction 
Functionalized aromatic amines are widely found in pharmaceuticals, natural products, and 
agricultural chemicals.34,54 Thus, general aromatic C-N bond forming reactions are required. 
Over the past two decades, the development of palladium catalyzed Buchwald-Hartwig 
nucleophilic aminations38,55 allowed a facile synthesis of aryl amines. However, these reactions 
usually require expensive catalysts and ligands. Moreover, elevated temperatures and 
stoichiometric amounts of base are often necessary. In 2004, Johnson reported an alternative 
electrophilic amination using diarylzinc reagents and O-benzoylhydroxylamine derivatives 5 
to afford tertiary amines under mild conditions.43,44,45 This amination56 has been extended to 
organometallics derived from Mg,45 Zn,57 Al,58 B,59 Si60 and Cu61 using Cu or Ni as catalysts. 
Despite the impressive progress made, the use of air sensitive reagents, ligands or toxic Ni-
catalysts still represent drawbacks. Recently, we reported a new class of highly functionalized 
organozinc reagents with enhanced air- and moisture-stability.62 These reagents were used to 
                                                          
54  a) C. Lamberth, J. Dinges, Bioactive Heterocyclic Compound Classes: Agrochemicals; Wiley-VCH, 2012; b) 
T. J. Barker, E. R. Jarvo, Synthesis, 2011, 3954–3964; c) R. J. Lundgren, B. D. Peters, P. G. Alsabeh, M. 
Stradiotto, Angew. Chem. Int. Ed. 2010, 49, 4071–4074; d) R. Hili, A. K. Yudin, Nat. Chem. Biol. 2006, 2, 
284–287; e) S. A. Lawrence, Amines: Synthesis Properties and Applications, University Press, Cambridge, 
2004; f) K. Weissermel, H. J. Arpe, Industrial Organic Chemistry, Wiley-VCH, Weinheim, 1997. 
55  a) D. S. Surry, S. L. Buchwald, Chem. Sci. 2011, 2, 27–50; b) D. S. Surry, S. L. Buchwald, Angew. Chem. Int. 
Ed. 2008, 47, 6338–6361. 
56  a) C. E. Hendrick, Q. Wang, J. Org. Chem. 2017, 82, 839–847; b) J. J. Farndon, X. Ma, J. F. Bower, J. Am. 
Chem. Soc. 2017, 139, 14005–14008; c) M. Corpet, C. Gosmini, Synthesis, 2014, 46, 2258–2271; d) I. P. 
Beletskaya, A. V. Cheprakov, Organometallics 2012, 31, 7753–7808. 
57  a) C. E. Hendrick, K. J. Bitting, S. Cho, Q. Wang, J. Am. Chem. Soc. 2017, 139, 11622–11628; b) S. L. 
McDonald, Q. Wang, Chem. Commun. 2014, 50, 2535–2538. 
58  S. Zhou, Z. Yang, X. Chen, Y. Li, L. Zhang, H. Fang, W. Wang, X. Zhu, S. Wang, J. Org. Chem. 2015, 80, 
6323–6328. 
59  a) R. P. Rucker, A. M. Whittaker, H. Dang, G. Lalic, Angew. Chem. Int. Ed. 2012, 51, 3953–3956; b) N. 
Matsuda, K. Hirano, T. Satoh, M. Miura, Angew. Chem. Int. Ed. 2012, 51, 3642–3645; c) Q. Xiao, L. Tian, R. 
Tan, Y. Xia, D. Qiu, Y. Zhang, J. Wang, Org. Lett. 2012, 14, 4230–4233; d) C. He, C. Chen, J. Cheng, C. Liu, 
W. Liu, Q. Li, A. Lei, Angew. Chem. Int. Ed. 2008, 47, 6414–6417; e) Z. Zhang, Y. Yu, L. S. Liebeskind, Org. 
Lett. 2008, 10, 3005–3008. 
60  a) Y. Miki, K. Hirano, T. Satoh, M. Miura, Org. Lett. 2013, 15, 172–175; b) M. H. Nguyen, A. B. Smith, III 
Org. Lett. 2013, 15, 4872–4875. 
61  a) N. Tezuka, K. Shimojo, K. Hirano, S. Komagawa, K. Yoshida, C. Wang, K. Miyamoto, T. Saito, R. Takita, 
M. Uchiyama, J. Am. Chem. Soc. 2016, 138, 9166–9171; b) M. T. Pirnot, Y.-M. Wang, S. L. Buchwald, 
Angew. Chem. Int. Ed. 2016, 55, 48–57. 
62  a) M. Ellwart, P. Knochel, Angew. Chem. Int. Ed. 2015, 54, 10662–10665; b) S. M. Manolikakes, M. Ellwart, 
C. I. Stathakis, P. Knochel, Chem. Eur. J. 2014, 20, 12289–12297; c) J. R. Colombe, S. Bernhardt, C. Stathakis, 
S. L. Buchwald, P. Knochel, Org. Lett. 2013, 15, 5754–5757; d) C. I. Stathakis, S. M. Manolikakes, P. 
Knochel, Org. Lett. 2013, 15, 1302–1305; e) C. I. Stathakis, S. Bernhardt, V. Quint, P. Knochel, Angew. Chem. 
Int. Ed. 2012, 51, 9428–9432; f) S. Bernhardt, G. Manolikakes, T. Kunz, P. Knochel, Angew. Chem. Int. Ed. 
2011, 50, 9205–9209. 
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improve the efficiency of cobalt-catalyzed Negishi cross-coupling63 and were useful for 
biological active molecule syntheses64 and high-throughput screenings65. Thus, we deveoped a 
cobalt-catalyzed electrophilic amination of organozinc pivalates with 
O-benzoylhydroxylamines. The reaction scope is especially broad, allowing the preparation of 
tertiary diarylalkylamines not available by copper- or nickel-catalyzed aminations. Also, the 
utility of this amination method was demonstrated by the synthesis of a potent clinical 
candidate for the treatment of tuberculosis.66 
 
1.2 Reaction Optimization 
Preliminary studies showed that phenylzinc pivalate (1a) is aminated with 
benzoylhydroxylmorpholine (5a) in the presence of various catalysts at room temperature 
(Table 1). ArZnCl·Mg(OPiv)2·LiCl is abbreviated as ArZnOPiv for the sake of clarity.
67 When 
using iron(II) or copper(I) catalysts, the main product is the corresponding homodimer (e.g. 
biphenyl, Table 1, entries 1–3). Better results are obtained with Ni(II)-catalysts (entries 4–5). 
Interestingly, THF soluble CoCl2·2LiCl proved to be the most effective catalyst and afforded 
N-phenylmorpholine (2a) in 93% isolated yield (entry 7). In this study, we also found that 
considerably more homodimer was generated using phenylzinc chloride compared to 
phenylzinc pivalate.68 Further optimizations showed that 2.5% CoCl2·2LiCl as well as 
1.1 equiv of PhZnOPiv were sufficient to achieve a complete conversion. 
  
                                                          
63  a) J. M. Hammann, F. H. Lutter, D. Haas, P. Knochel, Angew. Chem. Int. Ed. 2017, 56, 1082–1086; b) G. 
Cahiez, A. Moyeux, Chem. Rev. 2010, 110, 1435–1462. 
64  a) Y.-H. Chen, M. Ellwart, G. Toupalas, Y. Ebe, P. Knochel, Angew. Chem. Int. Ed. 2017, 56, 4612–4616; b) 
Y.-H. Chen, C. P. Tüllmann, M. Ellwart, P. Knochel, Angew. Chem. Int. Ed. 2017, 56, 9236–9239. 
65  T. J. Greshock, K. P. Moore, R. T. McClain, A. Bellomo, C. K. Chung, S. D. Dreher, P. S. Kutchukian, Z. 
Peng, I. W. Davies, P. Vachal, M. Ellwart, S. M. Manolikakes, P. Knochel, P. G. Nantermet, Angew. Chem. 
Int. Ed. 2016, 55, 13714–13718. 
66  K. Pethe, P. Bifani, J. Jang, S. Kang, S. Park, S. Ahn, J. Jiricek, J. Jung, H. K. Jeon, J. Cechetto, T. Christophe, 
H. Lee, M. Kempf, M. Jackson, A. J. Lenaerts, H. Pham, V. Jones, M. J. Seo, Y. M. Kim, M. Seo, J. J. Seo, 
D. Park, Y. Ko, I. Choi, R. Kim, S. Y. Kim, S. Lim, S.-A. Yim, J. Nam, H. Kang, H. Kwon, C.-T. Oh, Y. Cho, 
Y. Jang, J. Kim, A. Chua, B. H. Tan, M. B. Nanjundappa, S. P. S. Rao, W. S. Barnes, R. Wintjens, J. R. 
Walker, S. Alonso, S. Lee, J. Kim, S. Oh, T. Oh, U. Nehrbass, S.-J. Han, Z. No, J. Lee, P. Brodin, S.-N. Cho, 
K. Nam, J. Kim, Nat. Med. 2013, 19, 1157–1160. 
67  A. Hernán-Gómez, E. Herd, E. Hevia, A. R. Kennedy, P. Knochel, K. Koszinowski, S. M. Manolikakes, R. E. 
Mulvey, C. Schnegelsberg, Angew. Chem. Int. Ed. 2014, 53, 2706–2710. 
68  For a detailed investigation, see experimental section. 
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Table 1: Catalyst screening for the electrophilic amination. 
 
Entry Catalyst Yield (%)[a] 
1 Fe(acac)2 31 
2 CuI 36 
3 Cu(OTf)2 40 
4 NiCl2 84 
5 NiCl2(PPh3)2 72 
6 Co(acac)2 61 
7 CoCl2·2LiCl 98 (93)[b] 
[a] GC yield using undecane as internal standard. [b] Isolated yield. 
1.3 Scope and Limitations 
Using O-benzoylhydroxylmorpholine (5a) as typical amination reagent, we have determinated 
the scope of the amination of organozinc pivalates (Table 2). We have noticed that both 
electron-rich, electron-poor or sterically hindered arylzinc pivalates 1b–1e are aminated with 
benzoylhydroxylmorpholine (5a) smoothly to afford the desired products 2b–2e in 81–97% 
yield (entries 1–4).  
Table 2: The scope of organozinc pivalates for electrophilic amination. 
 
Entry (Hetero)arylzinc pivalate Product[a] 
 
 
 
1 1b 2b: 93% 
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2 1c 2c: 97% 
 
  
3 1d 2d: 81%[b] 
 
 
 
4 1e 2e: 96% 
 
  
5 1f 2f: 95%[b] 
 
 
 
6 1g 2g: 84%[c] 
 
 
 
7 1h 2h: 91%[b] 
 
  
8 1i 2i: 80%[b] 
[a] Isolated yields of analytically pure products. [b] TMEDA (5 mol%) was added. [c] Reaction time = 12 h. 
This electrophilic amination was extended to heteroarylzinc pivalates bearing a pyridine, 
benzylthiophene, pyrimidine and indole ring. Thus, heteroarylzinc pivalates 1f–1i were 
aminated with 5a in 80–95% yield (entries 5–8). Surprisingly, we observed that organozinc 
pivalates which were prepared via directed metallation using TMPMgCl·LiCl28a or 
TMPZnCl·LiCl31, (TMP = 2,2,6,6-tetramethylpiperidyl) did not undergo the amination 
reaction. We assume that a strong coordination of TMP-base to the cobalt center deactivates 
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the catalyst.69 Interestingly, the addition of 5% TMEDA (tetramethylethylenediamine) avoids 
this deactivation. 
Encouraged by these results, we have extended the scope of this amination to various 
O-benzoylhydroxylamines 5b–5f affording trisubstituted aniline derivatives 2j–2n in 78–97% 
yield (Table 3, entries 1–5). Notably, the reaction is compatible with 
benzoylhydroxylpiperidone (5c) bearing a sensitive ketone function and acidic alpha-protons. 
The cleavage of the allyl group was realized under mild conditions, affording either the 
primary 6 or secondary aniline derivative 3a in 91–93% yield (entries 1 and 3).70 
Table 3: Amination of arylzinc pivalates with various O-benzoylhydroxylamines of type 2. 
 
Entry Organozinc pivalate 1 N-Hydroxylamine benzoate 5 Product 2[a] 
 
  
 
1 1j 5b 
2j: R = allyl; 81% 
 6: R = H; 91% 
 
  
 
2 1c 5c 2k: 81% 
 
 
 
 
3 1c 5d 
2l: R = allyl; 78% 
3a: R = H; 93% 
 
   
4 1e 5e 2m: 97% 
                                                          
69  see experimental section. 
70  a) V. Cadierno, S. E. García-Garrido, J. Gimeno, N. Nebra, Chem. Commun. 2005, 4086–4088; b) F. Garro-
Helion, A. Merzouk, F. Guibé, J. Org. Chem. 1993, 58, 6109–6113. 
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5 1e 5f 2n: 89% 
[a] Isolated yields of analytically pure products.  
In contrast to previous electrophilic aminations, the reaction between arylzinc and 
benzoylhydroxylaniline derivatives proceeds also well. Thus, the amination of arylzinc 
pivalates 1e and 1j–1m with O-benzoylhydroxylaniline71 5g led to the diarylamines 2o–2s 
under standard conditions in 61–89% yield (Table 4, entries 1–5). Also anisylzinc pivalate (1e) 
underwent amination with the O-benzoyl hydroxylanilines 5h–5i leading to diarylamines 2t–
2u in 68–78% yield (entries 6–7). 
Table 4: Amination of arylzinc pivalates 1 with various O-benzoylhydroxylanilines 5. 
 
Entry Organozinc pivalate of type 1 Electrophile 5 Product[a] 
 
   
1 1j 5g 2o: 89% 
 
 
  
2 1e 5g 2p: 79% 
 
 
  
3 1k 5g 2q: 84% 
                                                          
71  a) K. N. Hojczyk, P. Feng, C. Zhan, M. Y. Ngai, Angew. Chem. Int. Ed. 2014, 53, 14559–14563; b) D. A. 
Evans, H.-J. Song, K. R. Fandrick, Org. Let. 2006, 8, 3351–3354; c) S.-C. Hung, S. R. Thopate, F.-C. Chi, S.-
W. Chang, J.-C. Lee, C.-C. Wang, Y.-S. Wen, J. Am. Chem. Soc. 2001, 123, 3153–3154; d) A. F. Abdel-
Magid, K. G. Carson, B. D. Harris, C. A. Maryanoff, R. D. Shah, J. Org. Chem. 1996, 61, 3849–3862. 
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4 1l 5g 2r: 66% 
 
 
  
5 1m 5g 2s: 61%[b] 
 
 
  
6 1e 5h 2t: 78% 
 
   
7 1e 5i 2u: 68% 
[a] Isolated yields of analytically pure products. [b] 1m (2.0 equiv); THF:NMP = 3:1; 12 h reaction time. 
 
1.4 Synthesis of Q203 
The synthetic utility of this electrophilic amination for the preparation of medicinally valuable 
molecules was demonstrated by a concise synthesis of the potential anti-tuberculosis drug 
candidate Q203 (7)66 (Scheme 25). The synthesis began with a cobalt-catalyzed cross-coupling 
of commercial available 4-iodopiperidine (8) with Grignard reagent72 9 under conditions 
reported by Yorimitsu, Oshima73 and Cossy74 providing the piperidine 10 in 90% yield. The 
Boc-protecting group was removed using trifluoroacetic acid followed by oxidation with BPO 
to afford hydroxylamine 11 in 84% yield (2 steps). The key step in the construction of 
diarylpiperidine 7 was the electrophilic amination with 4-cyanophenylzinc pivalate (1b) in the 
presence of 2.5% CoCl2·2LiCl generating piperidine 12 in 90% yield. With the core skeleton 
in hand, benzonitrile 12 was reduced with LAH (lithium aluminum hydride) and further 
coupled with acid 13 furnishing the amide Q203 (7) in 82% yield (6 steps, 56% overall yield).  
                                                          
72  F. M. Piller, P. Appukkuttan, A. Gavryushin, M. Helm, P. Knochel, Angew. Chem. Int. Ed. 2008, 47, 6802–
6806. 
73  H. Ohmiya, H. Yorimitsu, K. Oshima, J. Am. Chem. Soc. 2006, 128, 1886–1889. 
74  L. Gonnard, A. Guérinot, J. Cossy, Chem. Eur. J. 2015, 21, 12797–12803. 
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Scheme 25. Synthesis of Q203 (7) with cobalt-catalyzed C-C and C-N bond forming reactions. TMCD= 
(R,R)-tetramethylcyclohexanediamine; BPO= benzoyl peroxide; EDC= 1-[3-(dimethylamino)propyl]-
3-ethylcarbodimide hydrochloride; HOBt= 1-hydroxylbenzotriazole. 
 
1.5 Summary 
In summary, we have reported the first cobalt-catalyzed electrophilic amination with aryl- and 
heteroaryl-zinc pivalates and O-benzoylhydroxylamine derivatives under very mild conditions. 
The amination was further extended to O-benzoylhydroxylanilines which previously were not 
appropriate substrates using Cu-catalysis. Finally, the concise synthesis of Q203 (7) 
demonstrates the utility of our method. 
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2. Late Stage Functionalization of Secondary Amines via a 
Cobalt-Catalyzed Electrophilic Amination of Organozinc 
Reagents 
2.1 Introduction 
The formation of a carbon-nitrogen bond is one of the most important reactions for the 
elaboration of pharmaceuticals and agrochemicals.75 Especially the late-stage 
functionalization76 of secondary amines would be a valuable method for producing new 
biologically active compounds.77 Palladium-catalyzed nucleophilic aminations have 
tremendously improved the performance of aryl and heteroaryl aminations.37,78 However, 
electrophilic aminations pioneered by Johnson43,44 are a valuable alternative, since cheaper and 
less toxic metal catalysts of Cu, Ru, Ni, Fe and Co may be used.56a–b,57a,79 As described aboved, 
we developed a new cobalt-catalyzed electrophilic amination of organozinc pivalates62a–f,64a,80 
of type 1 with N-hydroxylamine benzoates 5 allowing the preparation of various functionalized 
amines of type 2 (Scheme 26).81 The required N-hydroxylamine benzoates 5 have been 
prepared from the corresponding amines 14 using benzoylperoxide (BPO), as previously 
reported.43,44 However, the scope of preparation of such N-hydroxylamine benzoates 5 is quite 
limited and considerably reduces the synthetic potential of these electrophilic aminations. 
                                                          
75  a) D. C. Blakemore, L. Castro, I. Churcher, D. C. Rees, A. W. Thomas, D. M. Wilson, A. Wood, Nat. Chem. 
2018, 10, 383–394; b) N. Schneider, D. M. Lowe, R. A. Sayle, M. A. Tarselli, G. A. Landrum, J. Med. Chem. 
2016, 59, 4385–4402. 
76  a) J. R. Clark, K. Feng, A. Sookezian, M. C. White, Nat. Chem. 2018, 10, 583–591; b) C. A. Kluttruff, M. 
Haile, J. Kraml, C. S. Tautermann, ChemMedChem 2018, 13, 983–987; c) M. Shang, M.-M. Wang, T. G. 
Saint-Denis, M.-H. Li, H.-X. Dai, J.-Q. Yu, Angew. Chem. Int. Ed. 2017, 56, 5317–5321; d) L. J. Durak, J. T. 
Payne, J. C. Lewis, ACS Catal. 2016, 6, 1451–1454; e) A. Sharma, J. Hartwig, Nature 2015, 517, 600–604; f) 
D. A. DiRocco, K. Dykstra, S. Krska, P. Vachal, D. V. Conway, M. Tudge, Angew. Chem. Int. Ed. 2014, 53, 
4802–4806; Reviews: g) T. Cernak, K. D. Dykstra, S. Tyagarajan, P. Vachal, S. W. Krska, Chem. Soc. Rev. 
2016, 45, 546–576; h) T. Gensch, M. N. Hopkinson, F. Glorius, J. Wencel-Delord, Chem. Soc. Rev. 2016, 45, 
2900–2936. 
77  a) T. Scattolin, K. Deckers, F. Schoenebeck, Angew. Chem. Int Ed. 2017, 56, 221–224; b) B. L. DeCorte, J. 
Med. Chem. 2016, 59, 9295–9304. 
78  J. F. Hartwig, Acc. Chem. Res. 2008, 41, 1534–1544. 
79  a) J. Liu, K. Wu, T. Shen, Y. Liang, M. Zou, Y. Zhu, X. Li, X. Li, N. Jiao, Chem. Eur. J. 2017, 23, 563–567; 
b) Z. Zhou, Z. Ma, N. E. Behnke, H. Gao, L. Kürti, J. Am. Chem. Soc. 2017, 139, 115–118; c) H. Gao, Z. 
Zhou, D.-H. Kwon, J. Coombs, S. Jones, N. E. Behnke, D. H. Ess, L. Kürti Nat. Chem. 2017, 9, 681–688; 
Reviews: d) X. Dong, Q. Liu, Y. Dong, H. Liu, Chem. Eur. J. 2017, 23, 2481–2511; e) X. Yan, X. Yang, C. 
Xi, Catal. Sci. Technol. 2014, 4, 4169–4177. 
80  a) M. Ellwart, Y.-H. Chen, C. P. Tüllmann, V. Malakhov, P. Knochel, Org. Synth. 2018, 95, 127–141; j) Y.-H. 
Chen, M. Ellwart, V. Malakhov, P. Knochel, Synthesis 2017, 49, 3215–3223. 
81  Y.-H. Chen, S. Graßl, P. Knochel, Angew. Chem. Int. Ed. 2018, 57, 1108–1111. 
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Scheme 26. Cobalt-catalyzed electrophilic amination using organozinc reagents 1 and 
N-hydroxylamine benzoates 5 leading to functionalized tertiary amines of type 2. 
Therefore, we developed a new method with a broad scope to prepare N-hydroxylamine 
benzoates 5 and demonstrate their utility for the performance of late-stage functionalizations 
of various amines including pharmaceuticals and peptides. Furthermore, we showed the 
efficiency of this method in the preparation of the two drugs gepirone82 (2v) and penfluridol83 
(15). 
 
2.2 Preparation of N-Hydroxylamine Benzoates 
Preliminary experiments have shown, that the benzoyloxylation of a typical functionalized 
amine such as 1,4-piperidone (14a) provides the corresponding benzoyloxyamine 5c in only 
27% yield using BPO (Method A, Scheme 27). An alternative method using a 
dimethyldioxirane (DMDO)84 oxidation and subsequent benzoylation with PhCOCl (BzCl) 
provides 5c in 64% yield (Method B). Unfortunately, this reaction could not be easily scaled 
up. Several other oxidation methods were tested, but were neither selective, nor high yielding.85 
However, the oxidation method of O’Neil for preparing N-hydroxylamines 16 proved to be 
convenient and general.86 According to this method, amine 14 was treated with acrylonitrile 
(MeOH, 55 °C, 12 h) providing a tertiary amine of type 17. Its oxidation with 
                                                          
82  P. A. J. Janssen, C. J. E. Niemegeers, K. H. L. Schellekens, F. M. Lenaerts, F. J. Verbruggen, J. M. Van 
Nueten, W. K. A. Schaper Eur. J. Pharmacol. 1970, 11, 139–154. 
83  J. P. Yevich, J. S. New, D. W. Smith, W. G. Lobeck, J. D. Catt, J. L. Minielli, M. S. Eison, D. P. Taylor, L. 
A. Riblet D. L. Temple Jr. J. Med. Chem. 1986, 29, 359–369. 
84  R. W. Murray, M. Singh, Syn. Commun. 1989, 19, 3509–3522. 
85  a) A. Banan, H. Valizadeh, A. Heydari, A. Moghimi, Synlett 2017, 28, 2315–2319; b) J. D. Fields, P. J. Kropp, 
J. Org. Chem. 2000, 65, 5937–5941; c) R. Bußmann, A. Heesing, Chem. Ber. 1987, 120, 1767–1781; d) W. 
W. Zajac, T. R. Walters, M. G. Darcy, J. Org. Chem. 1987, 53, 5856–5860; e) J. J. Yaouanc, G. Massf, G. 
Sturtz, Synthesis 1985, 8, 807–810. 
86 a) V. Matoušek, E. Pietrasiak, L. Sigrist, B. Czarniecki, A. Togni, Eur. J. Org. Chem. 2014, 15, 3087–3092; b) 
G. L. Ellis, I. A. O’Neil, V. E. Ramos, S. B. Kalindjian, A. P. Chorlton, D. J. Tapolczay, Tetrahedron Lett. 
2007, 48, 1687–1690; c) I. A. O’Neil, E. Cleator, D. Tapolczay, Tetrahedron Lett. 2001, 42, 8247–8249. 
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meta-chloroperbenzoic acid (mCPBA; CH2Cl2, −78 °C, 3 h) gives an amine N-oxide of type 
18, which underwent a Cope-elimination (25 °C, 9 h) affording N-hydroxylamines of type 16.86 
Benzoylation with BzCl (NEt3, DMAP, CH2Cl2, 0 °C, 0.5 h) furnished the desired 
hydroxylamine benzoates 5. Applying this sequence to 14a led to the desired product 5c in an 
overall yield of 61% (Method C).  
 
Scheme 27. Comparison of three preparations of N-hydroxylamine benzoate 5c from amine 14a. 
Method A: amine 4 (1.5 equiv), BPO (1.0 equiv), K2HPO4 (1.5 equiv), DMF, rt, 12 h; Method B: 1) 
amine 4 (1.0 equiv), DMDO (1.05 equiv), acetone, 0 °C, 1 h; 2) BzCl (1.2 equiv), NEt3 (1.5 equiv), 
DMAP (1 mol%), CH2Cl2, 0 °C, 30 min; Method C: 1) amine 4, (1.0 equiv), acrylonitrile (5.0 equiv), 
MeOH, 55 °C, 12 h; 2) mCPBA (1.1 equiv), CH2Cl2, −78 °C to 25 °C, 12 h; 3) BzCl (1.2 equiv), NEt3 
(1.5 equiv), DMAP (1 mol%), CH2Cl2, 0 °C, 30 min. 
This selective oxidation was performed on diverse amines 14b–14s affording via the 2-
cyanoethyl amines 17b–17s the desired hydroxylamine benzoates in satisfactory overall yields 
(Scheme 28). In contrast to Method B, Method C allows a convenient scale-up. Thus, the 
preparation of the hydroxylamine benzoate 5j derived from a piperazine (83% yield on 1 mmol 
scale) could readily be scaled-up (77% yield on 10 mmol scale; Scheme 28). Likewise, we have 
prepared the related piperazine and piperidine derived hydroxylamine benzoates 5k–5o (65–
81% yields). This method has been extended to biologically active amines, such as the alkaloid 
anabasine and the psychostimulant methylphenidate and led to the expected hydroxylamine 
benzoates 5p and 5q in 56–71% yields. Important drugs bearing cyclic secondary amines such 
as paroxetine (antidepressant), debenzylated donepezil (treatment of dementia) and lorcaserine 
(former morbid obesity medication) were smoothly converted to the desired products 5r–5t in 
73–76% yields. Also open-chain antidepressants like nortriptyline, sertraline, fluoxetine and 
duloxetine were predictably converted to the hydroxylamine esters 5u–5x in 66–90% yields. 
Finally, amino acids and a peptide such as a nipecotic acid derivative, an azetidine derivate and 
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a dipeptide were chemoselectively converted to the corresponding hydroxylamines 5y–5aa in 
52–79% yields. 
 
Scheme 28. Preparation of N-hydroxylamine benzoates 5. All experiments were performed on a 1 mmol 
scale and the reported yields are isolated yields of analytically pure products; [a] 10 mmol scale.  
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2.3 Cobalt-Catalyzed Electrophilic Amination 
Having in hand a general conversion of secondary amines 14 to the corresponding 
hydroxylamine benzoates 5, we have shown their cross-coupling with polyfunctional 
organozinc chlorides87 1 providing a wide range of tertiary amines of type 2. Thus, various 
aryl- and heteroaryl-zinc chlorides 1n–1q underwent a cobalt-catalyzed electrophilic amination 
with cyclic hydroxylamine benzoates 5k–5n in the presence of 5 mol% CoCl2 (THF, 25 °C, 
2 h) leading to polyfunctional tertiary amines 2w–2z in 83–92% yields (Scheme 29). This 
amination was found to be compatible with several important functional groups (secondary and 
tertiary alcohols, primary and secondary amines, amides and epoxides).88 For example, the 
reaction of 3-anisylzinc chloride (1r) with hydroxylamine ester 5o, bearing an acidic amide 
proton proceeded smoothly in the presence of 5 mol% CoCl2 affording the tertiary amine 2aa. 
These electrophilic aminations complement the nucleophilic amination of Buchwald and 
Hartwig.37,78 Thus, the melatonin receptor ligand 2aa as well as the 517-β-hydroxysteroid 
dehydrogenase inhibitor 2w have been prepared via the nucleophilic Pd-catalyzed amination 
in moderate yields (respectively 55%89 and 37%90), whereas the present electrophilic amination 
produces these pharmaceutical targets in 89% and 77% yield. The robustness of this amination 
has been used for completing a late-stage functionalization of several alkaloids and 
pharmaceuticals bearing a secondary amine. Thus, the corresponding hydroxylamine benzoates 
5p–5x provided, after treatment with the organozinc chlorides 1s–1aa, the desired 
functionalized pharmaceuticals or alkaloids 2bb–2jj in 61–90% yields. Alkylzinc chlorides91 
such as 1bb are also good reaction partners for this amination. Hence, zinc reagent 1bb has 
been aminated with 5j providing gepirone (2v), an antidepressant drug, in 82% yield. 
                                                          
87  A. D. Benischke, M. Ellwart, M. R. Becker, P. Knochel, Synthesis 2016, 48, 1101–1107. 
88  For a detailed study on the functional group tolerance of this cobalt catalyzed amination, see the experimental 
section. T. Gensch, M. Tenders, F. Glorius, J. Org. Chem. 2017, 82, 9154–9159. 
89  J. U. Flanagan, G. J. Atwell, D. M. Heinrich, D. G. Brooke, S. Silvia, L. J. M. Rigoreau, E. Trivier, A. P. 
Turnbull, T. Raynahm, S. M. F. Jamieson, W. A. Denny, Bioorg. Med. Chem. 2014, 22, 967–977. 
90  G. Li, H. Zhou, Y. Jiang, H. Keim, S. W. Topiol, S. B. Poda, Y. Ren, G. Chandrasena, D. Doller, Bioorg. Med. 
Chem. Lett. 2011, 21, 1236–1242. 
91  A. Metzger, F. M. Piller, P. Knochel Chem. Commun. 2008, 44, 5824–5826. 
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Scheme 29. Electrophilic amination of organozinc chlorides of type 1. All experiments were performed 
on a 1 mmol scale and the reported yields are isolated yields of analytically pure products.  
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Encouraged by these results, we envisioned a late stage functionalization of amino-acids and 
peptides. Therefore, the hydroxylamine benzoates derived from two β-amino-acids 5y–5z and 
dipeptide 5aa underwent the expected amination with organozinc chlorides 1cc, 1w and 1n 
leading to the arylated amino-acids 2kk–2ll and peptide 2mm in 62–78% yield (Scheme 30). 
As observed for benzoate 5o, the amidic proton of 5z and 5aa did not disturb the desired 
amination. 
 
Scheme 30. Functionalization of amino-acids 5y–5z and peptidic substrates 5aa, using the cobalt-
catalyzed amination of organozincs 1cc, 1w and 1n. 
 
2.4 Synthesis of Penfluridol (15) 
To demonstrate the synthetic versatility of this amination, we have also performed a short 
synthesis of penfluridol (15), a highly potent antipsychotic (Scheme 31). Thus, the 
arylmagnesium chloride 19 underwent a LaCl3·2LiCl
92 mediated addition to the 2-cyanoethyl-
piperidone (17a) (THF, 25 °C, 1.5 h) leading to the tertiary alcohol 20 in 52% yield. Without 
                                                          
92  Krasovskiy, A.; Kopp, F.; Knochel P. Angew. Chem. Int. Ed. 2006, 45, 497–500. 
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protection of the tertiary hydroxyl function, alcohol 20 was converted by the standard method 
to the hydroxylamine benzoate 21 in 74% yield. Protection of 21 with TMSCl followed by the 
cobalt-catalyzed amination, using the alkylzinc chloride 22 and desilylation (1M HCl, 25 °C, 
1 h) produces penfluridol (15) in 89% yield.  
 
Scheme 31. A new synthesis of penfluridol 15. 
 
2.5 Summary 
In summary, we have reported a very general and functional group tolerating synthesis of 
hydroxylamine benzoates 5 and demonstrated their utility in the cobalt-catalyzed amination of 
various alkyl-, aryl- and heteroaryl-zinc chlorides leading for the first time to complex 
polyfunctional amines in a predictable way. We have shown that this method allows the late 
stage functionalization of various drugs including peptidic target substrates and can be readily 
used for the synthesis of complex target amines such as the pharmaceuticals penfluridol (15) 
and gepirone (2v). 
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3. Preparation of Tertiary Amines by Triple Functionalization of 
Tris-(2-cyanoethyl)amine Using a Cobalt-Catalyzed 
Electrophilic Amination of Organozinc Halides 
3.1 Introduction 
The formation of carbon-nitrogen bonds is a central challenge in the elaboration of 
pharmaceuticals und agrochemicals.75 During the last decades, several new amine preparations 
have been developed.93 Therein, the palladium-catalyzed nucleophilic aminations reported by 
Buchwald55b and Hartwig55a tremendously improved the scope of especially aryl and heteroaryl 
amine formations.78 Lately, electrophilic aminations, pioneered by Narasaka94 and 
Johnson43,44, have proven to display a valuable alternative, since cheaper and less toxic 
catalysts derived from Cu, Ni, Co or Fe may be used.95 These aminations utilize electrophilic 
nitrogen sources, such as organic azides96, N-chloro amines97 or N-hydroxylamine benzoates98 
in combination with various organometallic reagents as nucleophiles. As described above, we 
have developed a preparation of N-hydroxylamines via a Cope-elimination on amines bearing 
a 2-cyanoethyl moiety.99 This method provided to be very robust, enabling the late stage 
functionalization of various polyfunctionalized amines.76 Therefore, we have envisioned to use 
tris(2-cyanoethyl)amine (23) as a precursor for a triple electrophilic amination using three 
different organozinc reagents19 of type 1, providing tertiary amines of type 2 (Scheme 32). This 
would enable to construct a variety of tailored tertiary amines, bearing three chosen moieties. 
                                                          
93  a) Y. Park, Y. Kim, S. Chang, Chem. Rev. 2017, 117, 9247–9301; b) J. X. Qiao, P. Y. S. Lam, in Boronic 
Acids, 2nd ed.; Wiley-VCH: Weinheim, Germany, 2011; 315–361. 
94  a) K. Narasaka, M. Kitamura, Eur. J. Org. Chem. 2005, 2005, 4505–4519; b) H. Tsutsui, Y. Hayashi, K. 
Narasaka, Chem. Lett. 1997, 26, 317–318. 
95  a) Z. Zhou, L. Kürti, Synlett 2019, 30, 1525–1535; b) M. Corpet, C. Gosmini, Synthesis 2014, 46, 2258−2271. 
96  S. Graßl, J. Singer, P. Knochel, Angew. Chem. Int. Ed. 2020, 59, 335–338. 
97  X. Qian, Z. Yu, A. Auffrant, C. Gosmini, Chem. Eur. J. 2013, 19, 6225–6229. 
98  a) Hemric, B. N.; Chen, A.; Wang, Q. J. Org. Chem. 2019, 84, 1468–1488; b) Hendrick, C. E.; Bitting, K. J.; 
Cho, S.; Wang, Q. J. Am. Chem. Soc. 2017, 139, 11622−11628; d) Liu, J.; Wu, K.; Shen, T.; Liang, Y.; Zou, 
M.; Zhu, Y.; Li, X.; Li, X.; Jiao, N. Chem. Eur. J. 2017, 23, 563−567; e) Hendrick, C. E.; Wang, Q. J. Org. 
Chem. 2017, 82, 839−847; f) Dong, X.; Liu, Q.; Dong, Y.; Liu, H. Chem. Eur. J. 2017, 23, 2481−2511. 
99  S. Graßl, Y.-H. Chen, C. Hamze, C. P. Tüllmann, P. Knochel, Org. Lett. 2018, 21, 494–497. 
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Scheme 32. General approach to construct triple functionalized tertiary amines of type 2 starting from 
amine 1. 
 
3.2 First Functionalization of Tris(2-cyanoethyl)amine 
Tris(2-cyanoethyl)amine (23) was treated with mCPBA (1.05 equiv) at −78 °C, to form the 
N-oxide 24, which reacts at 25 °C to the corresponding hydroxylamine 25 (Scheme 33). After 
benzoylation using benzoyl chloride (1.2 equiv) and triethylamine (1.5 equiv), the 
N-hydroxylamine benzoate 5bb was obtained in 57% yield. This benzoate 5bb was submitted 
to a cobalt-catalyzed electrophilic amination with alkylzinc halides of type 1. 
 
Scheme 33. Preparation of hydroxylamine benzoate 5bb starting from amine 23 and proposed 
mechanistic pathway. 
Thus, the amination of organometallics 1dd–1ff provided after amination with benzoate 5bb 
in the presence of CoCl2 (10 mol%) the tertiary amines 26a–26c in 61–73% yield (Table 5, 
entries 1–3). Remarkably, even the sterically hindered adamantylzinc bromide (1gg) was 
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readily aminated with hydroxylamine 5bb, leading to amine 26d in 51% yield (entry 4). Also, 
the pinene derived organometallic 1hh provided after a cobalt-catalyzed amination with 
benzoate 5bb the desired tertiary amine 26e in 66% yield (entry 5). As reported in the literature, 
hydroxylamine benzoates derived from aromatic amines are not stable and undergo [3,3]-
sigmatropic rearrangement of the OBz moiety to the aryl ring.100 Therefore, only alkylzinc 
reagents were used for the first two functionalizations.  
Table 5. Cobalt-catalyzed electrophilic amination of alkyl organozinc reagents 1dd–1hh using 
N-hydroxylamine benzoates 5bb, leading to tertiary amines of type 26. 
  
Entry Organozinc reagent 1 Product 26[a] 
 
  
1 1dd 26a : 65% 
 
  
2 1ee 26b: 73% 
  
 
3 1ff 26c: 61% 
 
  
4 1gg 26d: 51% 
 
 
 
5 1hh 26e: 66% 
[a] All reported yields are isolated yields of analytically pure products. 
                                                          
100  S. Ichikawa, S. Zhu, S. L. Buchwald, Angew. Chem. Int. Ed. 2018, 57, 8714–8718. 
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3.3 Second Functionalization of Tris(2-cyanoethyl)amine 
Next, we applied the oxidation procedure to the alkylated tertiary amines of type 26. As 
expected, a selective formation of the corresponding hydroxylamine was straightforward and 
after benzoylation provided the benzoates 5cc–5gg in 53–73% yield (Scheme 34). Those have 
been coupled a second time, using various alkylzinc reagents of type 1. Thus, treatment of 
cyclopentylamine benzoate 5cc with polyfunctional organozinc reagent 1ii in the presence of 
a cobalt-catalyst, led to the double functionalized amine 27a in 87% yield (Scheme 35). Also, 
the benzoates 5dd–5ee were smoothly alkylated using the functionalized organozinc reagents 
1jj–1kk, providing the tertiary amines 27b–27d in 74–94% yield. Noteworthy, the sterically 
hindered N-hydroxylamine benzoate 5ff was successfully reacted with isopropylzinc chloride 
(1ll), providing the bulky tertiary amine 27e in 72% yield.101 In addition, the pinene derived 
benzoate 5gg was alkylated with the menthol derived organozinc reagent 1mm, leading to the 
tertiary amine 27f in 77% yield. 
 
Scheme 34. Preparation of N-hydroxylamine benzoates of type 5 starting from amines of type 26. [a] 
All reported yields are isolated yields of analytically pure products. 
                                                          
101  K. Banert, M. Heck, A. Ihle, J. Kronawitt, T. Pester, T. Shoker, J. Org. Chem. 2018, 9, 5138–5148. 
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Scheme 35. Electrophilic amination of organozinc reagents of type 1 using benzoates of type 5 in the 
presence of CoCl2. [a] All reported yields are isolated yields of analytically pure products. 
 
3.4 Third Functionalization of Tris(2-cyanoethyl)amine 
With these double alkylated amines of type 27 in hand, we focused on the last functionalization. 
Therefore, the amines of type 27 have been treated with mCPBA (1.05 equiv; −78 °C to 25 °C), 
followed by benzoylation, providing to the unsymmetrical hydroxylamine benzoates 5hh–
5mm in 67–87% yield (Scheme 36). These have been submitted to a cobalt-catalyzed 
electrophilic amination with various functionalized aryl- and heteroarylzinc reagents of type 1. 
Thus, arylzinc chloride 1n was aminated with hydroxylamine benzoate 5hh in the presence of 
CoCl2 (5 mol%), providing the triple functionalized tertiary amine 2nn in 88% yield 
(Scheme 36). Also, benzoates 5ii–5kk are readily arylated with organozinc chlorides 1nn–1pp, 
leading to the corresponding aniline derivatives 2oo–2qq in 79–86% yield. As expected, 
various functional groups, such as esters, nitriles and a diaryl acetate were tolerated by this 
transformation. Interestingly, adamantly hydroxylamine benzoate 5ll smoothly reacted with 3-
chlorophenylzinc chloride ( ), affording the corresponding amine 2rr in 62% yield. 
Remarkably, the pinene-derived hydroxylamine benzoate (5mm) reacted in the presence of a 
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cobalt-catalyst with the aryl- and heteroarylzinc chlorides 1q and 1qq to give the arylated 
amines 2ss–2tt in 81–86% yield. 
 
Scheme 36. Preparation of N-hydroxylamine benzoates of type 5 starting from amines of type 27 and 
electrophilic amination of organozinc reagents of type 1 using benzoates of type 5 in the presence of 
CoCl2. [a] All reported yields are isolated yields of analytically pure products. 
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3.5 Summary 
In summary, we have developed a procedure to construct triple alkylated or arylated tertiary 
amines, starting from commercially available tris(2-cyanoethyl)amine (23). This iterative 
method involves standard steps such as an oxidation (generating after a Cope-elimination a 
hydroxylamine), a benzoylation and a cobalt-catalyzed electrophilic amination of organozinc 
reagents of type 1. Thus, various polyfunctionalized tertiary amines 2 have been prepared in 
good yields. 
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4. Iron-Mediated Electrophilic Amination of Organozinc Halides 
using Organic Azides Detailed Reaction Optimization 
4.1 Introduction 
The preparation of polyfunctional amines is central to organic synthesis.102 Nucleophilic 
aminations93 in which the amine plays the role of a nucleophile, such as the Buchwald-Hartwig 
amination55a–b, have been widely used for the preparation of aryl and heteroaryl amines. In 
contrast, electrophilic aminations are much less developed. Pioneer work from Narasaka94 and 
more recently from Johnson43,44 have led to a number of electrophilic aminations using for 
example N-hydroxylamines derivatives as electrophilic aminating reagent.95, 98 Recently, we 
have shown that the cobalt-catalyzed amination of organozinc halides and pivalates by 
N-hydroxylamine benzoates furnishes polyfunctional tertiary amines.81, 99 In the search of 
electrophilic amination reactions leading to secondary amines, we have envisioned the use of 
organic azides of type 28 as electrophilic nitrogen sources.103 In the early work of Trost104 and 
others105, such reactions have been performed using Grignard reagents. We envisioned, that 
organozinc halides of type 1 would be especially attractive, since these organometallics are 
compatible with the presence of various functional groups.87 In general organozinc reagents are 
not very reactive, so that we anticipated, that transition metal catalysts (Met) may be required 
for achieving the desired amination via transition state 29, leading to secondary amines of type 
3 (Scheme 37). 
 
Scheme 37. Tentative pathway for the electrophilic amination of organozinc halides 1 with organic 
azides 28 in the presence of a transition metal catalyst. 
                                                          
102  A. Ricci; Modern amination methods. Wiley-VCH: Weinheim, Germany, 2008. 
103  a) P. Starkov, T. F. Jamison, I. Marek, Chem. Eur. J. 2015, 21, 5278–5300; b) K. Shin, H. Kim, S. Chang, 
Acc. Chem. Res. 2015, 48, 1040–1052; c) E. Ciganek, in Organic Reactions 72, Wiley-VCH: Weinheim, 
Germany, 2009, 1–366; d) S. Bräse, C. Gil, K. Knepper, V. Zimmermann, Angew. Chem. Int. Ed. 2005, 44, 
5188–5240. 
104  B. M. Trost, W. H. Pearson, J. Am. Chem. Soc. 1983, 105, 1054–1056. 
105  a) B. V. S. Reddy, N. S. Reddy, Y. J. Reddy, Y. V. Reddy, Tetrahedron Lett. 2011, 52, 2547–2549; b) J. S. 
Yadav, B. V. S. Reddy, P. Borkar, P. J. Reddy, Tetrahedron Lett. 2009, 50, 6642–6645; c) J. S. Yadav, C. 
Madhuri, B. V. S. Reddy, G. S. K. K. Reddy, G. Sabitha, Synth. Commun. 2002, 32, 2771–2777; d) H. M. S. 
Kumar, B. V. S. Reddy, S. Anjaneyulu, J. S. Yadav, Tetrahedron Lett. 1999, 40, 8305–8306. 
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4.2 Reaction Optimization 
In preliminary experiments we have treated aryl azide (28a) with 4-anisylzinc chloride (1rr), 
prepared from the corresponding Grignard reagent by transmetalation with ZnCl2, in THF at 
25 °C. In the absence of a transition metal catalyst, no amination was observed (Table 6, 
entry 1). Also, metallic salts derived from Cu(I), Cu(II), Cr(II), Cr(III), Ni(II), Pd(II) provided 
only traces of the secondary amine 3b (entries 2–8). However, a Fe(II) or Fe(III)-catalysisgave 
valuable results, whereby FeCl3 was more active than FeCl2 (entries 9–10).106 Varying the 
stoichiometry showed, that 0.5 equiv of FeCl3 led to the best result, furnishing 3b in 68% 
isolated yield (entry 11–12). Further optimization of the reaction conditions showed, that 
performing the amination at 50 °C led to complete conversion to 3b within 1 h in 74% isolated 
yield (entry 11). 
Table 6. Optimization of the electrophilic amination of organozinc halides 1 with organic azides 28, 
leading to secondary amines of type 3. 
 
Entry Catalyst (loading) Yield [%] 
1 - 0 
2 CuCN·2LiCl (20 mol%) <5% 
3 CuCl2 (20 mol%) <5% 
4 CrCl3 (20 mol%) <5% 
5 CoCl2 (20 mol%) <5% 
6 CrCl2 (20 mol%) <5% 
7 NiCl2 (20 mol%) <5% 
8 PdCl2 (20 mol%) <5% 
9 FeCl2 (20 mol%) 51[a] 
10 FeCl3 (20 mol%) 55[a] 
11 FeCl3 (50 mol%) 68[b] (74[b,c]) 
12 FeCl3 (75 mol%) 32[a] 
[a] GC-yield; [b] isolated yield; [c] 50 °C, 1 h. 
                                                          
106  a) A. Fürstner, ACS Cent. Sci. 2016, 2, 778–789; b) I. Bauer, H.-J. Knölker, Chem. Rev. 2015, 115, 3170–
3387; c) C. Bolm, J. Legros, J. Le Paih, L. Zani, Chem. Rev. 2004, 104, 6217–6254. 
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4.3 Scope and Limitations 
These amination conditions were satisfactory for wide range of organic azides 28 as well as 
organozinc halides 1 (Scheme 38). Remarkably, arylzinc chlorides bearing electron-
withdrawing groups, and therefore being less nucleophilic, still react under our standard 
conditions (50 °C, 1 h). Thus, various highly functionalized diarylamines (3c–3i), containing 
functional groups such as halides, esters, cyano, N-morpholino amides as well as a primary 
amide group (CONH2), have been prepared in high yields (65–93% yield). 
 
Scheme 38. Scope of functionalized aryl azides of type 28 and arylzinc halides of type 1 in the iron-
mediated electrophilic amination procedure; [a] Isolated yields; R1 = aryl, alkyl. 
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As expected electron-rich arylzinc reagents react smoothly under the described conditions, 
leading to diarylamines 3j–3p bearing functional groups such as dimethylamino, OCF3, formyl 
or acetyl (47–84% yield). Alkylzinc reagents also showed to be suitable substrates and 
cyclopropylzinc chloride (1iii) was aminated by 4-nitrophenylazide in 64% yield. Interestingly, 
no electron-transfer from the zinc reagent to the nitro group is observed.107 
 
Scheme 39. Preparation of functionalized heteroaryl amines 3 using heterocyclic azides of type 28 and 
heteroarylzinc halides of type 1; [a] Isolated yields; [b] The used organozinc chlorides do not 
contain mgCl2. 
The preparation of secondary amines bearing N-heterocyclic groups is of prime importance for 
pharmaceutical applications.54 Therefore, heterocyclic zinc reagents 1q and 1aaa or 
heterocyclic azides 28n–28p have been aminated according to this novel iron-mediated 
amination, leading to the heterocyclic amines 3r–3z (53–91% yield, Scheme 39). 
                                                          
107  I. Sapountzis, P. Knochel, J. Am. Chem. Soc. 2002, 124, 9390–9391. 
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Scheme 40. A: Metalation of 3,6-dichloropyridazine (30) and subsequent iron-mediated electrophilic 
amination. B: Generation of 2-azido-N-methyl benzimidazole (28q) and following amination providing 
amine 3bb. 
Interestingly, the required heterocyclic zinc reagents can be generated by the selective 
metalation of a heterocyclic precursor. Thus, 3,6-dichloropyridazine (30) was readily zincated 
with TMPZnCl·LiCl (TMP=2,2,6,6-tetramethylpiperidyl) at 25 °C for 30 min, leading to the 
heterocyclic zinc species 1aaa, which then has been aminated with various aryl (Scheme 39, 
3s–3t) and heteroaryl (Scheme 40A, 3aa) azides. Despite the presence of TMP–H, generated 
during the zincation, the amination proceeds without interference. Also, heterocyclic azides, 
such as N-methyl benzimidazole (31) have been generated according to Fujieda108 via lithiation 
using nBuLi and subsequent trapping with TsN3. Further reaction with arylzinc chloride 1ss 
gave the desired secondary amine in 51% yield (Scheme 40B, 3bb). Finally, alkyl azides 
including bulky azides like 1-adamantyl azide 28r react smoothly with arylzinc derivatives 
such as 3-fluorophenylzinc chloride 1bbb, leading to the adamantylamine 3cc in 80% yield 
(Scheme 41A). This reaction was also extended to peptidic azides and azido esters (Scheme 
41b, R2 = OMe or NH–alkyl), which were arylated under standard conditions, providing the 
polyfunctional chiral amines 3dd–3ff under full retention of configuration (Scheme 41B). 
                                                          
108  S. Ohta, N. Tsuno, S. Nakamura, N. Taguchi, M. Yamashita, I. Kawasaki, M. Fujieda, Heterocycles 2000, 53, 
1939–1955. 
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Scheme 41. A: Iron-mediated amination of organozinc chloride 1bbb using the bulky alkyl azide 1-
azidoadamantane (28r), leading to amine 3cc in 80% isolated yield; B: Electrophilic amination of 
arylzinc halides 1x, 1aa and 1bbb using α-azido ester 28s and peptidic azides 28t–28u, providing the 
arylated substrates in 52–75% isolated yields under full retention of configuration. 
 
4.4 Preparation of an Androgen/Estrogen Receptor Modultor and Antrafenine 
As an application, we have prepared two amine derivatives of pharmaceutical relevance. The 
first target was the amide 32, a modulator for androgen and estrogen receptors, reported by 
Dalton.109 Thus, the treatment of aryl azide 28v with p-anisylzinc chloride (1rr) in the presence 
of 50 mol% FeCl3 (50 °C, 10 min) led to an intermediate amine, which then was directly 
acylated using acid chloride 33, providing the protected amide 34 in 74% yield (Scheme 42). 
After desilylation (TBAF) the desired product 32 was obtained in 71% overall yield. 
                                                          
109  J. T. Dalton (Pearl Cohen), US 2007/0265296A1, 2007. 
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Scheme 42. Preparation of androgen and estrogen receptor modulator 32 using the iron-mediated 
electrophilic amination; TBAF = tetrabutylammoniumfluoride. 
In a second application, we have prepared the pain relief drug antrafenine (35, Scheme 43). 
Starting from amino-alcohol 36, after acylation the iodide 37 was obtained in 81% yield. 
Following, a very fast iodine-magnesium exchange using iPrMgCl·LiCl (–78 °C, 30 sec) and 
subsequent transmetalation using ZnCl2 provided the corresponding organozinc chloride. This 
is submitted to an electrophilic amination with heterocyclic azide 28w, leading to antrafenine 
(11) in 64% yield. 
 
Scheme 43. Preparation of the pain relief drug antrafenine 35, using the iron-mediated electrophilic 
amination; R = 3-CF3-C6H5. 
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4.5 Summary 
In summary, we have developed a general electrophilic amination of polyfunctional organozinc 
halides 1 with organic azides 28, mediated by FeCl3 (0.5 equiv). The reactions are generally 
complete within 1 h at 50 °C, providing highly functionalized secondary amines 3. As 
mechanistic guideline we used a transition state of type 29 (Scheme 1). Iron-salts seem to have 
a unique ability to trigger efficiently this amination.  
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5. Copper-Catalyzed Electrophilic Thiolation of Organozinc 
Halides Using N-Thiophthalimides Leading to Polyfunctional 
Thioethers 
5.1 Introduction 
Thioethers are very common functional group in bioactive molecules110 and the synthesis of 
the sulphur linkage led to the development of numerous methodologies.111 Thus, Cu-catalyzed 
nucleophilic thiolations using aryl halides and organic thiols have been reported.112 Also, 
electrophilic thiolations involving electrophilic sulfur-reagents of type RS–X (X = SR, 
halogeno, N-succimidyl and arylsulfonyl) with various organometallics have found growing 
interest.113 In this respect, the use of polyfunctional organozinc reagents87 is of special interest, 
since they are readily prepared and tolerate a broad range of functional groups like an ester, a 
nitrile or an aldehyde. 
 
Scheme 44. General preparation of N-thiophthalimides 38 and their reaction with organozinc reagents 
1 to provide thioethers of type 4. 
                                                          
110  a) Y. Wang, S. Chackalamannil, W. Chang, W. Greenlee, V. Ruperto, R. A. Duffy, R. McQuade, J. E. 
Lachowicz Bioorg. Med. Chem. Lett. 2001, 11, 891–894; b) G. Liu, J. T. Link, Z. Pei, E. B. Reilly, S. Leitza, 
B. Nguyen, K. C. Marsh, G. F. Okasinski, T. W. von Geldern, M. Ormes, K. Fowler, M. Gallatin J. Med. 
Chem. 2000, 43, 4025–4040; c) B. Bonnet, D. Soullez, S. Girault, L. Maes, V. Landry, E. Davioud-Charvet, 
C. Sergheraert Bioorg. Med. Chem. Lett. 2000, 8, 95–103; d) L. R. Beard, D. F. Colon, T. K. Song, P. J. A. 
Davies, D. M. Kochhar, R. A. S. Chandraratna J. Med. Chem. 1996, 39, 3556–3563; e) Y. Nagai, A. Irie, H. 
Nakamura, K. Hino, H. Uno, H. Nishimura J. Med. Chem. 1982, 25, 1065–1070. 
111  a) T. Scattolin, E. Senol, G. Yin, Q. Guo, F. Schoenebeck Angew. Chem. Int Ed. 2018, 57, 12425–12429; b) 
X. Liu, Q. Cao, W. Xu, M.-T. Zeng, Z.-B. Dong Eur. J. Org. Chem. 2017, 38, 5795–5799; c) A. Ogawa, T. 
Ikeda, K. Kimura, T. Hirao J. Am. Chem. Soc. 1999, 121, 5108–5114; d) D. Melandri, P. C. Montevecchi, M. 
L. Navacchia Tetrahedron 1999, 55, 12227–12236; e) S. B. Lee, J.-I. Hong Tetrahedron Lett. 1995, 36, 8439–
8442; f) I. W. J. Still, F. D. Toste J. Org. Chem. 1996, 61, 7677–7680; g) H. Kuniyasu, A. Ogawa, K.-I. Sato, 
I. Ryu, N. Kambe, N. Sonoda J. Am. Chem. Soc. 1992, 114, 5902–5903. 
112  a) G. Bastug, S. P. Nolan J. Org. Chem. 2013, 78, 9303–9308; b) M. Carril, R. SanMartin, E. Domínguez 
Chem. Soc. Rev. 2008, 37, 639–647; c) M. A. Fernández-Rodríguez, Q. Shen, J. F. Hartwig J. Am. Chem. Soc. 
2006, 128, 2180–2181; d) F. Y. Kwong, S. L. Buchwald Org. Lett. 2002, 4, 3517–3520. 
113  a) Cheng, Y.; Liu, X.; Dong, Z.-B. Eur. J. Org. Chem. 2018, 6, 815–820; b) B.-X. Du, Z.-J. Quan, X.-Y. Da, 
Z. Zhang, X.-C. Wang Adv. Synth. Catal. 2015, 357, 1270–1276; c) Y. Zhang, Y. Li, X. Zhang, X. Jiang Chem. 
Commun. 2015, 51, 941–944; d) Y. Li, J. Pu, X. Jiang Org. Lett. 2014, 16, 2692–2695; e) J. T. Reeves, K. 
Camara, Z. S. Han, Y. Xu, L. Lee, C. A. Busacca, C. H. Senanayake Org. Lett. 2014, 16, 1196–1199; f) M. I. 
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Thus, we developed a convenient preparation of polyfunctional thioesters of type 4 by the 
reaction of functionalized aryl, heteroaryl, alkyl or benzylic organozinc halides 1 with 
N-thiophthalimides 38. These N-thiophthalimides were conveniently prepared by an optimized 
literature procedure based on the methods published by Liebeskind113h and Chen114, involving 
the reaction of commercial N-chlorophthalimide 39 with various organic thiols of type 40 
(Scheme 44). 
 
5.2 Reaction Opimization 
In preliminary experiments, we have examined the effect of a transition metal catalyst on the 
formation of thioether 1a. Therefore, 4-anisylzinc chloride (1rr) was treated with 
N-(cyclohexylthio)phthalimide (38a; 25 °C, 1 h). In the absence of a catalyst, a yield of only 
49% of 1a was obtained (Table 7, entry 1). Catalysis with FeCl2, CrCl2, Fe(acac)3, CoCl2, NiCl2 
and MnCl2 (5%) increased this yield up to 72% (entries 2–7). By testing various copper salts 
such as CuBr2, CuBr, CuCl2, Cu(OAc) and CuCN·2LiCl, we have further increased the yield 
up to 88% (entries 8–12). However, CuCl and Cu(OAc)2·H2O were found to give the best 
results (93–95% yield, entries 13–14). 
Table 7. Catalyst screening for the electrophilic thiolation of zinc organometallic 1rr. 
 
Entry Catalyst Yield [%][a] 
1 - 49 
2 FeCl2 54 
3 CrCl2 60 
4 Fe(acac)3 63 
5 CoCl2 64 
6 NiCl 71 
7 MnCl2 72 
8 CuBr2 74 
9 CuBr 79 
10 CuCl2 82 
                                                          
114  J. Qiu, D. Wu, P. G. Karmaker, H. Yin, F.-X. Chen Org. Lett. 2018, 20, 1600–1603. 
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11 Cu(OAc) 88 
12 CuCN·2LiCl 88 
13 CuCl 93 
14 Cu(OAc)·H2O 95[b] 
[a] GC yield using undecane as internal standard [b] Isolated yields of analytically pure products 
 
5.3 Scope and Limitations 
With this optimized procedure, we have examined the scope of organozinc reagents 1. Thus, 
the reaction of electron-rich (1v, 1rr, 1vv , 1ccc and 1ddd) as well as electron-poor arylzinc 
chlorides (1p and 1aa) with N-thiophthalimide 38a or 38b using 5% Cu(OAc)2·H2O provided 
the desired thioethers 4b–4h in 86–99% yield (Table 8, entries 1–7). Moreover, ferrocenylzinc 
chloride (1eee) was coupled with thiophthalimide 38b, furnishing the ferrocenyl thioether 4i in 
90% yield (entry 8). Also heteroarylzinc halides 1fff–1hhh underwent an electrophilic 
thiolation giving the thioethers 4j–4l in 71–94% yield (entries 9–11). Furthermore, alkyl and 
benzylic zinc halides 1iii–1kkk were successfully coupled with N-(phenylthio)phthalimide 
(38b) and N-(cyclohexylthio)-phthalimide (38a), furnishing the thioethers 4m–4o (entries 12–
14). Noteworthy, sensitive functional groups such as nitriles, esters, aldehydes and ketones 
were tolerated (entries 6, 7, 9, 10 and 14). Also, sterically hindered nucleophiles such as zinc 
organometallics 1ddd and 1hhh gave the desired thioethers 4d and 4l in 94–99% yield (entry 
5 and 11). 
Table 8. Thioethers of type 4 via a copper-catalyzed thiolation of organozinc reagents of type 1 with 
N-thiophthalimides of type 38. 
  
Entry Organozinc reagent 1 N-Thiophthalimide 38[a] Product of type 4 [b] 
1 
   
 1rr 38b 4b: 98% 
2 
   
 1v 38b 4c: 98% 
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3 
   
 1ccc 38a 4d: 90% 
4 
   
 1vv 38b 4e: 86% 
5 
 
 
 
 1ddd 38b 4f: 99% 
6 
   
 1aa 38b 4g: 98% 
7 
 
 
 
 1p 38b 4h: 95% 
8 
 
 
 
 1eee 38b 4i: 90% 
9 
   
 1fff 38b 4j: 89% 
10 
   
 1ggg 38b 4k: 71% 
11 
 
 
 
 1hhh 38b 4l: 94% 
12 
  
 
 1iii 38b 4m: 97% 
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13 
 
 
 
 1jjj 38b 4n: 96% (d.r. 71:29) 
14 
 
 
 
 1kkk 38a 4o: 98% (d.r. 97:3) 
[a] Pht = phthalimide; [b] Isolated yields of analytically pure products. 
Next, we have investigated the scope of polyfunctional thiophthalimides of type 38. We have 
found that both, alkyl and (hetero)aryl thiophthalimides gave excellent results. Therefore, the 
alkyl thiophthalimides 38a and 38c were coupled with arylzinc chlorides 1x and 1rr affording 
thioethers 4a and 4p in 71–95% yield (Table 9, entries 1–2). Also various functionalized aryl- 
and heteroaryl thiophthalimides have been prepared according to the method described above 
(Scheme 44) and subsequently coupled to form the corresponding thioether of type 1. Thus, 
the copper-catalyzed thiolation of organozinc reagents  , 1v–1y, 1rr, 1lll, 1ddd, 1mmm and 
thiophthalimides 38d–38l led to the expected thiolation products 4p–4z in 55–97% yield 
(entries 3–12). Electron-rich as well as electron-poor aryl and heteroaryl derivatives can be 
used for this thiolation. Furthermore, sensitive functional groups such as esters and nitriles 
attached to the N-thiophthalimide were tolerated (entries 8–9). Noteworthy, even highly 
reactive nitro groups are tolerated with only slightly reduced yields. Thus, the reaction of 
thiophthalimide 38f with organozinc chloride 1x provided thioether 4s in 55% yield (entry 6). 
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Table 9. Electrophile scope of electrophilic thioether formation using various N-thiophthalimides of 
type 38.  
 
Entry Zinc reagent 2 Pht–SR 3[a] Product of type 1[b] 
1 
   
 1rr 38a 4a: 95% 
2 
 
 
 
 1x 38c 4p: 71% 
3 
   
 1v 38d 4q: 94% 
4 
 
 
 
 1lll 38e 4r: 97% 
5 
 
  
 1y 38e 4s: 96% 
6 
  
 
 1x 38f 4t: 55% 
7 
 
 
 
 1ddd 38g 4u: 89% 
8 
   
 1v 38h 4v: 70% 
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9 
 
 
 
 1mmm 38i 4w: 90% 
10 
   
   38j 4x: 94% 
11 
   
   38k 4y: 85% 
12 
  
 
 1y 38l 4z: 81% 
[a] Pht = phthalimide; [b] Isolated yields of analytically pure products. 
Interestingly, this method was further extended to the introduction of a trifluoromethylthio 
(SCF3), a thiocyanate (SCN) as well as a phenylselenyl (SePh) moiety. SCF3 groups are 
important bioisosteres to alter the biological activity of drugs, what entails the requirement of 
elaborated methods for their introduction.115 Therefore, commercially available 
N-(trifluoromethylthio) phthalimide 38m was treated with arylzinc halides of type 1 in the 
presence of 10% Cu(OAc)2·H2O to give the corresponding trifluoromethylthiolated products 
(41a–41c) in 78–91% yield (Scheme 45). Next, we have extended the scope to thiocyanates. 
As expected, the reaction of N-thiophthalimide 38n with arylzinc chlorides of type 1 provided 
arylthiocyanates 42a–42c in 72–93% yield (Scheme 45). Due to the lower reactivity of these 
thiophthalimides (38m–38n), 10% Cu(OAc)2·H2O was necessary. Additionally, we have 
extended this method to the preparation of selenium compounds. Thus, selenophthalimide (43) 
was treated with 4-chlorophenylzinc chloride (2s) to give selenoether 43 in 83% yield (Scheme 
45).  
                                                          
115  a) M. Horvat, M. Jereb, J. Iskra Eur. J. Org. Chem. 2018, 3837–3843; b) S. Barata-Vallejo, S. Bonesi, A. 
Postigo Org. Biomol. Chem. 2016, 14, 7150–7182; c) K. Zhang, X. Xu, F. Qing Chin. J. Org. Chem. 2015, 
35, 556–569; d) X. H. Xu, K. Matsuzaki, N. Shibata Chem. Rev. 2015, 115, 731–764; e) A. B. Durr, G. Yin, 
I. Kalvet, F. Napoly, F. Schoenebeck Chem. Sci. 2016, 7, 1076–1081; f) G. Yin, I. Kalvet, U. Englert, F. 
Schoenebeck J. Am. Chem. Soc. 2015, 137, 4164–4172; g) S. Alazet, L. Zimmer, T. Billard Chem. Eur. J. 
2014, 20, 8589–8593; h) G. Landelle, A. Panossian, F. R. Leroux Curr. Top. Med. Chem. 2014, 14, 941–951; 
i) K. Kang, C. Xu, Q. Shen Org. Chem. Front. 2014, 1, 294–297; j) J. H. Clark, C. W. Jones, A. P. Kybett, M. 
A. McClinton, J. M. Miller, D. Bishop, R. J. Blade J. Fluor. Chem. 1990, 48, 249–253. 
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Scheme 45. Preparation of SCF3, SCN and SePh substituted aryl and heteroaryl derivatives via a 
copper-catalyzed thiolation of arylzinc chlorides. 
 
5.4 Synthesis of a Cathespin-D Inhibitor 
To show the utility of this method, we have applied this methodology to a short synthesis of 
the bioactive cathepsin-D inhibitor 44116 starting from 4-bromobenzonitrile 45 (Scheme 46). 
Thus, the conversion of 45 to the corresponding Grignard reagent was achieved with turbo-
Grignard (iPrMgCl·LiCl)72, leading after thiolation with elementary sulphur to the thiol 46 in 
95% yield.[11] In this procedure, it was important to remove iPrBr under vacuum after the 
Br/Mg-exchange step. Using the above described procedure, thiol 46 was converted to the 
corresponding N-thiophthalimide in 76% yield. A subsequent copper-catalyzed thiolation with 
heteroarylzinc chloride 47 afforded the desired thioether 48 in 94% yield. Next, the nitrile 
functionality was hydrolysed using acetaldoxime and NiCl2·6H2O to provide an intermediate 
amide in 91% yield.117 The corresponding aniline derivative 49 was obtained via a Hofmann 
rearrangement (Br2, NaOH) in 63% yield.
118 Finally, using an iodine/triphenylphosphine-
mediated amidation, the desired target 44 was obtained in 61% yield (97% based on recovered 
starting material).119 
                                                          
116  J. Dumas, D. Brittelli, J. Chen, B. Dixon, H. Hatoum-Mokdad, G. König, R. Sibley, J. Witowsky, S. Wong 
Bioorg. Med. Chem. Lett. 1999, 9, 2531–2536. 
117  X. Ma, Y. He, P. Wang, M. Lu Appl. Organomet. Chem. 2012, 26, 377–382. 
118  J. B. Lambert, D. Stec III Org. Magn. Reson. 1984, 22, 301–307. 
119  S. Wangngae, C. Duangkamol, M. Pattarawarapan, W. Phakhodee RSC Adv. 2015, 5, 25789–25793. 
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Scheme 46. Synthesis of bioactive cathepsin-D inhibitor 44; [a] Yield based on recovered starting 
material. 
 
5.5 Summary 
In summary, we have developed a new preparation of thioethers (4) from N-thiophthalimides 
38 via a Cu(OAc)2·H2O-catalyzed thiolation of organozinc halides 1. This method has a broad 
scope, tolerating various reactive functional groups including aldehydes and nitro groups. An 
extension to the introduction of SCF3, SCN and SePh groups was also achieved. The utility of 
the method was shown in a short synthesis of a bioactive cathepsin-D inhibitor 44. 
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6. Summary 
We have devolped various methods to construct either carbon-nitrogen or carbon-sulphur 
bonds, using organozinc reagents and electrophilic heteroatom sources. In our first approach 
we aminated aryl- and heteroarylzinc pivalates 1 with N-hydroxylamine benzoates 5 at 25 °C 
within 2–4 h in the presence of 2.5–5% CoCl2·2LiCl, furnishing the corresponding tertiary 
arylated or heteroarylated amines 2 in good yields (Scheme 47). This electrophilic amination 
provides also an access to diarylamines and aryl(heteroaryl)amines 2. A new tuberculosis drug 
candidate (Q203, 7) was prepared in 6 steps and 56% overall yield using this cobalt-catalyzed 
amination as the key step. 
 
Scheme 47. Electrophilic amination of aryl- and heteroarylzinc pivalates 1 using N-hydroxylamine 
benzoates 5 leading to functionalized tertiary amines 2 (22 examples with up to 97% yield). 
Next, to enhace this method, we developed a general preparation of polyfunctional 
hydroxylamine benzoates 5 from the corresponding secondary amines 14. This convenient 
synthesis allows the set-up of a late-stage functionalization of various secondary amines 
including pharmaceuticals and peptidic derivatives. Thus, a cross-coupling of hydroxylamine 
benzoates 5 with various alkyl-, aryl- and heteroaryl-zinc chlorides in the presence of 5 mol% 
CoCl2 (25 °C, 2 h) provides a range of polyfunctional tertiary amines 2 in good yields (Scheme 
48). This method has been used to prepare the two drugs penfluridol 15 and gepirone 2v. 
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Scheme 48. General preparation of N-hydroxylamine benzoates 5 from complex secondary amines 14 
and usage in a cobalt-catalyzed electrophilic amination of organozinc chlorides 1, leading to 
polyfunctional tertary amines 2 (exemplified on fluoxetine). 
This preparation of hydroxylamines was further developed and applied to a stepwise process 
to construct triple alkylated or arylated tertiary amines 2, starting from commercially available 
tris(2-cyanoethyl)amine 23 using a sequence of a selective oxidation (formation of N-oxide 
followed by a Cope-elimination) leading to a hydroxylamine, a benzoylation and a cobalt-
catalyzed electrophilic amination with organozinc halides 1. Various polyfunctionalized 
tertiary amines 2 have been prepared in good yields using this method (Scheme 49). 
 
Scheme 49. Iterative sequence to furnish tertiary amines 2 using three different organozinc reagents of 
type 1 and tris(2-cyanoethyl)amine (23) as nitrogen source. 
Since the previous described electrophilic amination is limited to the formation of tertiary 
amines 2, we developed a complementary procedure to obtain secondary amines 3. Therefore, 
a wide range of alkyl-, aryl- and heteroarylzinc halides 1 have been aminated with highly 
functionalized alkyl, aryl and heterocyclic azides 28 (Scheme 50). The reaction proceeds 
smoothly at 50 °C within 1 h in the presence of FeCl3 (0.5 equiv) to furnish the corresponding 
secondary amines 3 in good yields. This method was extended to peptidic azides, providing the 
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arylated substrates under full retention configuration. To demonstrate the utility of this 
reaction, we prepared two amine derivatives of pharmaceutical relevance using this iron-
mediated electrophilic amination as the key step. 
 
Scheme 50. Electrophlic amination of a wide range of alkyl-, aryl- and heteroarylzinc halides 1 with 
alkyl, aryl and heterocyclic azides 28 in the presence of FeCl3 (50%), providing highly functionalized 
secondary amines 3. 
Last, we developed an electrophilic thiolation of (hetero)aryl, benzylic and alkyl zinc halides 
1 with N-thiophthalimides 38. The reaction proceeds at 25 °C within 1 h in the presence of  
Cu(OAc)2·H2O (5–10 mol%) to furnish the corresponding polyfunctionalized thioethers 4 in 
good yields (Scheme 51). This electrophilic thiolation was extended to the introduction of 
trifluoromethylthio (SCF3), thiocyanate (SCN) and selenophenyl (SePh) groups. The utility of 
this method was shown in a seven step synthesis of a potent cathepsin D inhibitor 44 in 34% 
overall yield. 
 
Scheme 51. General preparation of N-thiophthalimides 38 and their reaction with organozinc reagents 
1 to provide thioethers of type 4. 
 
  
 
 
 
 
 
 
 
 
 
C. EXPERIMENTAL SECTION 
  
C. Experimental Section 
68 
1. General Considerations 
All reactions were carried out under an argon atmosphere in flame-dried glassware. Syringes 
which were used to transfer anhydrous solvents or reagents were purged with argon prior to 
use. THF was continuously refluxed and freshly distilled from sodium benzophenone ketyl 
under nitrogen and stored over molecular sieves. AcOEt was purchased from Sigma-Aldrich 
with a purity of 99% and used without distillation or drying prior to use. Yields refer to isolated 
yields of compounds estimated to be >95% pure as determined by 1H-NMR (25 °C) and 
capillary GC. 
 
1.1 Solvents 
Solvents were dried according to standard procedures by distillation over drying agents and 
stored under argon. 
CH2Cl2 was predried over CaCl2 and distilled from CaH2. 
EtOH was treated with phthalic anhydride (25 g/L) and sodium, heated to reflux for 6 h and 
distilled. 
Et2O was predried over CaH2 and dried with the solvent purification system SPS-400-2 from 
INNOVATIVE TECHNOLOGIES INC. 
Pyridine was dried over KOH and distilled. 
THF was continuously refluxed and freshly distilled from sodium benzophenone ketyl under 
nitrogen and then stored over molecular sieves. 
Solvents for column chromatography were distilled prior to use. 
 
1.2 Reagents 
All reagents were obtained from commercial sources and used without further purification 
unless otherwise stated. 
iPrMgCl·LiCl solution in THF was obtained from Albermale. 
nBuLi solution in hexane was obtained from Albermale. 
Zinc dust (> 98%) was obtained from Sigma Aldrich. 
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Preparation of Zn(OPiv)2 
Pivalic acid (20.4 g, 22.6 mL, 200 mmol, 1.90 equiv) was placed in a dry and argon-flushed 
500 mL three-necked round-bottom flask, equipped with a magnetic stirring bar, a septum and 
a pressure equalizer, and was dissolved in dry THF (120 mL). The mixture was cooled to 0 °C, 
and a solution of Et2Zn (13.0 g, 10.8 mL, 105 mmol, 1.00 equiv) in dry THF (120 mL) was 
cannulated to it over a period of 30 min under vigorous stirring. Then, the ice-bath was removed 
and stirring continued at 25 °C for one additional hour at which point bubbling was ceased (a 
thick slurry was formed). The solvent was removed in vacuo and the solid residue was dried 
for at least 4 h. Zn(OPiv)2 was received in quantitative yield, as a puffy amorphous white solid. 
 
Preparation of TMPMgCl·LiCl120 
In a dry and argon flushed Schlenk-flask TMPH (14.8 g, 105 mmol, 1.05 equiv) was added to 
iPrMgCl·LiCl (71.4 mL, 100 mmol, 1.40 M in THF, 1.00 equiv) at 25 °C and the mixture was 
stirred overnight at 40 °C. The freshly prepared TMPMgCl·LiCl was titrated prior to use at 
0 °C with benzoic acid using 4-(phenylazo)diphenylamine as indicator. 
 
Preparation of TMPZnCl·Mg(OPiv)2·LiCl62d 
A dry and argon flushed 250 mL Schlenk-flask, equipped with a magnetic stirring bar, was 
charged with a solution of TMPMgCl·LiCl (87.7 mL, 100 mmol, 1.00 equiv) and cooled at 
0 °C. Then, solid Zn(OPiv)2 (28.1 g, 105 mmol, 1.05 equiv, dried in vacuo at 400 °C prior to 
use) was added in one portion and the mixture was allowed to slowly warm up to 25 °C over 
ca. 1.5 h. Then THF (ca. 10–20 mL) was added to give TMPZnCl·Mg(OPiv)2·LiCl as a bright 
yellow solution. The freshly prepared TMPZnCl·Mg(OPiv)2·LiCl was titrated prior to use at 
0 °C with benzoic acid using 4-(phenylazo)diphenylamine as indicator. 
 
Preparation of CoCl2·2LiCl (1.0 M) 
A dry and argon-flushed 250 mL Schlenk-flask, equipped with a magnetic stirring bar and a 
rubber septum, was charged with anhydrous LiCl (140 mmol, 5.94 g, 2.00 equiv) and heated 
to 150 °C under high vacuum for 5 h. After cooling to 25 °C under vacuum, anhydrous CoCl2 
                                                          
120  W. Lin, O. Baron, P. Knochel, Org. Let. 2006, 8, 5673–5676. 
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(70.0 mmol, 9.09 g, 1.00 equiv) was added under argon. The Schlenk-flask was further heated 
to 130 °C for 3 h under high vacuum, cooled to 25 °C and charged with dry THF (70 mL). The 
mixture was vigorously stirred until all solids were dissolved (ca. 8 h). The reagent 
CoCl2·2LiCl (1 M in THF) is obtained as a dark blue solution. 
1.3 Content Determination of Organometallic Reagents 
Titration of Organozinc Reagents Using Iodine 
Accurately weighted aliquots of the iodine (50 mg, 0.20 mmol) were dissolved in dry THF 
(2 mL). To the resulting solution the organozinc reagent was added till complete disappearance 
of the dark brown colour of iodine. Thus, the concentration of the active species (in mmol/mL) 
is determined and thereof the yield of the zinc reagent.121 
Organolithium reagents were titrated against isopropanol using 1,10-phenanthroline as 
indicator in THF.122 
TMP bases were titrated against benzoic acid using 4-(phenylazo)diphenylamine as indicator 
in THF. 
 
1.4 Chromatography 
Flash column chromatography was performed using silica gel 60 (0.040–0.063 mm, 230–
400 mesh ASTM) from Merck. 
Thin layer chromatography was performed using SiO2 pre-coated aluminum plates (Merck 
60, F-254). The chromatograms were examined under UV light at 254 nm and/or by staining 
of the TLC plate with one of the solutions given below followed by heating with a heat gun: 
- Seebach’s stain: Phosphomolybdic acid (2.5 g), Ce(SO4)2 (1.0 g), conc. H2SO4 (6 mL), 
H2O (94 mL). 
- KMnO4 stain: KMnO4 (3.0 g), K2CO3 (20 g), 5% NaOH solution (5 mL), water 
(300 mL). 
 
                                                          
121  A. Krasovskiy, P. Knochel Synthesis 2006, 5, 890–891. 
122  H.-S. Lin, A. Paquette, Synth. Commun. 1994, 24, 2503–2506. 
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1.5 Analytical Data 
NMR spectra were recorded on VARIAN Mercury 200, BRUKER AXR 300, VARIAN VXR 
400 Sand BRUKER AMX 600 instruments in CDCl3 or C6D6 and chemical shifts are reported 
in parts per million (ppm) relative to the residual solvent peak. Abbreviations for signal 
coupling are as follows: s, singlet; d, doublet; t, triplet; q, quartet; m, multiplet; br, broad. 
Mass spectroscopy: High resolution (HR-MS) electron impact ionization (EI) and low 
resolution (MS) spectra were recorded on a FINNIGAN MAT 95Q instrument. EI was 
conducted with an electron energy of 70 eV. Electrospray ionization (ESI) spectra were 
recorded on a FINNIGAN LTQ FTICR instrument. GCs were recorded on machines of the 
types Hewlett-Packard 6890 or 5890 Series II (Hewlett Packard, 5% 
phenylmethylpolysiloxane; length: 10 m, diameter: 0.25 mm; film thickness: 0.25 μm). 
Infrared spectra (IR) were recorded from 4500 cm-1 to 650 cm-1 on a PERKIN ELMER 
Spectrum BX59343 instrument. For detection a SMITHS DETECTION DuraSamplIR II 
Diamond ATR sensor was used. The absorption bands are reported in wavenumbers (cm-1). 
Melting points (m.p.) were determined on a BÜCHI B-540 apparatus and are uncorrected. 
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2. Typical Procedures 
2.1 TP1 : Typical Procedure for the Preparation of the Organozinc Pivalates by 
Halogen-Magnesium Exchange and Subsequent Transmetalation with 
Zn(OPiv)2 
A dry and argon flushed Schlenk-flask equipped with a magnetic stirring bar and a septum was 
charged with the aromatic substrate (5.00 mmol, 1.00 equiv) and dry THF (15 mL). The 
reaction mixture was put to the appropriate temperature, before iPrMgCl·LiCl (4.30 mL, 1.28 
M, 5.50 mmol, 1.10 equiv) was added dropwise. The progress of the halogen-magnesium 
exchange was monitored by GC-analysis of reaction aliquots quenched with aq. sat. NH4Cl 
solution and/or I2. Upon completion of the exchange, solid Zn(OPiv)2 (1.61 g, 6.00 mmol, 
1.2 equiv) was added in one portion at 0 °C and the mixture was allowed to slowly warm up to 
25 °C. After stirring at ambient temperature for 15 min, the solvent was carefully removed in 
vacuo. The dried material was titrated using iodine solution (1 M in THF) in order to determine 
its actual content in zinc species and the yield of the reaction. 
 
2.2 TP2: Typical Procedure for the Preparation of the Organozinc Chlorides by 
Halogen-Magnesium Exchange and Subsequent Transmetalation with 
ZnCl2 
A dry and argon flushed Schlenk-flask equipped with a magnetic stirring bar and a septum was 
charged with the aryl halide (5.00 mmol, 1.00 equiv) and dissolved in dry THF (15 mL). The 
reaction mixture was set to the appropriate temperature, before iPrMgCl·LiCl (4.30 mL, 1.28 
M, 5.50 mmol, 1.10 equiv) was added dropwise. The progress of the halogen-magnesium 
exchange was monitored by GC-analysis of reaction aliquots quenched with aq. sat. NH4Cl 
solution and/or I2. Upon completion of the exchange, ZnCl2 (1 M in THF, 6.00 mL, 6.00 mmol, 
1.20 equiv) was added as a solution in THF at 0 °C and the mixture was allowed to slowly 
warm up to 25 °C. After stirring at ambient temperature for 15 min, the mixture was titrated 
using iodine in order to determine its actual content in zinc species and the yield of the 
reaction.123 
 
                                                          
123  A. Krasovskiy, P. Knochel Angew. Chem. Int. Ed. 2004, 43, 3333–3336. 
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2.3 TP3: Typical Procedure for the Preparation of the Organozinc Pivalates by 
Magnesium Insertion and Subsequent Transmetalation with Zn(OPiv)2 
A dry and argon flushed Schlenk-flask equipped with a magnetic stirring bar and a septum was 
charged with magnesium turnings (304 mg, 12.5 mmol, 2.50 equiv), LiCl (318 mg, 7.50 mmol, 
1.50 equiv) and THF (15 mL). The aromatic halide (5.00 mmol, 1.00 equiv) was added 
dropwise. If necessary, the Schlenk-flask was placed in a water bath for cooling during the 
initial heat evolution of the insertion reaction. The progress of the insertion reaction was 
monitored by GC-analysis of reaction aliquots quenched with aq. sat. NH4Cl solution and/or 
I2. Upon completion of the insertion, solid Zn(OPiv)2 (1.61 g, 6.00 mmol, 1.20 equiv) was 
added in one portion. After stirring at ambient temperature for 15 min, the solvent was carefully 
removed in vacuo. The dried material was titrated using iodine solution (1 M in THF) in order 
to determine its actual content in zinc species and the yield of the reaction. 
 
2.4 TP4: Typical Procedure for the Preparation of the Organozinc Chlorides by 
Magnesium Insertion and Subsequent Transmetalation with ZnCl2 
In a dry and argon flushed Schlenk-flask equipped with a magnetic stirring bar and a septum 
anhydrous LiCl (159 mg, 3.75 mmol, 1.50 equiv) and magnesium turnings (122 mg, 
5.00 mmol, 2.00 equiv) were suspended in dry THF (5 mL). The alkyl or aryl halide 
(2.50 mmol, 1.00 equiv) was added in one portion and magnesium turnings was activated by 
gentle heating. After the exothermic reaction started, the reaction mixture was cooled to 25 °C 
and stirred overnight. Upon completion of the insertion, a solution of ZnCl2 (1.00 M, 3.00 mL, 
3.00 mmol, 1.20 equiv) in dry THF was added at 0 °C and the mixture was allowed to slowly 
warm up to rt. After stirring at ambient temperature for 15 min, the mixture was titrated using 
iodine in order to determine its actual content in zinc species and the yield of the reaction.72 
 
2.5 TP5: Typical Procedure for the Preparation of the Organozinc Chlorides by 
Magnesium Insertion in the Presence of ZnCl2 
A dry and argon flushed Schlenk-flask equipped with a magnetic stirring bar and a septum was 
charged with anhydrous LiCl (159 mg, 3.75 mmol, 1.50 equiv), with anhydrous ZnCl2 
(409 mg, 3.00 mmol, 1.20 equiv), magnesium turnings (122 mg, 5.00 mmol, 2.00 equiv) and 
suspended in dry THF (5 mL). The aryl halide (2.50 mmol, 1.00 equiv) was added in one 
portion and the magnesium activated by gentle heating. After the exothermic reaction started, 
the reaction mixture was cooled to 25 °C and stirred for the indicated time. Upon completion 
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of the insertion the mixture was titrated using iodine in order to determine its actual content in 
zinc species and the yield of the reaction.91 
 
2.6 TP6: Typical Procedure for the Preparation of the Organozinc halides by 
Zinc Insertion 
A dry and argon flushed Schlenk-flask equipped with a magnetic stirring bar and a septum was 
charged with anhydrous LiCl (127 mg, 3.00 mmol, 1.20 equiv) and zinc dust (245 mg, 
3.75 mmol, 1.50 equiv) and suspended in dry THF (5 mL). Zinc was activated with 1,2-
dibromoethane (5 drops) and TMSCl (5 drops). Then, the aryl halide (2.50 mmol, 1.00 equiv) 
was added in one portion and the reaction mixture was stirred at the appropriate temperature 
for the indicated time. Upon completion of the insertion the mixture was filtered through a 
syringe filter and titrated using iodine in order to determine its actual content in zinc species 
and the yield of the reaction.21a 
 
2.7 TP7: Typical Procedure for the Preparation of the Organozinc Pivalates via 
Direct Metalation Using TMPMgCl·LiCl and Subsequent Transmetalation 
with Zn(OPiv)2 
A dry and argon flushed Schlenk-flask equipped with a magnetic stirring bar and a septum was 
charged with the aromatic substrate (3.00 mmol, 1.00 equiv) and dry THF (9 mL). The reaction 
mixture was put to the appropriate temperature, before TMPMgCl·LiCl (2.70 mL, 1.23 M, 
3.30 mmol, 1.10 equiv) was added dropwise. The progress of the deprotonation was monitored 
by GC-analysis of reaction aliquots quenched with I2. Upon completion of the metalation, solid 
Zn(OPiv)2 (963 mg, 3.60 mmol, 1.20 equiv) was added in one portion and the mixture was 
allowed to slowly warm up to 25 °C. After stirring at ambient temperature for 15 min, the 
solvent was carefully removed in vacuo. The dried material was titrated using iodine in order 
to determine its actual content in zinc species and the yield of the metalation. 
 
2.8 TP8: Typical Procedure for the Preparation of the Organozinc Pivalates via 
Direct Metalation Using TMPZnCl·Mg(OPiv)2·LiCl 
A dry and argon flushed Schlenk-flask equipped with a magnetic stirring bar and a septum was 
charged with the aromatic substrate (3.00 mmol, 1.00 equiv) and dry THF (9 mL). The reaction 
mixture was put to the appropriate temperature, before TMPZnCl·Mg(OPiv)2·LiCl (2.84 mL, 
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1.16 M, 3.30 mmol, 1.10 equiv) was added dropwise. The progress of the deprotonation was 
monitored by GC-analysis of reaction aliquots quenched with I2. Upon completion of the 
metalation, the solvent was carefully removed in vacuo. The dried material was titrated using 
iodine solution (1 M in THF) in order to determine its actual content in zinc species and the 
yield of the metalation. 
 
2.9 TP9: Typical Procedure for the Preparation of N-Hydroxylamine Benzoate 
Derivatives of Type 5 using Benzoyl Peroxide 
A dry and argon flushed flask equipped with a magnetic stirring bar and a septum was charged 
with K2HPO4 (1.31 g, 7.50 mmol, 1.50 equiv) and anhydrous benzoyl peroxide (1.21 g, 
5.00 mmol, 1.00 equiv). The mixture was suspended in DMF (20 mL) and amine (6.00 mmol, 
1.20 equiv) was added slowly. The reaction mixture was stirred at room temperature and 
checked by thin layer chromatography analysis. Upon full consumption of benzoyl peroxide, 
the reaction was quenched with sat. aqueous NH4Cl solution (30 mL). The organic layer was 
removed and the aqueous phase was extracted from EtOAc (3 x 15 mL). The combined organic 
layers were washed with sat. aqueous NaHCO3 solution (15 mL), brine (15 mL) and 
subsequent dried over mgSO4. Evaporation of the solvents in vacuo and purification by flash 
column chromatography afforded the desired products. 
 
2.10 TP10: Typical Procedure for the 1,4-Addition of Acrylonitrile to Secondary 
Amines 
A dry and argon flushed flask equipped with a magnetic stirring bar and a septum was charged 
with sodium metal (23 mg, 1.00 mmol, 1.00 equiv) and dissolved in dry MeOH (2 mL). In 
another dry and argon flushed flask equipped with a magnetic stirring bar and a septum, 
amine hydrochloride 14 (1.00 mmol, 1.00 equiv) was dissolved in dry MeOH (2 mL) and 
added to the previously prepared sodium methoxide solution. To the resulting solution, 
acrylonitrile (0.33 mL, 265 mg, 5.00 mmol, 5.00 equiv) was added and the reaction mixture 
was stirred at 55 °C overnight. The solvent was evaporated and the resulting crude purified by 
flash column chromatography to afford the desired product of type 17.86a 
In the case of non-hydrochloride amine starting materials, the addition of sodium methoxide 
is not necessary and can be overleaped. 
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2.11 TP11: Typical Procedure for the Preparation of N-Hydroxylamine 
Derivatives of Type 16 by Oxidation and Cope-Elimination 
A dry and argon flushed flask equipped with a magnetic stirring bar and a septum was charged 
with 1,4-addition product 17 (1.00 mmol, 1.00 equiv) and dissolved in dry CH2Cl2 (2 mL). The 
solution was cooled to −78 °C and mCPBA (190 mg, 1.10 mmol, 1.10 equiv) was added slowly 
as a solution in dry CH2Cl2 (2 mL). The mixture was stirred at −78 °C for 1 h. Following, the 
cooling bath was removed and the mixture stirred at 25 °C overnight. The solvent was removed 
and the acid by-product removed by filtration through a silica plug. After solvent removal, the 
resulting N-hydroxylamine was dissolved in CH2Cl2 (4 mL) followed by the addition of 
triethylamine (0.21 mL, 1.50 mmol, 1.50 equiv), DMAP (1 mg, 0.01 mmol, 1 mol%) and 
benzoyl chloride (168 mg, 1.20 mmol, 1.20 equiv) at 0 °C. The resulting solution was stirred 
at 0 °C for 1 h and quenched with sat. aqueous NH4Cl solution (2 mL). The mixture was 
extracted with EtOAc (3 x 5 mL) and the combined organic phases were washed with saturated 
NaHCO3 solution (2 mL), brine (2 mL), and dried over Na2SO4. The crude mixture was 
purified with flash column chromatography to afford the desired product.86a 
 
2.12 TP12: Typical Procedure for the Electrophilic Amination of Organozinc 
Pivalates with N-Hydroxylamine Derivatives 
A dry and argon flushed flask equipped with a magnetic stirring bar and a septum was charged 
with N-hydroxylamine benzoate derivative 5 (0.50 mmol, 1.00 equiv) and THF (2 mL). To the 
mixture CoCl2·2LiCl (13–25 µmol, 2.5–5.0 mol%) was added as a 1 M solution in THF. Then, 
presolved organozinc pivalate 1 (0.55 mmol, 1.10 equiv) in THF was added dropwise. The 
solution was stirred for 2 h at room temperature and the reaction progress checked by thin layer 
chromatography. Upon completion of starting material (approximately less than 2 h) the 
reaction was quenched with sat. aqueous NH4Cl solution (1 mL). The mixture was extracted 
from EtOAc (3 x 15 mL). The combined organic layers were washed with sat. aqueous 
NaHCO3 solution (15 mL), brine (15 mL) and subsequent dried over mgSO4. Evaporation of 
the solvents in vacuo and purification by flash column chromatography afforded the expected 
products. 
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2.13 TP13: Typical Procedure for the Electrophilic Amination of Organozinc 
Chlorides with N-Hydroxylamine Derivatives 
A dry and argon flushed flask equipped with a magnetic stirring bar and a septum was charged 
with N-hydroxylamine derivative 5 (0.50 mmol, 1.00 equiv) and THF (2 mL). To the mixture 
pre-dried CoCl2 (3–6 mg, 5.0–10 mol%) was added. Then, organozinc chloride 1 (0.75 mmol, 
1.50 equiv) in THF was added dropwise. The solution was stirred for 2 h at 25 °C and the 
reaction progress checked by thin layer chromatography. Upon completion of starting material 
(approximately less than 2 h) the reaction was quenched with sat. aqueous NH4Cl solution 
(1 mL). The mixture was extracted with EtOAc (3 x 15 mL). The combined organic layers were 
washed with sat. aqueous NaHCO3 solution (15 mL), brine (15 mL) and subsequent dried 
over mgSO4. Evaporation of the solvents in vacuo and purification by flash column 
chromatography afforded the expected products. 
 
2.14 TP14: Typical Procedure for the Electrophilic Amination by Reacting the 
Organozinc Chlorides with the Azides 
In a dry and argon flushed flask equipped with a magnetic stirring bar and a septum the azide 
(0.50 mmol, 1.0 equiv) was dissolved in dry THF (1 mL). First anhydrous FeCl3 (41 mg, 
0.25 mmol, 0.50 equiv) and then the organozinc chloride (0.875 mmol, 1.75 equiv) were added 
in one portion, respectively. The reaction was stirred at 50 °C for 1 h and subsequently quenched 
with sat. aqueous NH4Cl solution (5 mL). The mixture was extracted with EtOAc (3 × 10 mL). 
The combined org. layers were washed with sat. NaHCO3 solution (5 mL), brine (5 mL), and 
dried over Na2SO4. The crude product was finally purified by flash column chromatography. 
 
2.15 TP 15: General Preparation of N-thiophthalimides from Their 
Corresponding Thiol Using N-Chlorophthalimide 
A dry and argon flushed round bottom flask equipped with a magnetic stirring bar and a septum 
was charged with N-chlorophthalimide (908 mg, 5.00 mmol, 1.00 equiv), dry MeCN (2.6 mL) 
and pyridine (2.1 mL). The thiol (5.00 mmol, 1.00 equiv) in dry MeCN (2.6 mL) and dry 
pyridine (2.1 mL) was added dropwise at 0 °C over a period of 30 min and the resulting mixture 
was stirred for additional 30 min. After removal of most MeCN in vacuo, water (20 mL) was 
added dropwise at 0 °C over 10 min and stirred for a further period of 10 min. Filtration of the 
resulting suspension and washing of the filtrate with ice cold MeOH (3 × 5 mL) provide the 
corresponding N-thiophthalimide 50 in good yield. 
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2.16 TP 16: Preparation of Thioethers via a Cu(OAc)2·H2O Catalyzed 
Electrophilic Thiolation of Organozinc Reagents 
A dry and argon flushed reaction tube equipped with a magnetic stirring bar and a septum was 
charged with the selected N-thiophthalimide 40 (0.50 mmol, 1.00 equiv), Cu(OAc)2.H2O 
(5 mg, 25 μmol, 5.00 mol%) and dry THF (1 mL). The selected organometallic zinc reagent 1 
(0.55 mmol, 1.10 equiv) was added dropwise. The reaction mixture was stirred for 1 h at 25 °C 
and then quenched with aq. sat. NH4Cl. The aqueous phase was extracted with EtOAc 
(3×30 mL). The combined organic phases were dried over mgSO4 and concentrated in vacuo. 
The crude product was further purified by flash column chromatography on silica gel to provide 
the desired thioether 4. 
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3. Cobalt-Catalyzed Electrophilic Amination of Aryl- and 
Heteroaryl-Zinc Pivalates with N-Hydroxylamine Benzoates 
3.1 Comparison of PhZnCl and PhZnOPiv 
In order to study the advantage of using organozinc pivalates for cobalt-catalyzed amination, 
phenylzinc chloride in the presence of mgCl2 and phenylzinc pivalate were used with 
copper(II) or cobalt(II) as catalysts (Scheme 10). We have noticed that phenylzinc pivalate 
provided 10–15% more product under both catalysts. The pivalate reduced the amount of 
homodimer (biphenyl) formation in both cases. 
Table 10. Comparison between PhZnCl·MgCl2 and PhZnCl·Mg(OPiv)2 with copper or cobalt catalyst. 
 
 
3.2 Investigation of the Effect of TMPH on the Reactivity of Organozinc 
Pivalate Reagents Derived by Directed Metalation Using TMP-Bases 
We have observed, that organozinc pivalates prepared by directed metalation using TMP bases 
do not undergo the described electrophilic amination, but lead to an undefined mixture of 
products. However, the addition of 5.0 mol% tetramethylethylenediamine (TMEDA) is 
sufficient enough to restore the reactivity in the amination procedure (Scheme 52). TMEDA 
most likely acts as a ligand for the cobalt catalyst and we assume that this metal-ligand 
coordination protects the catalyst toward desactivation. 
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Scheme 52. Electrophilic amination of TMP metalation derived organozinc reagent 1h with and without 
5.0 mol% of TMEDA 
Further, we performed the reaction of phenylzinc pivalate with O-benzoyl hydroxylamine 5a 
in the presence of various additives. We observed, that the addition of 4.00 equiv of TMPH do 
not harm the reaction. Thus, residual TMPH seems not to be the origin for the reduced 
reactivity. However, the addition of 0.5 equiv TMPMgCl·LiCl also lead to a catalyst 
desactivation (Scheme 53). In summary, TMEDA coordination to the cobalt centre protects the 
catalyst if TMPMgCl·LiCl is used to generate the organozinc pivalate. 
 
Scheme 53. Background reaction for clarifying the origin of the hindered reactivity. 
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3.3 Preparation of Organozinc Pivalates 
Phenylzinc Pivalate (1a) 
 
A dry and argon flushed Schlenk-flask equipped with a magnetic stirring bar and a septum was 
charged with phenylmagnesium chloride (3.21 mL, 1.56 M, 5.00 mmol, 1.00 equiv). Solid 
Zn(OPiv)2 (1.61 g, 6.00 mmol, 1.20 equiv) was added in one portion while the temperature was 
maintained at 20 °C with a water bath. After stirring at ambient temperature for 15 min, the 
solvent was carefully removed in vacuo to afford phenylzinc pivalate (1a) (3.81 g) as a white 
solid. Titration with iodine gave 1.26 mmol/g concentration of active zinc species, 
corresponding to 96% yield. 
 
(4-Cyanophenyl)zinc Pivalate (1b) 
 
According to TP1 4-bromobenzonitrile (910 mg, 5.00 mmol) was dissolved in dry THF 
(15 mL) and iPrMgCl·LiCl (4.30 mL, 1.28 M, 5.50 mmol) was added. After stirring for 12 h at 
0 °C solid Zn(OPiv)2 (1.61 g, 6.00 mmol) was added and after evaporation of the solvent the 
arylzinc pivalate 1b (2.69 g) was obtained as a yellowish solid. Titration with iodine gave 
1.34 mmol/g concentration of active zinc species, corresponding to 72% yield. 
 
(4-(Trifluoromethyl)phenyl)zinc Pivalate (1c) 
 
According to TP1 1-bromo-3-(trifluoromethyl)benzene (563 mg, 2.50 mmol) was dissolved in 
dry THF (7.5 mL) and iPrMgCl·LiCl (2.15 mL, 1.28 M, 2.75 mmol) was added. After stirring 
for 4 h at 25 °C solid Zn(OPiv)2 (803 mg, 3.00 mmol) was added and after evaporation of the 
solvent the arylzinc pivalate 1c (2.25 g) was obtained as a yellowish solid. Titration with iodine 
gave 1.01 mmol/g concentration of active zinc species, corresponding to 91% yield. 
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(2-(Ethoxycarbonyl)-6-chlorophenyl)zinc Pivalate (1d) 
 
According to TP7, ethyl 3-chlorobenzoate (554 mg, 3.00 mmol) in dry THF (9 mL) was treated 
with TMPMgCl·LiCl (2.68 mL, 1.23 M, 3.30 mmol) for 6 h at 0 °C. After transmetalation with 
solid Zn(OPiv)2 (963 mg, 3.60 mmol) and careful evaporation of the solvent the arylzinc 
pivalate 1d (2.33 g) was obtained as a pale orange solid. Titration with iodine gave 
1.20 mmol/g concentration of active zinc species, corresponding to 93% yield. 
 
(4-Methoxyphenyl)zinc Pivalate (1e) 
 
According to TP1 1-iodo-4-methoxybenzene (1.17 g, 5.00 mmol) was dissolved in dry THF 
(15 mL) and iPrMgCl·LiCl (4.30 mL, 1.28 M, 5.50 mmol) was added. After stirring for 30 min 
at 0 °C solid Zn(OPiv)2 (1.61 g, 6.00 mmol) was added and after evaporation of the solvent the 
arylzinc pivalate 1e (4.22 g) was obtained as a white solid. Titration with iodine gave 
1.09 mmol/g concentration of active zinc species, corresponding to 92% yield. 
 
(3-Chloropyridin-2-yl)zinc Pivalate (1f) 
 
According to TP7 3-chloro-2-iodopyridine (837 mg, 3.00 mmol) was dissolved in dry THF 
(15 mL) and treated with TMPMgCl·LiCl (2.68 mL, 1.23 M, 3.30 mmol) for 6 h at 0 °C. After 
transmetalation with solid Zn(OPiv)2 (963 mg, 3.60 mmol) and careful evaporation of the 
solvent heteroarylzinc pivalate 1f (4.83 g) was obtained as a brownish solid. Titration with 
iodine gave 0.89 mmol/g concentration of active zinc species, corresponding to 86% yield.  
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Benzo[b]thiophen-3-ylzinc Pivalate (1g) 
 
According to TP3 3-bromobenzo[b]thiophene (1.07 g, 5.00 mmol) was added to mixture of 
magnesium turnings (304 mg, 12.5 mmol), LiCl (318 mg, 7.50 mmol) and dry THF (15 mL). 
After stirring for 3 h at 25 °C solid Zn(OPiv)2 (1.61 g, 6.00 mmol) was added and after 
evaporation of the solvent the arylzinc pivalate 1g (4.89 g) was obtained as a yellow solid. 
Titration with iodine gave 0.93 mmol/g concentration of active zinc species, corresponding to 
93% yield. 
 
(2,6-Dimethoxypyrimidin-4-yl)zinc Pivalate (1h) 
 
According to TP7, 2,6-dimethoxypyrimidine (420 mg, 3.00 mmol) in dry THF (9 mL) was 
treated with TMPMgCl·LiCl (2.68 mL, 1.23 M, 3.30 mmol) for 30 min at 25 °C. After 
transmetalation with solid Zn(OPiv)2 (963 mg, 3.60 mmol) and careful evaporation of the 
solvent the heteroarylzinc pivalate 1h (2.18 g) was obtained as a brown solid. Titration with 
iodine gave 1.17 mmol/g concentration of active zinc species, corresponding to 85% yield. 
 
(3-Formyl-1-methyl-1H-indol-2-yl)zinc Pivalate (1i) 
 
According to TP8 1-methyl-1H-indole-3-carbaldehyde (318 mg, 2.00 mmol) in dry THF 
(6 mL) reacted with TMPZnCl·Mg(OPiv)2·LiCl (1.90 mL, 1.16 M, 2.20 mmol) at 25 °C and 
stirred at this temperature for 30 min. After solvent removal in vacuo heteroarylzinc pivalate 
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1i (2.06 g) was obtained as a yellow solid. Titration with iodine gave 0.85 mmol/g 
concentration of active zinc species, corresponding to 88% yield. 
 
(4-(Ethoxycarbonyl)phenyl)zinc Pivalate (1j) 
 
According to TP1 ethyl 4-iodobenzoate (1.38 g, 5.00 mmol) was dissolved in dry THF (15 mL) 
and iPrMgCl·LiCl (4.30 mL, 1.28 M, 5.50 mmol) was added. After stirring for 30 min at -30 °C 
solid Zn(OPiv)2 (1.61 g, 6.00 mmol) was added and after evaporation of the solvent the 
arylzinc pivalate 1j (3.77 g) was obtained as a yellowish solid. Titration with iodine gave 
1.22 mmol/g concentration of active zinc species, corresponding to 92% yield. 
 
(3-Fluorophenyl)zinc Pivalate (1k) 
 
According to TP1 1-fluoro-3-iodobenzene (1.11 g, 5.00 mmol) was dissolved in 15 mL of dry 
THF and iPrMgCl·LiCl (4.30 mL, 1.28 M, 5.50 mmol) was added. After stirring for 30 min 
at -30 °C solid Zn(OPiv)2 (1.61 g, 6.00 mmol) was added and after evaporation of the solvent 
the arylzinc pivalate 1k (3.73 g) was obtained as a pale grey solid. Titration with iodine gave 
1.26 mmol/g concentration of active zinc species, corresponding to 94% yield. 
 
(2,2-Difluorobenzo[d][1,3]dioxol-5-yl)zinc Pivalate (1l) 
 
According to TP1 5-bromo-2,2-difluorobenzo[d][1,3]dioxole (1.19 g, 5.00 mmol) was 
dissolved in dry THF (15 mL) and iPrMgCl·LiCl (4.30 mL, 1.28 M, 5.50 mmol) was added. 
After stirring for 5 h at room temperature, solid Zn(OPiv)2 (1.61 g, 6.00 mmol) was added and 
after evaporation of the solvent the arylzinc pivalate 1l (4.13 g) was obtained as a pale grey 
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solid. Titration with iodine gave 0.98 mmol/g concentration of active zinc species, 
corresponding to 81% yield. 
 
(Pyridin-3-yl)zinc Pivalate (1m) 
 
According to TP1 3-bromopyridine (790 mg, 5.00 mmol) was dissolved in dry THF (15 mL) 
and iPrMgCl·LiCl (4.30 mL, 1.28 M, 5.50 mmol) was added. After stirring for 4 h at room 
temperature, solid Zn(OPiv)2 (1.61 g, 6.00 mmol) was added and after evaporation of the 
solvent the arylzinc pivalate 1m (3.78 g) was obtained as a pale grey solid. Titration with iodine 
gave 1.19 mmol/g concentration of active zinc species, corresponding to 90% yield. 
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3.4 Preparation of N-Hydroxylamine Benzoate Derivatives 
4-Benzoyloxy-morpholine (5a) 
 
According to TP9 dry benzoyl peroxide (1.21 g, 5.00 mmol) and K2HPO4 (1.31 g, 7.50 mmol) 
were suspended in dry DMF (20 mL). Morpholine (523 mg, 6.00 mmol) was slowly added and 
the resulting mixture was stirred for 3 h at room temperature. Purification of the crude product 
by flash chromatography (silica gel, isohexane/EtOAc = 1:1) afforded the title compound as a 
pale white solid (623 mg, 3.05 mmol, 61%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.03–7.98 (m, 2H), 7.60–7.54 (m, 1H), 7.47–7.41 (m, 
2H), 4.03–3.82 (m, 4H), 3.45 (d, J = 10.0 Hz, 2H), 3.10–2.99 (m, 2H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 164.6, 133.2, 129.4 (2C), 129.1, 128.5 (2C), 65.9 
(2C), 57.0 (2C). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3334, 3322, 3312, 2958, 2932, 2902, 2862, 1738, 1636, 
1602, 1578, 1538, 1490, 1452, 1436, 1378, 1308, 1292, 1256, 1248, 1178, 1168, 1156, 1102, 
1084, 1066, 1048, 1024, 1008, 858, 804, 708, 694, 678. 
m.p. (°C): 65.7–69.8. 
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N,N-Diallyl-O-benzoylhydroxylamine (5b) 
 
According to TP9 dry benzoyl peroxide (1.21 g, 5.00 mmol) and K2HPO4 (1.31 g, 7.50 mmol) 
were suspended in dry DMF (20 mL). Diallylamine (583 mg, 6.00 mmol) was slowly added 
and the resulting mixture stirred for 6 h at room temperature. Purification of the crude product 
by flash chromatography (silica gel, isohexane/EtOAc = 4:1) afforded the title compound as a 
yellow oil (684 mg, 3.15 mmol, 63%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.00–7.91 (m, 2H), 7.50 (tt, J = 7.5, 1.9 Hz, 1H), 7.38 
(dd, J = 8.4, 7.1 Hz, 2H), 5.98 (ddt, J = 16.9, 10.2, 6.6 Hz, 2H), 5.23 (dq, J = 17.2, 1.5 Hz, 2H), 
5.14 (dq, J = 10.3, 1.2 Hz, 2H), 3.62 (dt, J = 6.8, 1.3 Hz, 4H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 165.2, 132.9, 132.5 (2C), 129.3 (2C), 129.1, 128.3 
(2C), 119.4 (2C), 61.6 (2C). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3080, 2984, 2838, 1738, 1646, 1602, 1450, 1436, 1416, 
1314, 1280, 1238, 1176, 1082, 1062, 1024, 988, 922, 860, 818, 798, 706, 686. 
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4-Oxopiperidin-1-yl Benzoate (5c) 
 
According to TP9 dry benzoyl peroxide (1.21 g, 5.00 mmol) and K2HPO4 (1.31 g, 7.50 mmol) 
were suspended in dry DMF (20 mL). Piperidin-4-one (595 mg, 6.00 mmol) was slowly added 
and the resulting mixture stirred for 48 h at room temperature. Purification of the crude product 
by flash chromatography (silica gel, isohexane/EtOAc = 1:1) afforded the title compound as a 
colourless oil (307 mg, 1.40 mmol, 28%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.05–8.00 (m, 2H), 7.63–7.58 (tt, J = 7.5, 1.3 Hz 1H), 
7.5–7.44 (m, 2H), 3.57 (s, 4H), 2.71 (t, J = 6.3 Hz, 4H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 206.1, 164.6, 133.5, 129.5 (2C), 128.8 128.6 (2C), 
55.4 (2C), 38.6 (2C). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2972, 2846, 1716, 1600, 1450, 1412, 1366, 1348, 1314, 
1274, 1242, 1212, 1178, 1148, 1110, 1082, 1060, 1024, 998, 870, 764, 706, 688, 668. 
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N-Allyl-O-benzoyl-N-cyclopentylhydroxylamine (5d) 
 
According to TP9 dry benzoyl peroxide (1.21 g, 5.00 mmol) and K2HPO4 (1.31 g, 7.50 mmol) 
were suspended in dry DMF (20 mL). N-allylcyclopentanamine (751 mg, 6.00 mmol) was 
slowly added and the resulting mixture stirred for 6 h at room temperature. Purification of the 
crude product by flash chromatography (silica gel, isohexane/EtOAc = 9:1) afforded the title 
compound as a colourless oil (920 mg, 3.75 mmol, 75%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.01–7.96 (m, 2H), 7.53 (tt, J = 7.6, 1.8 Hz 1H), 7.44–
7.38 (m, 2H), 6.02 (ddt, J = 16.9, 10.2, 6.7 Hz, 1H), 5.20 (dq, J = 17.2, 1.5 Hz, 1H), 5.11 (dq, 
J = 10.2, 1.2 Hz, 1H), 3.72–3.54 (m, 2H), 3.47 (p, J = 7.5 Hz, 1H), 1.89–1.50 (m, 8H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 165.6, 133.0, 132.9, 129.4 (2C), 129.3, 128.4 (2C), 
119.2, 68.3, 61.3, 29.8 (2C), 24.6 (2C). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2960, 2870, 1740, 1450, 1314, 1258, 1238, 1176, 1082, 
1060, 1024, 992, 972, 922, 816, 798, 706, 688, 672. 
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(S)-O-Benzoyl-N-methyl-N-(1-phenylethyl)hydroxylamine (5e) 
 
According to TP9 dry benzoyl peroxide (1.21 g, 5.00 mmol) and K2HPO4 (1.31 g, 7.50 mmol) 
were suspended in dry DMF (20 mL). (S)-N-methyl-1-phenylethan-1-amine (811 mg, 
6.00 mmol) was slowly added and the resulting mixture stirred for 3 h at room temperature. 
Purification of the crude product by flash chromatography (silica gel, isohexane/EtOAc = 3:2) 
afforded the title compound as a colourless oil (574 mg, 2.25 mmol, 45%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.97–7.86 (m, 2H), 7.55 (t, J = 7.5 Hz, 1H), 7.48–
7.39 (m, 4H), 7.35 (t, J = 7.5 Hz, 2H), 7.31–7.25 (m, 1H), 4.09 (q, J = 6.6 Hz, 1H), 2.83 (s, 
3H), 1.54 (d, J = 6.6 Hz, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 165.2, 141.4, 132.9, 129.4 (2C), 128.6, 128.4 (2C), 
128.4 (2C), 127.8 (2C), 127.7, 68.7, 44.4, 20.1. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3062, 3032, 2980, 1740, 1700, 1684, 1602, 1494, 1452, 
1372, 1314, 1248, 1192, 1176, 1080, 1060, 1024, 1004, 916, 868, 760, 702, 672. 
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N-Allyl-O-benzoyl-N-methylhydroxylamine (5f) 
 
According to TP9 dry benzoyl peroxide (1.21 g, 5.00 mmol) and K2HPO4 (1.31 g, 7.50 mmol) 
were suspended in dry DMF (20 mL). N-methylprop-2-en-1-amine (427 mg, 6.00 mmol) was 
slowly added and the resulting mixture stirred for 6 h at room temperature. Purification of the 
crude product by flash chromatography (silica gel, isohexane/EtOAc = 6:1) afforded the title 
compound as a brownish oil (717 mg, 3.75 mmol, 75%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.94 (d, J = 8.5 Hz, 2H), 7.53–7.46 (m, 1H), 7.41–
7.34 (m, 2H), 6.01–5.89 (m, 1H), 5.27–5.11 (m, 2H), 3.58 (d, J = 6.6 Hz, 2H), 2.84 (d, 
J = 1.6 Hz, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 165.0, 132.9, 132.4, 129.3 (2C), 128.3 (2C), 127.9, 
119.3, 63.8, 46.1. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3072, 2968, 2880, 1736, 1602, 1450, 1314, 1264, 1244, 
1204, 1176, 1086, 1056, 1024, 994, 976, 926, 862, 814, 796, 706, 688, 678. 
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3.5 Preparation of N-Hydroxylaniline Derivatives 
Additional Information 
All O-hydroxylaniline derivatives of type 5 are not stable at room temperature and will 
decompose within minutes. Thus, all samples were dried at 0 °C in vacuo and instantly after 
solvent removal resolved in dry THF to obtain a stock solution of known concentration. In 
solution all prepared N-hydroxylaniline derivatives of type 5 are sufficiently stable at 0 °C (at 
least for 2 weeks). 
 
N-(4-Fluorophenyl)hydroxylamine71b 
 
A flask equipped with a magnetic stirring bar and a septum was charged with NH4Cl (1.07 g, 
20.0 mmol, 1.00 equiv) and 1-fluoro-4-nitrobenzene (2.82 g, 20.0 mmol, 1.00 equiv). The 
mixture was suspended in water (50 mL) and zinc dust (1.44 g, 22.0 mmol, 1.10 equiv) was 
added slowly. The reaction mixture was stirred for 40 min at 70 °C and subsequent filtered 
through a glass frit. The filtrate was extracted from diethyl ether (3 x 35 mL) and the combined 
organic layers were dried over mgSO4. Evaporation of the solvents in vacuo gave the crude 
product as brown solid. The title compound was used without further purification. 
 
N-(m-Tolyl)hydroxylamine71a 
 
A dry and argon flushed flask equipped with a magnetic stirring bar and a septum was charged 
with 5% rhodium on activated aluminium oxide (105 mg, 0.30 mol% Rh) and 1-methyl-3-
nitrobenzene (686 mg, 5.00 mmol, 1.00 equiv). The mixture was suspended in dry THF 
(10 mL) and hydrazine monohydrate (300 mg, 6.0 mmol, 1.2 equiv) was added dropwise while 
maintaining the temperature below 0 °C. The reaction mixture was stirred for 20 min at 0 °C 
and subsequent filtered through kieselguhr. The filtrate was concentrated in vacuo to give the 
crude product as yellow solid. The title compound was used without further purification. 
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N-Ethyl-N-phenylhydroxylamine 
 
A dry and argon flushed flask equipped with a magnetic stirring bar and a septum was charged 
with N-phenylhydroxylamine (327 mg, 3.00 mmol, 1.00 equiv) and dissolved in dry methanol 
(10 mL). Acetaldehyde (264 mg, 6 mmol, 2.00 equiv) was added at 0 °C. The resulting mixture 
was stirred for 5 min at 0 °C and subsequent NaBH4 (114 mg, 3.00 mmol, 1.00 equiv) was 
added. The suspension was stirred at 0 °C and checked by thin layer chromatography analysis. 
After full consumption of starting material (after 45 min) the reaction was quenched with sat. 
aqueous NH4Cl solution (10 mL). The organic layer was removed and the aqueous phase was 
extracted from EtOAc (3 x 10 mL). The combined organic layers were dried over mgSO4 and 
concentrated in vacuo. Purification of the crude product by flash chromatography (silica gel, 
isohexane/EtOAc = 9:1) afforded the title compound as a yellow oil (249 mg, 1.82 mmol, 
61%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.33–7.27 (m, 2H), 7.19–7.14 (m, 2H), 7.02 (tt, 
J = 7.2, 1.2 Hz, 1H), 6.84 (s, 1H), 3.32 (q, J = 7.0 Hz, 2H), 1.20 (t, J = 7.0 Hz, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 152.5, 128.7 (2C), 122.7, 117.4 (2C), 54.3, 11.3. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3240, 3064, 2974, 2938, 2874, 1596, 1488, 1452, 1378, 
1222, 1128, 1076, 1058, 1030, 910, 756, 732, 692. 
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N-Ethyl-N-(4-fluorophenyl)hydroxylamine 
 
A dry and argon flushed flask equipped with a magnetic stirring bar and a septum was charged 
with crude N-(4-fluorophenyl)hydroxylamine (324 mg, 2.55 mmol, 1.00 equiv) and dissolved 
in dry methanol (10 mL). Acetaldehyde (225 mg, 5.10 mmol, 2.00 equiv) was added at 0 °C. 
The resulting mixture was stirred for 5 min at 0 °C and subsequent NaBH4 (96 mg, 2.55 mmol, 
1.00 equiv) was added. The suspension was stirred at 0 °C and checked by thin layer 
chromatography analysis. After full consumption of starting material (after 1 h) the reaction 
was quenched with sat. aqueous NH4Cl solution (10 mL). The organic layer was removed and 
the aqueous phase was extracted from EtOAc (3 x 10 mL). The combined organic layers were 
dried over mgSO4 and concentrated in vacuo. Purification of the crude product by flash 
chromatography (silica gel, isohexane/EtOAc = 9:1) afforded the title compound as a 
colourless oil (253 mg, 1.63 mmol, 64%). 
1H-NMR (400 MHz, Acetone-d6): δ / ppm = 7.95 (s, 1H), 7.17–7.11 (m, 2H), 7.03–6.97 (m, 
2H), 3.29 (q, J = 7.0 Hz, 2H), 1.15 (t, J = 7.0 Hz, 3H). 
13C-NMR (101 MHz, Acetone-d6): δ / ppm = 157.65 (d, J = 236.9 Hz), 150.23 (d, J = 2.2 Hz), 
117.68 (d, J = 7.7 Hz, 2C), 114.67 (d, J = 22.3 Hz, 2C), 53.24 , 10.79. 
19F NMR (377 MHz, Acetone-d6): δ / ppm = -126.1. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3060, 2978, 2348, 2308, 2174, 1988, 1720, 1598, 1494, 
1384, 1376, 1072, 756, 694. 
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N-Ethyl-N-(m-tolyl)hydroxylamine 
 
A dry and argon flushed flask equipped with a magnetic stirring bar and a septum was charged 
with crude N-(m-tolyl)hydroxylamine (554 mg, 4.50 mmol, 1.00 equiv) and dissolved in dry 
methanol (10 mL). Acetaldehyde (396 mg, 9.00 mmol, 2.00 equiv) was added at 0 °C. The 
resulting mixture was stirred for 5 min at 0 °C and subsequent NaBH4 (170 mg, 4.50 mmol, 
1.00 equiv) was added. The suspension was stirred at 0 °C and checked by thin layer 
chromatography analysis. After full consumption of starting material (after 1 h) the reaction 
mixture was quenched with sat. aqueous NH4Cl solution (10 mL). The organic layer was 
removed and the aqueous phase was extracted from EtOAc (3 x 10 mL). The combined organic 
layers were dried over mgSO4 and concentrated in vacuo. Purification of the crude product by 
flash chromatography (silica gel, isohexane/EtOAc = 4:1) afforded the title compound as a 
colourless oil (447 mg, 2.88 mmol, 64%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.17 (t, J = 7.8 Hz, 1H), 7.02–6.90 (m, 2H), 6.82 (d, 
J = 7.5 Hz, 1H), 6.12 (s, 1H), 3.32 (q, J = 7.0 Hz, 2H), 2.33 (s, 3H), 1.21 (t, J = 7.0 Hz, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 150.0, 138.7, 128.5, 125.0, 118.8, 115.1, 53.4, 21.6, 
11.3. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2988, 1752, 1712, 1614, 1607, 1586, 1575, 1503 1489, 
1454, 1338, 1276, 1251, 1203, 1120, 1103, 1081, 904, 819, 789, 768, 705, 627. 
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O-Benzoyl-N-ethyl-N-phenylhydroxylamine (5g) 
 
A dry and argon flushed flask equipped with a magnetic stirring bar and a septum was charged 
with N-ethyl-N-phenylhydroxylamine (249 mg, 1.82 mmol, 1.00 equiv) and dissolved in dry 
dichloromethane (10 mL). Triethylamine (184 mg, 1.82 mmol, 1.00 equiv) was added at 0 °C. 
The resulting mixture was stirred for 5 min at 0 °C and subsequent benzoyl chloride (256 mg, 
1.82 mmol, 1.00 equiv) was added. The solution was stirred at 0 °C and checked by thin layer 
chromatography analysis. After full consumption of starting material (after 1.5 h) the reaction 
mixture was quenched with sat. aqueous NH4Cl solution (10 mL). The organic layer was 
removed and the aqueous phase was extracted from EtOAc (3 x 10 mL). The combined organic 
layers were dried over Na2SO4 and concentrated in vacuo. Purification of the crude product by 
flash chromatography (neutral alumina, isohexane/EtOAc = 9:1) afforded the title compound 
as a colourless oil (229 mg, 0.95 mmol, 52%). 
1H-NMR (400 MHz, Acetone-d6): δ / ppm = 8.16–8.12 (m, 2H), 7.70 (tt, J = 7.0, 1.3 Hz 1H), 
7.61–7.55 (m, 2H), 7.37–7.31 (m, 2H), 7.16–7.11 (m, 2H), 7.18 (tt, J = 7.5, 1.0 Hz, 1H), 3.65 
(q, J = 7.0 Hz, 2H), 1.22 (t, J = 7.0 Hz, 3H). 
13C-NMR (101 MHz, Acetone-d6): δ / ppm = 165.0, 151.4, 134.4, 130.3 (3C), 129.9 (2C), 
129.8 (2C), 124.4, 118.4 (2C), 53.5, 11.7. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3064, 2982, 2940, 1748, 1598, 1586, 1490, 1450, 1382, 
1316, 1294, 1240, 1178, 1160, 1134, 1100, 1078, 1054, 1024, 1002, 862, 756, 708, 694, 672. 
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O-Benzoyl-N-ethyl-N-(4-fluorophenyl)hydroxylamine (5h) 
 
A dry and argon flushed flask equipped with a magnetic stirring bar and a septum was charged 
with N-ethyl-N-(4-fluorophenyl)hydroxylamine (253 mg, 1.63 mmol, 1.00 equiv) and 
dissolved in dry dichloromethane (10 mL). Triethylamine (165 mg, 1.63 mmol, 1.00 equiv) 
was added at 0 °C. The resulting mixture was stirred for 5 min at 0 °C and subsequent benzoyl 
chloride (229 mg, 1.63 mmol, 1.00 equiv) was added. The solution was stirred at 0 °C and 
checked by thin layer chromatography analysis. After full consumption of starting material 
(after 1.5 h) the reaction was quenched with sat. aqueous NH4Cl solution (10 mL). The organic 
layer was removed and the aqueous phase was extracted from EtOAc (3 x 10 mL). The 
combined organic layers were dried over Na2SO4 and concentrated in vacuo. Purification of 
the crude product by flash chromatography (neutral alumina, isohexane/EtOAc = 9:1) afforded 
the title compound as a pale yellow oil (246 mg, 0.95 mmol, 58%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.01–7.96 (m, 2H), 7.78 (tt, J = 7.6, 2.0 Hz, 1H), 
7.61–7.54 (m, 2H), 6.92–6.86 (m, 2H), 6.66–6.61 (m, 2H), 3.10 (q, J = 6.4 Hz, 2H), 1.25 (t, J 
= 6.4 Hz, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 166.1, 162.5 (d, J = 251 Hz), 147.6, 133.4, 129.6 
(2C), 129.1 (2C), 127.4, 119.5 (d, J = 8.5 Hz, 2C), 114.8 (d, J = 8.3 Hz, 2C), 48.0, 13.0. 
19F NMR (377 MHz, CDCl3): δ / ppm = -125.8. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3068, 2978, 1614, 1574, 1522, 1508, 1448, 1436, 1422, 
1380, 1318, 1292, 1258, 1156, 1122, 976, 852, 790, 700. 
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O-Benzoyl-N-ethyl-N-(m-tolyl)hydroxylamine (5i) 
 
A dry and argon flushed flask equipped with a magnetic stirring bar and a septum was charged 
with N-ethyl-N-(m-tolyl)hydroxylamine (447 mg, 2.88 mmol, 1.00 equiv) and dissolved in dry 
dichloromethane (10 mL). Triethylamine (291 mg, 2.88 mmol, 1.00 equiv) was added at 0 °C. 
The resulting mixture was stirred for 5 min at 0 °C and subsequent benzoyl chloride (405 mg, 
2.88 mmol, 1.00 equiv) was added. The solution was stirred at 0 °C and checked by thin layer 
chromatography analysis. After full consumption of starting material (after 1.5 h) the reaction 
was quenched with sat. aqueous NH4Cl solution (10 mL). The organic layer was removed and 
the aqueous phase was extracted from EtOAc (3 x 10 mL). The combined organic layers were 
dried over Na2SO4 and concentrated in vacuo. Purification of the crude product by flash 
chromatography (neutral alumina, isohexane/EtOAc = 9.5:0.5) afforded the title compound as 
a yellow oil (398 mg, 1.56 mmol, 54%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.15–8.10 (m, 2H), 7.62 (tt, J = 7.5, 1.8 Hz, 1H), 
7.52–7.47 (m, 2H), 7.23–7.17 (m, 1H), 7.01–6.96 (m, 2H), 6.91 (d, J = 7.6 Hz, 1H), 3.61 (q, J 
= 7.0 Hz, 2H), 2.33 (s, 3H), 1.26 (t, J = 7.1 Hz, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 165.0, 150.1, 138.8, 133.4, 129.7 (2C), 128.9, 128.8, 
128.6 (2C), 125.1, 118.9, 115.2, 53.5, 21.7, 11.4. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2978, 2936, 1742, 1700, 1624, 1616, 1602, 1576, 1560, 
1518, 1488, 1450, 1408, 1378, 1316, 1286, 1242, 1204, 1178, 1166, 1128, 1104, 1080, 1056, 
1024, 906, 818, 780, 728, 708, 672. 
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3.6 Preparation of Amination Products of type 2 
4-Phenylmorpholine (2a) 
 
According to TP12 4-benzoyloxy-morpholine (5a, 104 mg, 0.50 mmol) was dissolved in dry 
THF (2 mL). CoCl2·2LiCl (13 µL, 1.00 M, 2.5 mol%) was added and subsequent phenylzinc 
pivalate (1a, 437 mg, 1.26 mmol/g, 0.55 mmol) was added dropwise and the resulting mixture 
was stirred for 2 h at room temperature. Purification of the crude product by flash 
chromatography (silica gel, isohexane/EtOAc = 9:1) afforded the title compound as a 
colourless oil (76 mg, 0.47 mmol, 93%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.30 (t, J = 7.9 Hz, 2H), 6.97–6.87 (m, 3H), 3.88 (t, 
J = 5.3 Hz, 4H), 3.17 (t, J = 4.9 Hz, 4H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 151.2, 129.2 (2C), 120.1, 115.8 (2C), 66.9 (2C), 49.4 
(2C). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2964, 2892, 2856, 2824, 1624, 1616, 1600, 1578, 1560, 
1496, 1450, 1418, 1406, 1380, 1364, 1332, 1304, 1262, 1234, 1122, 1068, 926, 758, 740, 722, 
692. 
MS (EI, 70 eV): m/z (%) = 163 (56), 132 (21), 105 (100), 77 (54). 
HRMS (EI): m/z calc. for [C10H13NO]: 163.0997; found 163.0992. 
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4-Morpholinobenzonitrile (2b) 
 
According to TP12 4-benzoyloxy-morpholine (5a, 104 mg, 0.50 mmol) was dissolved in dry 
THF (2 mL). CoCl2·2LiCl (13 µL, 1.00 M, 2.5 mol%) was added and subsequent 
(4-cyanophenyl)zinc pivalate (1b, 410 mg, 1.34 mmol/g, 0.55 mmol) was added dropwise and 
the resulting mixture was stirred for 2 h at room temperature. Purification of the crude product 
by flash chromatography (silica gel, isohexane/EtOAc = 9:1) afforded the title compound as a 
pale white solid (88 mg, 0.47 mmol, 93%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.57–7.45 (m, 2H), 6.89–6.82 (m, 2H), 3.84 (t, J = 5.3 
Hz, 4H), 3.27 (t, J = 5.1 Hz, 4H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 153.5, 133.5 (2C), 119.9, 114.1 (2C), 100.9, 66.5 
(2C), 47.3 (2C). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2982, 2974, 2926, 2898, 2872, 2858, 2832, 2216, 1604, 
1516, 1452, 1440, 1384, 1364, 1306, 1296, 1266, 1244, 1222, 1196, 1180, 1112, 1074, 1062, 
1048, 1026, 1006, 926, 852, 834, 814, 782, 718, 680. 
MS (EI, 70 eV): m/z (%) = 188 (49), 129 (100), 101 (33). 
HRMS (EI): m/z calc. for [C11H12N2O]: 188.0950; found 188.0944. 
m.p. (°C): 120.8–121.4. 
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4-(3-(Trifluoromethyl)phenyl)morpholine (2c) 
 
According to TP12 4-benzoyloxy-morpholine (5a, 104 mg, 0.50 mmol) was dissolved in dry 
THF (2 mL). CoCl2·2LiCl (13 µL, 1.00 M, 2.5 mol%) was added and subsequent 
(4-(trifluoromethyl)phenyl)zinc pivalate (1c, 545 mg, 1.01 mmol/g, 0.55 mmol) was added 
dropwise and the resulting mixture was stirred for 2 h at room temperature. Purification of the 
crude product by flash chromatography (silica gel, isohexane/EtOAc = 9:1) afforded the title 
compound as a pale white solid (114 mg, 0.50 mmol, 99%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.39 (td, J = 8.1, 0.9 Hz, 1H), 7.16–7.12 (m, 2H), 
7.08 (dd, J = 8.3, 2.5 Hz, 1H), 3.87 (t, J = 4.8 Hz, 4H), 3.20 (t, J = 4.8 Hz, 4H). 
 13C-NMR (101 MHz, CDCl3): δ / ppm = 151.4, 131.5 (q, J = 31.8 Hz), 129.6, 124.3 (d, 
J = 272.4 Hz), 118.5, 116.2 (q, J = 3.8 Hz), 111.9 (q, J = 3.9 Hz), 66.7 (2C), 48.7 (2C). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3332, 1712, 1698, 1638, 1610, 1590, 1496, 1448, 1354, 
1320, 1310, 1294, 1266, 1236, 1162, 1116, 1100, 1074, 994, 948, 860, 786, 728, 696. 
MS (EI, 70 eV): m/z (%) = 231 (65), 173 (100), 145 (27), 57 (12). 
HRMS (EI): m/z calc. for [C11H12F3NO]: 231.0871; found 231.0865. 
m.p. (°C): 55.1 - 58.8. 
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Ethyl 3-chloro-2-morpholinobenzoate (2d) 
 
According to TP12 4-benzoyloxy-morpholine (5a, 104 mg, 0.50 mmol) was dissolved in dry 
THF (2 mL). CoCl2·2LiCl (13 µL, 1.00 M, 2.5 mol%) and tetramethylethylenediamine (3.7 µL, 
5.0 mol%) was added and subsequent (2-(ethoxycarbonyl)-6-chlorophenyl)zinc pivalate (1d, 
458 mg, 1.20 mmol/g, 0.55 mmol) was added dropwise and the resulting mixture was stirred 
for 2 h at room temperature. Purification of the crude product by flash chromatography (silica 
gel, isohexane/EtOAc = 9:1) afforded the title compound as a yellowish oil (109 mg, 
0.50 mmol, 81%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.46 (dd, J = 7.9, 1.6 Hz, 1H), 7.39 (dd, J = 7.7, 
1.6 Hz, 1H), 7.06 (t, J = 7.8 Hz, 1H), 4.39 (q, J = 7.1 Hz, 2H), 3.79 (t, J = 4.8 Hz, 4H), 3.16 (t, 
J = 4.8 Hz, 4H), 1.41 (t, J = 7.1 Hz, 3H). 
 13C-NMR (101 MHz, CDCl3): δ / ppm = 168.4, 146.4, 133.9, 133.0, 132.6, 128.2, 125.0, 67.8 
(2C), 61.8, 50.4 (2C), 14.5. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2966, 2858, 2254, 1722, 1460, 1444, 1374, 1288, 1268, 
1250, 1228, 1208, 1148, 1110, 1044, 940, 904, 724. 
MS (EI, 70 eV): m/z (%) = 269 (26), 240 (68), 182 (100). 
HRMS (EI): m/z calc. for [C13H16ClNO3]: 269.0819; found 269.0822. 
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4-(4-Methoxyphenyl)morpholine (2e) 
 
According to TP12 4-benzoyloxy-morpholine (5a, 104 mg, 0.50 mmol) was dissolved in dry 
THF (2 mL). CoCl2·2LiCl (13 µL, 1.00 M, 2.5 mol%) was added and subsequent 
(4-methoxyphenyl)zinc pivalate (1e, 505 mg, 1..09 mmol/g, 0.55 mmol) was added dropwise 
and the resulting mixture was stirred for 2 h at room temperature. Purification of the crude 
product by flash chromatography (silica gel, isohexane/EtOAc = 9:1) afforded the title 
compound as a pale white solid (93 mg, 0.48 mmol, 96%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 6.94–6.84 (m, 4H), 3.87 (t, J = 4.8 Hz, 4H), 3.77 (s, 
3H), 3.06 (t, J = 4.8 Hz, 4H). 
 13C-NMR (101 MHz, CDCl3): δ / ppm = 154.0, 145.5, 117.9 (2C), 114.5 (2C), 67.0, 55.6 
(2C), 50.9 (2C). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2972, 2908, 2888, 2854, 2836, 2816, 1724, 1674, 1512, 
1464, 1452, 1424, 1382, 1364, 1330, 1292, 1264, 1244, 1228, 1214, 1184, 1172, 1152, 1118, 
1068, 1052, 1028, 926, 860, 850, 816, 806, 796, 716, 702. 
MS (EI, 70 eV): m/z (%) = 193 (71), 135 (100), 120 (59), 71 (14). 
HRMS (EI): m/z calc. for [C11H15NO2]: 193.1103; found 193.1088. 
m.p. (°C): 61.9–65.2. 
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4-(3-Chloropyridin-2-yl)morpholine (2f) 
 
According to TP12 4-benzoyloxy-morpholine (5a, 104 mg, 0.50 mmol) was dissolved in dry 
THF (2 mL). CoCl2·2LiCl (13 µL, 1.00 M, 2.5 mol%) and tetramethylethylenediamine (3.7 µL, 
5.0 mol%) was added and subsequent (3-chloropyridin-2-yl)zinc pivalate (1f, 618 mg, 
0.89 mmol/g, 0.55 mmol) was added dropwise and the resulting mixture was stirred for 2 h at 
room temperature. Purification of the crude product by flash chromatography (silica gel, 
isohexane/EtOAc = 9:1) afforded the title compound as a pale white solid (98 mg, 0.50 mmol, 
99%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.18 (dd, J = 4.8, 1.7 Hz, 1H), 7.58 (dd, J = 7.7, 
1.7 Hz, 1H), 6.85 (dd, J = 7.7, 4.7 Hz, 1H), 3.85 (t, J = 4.6 Hz, 4H), 3.35 (t, J = 4.9 Hz, 4H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 158.2, 145.9, 138.9, 122.7, 118.2, 66.9 (2C), 49.5 
(2C). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2960, 2900, 2854, 1574, 1464, 1450, 1428, 1422, 1366, 
1344, 1322, 1308, 1276, 1268, 1258, 1246, 1236, 1224, 1212, 1156, 1108, 1082, 1070, 1046, 
1032, 940, 924, 908, 846, 798, 778, 760, 696. 
MS (EI, 70 eV): m/z (%) = 198 (44), 140 (69), 23 (100). 
HRMS (EI): m/z calc. for [C9H11ClN2O]: 198.0560; found 198.0554. 
m.p. (°C): 132.1–132.8. 
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4-(Benzo[b]thiophen-3-yl)morpholine (2g) 
 
According to TP12 4-benzoyloxy-morpholine (5a, 104 mg, 0.50 mmol) was dissolved in dry 
THF (2 mL). CoCl2·2LiCl (13 µL, 1.00 M, 2.5 mol%) was added and subsequent 
benzo[b]thiophen-3-ylzinc pivalate (1g, 591 mg, 0.93 mmol/g, 0.55 mmol) was added 
dropwise and the resulting mixture was stirred for 12 h at room temperature. Purification of the 
crude product by flash chromatography (silica gel, isohexane/EtOAc = 9:1) afforded the title 
compound as a yellowish oil (92 mg, 0.42 mmol, 84%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.79 (ddd, J = 20.0, 6.7, 2.6 Hz, 2H), 7.41–7.33 (m, 
2H), 6.64 (s, 1H), 3.95 (t, J = 4.8 Hz, 4H), 3.15 (t, J = 4.9 Hz, 4H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 146.7, 139.4, 134.4, 124.7, 123.7, 123.4, 121.8, 
107.3, 67.1 (2C), 52.9 (2C). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2958, 2918, 2890, 2854, 2822, 1520, 1450, 1430, 1368, 
1356, 1282, 1260, 1190, 1116, 1020, 902, 760, 736. 
MS (EI, 70 eV): m/z (%) = 219 (71), 161 (50), 111 (26), 57 (100). 
HRMS (EI): m/z calc. for [C12H13NOS]: 219.0718; found 219.0706. 
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4-(2,6-Dimethoxypyrimidin-4-yl)morpholine (2h) 
 
According to TP12 4-benzoyloxy-morpholine (5a, 104 mg, 0.50 mmol) was dissolved in dry 
THF (2 mL). CoCl2·2LiCl (13 µL, 1.00 M, 2.5 mol%) and tetramethylethylenediamine (3.7 µL, 
5.0 mol%) was added and subsequent (2,6-dimethoxypyrimidin-4-yl)zinc pivalate (1h, 
470 mg, 1.17 mmol/g, 0.55 mmol) was added dropwise and the resulting mixture was stirred 
for 2 h at room temperature. Purification of the crude product by flash chromatography (silica 
gel, isohexane/EtOAc = 9:1) afforded the title compound as a pale white solid (102 mg, 
0.46 mmol, 91%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.00 (s, 1H), 3.65 (s, 3H), 3.64 (s, 3H), 3.52–3.48 (t, 
J = 5.1 Hz, 4H), 3.29 (t, J = 5.3 Hz, 4H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 171.5, 164.4, 163.8, 78.3, 65.5 (2C), 53.2, 52.6, 43.6 
(2C). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2954, 2924, 2854, 1586, 1494, 1460, 1378, 1312, 1280, 
1272, 1084, 910, 878, 840, 786, 686. 
MS (EI, 70 eV): m/z (%) = 225 (94), 168 (100), 105 (84), 77 (26). 
HRMS (EI): m/z calc. for [C10H15N3O3]: 225.1113; found 225.1110. 
m.p. (°C): 184.3–190.1. 
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1-Methyl-2-morpholino-1H-indole-3-carbaldehyde (2i) 
 
According to TP12 4-benzoyloxy-morpholine (5a, 104 mg, 0.50 mmol) was dissolved in dry 
THF (2 mL). CoCl2·2LiCl (13 µL, 1.00 M, 2.5 mol%) and tetramethylethylenediamine (3.7 µL, 
5.0 mol%) was added and subsequent (3-formyl-1-methyl-1H-indol-2-yl)zinc pivalate (1i, 
647 mg, 0.85 mmol/g, 0.55 mmol) was added dropwise and the resulting mixture was stirred 
for 2 h at room temperature. Purification of the crude product by flash chromatography (silica 
gel, isohexane/EtOAc = 9:1) afforded the title compound as a pale white solid (99 mg, 
0.40 mmol, 80%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 10.33 (s, 1H), 8.30–8.24 (m, 1H), 7.31–7.21 (m, 3H), 
3.91 (t, J = 4.4 Hz, 4H), 3.67 (s, 3H), 3.42 (t, J = 4.4 Hz, 4H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 183.3, 154.9, 134.9, 125.2, 123.3, 123.0, 121.4, 
109.3, 108.7, 67.4 (2C), 52.7 (2C), 29.9. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2964, 2890, 2852, 1634, 1610, 1580, 1526, 1470, 1444, 
1414, 1394, 1362, 1326, 1310, 1264, 1250, 1114, 1068, 1040, 978, 864, 810, 750, 740. 
MS (EI, 70 eV): m/z (%) = 244 (87), 227 (100), 158 (60). 
HRMS (EI): m/z calc. for [C14H16N2O2]: 244.1212; found 244.1199. 
m.p. (°C): 198.1–200.5. 
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Ethyl 4-(diallylamino)benzoate (2j) 
 
According to TP12 N,N-diallyl-O-benzoylhydroxylamine (5b, 109 mg, 0.50 mmol) was 
dissolved in dry THF (2 mL). CoCl2·2LiCl (13 µL, 1.00 M, 2.5 mol%) was added and 
subsequent (4-(ethoxycarbonyl)phenyl)zinc pivalate (1j, 451 mg, 1.22 mmol/g, 0.55 mmol) 
was added dropwise and the resulting mixture was stirred for 2 h at room temperature. 
Purification of the crude product by flash chromatography (silica gel, isohexane/EtOAc = 9:1) 
afforded the title compound as a pale white solid (106 mg, 0.44 mmol, 87%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.90–7.85 (m, 2H), 6.69–6.62 (m, 2H), 5.84 (ddt, 
J = 17.1, 9.9, 4.7 Hz, 2H), 5.22–5.11 (m, 4H), 4.31 (q, J = 7.1 Hz, 2H), 3.97 (dt, J = 4.1, 1.7 Hz, 
4H), 1.35 (t, J = 7.1 Hz, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 166.7, 151.7, 132.5 (2C), 131.1 (2C), 117.5, 116.2 
(2C), 110.8 (2C), 59.9, 52.4 (2C), 14.3. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2980, 2904, 1698, 1602, 1522, 1446, 1394, 1366, 1316, 
1276, 1236, 1182, 1106, 1024, 990, 946, 920, 830, 770, 700. 
MS (EI, 70 eV): m/z (%) = 245 (100), 218 (62), 200 (44), 130 (56). 
HRMS (EI): m/z calc. for [C15H19NO2]: 245.1416; found 245.1411. 
m.p. (°C): 101.3–104.1. 
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1-(3-(Trifluoromethyl)phenyl)piperidin-4-one (2k) 
 
According to TP12 4-oxopiperidin-1-yl benzoate (5c, 109 mg, 0.50 mmol) was dissolved in 
dry THF (2 mL). CoCl2·2LiCl (13 µL, 1.00 M, 2.5 mol%) was added and subsequent 
(4-(trifluoromethyl)phenyl)zinc pivalate (1c, 545 mg, 1.01 mmol/g, 0.55 mmol) was added 
dropwise and the resulting mixture was stirred for 2 h at room temperature. Purification of the 
crude product by flash chromatography (silica gel, isohexane/EtOAc = 9:1) afforded the title 
compound as a yellow oil (106 mg, 0.44 mmol, 87%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.32 (t, J = 8.0 Hz, 1H), 7.08 (t, J = 2.1 Hz, 1H), 7.04 
(dd, J = 8.2, 2.1 Hz, 2H), 3.59 (t, J = 6.1 Hz, 4H), 2.51 (t, J = 6.1 Hz, 4H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 207.6, 149.3, 131.8 (q, J = 31.9 Hz), 130.0, 124.1 (q, 
J = 271.9 Hz), 118.5, 116.01 (q, J = 3.8 Hz), 111.89 (q, J = 3.9 Hz), 48.2 (2C), 40.5 (2C). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2972, 2908, 2834, 1716, 1610, 1588, 1496, 1452, 1412, 
1386, 1354, 1322, 1220, 1162, 1118, 1100, 1074, 1038, 994, 940, 858, 810, 784, 722, 696, 656. 
MS (EI, 70 eV): m/z (%) = 243 (100), 200 (46), 173 (96), 145 (40). 
HRMS (EI): m/z calc. for [C12H12F3NO]: 243.0871; found 243.0865. 
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N-Allyl-N-cyclopentyl-3-(trifluoromethyl)aniline (2l) 
 
According to TP12 N-allyl-O-benzoyl-N-cyclopentylhydroxylamine (5d, 123 mg, 0.50 mmol) 
was dissolved in dry THF (2 mL). CoCl2·2LiCl (13 µL, 1.00 M, 2.5 mol%) was added and 
subsequent (4-(trifluoromethyl)phenyl)zinc pivalate (1c, 545 mg, 1.01 mmol/g, 0.55 mmol) 
was added dropwise and the resulting mixture was stirred for 2 h at room temperature. 
Purification of the crude product by flash chromatography (silica gel, isohexane/EtOAc = 9:1) 
afforded the title compound as a colourless oil (105 mg, 0.39 mmol, 78%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.26 (s, 1H), 6.94 (s, 1H), 6.88 (dt, J = 8.7, 4.5 Hz, 
2H), 5.88 (ddt, J = 17.2, 10.4, 4.1 Hz, 1H), 5.26–5.13 (m, 2H), 4.16 (h, J = 7.7, 7.1 Hz, 1H), 
3.84 (dt, J = 4.3, 1.9 Hz, 2H), 2.05–1.90 (m, 2H), 1.82–1.46 (m, 6H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 150.1, 135.4, 131.6 (q, J = 31.3 Hz), 129.4, 124.73 
(q, J = 272.4 Hz), 116.3, 115.7, 112.54 (q, J = 3.9 Hz), 109.45 (q, J = 4.0 Hz), 59.4, 48.7, 29.4 
(2C), 24.0 (2C). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2958, 2872, 1610, 1586, 1498, 1456, 1398, 1368, 1322, 
1312, 1246, 1186, 1160, 1116, 1076, 1018, 988, 958, 918, 870, 850, 778, 736, 696, 662. 
MS (EI, 70 eV): m/z (%) = 269 (42), 240 (100), 145 (38), 69 (17). 
HRMS (EI): m/z calc. for [C15H18F3N]: 269.1391; found 269.1389. 
  
C. Experimental Section 
111 
(S)-4-Methoxy-N-methyl-N-(1-phenylethyl)aniline (2m) 
 
According to TP12 (S)-O-benzoyl-N-methyl-N-(1-phenylethyl)hydroxylamine (5e, 128 mg, 
0.50 mmol) was dissolved in dry THF (2 mL). CoCl2·2LiCl (13 µL, 1.00 M, 2.5 mol%) was 
added and subsequent (4-methoxyphenyl)zinc pivalate (1e, 505 mg, 1.09 mmol/g, 0.55 mmol) 
was added dropwise and the resulting mixture was stirred for 2 h at room temperature. 
Purification of the crude product by flash chromatography (silica gel, isohexane/EtOAc = 9:1) 
afforded the title compound as a pale white solid (117 mg, 0.49 mmol, 97%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.36 (d, J = 4.3 Hz, 4H), 7.32–7.26 (m, 1H), 6.88 (s, 
4H), 4.94 (q, J = 6.9 Hz, 1H), 3.81 (s, 3H), 2.64 (s, 3H), 1.53 (d, J = 6.8 Hz, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 128.3 (2C), 127.8, 127.1 (2C), 126.9, 116.3, 114.6 
(4C), 114.2, 58.6, 55.7, 32.9, 16.2. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2972, 2936, 2834, 1686, 1510, 1464, 1450, 1372, 1244, 
1180, 1110, 1038, 816, 784, 754, 702. 
MS (EI, 70 eV): m/z (%) = 241 (100), 226 (83), 164 (15), 136 (56), 105 (74). 
HRMS (EI): m/z calc. for [C16H19NO]: 241.1467; found 241.1460. 
m.p. (°C): 110.9–111.4. 
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N-Allyl-4-methoxy-N-methylaniline (2n) 
 
According to TP12 N-allyl-O-benzoyl-N-methylhydroxylamine (5f, 96 mg, 0.50 mmol) was 
dissolved in dry THF (2 mL). CoCl2·2LiCl (13 µL, 1.00 M, 2.5 mol%) was added and 
subsequent (4-methoxyphenyl)zinc pivalate (1e, 505 mg, 1.09 mmol/g, 0.55 mmol) was added 
dropwise and the resulting mixture was stirred for 2 h at room temperature. Purification of the 
crude product by flash chromatography (silica gel, isohexane/EtOAc = 9:1) afforded the title 
compound as a brownish oil (79 mg, 0.45 mmol, 89%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 6.86–6.81 (m, 2H), 6.76–6.70 (m, 2H), 5.85 (ddt, J = 
17.2, 10.2, 5.4 Hz, 1H), 5.24–5.11 (m, 2H), 3.85–3.82 (m, 2H), 3.76 (s, 3H), 2.86 (s, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 151.7, 144.5, 134.3, 116.6, 114.7 (2C) 114.7 (2C), 
56.6, 55.8, 38.7. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2936, 2910, 2832, 1678, 1664, 1512, 1464, 1454, 1442, 
1296, 1276, 1244, 1210, 1182, 1040, 824, 814. 
MS (EI, 70 eV): m/z (%) = 177 (100), 162 (40), 150 (55), 136 (56), 121 (12). 
HRMS (EI): m/z calc. for [C11H15NO]: 177.1154; found 177.1150. 
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Ethyl 4-(ethyl(phenyl)amino)benzoate (2o) 
 
According to TP12 O-benzoyl-N-ethyl-N-phenylhydroxylamine (5g, 1.00 mL, 0.50 M, 
0.50 mmol) was dissolved in dry THF (2 mL). CoCl2·2LiCl (25 µL, 1.00 M, 5.0 mol%) was 
added and subsequent (4-(ethoxycarbonyl)phenyl)zinc pivalate (1j, 451 mg, 1.22 mmol/g, 
0.55 mmol) was added dropwise and the resulting mixture was stirred for 2 h at room 
temperature. Purification of the crude product by flash chromatography (silica gel, 
isohexane/EtOAc = 9:1) afforded the title compound as a pale white solid (135 mg, 0.45 mmol, 
89%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.87 (dt, J = 9.1, 2.8 Hz, 2H), 7.46–7.40 (m, 2H), 
7.28–7.20 (m, 3H), 6.73 (dt, J = 8.9, 2.0 Hz, 2H), 4.34 (q, J = 7.1 Hz, 2H), 3.83 (q, J = 7.1 Hz, 
2H), 1.38 (t, J = 7.1 Hz, 3H), 1.27 (t, J = 7.1 Hz, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 166.8, 151.6, 146.0, 131.1 (2C), 129.9 (2C), 126.9 
(2C), 125.6, 119.0, 113.6 (2C), 60.2, 46.7, 14.5, 12.5. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2984, 2944, 2908, 2208, 1736, 1650, 1480, 1466, 1448, 
1394, 1372, 1300, 1234, 1182, 1160, 1098, 1044, 1004, 938, 918, 846, 786. 
MS (EI, 70 eV): m/z (%) = 269 (65), 254 (100), 167 (12). 
HRMS (EI): m/z calc. for [C17H19NO2]: 269.1416; found 269.1411. 
m.p. (°C): 135.5–136.2. 
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N-Ethyl-4-methoxy-N-phenylaniline (2p) 
 
According to TP12 O-benzoyl-N-ethyl-N-phenylhydroxylamine (5g, 1.00 mL, 0.50 M, 
0.50 mmol) was dissolved in dry THF (2 mL). CoCl2·2LiCl (25 µL, 1.00 M, 5.0 mol%) was 
added and subsequent (4-methoxyphenyl)zinc pivalate (1e, 505 mg, 1.09 mmol/g, 0.55 mmol) 
was added dropwise and the resulting mixture was stirred for 2 h at room temperature. 
Purification of the crude product by flash chromatography (silica gel, isohexane/EtOAc = 9:1) 
afforded the title compound as a pale white solid (90 mg, 0.40 mmol, 79%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.20–7.14 (m, 2H), 7.11–7.06 (dt, J = 9.1, 2.6 Hz, 
2H), 6.93–6.88 (dt, J = 8.8, 2.4 Hz, 2H), 6.76–6.71 (m, 3H), 3.82 (s, 3H), 3.70 (q, J = 7.1 Hz, 
2H), 1.20 (t, J = 7.1 Hz, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 156.5, 148.7, 140.3, 129.0 (2C), 127.7 (2C), 117.6, 
115.3 (2C), 114.8 (2C), 55.5, 46.5, 12.6. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2930, 2872, 2364, 1738, 1598, 1508, 1500, 1466, 1444, 
1372, 1268, 1240, 1100, 1040, 748, 732. 
MS (EI, 70 eV): m/z (%) = 227 (73), 212 (100). 
HRMS (EI): m/z calc. for [C15H17NO]: 227.1310; found 227.1299. 
m.p. (°C): 105.2–107.1. 
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N-Ethyl-3-fluoro-N-phenylaniline (2q) 
 
According to TP12 O-benzoyl-N-ethyl-N-phenylhydroxylamine (5g, 1.00 mL, 0.50 M, 
0.50 mmol) was dissolved in dry THF (2 mL). CoCl2·2LiCl (25 µL, 1.00 M, 5.0 mol%) was 
added and subsequent (3-fluorophenyl)zinc pivalate (1k, 437 mg, 1.26 mmol/g, 0.55 mmol) 
was added dropwise and the resulting mixture was stirred for 2 h at room temperature. 
Purification of the crude product by flash chromatography (silica gel, isohexane/EtOAc = 9:1) 
afforded the title compound as a pale white solid (90 mg, 0.42 mmol, 84%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.30–7.24 (m, 2H), 7.09–7.01 (m, 4H), 6.52 (dd, J = 
8.0, 2.6 Hz, 1H), 6.49–6.39 (m, 2H), 3.68 (q, J = 7.1 Hz, 2H), 1.15 (q, J = 7.6, 7.1 Hz, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 163.80 (d, J = 242.9 Hz), 149.72 (d, J = 10.3 Hz), 
146.8, 130.01 (d, J = 10.1 Hz), 129.6 (2C), 124.7 (2C), 123.8, 112.7, 105.42 (d, J = 21.5 Hz), 
104.01 (d, J = 25.1 Hz), 46.6, 12.6. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 1732, 1614, 1590, 1578, 1492, 1448, 1374, 1348, 1268, 
1244, 1186, 1162, 1126, 1096, 1046, 996, 964, 904, 848, 834, 726, 702, 686. 
MS (EI, 70 eV): m/z (%) = 215 (50), 200 (100). 
HRMS (EI): m/z calc. for [C14H14FN]: 215.1110; found 215.1099. 
m.p. (°C): 72.3–72.8. 
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N-Ethyl-2,2-difluoro-N-phenylbenzo[d][1,3]dioxol-5-amine (2r) 
 
According to TP12 O-benzoyl-N-ethyl-N-phenylhydroxylamine (5g, 1.00 mL, 0.50 M, 
0.50 mmol) was dissolved in dry THF (2 mL). CoCl2·2LiCl (25 µL, 1.00 M, 5.0 mol%) was 
added and subsequent (2,2-difluorobenzo[d][1,3]dioxol-5-yl)zinc pivalate (1l, 561 mg, 
0.98 mmol/g, 0.55 mmol) was added dropwise and the resulting mixture was stirred for 2 h at 
room temperature. Purification of the crzude product by flash chromatography (silica gel, 
isohexane/EtOAc = 9:1) afforded the title compound as a pale white solid (91 mg, 0.33 mmol, 
66%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.29–7.23 (m, 2H), 6.97–6.89 (m, 4H), 6.75 (d, J = 2.2 
Hz, 1H), 6.70 (dd, J = 8.6, 2.3 Hz, 1H), 3.72 (q, J = 7.1 Hz, 2H), 1.21 (t, J = 7.1 Hz, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 147.7, 144.4, 138.8, 131.8 (t, J = 254.2 Hz), 129.4 
(2C), 121.0, 119.8 (2C), 116.9, 109.7, 104.6, 46.9, 12.6. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3164, 3006, 2944, 2294, 2254, 1636, 1534, 1508, 1498, 
1444, 1422, 1376, 1274, 1202, 1038, 984, 918, 886, 830, 782, 750. 
MS (EI, 70 eV): m/z (%) = 277 (19), 262 (36), 151 (18). 
HRMS (EI): m/z calc. for [C15H13F2NO2]: 277.0917; found 277.0911. 
m.p. (°C): 180.2–182.8. 
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N-Ethyl-N-phenylpyridin-3-amine (2s) 
 
According to TP12 O-benzoyl-N-ethyl-N-phenylhydroxylamine (5g, 1.00 mL, 0.50 M, 
0.50 mmol) was dissolved in dry THF (2 mL). CoCl2·2LiCl (25 µL, 1.00 M, 5.0 mol%) was 
added and subsequent (pyridin-3-yl)zinc pivalate (1m, 462 mg, 1.19 mmol/g, 0.55 mmol) was 
added dropwise and the resulting mixture was stirred for 2 h at room temperature. Purification 
of the crude product by flash chromatography (silica gel, isohexane/EtOAc = 9:1) afforded the 
title compound as a brownish solid (31 mg, 0.16 mmol, 31%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.20 (d, J = 2.5 Hz, 1H), 8.02 (dd, J = 4.5, 1.4 Hz, 
1H), 7.30–7.24 (m, 2H), 7.12–7.00 (m, 5H), 3.71 (q, J = 7.1 Hz, 2H), 1.16 (t, J = 7.1 Hz, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 147.3, 146.6, 145.5, 144.2, 129.3 (2C), 124.8, 123.9, 
123.5 (2C), 120.3, 43.1, 14.6. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2966, 2956, 2924, 2854, 1710, 1704, 1600, 1580, 1566, 
1494, 1424, 1376, 1348, 1268, 1262, 1246, 1134, 1094, 1062, 794, 754, 710, 700. 
MS (EI, 70 eV): m/z (%) = 198 (51), 183 (100), 105 (25), 77 (24). 
HRMS (EI): m/z calc. for [C13H14N2]: 198.1157; found 198.1160. 
m.p. (°C): 117.2–120.1. 
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N-Ethyl-4-fluoro-N-(4-methoxyphenyl)aniline (2t) 
 
According to TP12 O-benzoyl-N-ethyl-N-(4-fluorophenyl)hydroxylamine (5h, 1.00 mL, 
0.50 M, 0.50 mmol) was dissolved in dry THF (2 mL). CoCl2·2LiCl (25 µL, 1.00 M, 5.0 mol%) 
was added and subsequent (4-methoxyphenyl)zinc pivalate (1e, 505 mg, 1.09 mmol/g, 
0.55 mmol) was added dropwise and the resulting mixture was stirred for 2 h at room 
temperature. Purification of the crude product by flash chromatography (silica gel, 
isohexane/EtOAc = 9:1) afforded the title compound as a pale white solid (96 mg, 0.39 mmol, 
78%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 6.94–6.89 (m, 2H), 6.86–6.77 (m, 4H), 6.69–6.63 (m, 
2H), 3.73 (s, 3H), 3.58 (q, J = 7.1 Hz, 2H), 1.10 (t, J = 7.0 Hz, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 156.6 (J = 237.6 Hz), 155.7, 145.1 (J = 2.2 Hz), 
141.0, 125.6 (2C), 118.8 (d, J = 7.5 Hz, 2C), 115.7 (d, J = 22.5 Hz, 2C) , 114.8 (2C), 55.5, 
46.8, 12.6. 
19F-NMR (377 MHz, CDCl3) δ / ppm = -125.8. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2974, 2948, 2836, 1504, 1466, 1442, 1372, 1290, 1266, 
1240, 1226, 1180, 1132, 1036, 820, 760. 
MS (EI, 70 eV): m/z (%) = 245 (66), 230 (100), 202 (26), 122 (16). 
HRMS (EI): m/z calc. for [C15H16FNO]: 245.1216; found 245.1208. 
m.p. (°C): 122.2–125.8. 
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N-Ethyl-N-(4-methoxyphenyl)-3-methylaniline (2u) 
 
According to TP12 O-benzoyl-N-ethyl-N-(m-tolyl)hydroxylamine (5i, 1.00 mL, 0.50 M, 
0.50 mmol) was dissolved in dry THF (2 mL). CoCl2·2LiCl (25 µL, 1.00 M, 5.0 mol%) was 
added and subsequent (4-ethoxyphenyl)zinc pivalate (1e, 505 mg, 1.09 mmol/g, 0.55 mmol) 
was added dropwise and the resulting mixture was stirred for 2 h at room temperature. 
Purification of the crude product by flash chromatography (silica gel, isohexane/EtOAc = 9:1) 
afforded the title compound as a pale white solid (82 mg, 0.34 mmol, 68%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.02–6.96 (m, 3H), 6.84–6.79 (m, 2H), 6.51–6.45 (m, 
3H), 3.73 (s, 3H), 3.60 (q, J = 7.1 Hz, 2H), 2.17 (s, 3H), 1.11 (t, J = 7.1 Hz, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 156.5, 148.8, 140.5, 138.8, 129.0, 127.7 (2C), 118.8, 
116.2, 114.9 (2C), 112.7, 55.6, 46.6, 21.9, 12.8. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2935, 2882, 2371, 1741, 1599, 1515, 1510, 1501, 1498, 
1467, 1454, 1382, 1278, 1235, 1160,, 1104, 1049, 760, 736. 
MS (EI, 70 eV): m/z (%) = 241 (55), 226 (100). 
HRMS (EI): m/z calc. for [C16H19NO]: 241.1467; found 241.1462. 
m.p. (°C): 115.3–118.2. 
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3.7 Synthesis of Tuberculosis Target Q203 
(4-(Trifluoromethoxy)phenyl)magnesium Bromide (9) 
 
A dry and argon-flushed Schlenk –flask was charged with magnesium turnings (111 mg, 
4.57 mmol) and LiCl (5.0 mL, 0.50 M in THF, 2.5 mmol). 1-Bromo-4-
(trifluoromethoxy)benzene (917 mg, 3.80 mmol) in THF (2.0 mL) was added in one portion at 
room temperature. The reaction mixture was stirred for 3 h to afford the title magnesium 
reagent in 0.64 M solution, corresponding to 94% yield. 
 
Tert-butyl 4-(4-(trifluoromethoxy)phenyl)piperidine-1-carboxylate (10) 
 
A dry and argon-flushed Schlenk-flask was charged with N-Boc-4-iodo-piperidine (8, 311 mg, 
1.00 mmol) and THF (1 mL). CoCl2•2LiCl (50 µL, 1.00 M in THF, 5.0 mol%) and 
(R,R)-tetramethylcyclohexanediamine (11 mg, 6.0 mol%) were added the solution. Grignard 
reagent 9 (1.88 mL, 0.64 M in THF 1.20 mmol) was then added dropwise at 0 °C and the 
resulting mixture was stirred for 1 h. The reaction was quenched by addition of a saturated 
aqueous solution of NH4Cl and the aqueous phase was extracted with EtOAc (3 x 5 mL). The 
combined organic phases were dried over Na2SO4, filtered and the solvent was removed in 
vacuo. Purification via flash column chromatography (silica gel, isohexane/EtOAc = 8:1) 
afforded the title compound as a colourless oil (311 mg, 0.90 mmol, 90%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.21 (dt, J = 8.8, 2.1 Hz, 2H), 7.17–7.13 (m, 2H), 
4.24 (s, 2H), 2.80 (t, J = 12.5 Hz, 2H), 2.66 (tt, J = 12.2, 3.5 Hz, 1H), 1.81 (d, J = 13.3 Hz, 2H), 
1.65–1.53 (m, 2H), 1.48 (s, 9H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 154.8, 147.6, 144.4, 128.0 (2C), 121.0 (2C), 120.3 
(q, J = 100.1 Hz), 79.6, 44.3 (2C), 42.14, 33.2 (2C), 28.5 (3C). 
19F-NMR (377 MHz, CDCl3) δ / ppm = -57.9. 
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IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2980, 2938, 1692, 1510, 1480, 1468, 1446, 1424, 1394, 
1366, 1322, 1260, 1230, 1164, 1124, 1016, 856, 840, 668. 
MS (EI, 70 eV): m/z (%) = 345 (10), 289 (100), 245 (46), 127 (23). 
HRMS (EI): m/z calc. for [C17H22F3NO3]: 345.1552; found 345.1545. 
 
4-(4-(Trifluoromethoxy)phenyl)piperidin-1-yl benzoate (11) 
 
In a dry and argon flushed flask, a solution of N-Boc-piperidine 10 (250 mg, 0.72 mmol) in dry 
CH2Cl2 (2.5 mL) was treated with trifluoroacetic acid (0.28 mL, 3.62 mmol) at room 
temperature and stirred for 2 h. The reaction mixture was quenched with sat. aqueous NaHCO3 
solution (2 mL) and extracted with EtOAc (3 x 5 mL). The combined organic phases were dried 
over Na2SO4 and filtered, then the solvent was removed in vacuo. The crude product was used 
for next step without further purification. According to TP9 dry benzoyl peroxide (280 mg, 
0.86 mmol) and K2HPO4 (815 mg, 4.68 mmol, 5.40 equiv) were suspended in dry DMF 
(20 mL). The crude 4-(4-(trifluoromethoxy)phenyl)piperidine was slowly added and the 
resulting mixture stirred for 36 h at room temperature. Purification of the crude product by 
flash chromatography (silica gel, isohexane/EtOAc = 9:1) afforded the title compound as a pale 
white solid (220 mg, 0.72 mmol, 84%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.06–8.01 (m, 2H), 7.58 (t, J = 7.4 Hz, 1H), 7.45 (t, 
J = 7.7 Hz, 2H), 7.25 (d, J = 4.2 Hz, 2H), 7.16 (d, J = 8.2 Hz, 2H), 3.69 (d, J = 10.6 Hz, 2H), 
2.91 (t, J = 10.5 Hz, 2H), 2.66 (t, J = 12.1 Hz, 1H), 2.14 (qd, J = 12.5, 2,1 Hz, 2H), 1.99 (d, 
J = 12.4 Hz, 2H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 164.8, 147.7, 143.5, 133.1 (2C), 129.4 (2C), 128.4 
(2C), 128.1 (2C), 121.1 (2C), 120.4 (q, J = 100.1 Hz), 57.3 (2C), 41.2, 32.8 (2C). 
19F-NMR (377 MHz, CDCl3) δ / ppm = -57.8. 
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IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2948, 2926, 2838, 1730, 1512, 1450, 1316, 1280, 1262, 
1220, 1200, 1192, 1166, 1090, 1068, 1016, 722, 710, 676. 
m.p. (°C): 150.2–120.8. 
 
4-(4-(4-(Trifluoromethoxy)phenyl)piperidin-1-yl)benzonitrile (12) 
 
According to TP12 4-(4-(trifluoromethoxy)phenyl)piperidin-1-yl benzoate (11, 220 mg, 
0.72 mmol) was dissolved in dry THF (10 mL). CoCl2·2LiCl (18 µL, 1.00 M, 5.0 mol%) was 
added and subsequent (4-cyanophenyl)zinc pivalate (1b, 642 mg, 1.34 mmol/g, 0.86 mmol, 
1.20 equiv) was added dropwise and the resulting mixture was stirred for 2 h at room 
temperature. Purification of the crude product by flash chromatography (silica gel, 
isohexane/EtOAc = 5:1) afforded the title compound as a pale white solid (225 mg, 0.65 mmol, 
90%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.50 (dt, J =8.9, 2.2 Hz, 2H), 7.24 (dt, J =8.4, 1.9 Hz, 
2H), 7.19–7.14 (m, 2H), 6.91 (dt, J =8.9, 2.4 Hz, 2H), 3.99 (dp, J = 13.0, 1.9 Hz, 2H), 2.98 (td, 
J = 12.8, 2.6 Hz, 2H), 2.77 (tt, J = 12.2, 3.7 Hz, 1H), 2.01–1.93 (m, 2H), 1.79 (dtd, J = 13.2, 
12.1, 3.9 Hz, 2H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 153.3, 147.8, 144.0, 133.6 (2C), 129.4, 128.0 (2C), 
121.1 (2C), 120.6 (q, J = 100.7 Hz), 114.5 (2C), 99.9, 48.3 (2C), 41.9, 32.7 (2C). 
19F-NMR (377 MHz, CDCl3) δ / ppm = -57.9. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2942, 2926, 2838, 2212, 1686, 1604, 1510, 1464, 1448, 
1390, 1354, 1326, 1254, 1216, 1196, 1176, 1158, 1114, 1102, 1092, 1010, 920, 882, 848, 820, 
780, 716, 684, 676. 
MS (EI, 70 eV): m/z (%) = 345 (75), 184 (31), 157 (100), 102 (38). 
HRMS (EI): m/z calc. for [C19H17F3N2O]: 346.1293; found 345.1211 [M-H
+]. 
m.p. (°C): 199.8–204.1.  
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6-Chloro-2-ethyl-N-(4-(4-(4-(trifluoromethoxy)phenyl)piperidin-1-
yl)benzyl)imidazo[1,2-a]pyridine-3-carboxamide–Q203 (7) 
 
A solution of benzonitrile 12 (80 mg, 0.23 mmol, 1.00 equiv) in dry THF (2.5 mL) was treated 
with lithium aluminium hydride (35 mg, 0.93 mmol, 4.00 equiv) at room temperature. The 
resulting reaction mixture was reflux for 2 h. The reaction was cooled and quenched with sat. 
aqueous NH4Cl solution (2 mL) followed by extraction with EtOAc (3 x 5 mL). The combined 
organic phases were dried over Na2SO4 and filtered, then the solvent was removed in vacuo. 
The crude product was dissolved in DMF (1 mL) followed by the addition of acid 13 (was 
prepared according to literature procedure; analytical data is consistent to literature)124 (67 mg, 
0.28 mmol), 1-[3-(dimethylamino)propyl]-3-ethylcarbodimide hydrochloride (EDC, 66 mg, 
0.35 mmol), 1-hydroxylbenzotriazole (HOBt, 19 mg, 0.14 mmol) and triethylamine (60 µL, 
0.46 mmol) at room temperature. The resulting solution was stirred at 70 °C for 2 h and cooled 
to room temperature. Water (5 mL) was added into the crude residue, the resulting solution was 
extracted with EtOAc (3 x 5 mL). The crude mixture was purified by flash column 
chromatography (silica gel, isohexane/EtOAc/methylene chloride = 1:1:1) to give Q203 as a 
pale white solid (103 mg, 0.19 mmol, 82% over two steps). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 9.55 (dd, J = 2.1, 0.8 Hz, 1H), 7.56 (dd, J = 9.5, 
0.9 Hz, 1H), 7.34–7.29 (m, 4H), 7.27 (s, 1H), 7.18 (d, J = 8.4 Hz, 2H), 7.02 (d, J = 8.1 Hz, 2H), 
6.07 (t, J = 5.7 Hz, 1H), 4.64 (d, J = 5.5 Hz, 2H), 3.92–3.72 (m, 2H), 2.99 (q, J = 7.6 Hz, 2H), 
2.87 (d, J = 2.9 Hz, 2H), 2.70 (tt, J = 11.7, 4.1 Hz, 1H), 2.03–1.84 (m, 4H), 1.42 (t, J = 7.5 Hz, 
3H).  
                                                          
124  S. Kang, R. Y. Kim, M. J. Seo, S. Lee, Y. M. Kim, M. Seo, J. J. Seo, Y. Ko, I. Choi, J. Jang, J. Med. Chem. 
2014, 57, 5293–5305. 
C. Experimental Section 
124 
3.8 Deprotection Procedures to Afford Primary and Secondary Amines 
Ethyl 4-aminobenzoate ( 6) 
 
To a solution of allylaniline 3j (123 mg, 0.50 mmol, 1.00 equiv) in CH2Cl2 (5 mL) 
N,N-dimethylbarbituric acid (468 mg, 3.00 mmol, 6.00 equiv) and Pd(PPh3)4 (78 mg, 
0.05 mmol, 10 mol%) were added. The reaction mixture was stirred at 40 °C for 24 h and 
checked by GC analysis. After full consumption of the starting material, the mixture was 
quenched with sat. aqueous NH4Cl solution and extract with EtOAc (3 x 10 mL). The 
combined organic phases were dried over Na2SO4 and filtered, then the solvent was removed 
in vacuo. The crude mixture was purified by flash column chromatography (silica gel, 
isohexane/EtOAc = 1:1) to give the title compound as a colourless solid (75 mg, 0.46 mmol, 
91%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.87–7.83 (m, 2H), 6.65–6.60 (m, 2H), 4.31 (q, J = 7.1 
Hz, 2H), 4.20–3.97 (m, 2H), 1.35 (t, J = 7.1 Hz, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 166.8, 150.8, 131.5 (2C), 119.9, 113.8 (2C), 60.3, 
14.4. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2958, 2874, 1614, 1594, 1514, 1492, 1476, 1436, 1344, 
1318, 1280, 1248, 1158, 1116, 1096, 1068, 1044, 1026, 992, 900, 856, 780, 696, 660. 
MS (EI, 70 eV): m/z (%) = 165 (40), 137 (39), 120 (100), 92 (20). 
HRMS (EI): m/z calc. for [C9H11NO2]: 165.0790; found 165.0783. 
m.p. (°C): 81.1–84.6. 
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N-Cyclopentyl-3-(trifluoromethyl)aniline (3a) 
 
To a solution of allylaniline 2l (135 mg, 0.50 mmol, 1.00 equiv) and ruthenium-catalyst 
(dichlorodi-μ-chlorobis[(1,2,3,6,7,8-η-2,7-dimethyl-2,6-octadiene-1,8-diyl]diruthenium(IV)) 
(7 mg, 0.01 mmol, 2.0 mol%) in water (5 mL) was stirred at 90 °C for 14 h. The reaction 
mixture was cooled to room temperature and extracted with EtOAc (3 x 10 mL). The combined 
organic phases were dried over Na2SO4 and filtered, then the solvent was removed in vacuo. 
The crude mixture was purified by flash column chromatography (silica gel, 
isohexane/EtOAc = 6:1) to give the title compound as a colourless oil (107 mg, 0.47 mmol, 
93%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.27 (t, J = 7.8 Hz, 1H), 6.93 (d, J = 7.6 Hz, 1H), 6.75 
(dd, J = 8.2, 2.4 Hz, 1H), 3.89 (s, 1H), 3.87–3.80 (m, 1H), 2.13–2.03 (m, 2H), 1.83–1.63 (m, 
4H), 1.56–1.46 (m, 2H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 148.1, 131.45 (q, J = 31.6 Hz), 129.5, 124.44 (q, 
J = 272.4 Hz), 116.0, 113.13 (q, J = 3.9 Hz), 109.13 (q, J = 3.9 Hz), 54.5, 33.4, 24.0. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3420, 3340, 3222, 2984, 2898, 1680, 1634, 1594, 1574, 
1514, 1474, 1442, 1392, 1366, 1310, 1274, 1240, 1170, 1124, 1110, 1080, 1024, 908, 882, 846, 
772, 732, 700. 
MS (EI, 70 eV): m/z (%) = 229 (34), 200 (100), 161 (13). 
HRMS (EI): m/z calc. for [C12H14F3N]: 229.1078; found 229.1073. 
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4. Late Stage Functionalization of Secondary Amines via a 
Cobalt-Catalyzed Electrophilic Amination of Organozinc 
Reagents 
4.1 Comparison of Hydoxylamine Benzoate Preparations 
 
Method A: A dry and argon flushed flask equipped with a magnetic stirring bar and a septum 
was charged with K2HPO4 (1.31 g, 7.50 mmol, 1.50 equiv) and anhydrous benzoyl peroxide 
(1.21 g, 5.00 mmol, 1.00 equiv). The mixture was suspended in DMF (20 mL) and amine 32 
(7.50 mmol, 1.50 equiv) was added slowly. The reaction mixture was stirred at room 
temperature and checked by thin layer chromatography analysis. Upon full consumption of 
benzoyl peroxide, the reaction was quenched with sat. aqueous NH4Cl solution (30 mL). The 
organic layer was removed and the aqueous phase was extracted from EtOAc (3 x 15 mL). The 
combined organic layers were washed with sat. aqueous NaHCO3 solution (15 mL), brine 
(15 mL) and subsequent dried over mgSO4. Evaporation of the solvents in vacuo and 
purification by flash column chromatography afforded the desired products. 
Method B84: In an argon flushed flask, amine 32 (1.00 mmol, 1.00 equiv) was dissolved in 
acetone (10 mL) and dimethyldioxirane (0.075 M, 14 mL, 1.05 mmol, 1.00 equiv) was added 
as a solution in acetone at 0 °C. The mixture was stirred at 0 °C for 30 min and then 
concentrated in vacuo. The resulting N-hydroxylamine was dissolved in CH2Cl2 (4 mL) 
followed by the addition of triethylamine (0.21 mL, 1.50 mmol, 1.50 equiv), DMAP (1 mg, 
0.01 mmol, 1.0 mol%) and benzoyl chloride (168 mg, 1.20 mmol, 1.20 equiv) at 0 °C. The 
resulting solution was stirred at 0 °C for 1 h and quenched with sat. aqueous NH4Cl solution 
(2 mL). The mixture was extracted with EtOAc (3 x 5 mL) and the combined organic phases 
were washed with saturated NaHCO3 solution (2 mL), brine (2 mL), and dried over Na2SO4. 
The crude mixture was purified with flash column chromatography to afford the desired 
product. 
Method C: 1) amine 32, (1.0 equiv), acrylonitrile (5.0 equiv), MeOH, 55 °C, 12 h; 2) mCPBA 
(1.1 equiv), CH2Cl2, −78 °C to rt, 12 h; 3) BzCl (1.2 equiv), NEt3 (1.5 equiv), DMAP 
(1 mol%), CH2Cl2, 0 °C, 30 min. A detailed procedure is given in the following. 
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4.2 Functional Group Tolerance Test 
To investigate the functional group tolerance of the described amination procedure, we 
performed the amination according to TP13 and added various additives (Table 11). Therefore, 
morpholino benzoate (5a, 42 mg, 0.20 mmol, 1.00 equiv) was reacted with 4-
methoxyphenylzinc chloride (1rr, 0.50 M, 0.60 mL, 0.30 mmol, 1.50 equiv) under cobalt-
catalysis (CoCl2) in the presence of the given additive (0.20 mmol, 1.00 equiv). 
Table 11. Perforance of the cobalt-catalyzed electrophilic amination in the presence of various 
additives, to show its tolerance towards functional groups 
 
Entry Additive Yield [%] 
1 none 96% 
2 1,1-diphenylethan-1-ol 90% 
3 2,2,4,4-tetramethylpentan-3-ol 96% 
4 3,5-dimethylaniline 96% 
5 butylamine 56% 
6 morpholine 96% 
7 N-methylbenzamide 96% 
8 7-oxabicyclo[4.1.0]heptane 81% 
9 2-(4-bromophenyl)oxirane 96% 
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4.3 Preparation of Organozinc Chlorides 
(4-Chlorophenyl)zinc Chloride ( ) 
 
According to TP4, 1-bromo-4-chlorobenzene (479 mg, 2.50 mmol, 1.00 equiv) was added to 
a suspension of anhydrous LiCl (159 mg, 3.75 mmol, 1.50 equiv) and magnesium turnings 
(122 mg, 5.00 mmol, 2.00 equiv) in dry THF (5 mL). The mixture was stirred at 25 °C 
overnight and then ZnCl2 (1 M in THF, 3.0 mL, 3.00 mmol, 1.20 equiv) was added as a solution 
in THF at 0 °C. Titration with iodine gave a concentration of 0.29 mmol/mL active zinc 
species, corresponding to 98% yield. 
 
Benzo[b]thiophen-2-ylzinc Chloride (1o) 
 
According to TP4, 2-bromobenzo[b]thiophene (533 mg, 2.50 mmol, 1.00 equiv) was added to 
a suspension of anhydrous LiCl (159 mg, 3.75 mmol, 1.50 equiv) and magnesium turnings 
(122 mg, 5.00 mmol, 2.00 equiv) in dry THF (5 mL). The mixture was stirred at 25 °C 
overnight and then ZnCl2 (1 M in THF, 3.0 mL, 3.00 mmol, 1.20 equiv) was added as a solution 
in THF at 0 °C. Titration with iodine gave a concentration of 0.27 mmol/mL active zinc 
species, corresponding to 92% yield. 
 
(4-Cyano-3-fluorophenyl)zinc Chloride (1p) 
 
According to TP2, 2-fluoro-4-iodobenzonitrile (1.23 g, 5.00 mmol, 1.00 equiv) was dissolved 
in dry THF (5 mL) and iPrMgCl·LiCl (4.30 mL, 1.28 M, 5.50 mmol, 1.10 equiv) was added. 
After stirring for 2 h at −20 °C ZnCl2 (1 M in THF, 6.0 mL, 6.00 mmol) was added. Titration 
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with iodine gave a concentration of 0.29 mmol/mL active zinc species, corresponding to 92% 
yield. 
 
(2,6-Dimethoxypyrimidin-4-yl)zinc Chloride (1q) 
 
According to TP4, 4-bromo-2,6-dimethoxypyrimidine (549 mg, 2.50 mmol, 1.00 equiv) was 
added to a suspension of anhydrous LiCl (159 mg, 3.75 mmol, 1.50 equiv) and magnesium 
turnings (122 mg, 5.00 mmol, 2.00 equiv) in dry THF (5 mL). The mixture was stirred at 25 °C 
overnight and then ZnCl2 (1 M in THF, 3.0 mL, 3.00 mmol, 1.20 equiv) was added as a solution 
in THF at 0 °C. Titration with iodine gave a concentration of 0.28 mmol/mL active zinc 
species, corresponding to 96% yield. 
 
(3-Methoxyphenyl)zinc Chloride (1r) 
 
According to TP4, 1-bromo-3-methoxybenzene (468 mg, 2.50 mmol, 1.00 equiv) was added 
to a suspension of anhydrous LiCl (159 mg, 3.75 mmol, 1.50 equiv) and magnesium turnings 
(122 mg, 5.00 mmol, 2.00 equiv) in dry THF (5 mL). The mixture was stirred at 25 °C 
overnight and then ZnCl2 (1 M in THF, 3.0 mL, 3.00 mmol, 1.20 equiv) was added as a solution 
in THF at 0 °C. Titration with iodine gave a concentration of 0.29 mmol/mL active zinc 
species, corresponding to 99% yield. 
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(4-Fluoro-3-methylphenyl)zinc Chloride (1s) 
 
According to TP4, 4-bromo-1-fluoro-2-methylbenzene (473 mg, 2.50 mmol, 1.00 equiv) was 
added to a suspension of anhydrous LiCl (159 mg, 3.75 mmol, 1.50 equiv) and magnesium 
turnings (122 mg, 5.00 mmol, 2.00 equiv) in dry THF (5 mL). The mixture was stirred at 25 °C 
overnight and then ZnCl2 (1 M in THF, 3.0 mL, 3.00 mmol, 1.20 equiv) was added as a solution 
in THF at 0 °C. Titration with iodine gave a concentration of 0.28 mmol/mL active zinc 
species, corresponding to 96% yield. 
 
(3,4-Difluorophenyl)zinc Chloride (1t) 
 
According to TP4, 4-bromo-1,2-difluorobenzene (483 mg, 2.50 mmol, 1.00 equiv) was added 
to a suspension of anhydrous LiCl (159 mg, 3.75 mmol, 1.50 equiv) and magnesium turnings 
(122 mg, 5.00 mmol, 2.00 equiv) in dry THF (5 mL). The mixture was stirred at 25 °C 
overnight and then ZnCl2 (1 M in THF, 3.0 mL, 3.00 mmol, 1.20 equiv) was added as a solution 
in THF at 0 °C. Titration with iodine gave a concentration of 0.26 mmol/mL active zinc 
species, corresponding to 90% yield. 
 
(3,5-dimethylisoxazol-4-yl)zinc Chloride (1u) 
 
According to TP4, 4-bromo-3,5-dimethylisoxazole (440 mg, 2.50 mmol, 1.00 equiv) was 
added to a suspension of anhydrous LiCl (159 mg, 3.75 mmol, 1.50 equiv) and magnesium 
turnings (122 mg, 5.00 mmol, 2.00 equiv) in dry THF (5 mL). The mixture was stirred at 25 °C 
overnight and then ZnCl2 (1 M in THF, 3.0 mL, 3.00 mmol, 1.20 equiv) was added as a solution 
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in THF at 0 °C. Titration with iodine gave a concentration of 0.26 mmol/mL active zinc 
species, corresponding to 88% yield. 
 
(2,4,6-Trimethoxyphenyl)zinc Chloride (1v) 
 
According to TP4, 2-bromo-1,3,5-trimethoxybenzene (618 mg, 2.50 mmol, 1.00 equiv) was 
added to a suspension of anhydrous LiCl (159 mg, 3.75 mmol, 1.50 equiv) and magnesium 
turnings (122 mg, 5.00 mmol, 2.00 equiv) in dry THF (5 mL). The mixture was stirred at 25 °C 
overnight and then ZnCl2 (1 M in THF, 3.0 mL, 3.00 mmol, 1.20 equiv) was added as a solution 
in THF at 0 °C. Titration with iodine gave a concentration of 0.26 mmol/mL active zinc 
species, corresponding to 89% yield. 
 
(3,5-Dimethylphenyl)zinc Chloride (1w) 
 
According to TP4, 1-bromo-3,5-dimethylbenzene (458 mg, 2.50 mmol, 1.00 equiv) was added 
to a suspension of anhydrous LiCl (159 mg, 3.75 mmol, 1.50 equiv) and magnesium turnings 
(122 mg, 5.00 mmol, 2.00 equiv) in dry THF (5 mL). The mixture was stirred at 25 °C 
overnight and then ZnCl2 (1 M in THF, 3.0 mL, 3.00 mmol, 1.20 equiv) was added as a solution 
in THF at 0 °C. Titration with iodine gave a concentration of 0.29 mmol/mL active zinc 
species, corresponding to 99% yield. 
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Naphthalen-1-ylzinc Chloride (1x) 
 
According to TP4, 1-bromonaphthalene (518 mg, 2.50 mmol, 1.00 equiv) was added to a 
suspension of anhydrous LiCl (159 mg, 3.75 mmol, 1.50 equiv) and magnesium turnings 
(122 mg, 5.00 mmol, 2.00 equiv) in dry THF (5 mL). The mixture was stirred at 25 °C 
overnight and then ZnCl2 (1 M in THF, 3.0 mL, 3.00 mmol, 1.20 equiv) was added as a solution 
in THF at 0 °C. Titration with iodine gave a concentration of 0.27 mmol/mL active zinc 
species, corresponding to 92% yield. 
 
(1-Methyl-1H-indol-5-yl)zinc Chloride (1y) 
 
According to TP4, 5-bromo-1-methyl-1H-indole (525 mg, 2.50 mmol, 1.00 equiv) was added 
to a suspension of anhydrous LiCl (159 mg, 3.75 mmol, 1.50 equiv) and magnesium turnings 
(122 mg, 5.00 mmol, 2.00 equiv) in dry THF (5 mL). The mixture was stirred at 25 °C 
overnight and then ZnCl2 (1 M in THF, 3.0 mL, 3.00 mmol, 1.20 equiv) was added as a solution 
in THF at 0 °C. Titration with iodine gave a concentration of 0.26 mmol/mL active zinc 
species, corresponding to 82% yield. 
 
(6-(8-((Trimethylsilyl)oxy)-1,4-dioxaspiro[4.5]decan-8-yl)pyridin-3-yl)zinc chloride (1z) 
 
According to TP4, 5-iodo-2-(8-((trimethylsilyl)oxy)-1,4-dioxaspiro[4.5]decan-8-yl)pyridine 
(1.08 g, 2.50 mmol, 1.00 equiv) was added to a suspension of anhydrous LiCl (159 mg, 
3.75 mmol, 1.50 equiv) and magnesium turnings (122 mg, 5.00 mmol, 2.00 equiv) in dry THF 
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(5 mL). The mixture was stirred at 25 °C overnight and then ZnCl2 (1 M in THF, 3.0 mL, 
3.00 mmol, 1.20 equiv) was added as a solution in THF at 0 °C. Titration with iodine gave a 
concentration of 0.23 mmol/mL active zinc species, corresponding to 78% yield. 
 
(4-(Ethoxycarbonyl)phenyl)zinc Chloride (1aa) 
 
According to TP2 ethyl 4-iodobenzoate (1.38 g, 5.00 mmol, 1.00 equiv) was dissolved in dry 
THF (5 mL) and iPrMgCl·LiCl (4.30 mL, 1.28 M, 5.50 mmol, 1.10 equiv) was added. After 
stirring for 30 min at -30 °C ZnCl2 (1 M in THF, 6.0 mL, 6.00 mmol) was added. Titration with 
iodine gave a concentration of 0.30 mmol/mL active zinc species, corresponding to 95% yield. 
 
(2-fluoro-[1,1'-biphenyl]-4-yl)zinc Chloride (1cc) 
 
According to TP4, 4-bromo-2-fluoro-1,1'-biphenyl (628 mg, 2.50 mmol, 1.00 equiv) was 
added to a suspension of anhydrous LiCl (159 mg, 3.75 mmol, 1.50 equiv) and magnesium 
turnings (122 mg, 5.00 mmol, 2.00 equiv) in dry THF (5 mL). The mixture was stirred at 25 °C 
overnight and then ZnCl2 (1 M in THF, 3.0 mL, 3.00 mmol, 1.20 equiv) was added as a solution 
in THF at 0 °C. Titration with iodine gave a concentration of 0.28 mmol/mL active zinc 
species, corresponding to 96% yield. 
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4.4 Preparation of 1,4-Addition Products of Type 17 
3-(4-(Pyrimidin-2-yl)piperazin-1-yl)propanenitrile (17b) 
 
According to TP10, 2-(piperazin-1-yl)pyrimidine (14b, 164 mg, 1.00 mmol, 1.00 equiv) was 
dissolved in dry MeOH (5 mL) and acrylonitrile (0.33 mL, 265 mg, 5.00 mmol, 5.00 equiv) 
was added. After stirring the mixture at 55 °C overnight the solvent was removed and the crude 
product purified by flash column chromatography (EtOAc:MeOH 9.5:0.5) to afford the title 
compound as a colourless oil (211 mg, 0.97 mmol, 97%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.24 (d, J = 4.7 Hz, 2H), 6.43 (t, J = 4.8 Hz, 1H), 
3.85–3.70 (m, 4H), 2.67 (t, J = 7.0 Hz, 2H), 2.53–2.45 (m, 6H). 
13C NMR (101 MHz, CDCl3): δ / ppm = 161.6, 157.7, 118.7, 110.0, 53.5, 52.6, 43.5, 16.0. 
Analytical data according to literature.125 
 
3-(4-(Morpholine-4-carbonyl)piperazin-1-yl)propanenitrile (17c) 
 
According to TP10, morpholino(piperazin-1-yl)methanone (14c, 199 mg, 1.00 mmol, 
1.00 equiv) was dissolved in dry MeOH (5 mL) and acrylonitrile (0.33 mL, 265 mg, 
5.00 mmol, 5.00 equiv) was added. After stirring the mixture at 55 °C overnight the solvent 
was removed and the crude product purified by flash column chromatography (EtOAc:MeOH 
9.5:0.5) to afford the title compound as a colourless oil (235 mg, 0.93 mmol, 93%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 3.61 (q, J = 4.6 Hz, 2H), 3.20 (dt, J = 18.8, 4.8 Hz, 
4H), 2.64 (q, J = 6.1 Hz, 1H), 2.45 (dq, J = 13.8, 4.6 Hz, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 163.5, 118.7, 66.5 (2C), 53.2, 52.3 (2C), 47.2 (2C), 
46.4 (2C), 15.8. 
                                                          
125  K. Ishizumi, A. Kojima, F. Antoku Chem. Pharm. Bull. 1991, 39, 2288–2300. 
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IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2975, 2935, 2852, 2601, 2497, 1641, 1473, 1469, 1460, 
1443, 1419, 1397, 1359, 1352, 1302, 1288, 1279, 1266, 1245, 1229, 1169, 1152, 1128, 1114, 
1109, 1100, 1067, 1044, 1037, 1022, 996, 969, 931, 901, 871, 839, 785, 761. 
MS (EI, 70 eV): m/z (%) = 252 (18), 166 (35), 114(100), 86 (38). 
HRMS (EI): m/z calc. for [C12H20N4O2]: 252.1586; found 252.1583. 
 
3-(4-(3-Fluorobenzoyl)piperazin-1-yl)propanenitrile (17d) 
 
According to TP10, (3-fluorophenyl)(piperazin-1-yl)methanone (14d, 208 mg, 1.00 mmol, 
1.00 equiv) was dissolved in dry MeOH (5 mL) and acrylonitrile (0.33 mL, 265 mg, 
5.00 mmol, 5.00 equiv) was added. After stirring the mixture at 55 °C overnight the solvent 
was removed and the crude product purified by flash column chromatography (EtOAc:MeOH 
9.5:0.5) to afford the title compound as a colourless oil (256 mg, 0.98 mmol, 98%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.31 (t, J = 7.8, 5.5 Hz, 1H), 7.11–6.99 (m, 3H), 3.70 
(s, 2H), 3.35 (s, 2H), 2.62 (t, J = 6.8 Hz, 2H), 2.55–2.32 (m, 7H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 168.7 (d, J = 2.3 Hz), 162.4 (d, J = 248.0 Hz), 137.6 
(d, J = 6.9 Hz), 130.4 (d, J = 8.0 Hz), 122.7 (d, J = 3.2 Hz), 118.7, 116.8 (d, J = 21.1 Hz), 
114.26 (d, J = 22.7 Hz), 53.0, 52.8, 52.1, 47.4, 42.0, 15.9. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2931, 2822, 2819, 1626, 1583, 1490, 1461, 1439, 1426, 
1370, 1354, 1300, 1280, 1267, 1213, 1139, 1133, 1096, 1021, 1000, 964, 940, 931, 880, 832, 
795, 747, 710, 687. 
MS (EI, 70 eV): m/z (%) = 261 (23), 166 (40), 123 (100), 95 (40). 
HRMS (EI): m/z calc. for [C14H16FN3O]: 261.1277; found 261.1273. 
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3-(3,4-dihydroisoquinolin-2(1H)-yl)propanenitrile (17e) 
 
According to TP10, 1,2,3,4-tetrahydroisoquinoline (14e, 133 mg, 1.00 mmol, 1.00 equiv) was 
dissolved in dry MeOH (5 mL) and acrylonitrile (0.33 mL, 265 mg, 5.00 mmol, 5.00 equiv) 
was added. After stirring the mixture at 55 °C overnight the solvent was removed and the crude 
product purified by flash column chromatography (EtOAc:MeOH 9.5:0.5) to afford the title 
compound as a colourless oil (180 mg, 0.97 mmol, 97%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.11–7.01 (m, 3H), 7.00–6.91 (m, 1H), 3.64 (s, 2H), 
2.85 (t, J = 5.9 Hz, 2H), 2.81 (t, J = 7.1 Hz, 2H), 2.74 (t, J = 5.8 Hz, 2H), 2.54 (t, J = 7.1 Hz, 
2H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 133.9, 133.9, 128.7, 126.6, 126.4, 125.8, 118.8, 55.4, 
53.2, 50.6, 28.9, 16.3. 
Analytical Data according to Literature126 
 
3-(4,7-Dihydrothieno[2,3-c]pyridin-6(5H)-yl)propanenitrile (17f) 
 
According to TP10, 4,5,6,7-tetrahydrothieno[2,3-c]pyridine (14f, 139 mg, 1.00 mmol, 
1.00 equiv) was dissolved in dry MeOH (5 mL) and acrylonitrile (0.33 mL, 265 mg, 
5.00 mmol, 5.00 equiv) was added. After stirring the mixture at 55 °C overnight the solvent 
was removed and the crude product purified by flash column chromatography (EtOAc:MeOH 
9.5:0.5) to afford the title compound as a colourless oil (190 mg, 0.99 mmol, 99%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.12 (d, J = 5.1 Hz, 1H), 6.76 (d, J = 5.1 Hz, 1H), 
3.67 (d, J = 1.7 Hz, 2H), 2.98–2.89 (m, 6H), 2.63 (t, J = 7.1 Hz, 2H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 133.2, 132.9, 125.1, 123.0, 118.8, 52.7, 52.5, 50.6, 
25.2, 16.5. 
                                                          
126  H. Stamm, J. Hoenicke Arch. Pharm. 1974, 5, 340–348. 
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IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2924, 2822, 1464, 1430, 1414, 1361, 1320, 1243, 1213, 
1169, 1137, 1117, 1081, 1048, 1017, 987, 974, 903, 833, 775, 707, 668. 
MS (EI, 70 eV): m/z (%) = 192 (5), 152 (78), 135 (78), 110 (100), 84 (14). 
HRMS (EI): m/z calc. for [C10H12N2S]: 192.0721; found 192.0714. 
 
N-(1-(2-Cyanoethyl)piperidin-3-yl)cyclopropanecarboxamide (17g) 
 
According to TP10, N-(piperidin-3-yl)cyclopropanecarboxamide (14g, 168 mg, 1.00 mmol, 
1.00 equiv) was dissolved in dry MeOH (5 mL) and acrylonitrile (0.33 mL, 265 mg, 
5.00 mmol, 5.00 equiv) was added. After stirring the mixture at 55 °C overnight the solvent 
was removed and the crude product purified by flash column chromatography (EtOAc:MeOH 
9.5:0.5) to afford the title compound as a colourless oil (210 mg, 0.95 mmol, 95%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 6.59 (s, 1H), 3.96 (s, 1H), 2.64–2.39 (m, 6H), 2.37–
2.23 (m, 2H), 1.64 (s, 1H), 1.47 (s, 3H), 1.34 (s, 1H), 0.80 (s, 2H), 0.60 (s, 2H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 172.8, 118.9, 57.6, 53.1, 52.9, 45.1, 28.9, 22.2, 16.1, 
14.5, 6.9 (2C). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2980, 2851, 2360, 2341, 1700, 1652, 1645, 1640, 1635, 
1627, 1558, 1539, 1506, 1456, 1436, 1429, 1423, 1419, 1405, 1399, 1394, 1359, 1352, 1279, 
1265, 1229, 1152, 1114, 1109, 1100, 1044, 1022, 995, 931, 901, 871, 838, 784, 761. 
MS (EI, 70 eV): m/z (%) = 221 (11), 181 (56), 140 (100). 
HRMS (EI): m/z calc. for [C12H19N3O]: 221.1528; found 221.1521. 
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(S)-3-(2-(pyridin-3-yl)piperidin-1-yl)propanenitrile (17h) 
 
According to TP10, anabasine (14h, 162 mg, 1.00 mmol, 1.00 equiv) was dissolved in dry 
MeOH (5 mL) and acrylonitrile (0.33 mL, 265 mg, 5.00 mmol, 5.00 equiv) was added. After 
stirring the mixture at 55 °C overnight the solvent was removed and the crude product purified 
by flash column chromatography (EtOAc:MeOH 9.5:0.5) to afford the title compound as a 
colourless oil (213 mg, 0.99 mmol, 99%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.51–8.39 (m, 2H), 7.70 (dt, J = 7.9, 2.0 Hz, 1H), 
7.22 (dd, J = 7.9, 4.8 Hz, 1H), 3.13–3.02 (m, 2H), 2.71–2.61 (m, 1H), 2.40–2.29 (m, 1H), 2.28–
2.15 (m, 2H), 2.09 (td, J = 11.6, 3.0 Hz, 1H), 1.78–1.53 (m, 4H), 1.52–1.40 (m, 1H), 1.30 (qt, 
J = 12.5, 3.8 Hz, 1H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 149.1, 148.9, 139.6, 135.0, 123.8, 118.8, 65.5, 52.9, 
50.1, 36.7, 25.7, 24.6, 15.6. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3852, 3744, 2934, 2854, 2796, 2364, 2341, 1733, 1717, 
1700, 1695, 1684, 1675, 1669, 1652, 1646, 1635, 1616, 1576, 1558, 1539, 1521, 1506, 1472, 
1456, 1436, 1423, 1419, 1322, 1128, 1107, 1025, 984, 805, 760, 716. 
MS (ESI, 70 eV): m/z (%) = 216 (100), 175 (5). 
HRMS (ESI): m/z calc. for [C13H17N3]: 215.1422; found 216.1491 [M+H]. 
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Methyl 2-(1-(2-cyanoethyl)piperidin-2-yl)-2-phenylacetate (17i) 
 
According to TP10, methylphenidate hydrochloride (14i, 270 mg, 1.00 mmol, 1.00 equiv) was 
dissolved in dry MeOH (5 mL) and added to a solution of sodium metal (23 mg, 1.00 mmol, 
1.00 equiv). Then, acrylonitrile (0.33 mL, 265 mg, 5.00 mmol, 5.00 equiv) was added and the 
resulting mixture was stirred at 55 °C overnight. The solvent was removed and the crude 
product purified by flash column chromatography (EtOAc:MeOH 9.5:0.5) to afford the title 
compound as a colourless oil (258 mg, 0.90 mmol, 90%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.35–7.29 (m, 2H), 7.28–7.18 (m, 3H), 4.01 (d, J = 
11.7 Hz, 1H), 3.62 (s, 3H), 3.28–3.21 (m, 1H), 3.15–3.06 (m, 1H), 2.97–2.82 (m, 2H), 2.68–
2.59 (m, 1H), 2.49–2.31 (m, 2H), 1.50–1.22 (m, 5H), 0.9 (d, J = 13.3 Hz, 1H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 174.1, 136.6, 128.8 (2C), 128.5 (2C), 127.6, 119.3, 
60.7, 52.7, 52.1, 50.0, 47.7, 20.9, 20.5, 20.0, 18.2. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2947, 2919, 2854, 2358, 2339, 1733, 1723, 1717, 1700, 
1695, 1684, 1652, 1635, 1558, 1539, 1521, 1506, 1496, 1472, 1456, 1448, 1436, 1433, 1419, 
1346, 1285, 1201, 1188, 1163, 1155, 1146, 1125, 1013, 994, 869, 781, 729, 695. 
MS (ESI, 70 eV): m/z (%) = 287 (100), 246 (14), 137 (46). 
HRMS (ESI): m/z calc. for [C17H22N2O2]: 286.1681; found 287.1753 [M+H]. 
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3-((3S,4R)-3-((Benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidin-1-yl) 
propanenitrile (17j) 
 
According to TP10, paroxetine hydrochloride (14j, 366 mg, 1.00 mmol, 1.00 equiv) was 
dissolved in dry MeOH (5 mL) and added to a solution of sodium metal (23 mg, 1.00 mmol, 
1.00 equiv). Then, acrylonitrile (0.33 mL, 265 mg, 5.00 mmol, 5.00 equiv) was added and the 
resulting mixture was stirred at 55 °C overnight. The solvent was removed and the crude 
product purified by flash column chromatography (hexane:EtOAc 1:1) to afford the title 
compound as a colourless oil (371 mg, 0.97 mmol, 97%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.18–7.12 (m, 2H), 7.00–6.96 (m, 2H), 6.62 (d, J = 
8.4 Hz, 1H), 6.34 (d, J = 2.5 Hz, 1H), 6.13 (dd, J = 8.5, 2.5 Hz, 1H), 5.88 (s, 2H), 3.57 (dd, J 
= 9.3, 2.7 Hz, 1H), 3.44 (dd, J = 9.4, 6.8 Hz, 1H), 3.23 (d, J = 9.7 Hz, 1H), 3.02 (d, J = 10.8 Hz, 
1H), 2.83–2.74 (m, 2H), 2.57 (t, J = 7.0 Hz, 2H), 2.46 (td, J = 11.0, 5.1 Hz, 1H), 2.24–2.13 (m, 
3H), 1.91–1.81 (m, 2H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 161.6 (d, J = 244.5 Hz), 154.3, 148.2, 141.6, 139.3, 
128.8, 118.8, 115.5 (d, J = 21.1 Hz), 107.9, 105.5 (d, J = 9.0 Hz), 101.1, 101.1, 101.0, 97.9 (d, 
J = 9.2 Hz), 69.4, 57.1, 53.7, 53.6, 43.8, 42.0, 34.1, 16.0. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2938, 2933, 2919, 2900, 2815, 2774, 2249, 1631, 1604, 
1509, 1502, 1487, 1467, 1378, 1351, 1269, 1242, 1221, 1182, 1159, 1136, 1102, 1090, 1060, 
1036, 1015, 974, 932, 832, 817, 783, 762, 731. 
MS (EI, 70 eV): m/z (%) = 382 (51), 342 (54), 329 (28), 245 (100), 204 (39), 192 (50), 171 
(24), 109 (49), 97 (98), 58 (78). 
HRMS (EI): m/z calc. for [C22H23FN2O3]: 382.1693; found 382.1687. 
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3-(4-((5,6-dimethoxy-1-oxo-2,3-dihydro-1H-inden-2-yl)methyl)piperidin-1-
yl)propanenitrile (17k) 
 
According to TP10, 5,6-dimethoxy-2-(piperidin-4-ylmethyl)-2,3-dihydro-1H-inden-1-one 
(14k, 289 mg, 1.00 mmol, 1.00 equiv) was dissolved in dry MeOH (5 mL) and added to a 
solution of sodium metal (23 mg, 1.00 mmol, 1.00 equiv). Then, acrylonitrile (0.33 mL, 
265 mg, 5.00 mmol, 5.00 equiv) was added and the resulting mixture was stirred at 55 °C 
overnight. The solvent was removed and the crude product purified by flash column 
chromatography (pure EtOAc) to afford the title compound as a colourless oil (300 mg, 
0.87 mmol, 87%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.17 (s, 1H), 6.86 (s, 1H), 3.97 (s, 3H), 3.91 (s, 3H), 
3.25 (dd, J = 17.5, 8.1 Hz, 1H), 2.95–2.86 (m, 2H), 2.75–2.65 (m, 4H), 2.51 (t, J = 7.2 Hz, 2H), 
2.13–2.03 (m, 2H), 1.91 (ddd, J = 13.1, 7.9, 4.4 Hz, 1H), 1.81–1.68 (m, 2H), 1.62–1.45 (m, 
2H), 1.40–1.19 (m, 2H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 203.1, 154.7, 149.9, 144.6, 127.5, 118.3, 109.5, 
108.8, 56.4, 55.9, 53.5, 53.5, 50.3, 45.4, 34.1, 33.4, 32.1, 30.9, 30.8, 16.2. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2921, 1686, 1649, 1606, 1590, 1500, 1462, 1316, 1269, 
1246, 1214, 1125, 1032, 969. 
MS (EI, 70 eV): m/z (%) = 342 (72), 288 (54), 226 (23), 136 (100), 98 (45), 58 (23). 
HRMS (EI): m/z calc. for [C20H26N2O3]: 342.4390; found 342.4394. 
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(R)-3-(8-Chloro-1-methyl-1,2,4,5-tetrahydro-3H-benzo[d]azepin-3-yl)propanenitrile 
(17l) 
 
According to TP10, lorcaserin hydrochloride (14l, 232 mg, 1.00 mmol, 1.00 equiv) was 
dissolved in dry MeOH (5 mL) and added to a solution of sodium metal (23 mg, 1.00 mmol, 
1.00 equiv). Then, acrylonitrile (0.33 mL, 265 mg, 5.00 mmol, 5.00 equiv) was added and the 
resulting mixture was stirred at 55 °C overnight. The solvent was removed and the crude 
product purified by flash column chromatography (hexane:EtOAc 3:1) to afford the title 
compound as a colourless oil (239 mg, 0.96 mmol, 96%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.13 (d, J = 2.2 Hz, 1H), 7.09 (dd, J = 7.9, 2.2 Hz, 
1H), 7.00 (d, J = 8.0 Hz, 1H), 3.11 (p, J = 7.4 Hz, 1H), 3.00–2.77 (m, 5H), 2.73 (d, J = 12.2 Hz, 
1H), 2.57–2.42 (m, 4H), 1.35 (d, J = 7.3 Hz, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 147.0, 139.3, 132.0, 130.7, 126.3, 126.0, 118.9, 61.4, 
54.6, 54.5, 38.8, 35.8, 18.2, 15.8. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2958, 2936, 2932, 2917, 2891, 2883, 2879, 2814, 2782, 
2779, 2245, 1594, 1569, 1488, 1466, 1452, 1435, 1402, 1369, 1359, 1341, 1330, 1311, 1283, 
1265, 1187, 1176, 1151, 1123, 1114, 1106, 1058, 1048, 1028, 1004, 975, 952, 934, 895, 877, 
842, 818, 772. 
MS (EI, 70 eV): m/z (%) = 248 (1), 208 (100), 115 (27). 
HRMS (EI): m/z calc. for [C14H17ClN2]: 248.1080; found 248.1076. 
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3-((3-(10,11-Dihydro-5H-dibenzo[a,d][7]annulen-5-ylidene)propyl)(methyl)amino) 
propanenitrile (17m) 
 
According to TP10, nortiptyline hydrochloride (14m, 300 mg, 1.00 mmol, 1.00 equiv) was 
dissolved in dry MeOH (5 mL) and added to a solution of sodium metal (23 mg, 1.00 mmol, 
1.00 equiv). Then, acrylonitrile (0.33 mL, 265 mg, 5.00 mmol, 5.00 equiv) was added and the 
resulting mixture was stirred at 55 °C overnight. The solvent was removed and the crude 
product purified by flash column chromatography (hexane:EtOAc 1:3) to afford the title 
compound as a colourless oil (313 mg, 0.99 mmol, 99%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.30–7.27 (m, 1H), 7.23–7.12 (m, 6H), 7.06–7.03 (m, 
1H), 5.86 (t, J = 7.4 Hz, 1H), 3.41 (s, 1H), 3.31 (s, 1H), 2.97 (s, 1H), 2.79 (s, 1H), 2.66 (t, J = 
7.1 Hz, 2H), 2.49 (q, J = 6.2, 5.7 Hz, 2H), 2.41–2.35 (m, 2H), 2.29 (q, J = 7.4 Hz, 2H), 2.20 (s, 
3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 143.9, 141.1, 140.0, 139.3, 137.0, 130.0, 128.8, 
128.6, 128.1, 128.1, 127.5, 127.1, 126.0, 125.8, 56.7, 52.5, 41.4, 33.8, 32.0, 27.2, 18.7, 15.9. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3062, 3015, 2943, 2938, 2934, 2927, 2923, 2918, 2849, 
2843, 2832, 2798, 2795, 2248, 1485, 1464, 1452, 1443, 1427, 1373, 1360, 1333, 1306, 1279, 
1246, 1220, 1181, 1142, 1126, 1097, 1052, 1038, 948, 923, 893, 861, 777, 768, 756, 743, 719. 
MS (EI, 70 eV): m/z (%) = 316 (1), 218 (13), 202 (22), 97 (100). 
HRMS (EI): m/z calc. for [C22H24N2]: 316.1939; found 316.1931. 
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3-(((1S,4S)-4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydronaphthalen-1-yl)(methyl)amino) 
propanenitrile (17n) 
 
According to TP10, sertraline hydrochloride (14n, 343 mg, 1.00 mmol, 1.00 equiv) was 
dissolved in dry MeOH (5 mL) and added to a solution of sodium metal (23 mg, 1.00 mmol, 
1.00 equiv). Then, acrylonitrile (0.33 mL, 265 mg, 5.00 mmol, 5.00 equiv) was added and the 
resulting mixture was stirred at 55 °C overnight. The solvent was removed and the crude 
product purified by flash column chromatography (hexane:EtOAc 1:4) to afford the title 
compound as a colourless oil (352 mg, 0.98 mmol, 98%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.86 (d, J = 7.8 Hz, 1H), 7.34–7.27 (m, 2H), 7.17 (d, 
J = 8.4 Hz, 1H), 7.13–7.09 (m, 1H), 6.91 (dt, J = 7.7, 0.9 Hz, 1H), 6.80 (dd, J = 8.3, 2.1 Hz, 
1H), 4.15 (dd, J = 5.8, 3.3 Hz, 1H), 3.94 (dd, J = 10.2, 5.8 Hz, 1H), 2.80 (hept, J = 6.5, 6.0 Hz, 
2H), 2.55 (t, J = 6.7 Hz, 2H), 2.31 (s, 3H), 2.21–2.10 (m, 1H), 2.06–1.98 (m, 1H), 1.74–1.57 
(m, 2H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 147.3, 138.4, 138.0, 132.2, 130.7, 130.3, 130.0, 
130.0, 128.6, 128.2, 127.3, 127.2, 118.9, 62.7, 49.2, 43.4, 36.8, 30.0, 17.7, 16.1. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2939, 2862, 2799, 2248, 1586, 1559, 1485, 1466, 1450, 
1427, 1418, 1390, 1357, 1336, 1317, 1271, 1254, 1201, 1154, 1131, 1069, 1062, 1043, 1028, 
993, 941, 911, 882, 849, 828, 784, 763, 739, 712, 686, 678. 
MS (EI, 70 eV): m/z (%) = 358 (3), 318 (41), 275 (100), 202 (14), 159 (90), 129 (64), 91 (22), 
44 (51). 
HRMS (EI): m/z calc. for [C20H20Cl2N2]: 358.1002; found 358.1004. 
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3-(Methyl(3-phenyl-3-(4-(trifluoromethyl)phenoxy)propyl)amino)propanenitrile (17o) 
 
According to TP10, fluoxetine hydrochloride (14o, 346 mg, 1.00 mmol, 1.00 equiv) was 
dissolved in dry MeOH (5 mL) and added to a solution of sodium metal (23 mg, 1.00 mmol, 
1.00 equiv). Then, acrylonitrile (0.33 mL, 265 mg, 5.00 mmol, 5.00 equiv) was added and the 
resulting mixture was stirred at 55 °C overnight. The solvent was removed and the crude 
product purified by flash column chromatography (hexane:EtOAc 1:2) to afford the title 
compound as a colourless oil (355 mg, 0.98 mmol, 98%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.43 (d, J = 8.7 Hz, 2H), 7.38–7.32 (m, 4H), 7.29–
7.25 (m, 1H), 6.92 (d, J = 8.6 Hz, 2H), 5.39 (dd, J = 8.4, 4.8 Hz, 1H), 2.76–2.59 (m, 2H), 2.46 
(dt, J = 27.5, 6.5 Hz, 3H), 2.29 (s, 3H), 2.21–2.13 (m, 1H), 2.02–1.94 (m, 1H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 160.5, 141.0, 128.88–128.65 (m), 127.96–127.74 
(m), 126.8 (q, J = 3.3 Hz), 126.06–125.85 (m), 126.0, 125.9, 124.4 (q, J = 271.1 Hz), 122.8 (q, 
J = 32.7 Hz), 118.9, 115.8, 115.7, 77.8, 77.7, 53.0, 52.8, 41.6, 36.4, 16.3. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2959, 2955, 2944, 2941, 2933, 2926, 2850, 2840, 2807, 
2803, 2781, 1613, 1589, 1516, 1494, 1466, 1454, 1423, 1357, 1324, 1310, 1250, 1205, 1177, 
1160, 1109, 1067, 1049, 1028, 1009, 999, 951, 917, 836, 814, 760, 701.z 
MS (EI, 70 eV): m/z (%) = 362 (2), 218 (8), 97 (100), 58 (10), 44 (15). 
HRMS (EI): m/z calc. for [C20H21F3N2O]: 362.1598; found 362.1598. 
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(S)-3-(Methyl(3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propyl)amino)propanenitrile 
(17p) 
 
According to TP10, duloxetine hydrochloride (14p, 334 mg, 1.00 mmol, 1.00 equiv) was 
dissolved in dry MeOH (5 mL) and added to a solution of sodium metal (23 mg, 1.00 mmol, 
1.00 equiv). Then, acrylonitrile (0.33 mL, 265 mg, 5.00 mmol, 5.00 equiv) was added and the 
resulting mixture was stirred at 55 °C overnight. The solvent was removed and the crude 
product purified by flash column chromatography (EtOAc:MeOH 9.5:0.5) to afford the title 
compound as a colourless oil (347 mg, 0.99 mmol, 99%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.41–8.34 (m, 1H), 7.81 (dt, J = 7.9, 2.8 Hz, 1H), 
7.56–7.48 (m, 2H), 7.43 (d, J = 8.2 Hz, 1H), 7.32 (t, J = 8.0 Hz, 1H), 7.24 (dd, J = 5.0, 1.2 Hz, 
1H), 7.14 (dd, J = 3.5, 1.2 Hz, 1H), 7.00–6.92 (m, 2H), 5.89 (dd, J = 7.9, 5.3 Hz, 1H), 2.70 
(hept, J = 6.4 Hz, 3H), 2.65–2.56 (m, 1H), 2.51–2.38 (m, 3H), 2.33 (s, 3H), 2.27–2.17 (m, 1H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 153.3, 145.1, 134.6, 127.6, 126.6, 126.3, 126.1, 
125.9, 125.3, 125.0, 124.8, 122.0, 120.6, 118.9, 107.1, 73.9, 53.1, 53.0, 41.7, 36.7, 16.2. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2954, 2806, 1626, 1595, 1576, 1505, 1460, 1395, 1372, 
1319, 1263, 1233, 1155, 1093, 1063, 1017, 974, 907, 788, 770, 726. 
MS (ESI, 70 eV): m/z (%) = 351 (100), 299 (8), 97 (48). 
HRMS (ESI): m/z calc. for [C21H22N2OS]: 350.1453; found 351.1522 [M+H]. 
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Ethyl 1-(2-cyanoethyl)piperidine-3-carboxylate (17q) 
 
According to TP10, ethyl piperidine-3-carboxylate (14q, 157 mg, 1.00 mmol, 1.00 equiv) was 
dissolved in dry MeOH (5 mL) and added to a solution of sodium metal (23 mg, 1.00 mmol, 
1.00 equiv). Then, acrylonitrile (0.33 mL, 265 mg, 5.00 mmol, 5.00 equiv) was added and the 
resulting mixture was stirred at 55 °C overnight. The solvent was removed and the crude 
product purified by flash column chromatography (EtOAc:MeOH 9.5:0.5) to afford the title 
compound as a colourless oil (200 mg, 0.95 mmol, 95%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 4.12 (q, J = 7.1 Hz, 1H), 2.95–2.88 (m, 1H), 2.76–
2.65 (m, 1H), 2.60–2.46 (m, 2H), 2.30 (t, J = 10.4 Hz, 1H), 2.13 (td, J = 10.7, 3.1 Hz, 1H), 
1.96–1.87 (m, 1H), 1.78–1.69 (m, 1H), 1.63–1.40 (m, 1H), 1.25 (t, J = 7.1 Hz, 2H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 173.8, 118.8, 60.5, 54.9, 53.7, 53.3, 41.7, 26.6, 24.4, 
15.9, 14.2. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2943, 2813, 1725, 1469, 1447, 1370, 1307, 1235, 1217, 
1214, 1182, 1153, 1135, 1103, 1032, 859. 
MS (ESI, 70 eV): m/z (%) = 210 (15), 170 (100), 137 (24), 96 (31), 53 (39).  
HRMS (EI): m/z calc. for [C11H18N2O2]: 210.1368; found 210.1361. 
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1-(2-cyanoethyl)-N-(3,5-dimethylphenyl)azetidine-3-carboxamide (17r) 
 
According to TP10, N-(3,5-dimethylphenyl)azetidine-3-carboxamide (14r, 204 mg, 
1.00 mmol, 1.00 equiv) was dissolved in dry MeOH (5 mL)and added to a solution of sodium 
metal (23 mg, 1.00 mmol, 1.00 equiv). Then, acrylonitrile (0.33 mL, 265 mg, 5.00 mmol, 
5.00 equiv) was added and the resulting mixture was stirred at 55 °C overnight. The solvent 
was removed and the crude product purified by flash column chromatography (pure EtOAc) to 
afford the title compound as a colourless oil (196 mg, 0.76 mmol, 76%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.19 (s, 1H), 7.21 (s, 2H), 6.76 (s, 1H), 3.54 (p, J = 
7.0 Hz, 4H), 3.17 (ddd, J = 7.5, 5.1, 2.4 Hz, 1H), 2.76 (t, J = 6.6 Hz, 2H), 2.42 (t, J = 6.6 Hz, 
2H), 2.29 (s, 6H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 165.0, 139.2, 138.5 (2C), 138.1, 126.1, 125.9, 118.7, 
118.0 (2C), 51.9, 43.9 (2C), 21.4, 18.3 (2C). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3292, 2946, 2915, 2831, 1679, 1610, 1598, 1530, 1459, 
1454, 1449, 1426, 1310, 1193, 1129, 1037, 844, 690. 
MS (EI, 70 eV): m/z (%) = 257 (3), 137 (8), 120 (100), 105 (10). 
HRMS (EI): m/z calc. for [C15H19N3O]: 257.3370; found 257.3373. 
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Methyl (2-cyanoethyl)-L-prolyl-L-phenylalaninate (17s) 
 
According to TP10, methyl L-prolyl-L-phenylalaninate (14s, 276 mg, 1.00 mmol, 1.00 equiv) 
was dissolved in dry MeOH (5 mL) and acrylonitrile (0.33 mL, 265 mg, 5.00 mmol, 
5.00 equiv) was added. After stirring the mixture at 55 °C overnight the solvent was removed 
and the crude product purified by flash column chromatography (pure EtOAc) to afford the 
title compound as a colourless oil (300 mg, 0.91 mmol, 91%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.66 (d, J = 8.6 Hz, 1H), 7.32–7.26 (m, 2H), 7.26–
7.21 (m, 1H), 7.19–7.15 (m, 2H), 4.79 (td, J = 8.7, 5.2 Hz, 1H), 3.76 (s, 3H), 3.25 (dd, J = 14.0, 
5.2 Hz, 1H), 3.19 (t, J = 7.1 Hz, 1H), 3.06 (dd, J = 9.7, 4.1 Hz, 2H), 2.96 (ddd, J = 12.4, 8.1, 
6.7 Hz, 1H), 2.72 (dt, J = 12.4, 6.1 Hz, 1H), 2.57–2.40 (m, 2H), 2.33 (ddd, J = 10.1, 8.6, 6.2 
Hz, 1H), 2.08 (dtd, J = 12.6, 10.0, 7.7 Hz, 1H), 1.78–1.68 (m, 1H), 1.66–1.45 (m, 2H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 174.0, 172.0, 136.4, 129.2 (2C), 128.5 (2C), 127.0, 
118.7, 67.3, 53.8, 52.7, 52.4, 50.7, 37.4, 30.5, 24.2, 18.2. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2952, 1741, 1668, 1506, 1455, 1436, 1360, 1215, 1200, 
1177, 1128, 1030, 988, 746, 701. 
MS (EI, 70 eV): m/z (%) = 329 (1), 262 (5), 123 (100), 91 (21), 51 (21). 
HRMS (EI): m/z calc. for [C18H23N3O3]: 329.1739; found 329.1745. 
 
4.5 Preparation of N-Hydroxylamine Derivatives of Type 2 
Additional Information 
Most N-hydroxylamine derivatives of type 2 decompose prior to their melting points. Thus, no 
melting point was detected. 
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4-(Pyrimidin-2-yl)piperazin-1-yl benzoate (5j) 
 
According to TP11 3-(4-(pyrimidin-2-yl)piperazin-1-yl)propanenitrile (17b, 217 mg, 
1.00 mmol, 1.00 equiv) was dissolved in dry CH2Cl2 (2 mL) and cooled to −78 °C. Then, 
mCPBA (190 mg, 1.10 mmol, 1.10 equiv) was slowly added as a solution in dry CH2Cl2 (2 mL) 
and the resulting mixture was stirred at −78 °C for 1 h. Following, the cooling bath was 
removed and the mixture stirred at 25 °C overnight. The solvent was removed and the acid by-
product removed by filtration through a silica plug. After solvent removal, the resulting 
N-hydroxylamine was dissolved in CH2Cl2 (4 mL) followed by the addition of triethylamine 
(0.21 mL, 1.50 mmol, 1.50 equiv), DMAP (1 mg, 0.01 mmol, 1.00 mol%) and benzoyl 
chloride (168 mg, 1.20 mmol, 1.20 equiv) at 0 °C. The resulting solution was stirred at 0 °C 
for 1 h and quenched with sat. aqueous NH4Cl solution (2 mL). The mixture was extracted with 
EtOAc (3 x 5 mL) and the combined organic phases were washed with saturated NaHCO3 
solution (2 mL), brine (2 mL), and dried over Na2SO4. The crude mixture was purified with 
flash column chromatography (hexane:EtOAc 3:1) to afford the desired product a pale white 
solid (230 mg, 0.81 mmol, 81%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.33 (d, J = 4.7 Hz, 1H), 8.04–8.00 (m, 1H), 7.60–
7.54 (m, 1H), 7.47–7.42 (m, 1H), 6.54 (t, J = 4.8 Hz, 1H), 4.65 (d, J = 13.3 Hz, 1H), 3.63–3.46 
(m, 2H), 3.01 (s, 1H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 164.7, 161.4, 157.8 (2C), 133.2, 129.5 (2C), 129.2, 
128.5 (2C), 110.4, 55.9 (2C), 42.2 (2C). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2931, 2824, 2812, 1613, 1582, 1497, 1453, 1364, 1354, 
1304, 1240, 1262, 1219, 1143, 1159, 1096, 1021, 1010, 964, 940, 931, 883, 852, 791, 751, 720, 
657. 
MS (EI, 70 eV): m/z (%) = 284 (3), 163 (32), 122 (29), 105 (100), 77 (14). 
HRMS (EI): m/z calc. for [C15H16N4O2]: 284.1273; found 284.1266. 
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4-(Morpholine-4-carbonyl)piperazin-1-yl benzoate (5k) 
 
According to TP11 3-(4-(morpholine-4-carbonyl)piperazin-1-yl)propanenitrile (17c, 252 mg, 
1.00 mmol, 1.00 equiv) was dissolved in dry CH2Cl2 (2 mL) and cooled to −78 °C. Then, 
mCPBA (190 mg, 1.10 mmol, 1.10 equiv) was slowly added as a solution in dry CH2Cl2 (2 mL) 
and the resulting mixture was stirred at −78 °C for 1 h. Following, the cooling bath was 
removed and the mixture stirred at 25 °C overnight. The solvent was removed and the acid by-
product removed by filtration through a silica plug. After solvent removal, the resulting 
N-hydroxylamine was dissolved in CH2Cl2 (4 mL) followed by the addition of triethylamine 
(0.21 mL, 1.50 mmol, 1.50 equiv), DMAP (1 mg, 0.01 mmol, 1.00 mol%) and benzoyl 
chloride (168 mg, 1.20 mmol, 1.20 equiv) at 0 °C. The resulting solution was stirred at 0 °C 
for 1 h and quenched with sat. aqueous NH4Cl solution (2 mL). The mixture was extracted with 
EtOAc (3 x 5 mL) and the combined organic phases were washed with saturated NaHCO3 
solution (2 mL), brine (2 mL), and dried over Na2SO4. The crude mixture was purified with 
flash column chromatography (hexane:EtOAc 4:1) to afford the desired product a pale white 
solid (179 mg, 0.56 mmol, 56%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.97 (dd, J = 38.1, 7.8 Hz, 2H), 7.54 (dt, J = 27.9, 
7.5 Hz, 1H), 7.40 (dt, J = 18.0, 7.7 Hz, 2H), 3.75 (dt, J = 49.1, 5.4 Hz, 2H), 3.63 (p, J = 6.3, 
5.7 Hz, 6H), 3.40 (dd, J = 10.5, 5.2 Hz, 1H), 3.23 (tt, J = 10.1, 4.6 Hz, 6H), 2.92 (t, J = 10.6 Hz, 
1H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 163.3 (2C), 161.7 (2C), 133.3 (2C), 129.4 (2C), 129.0 
(2C), 128.5 (2C), 66.6 (2C), 55.8 (2C), 47.3 (2C), 45.0 (2C). 
NMR spectroscopy indicated the presence of rotamers. Therefore, 2 sets of carbon signals are 
observed. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2964, 2923, 2853, 1766, 1736, 1691, 1641, 1600, 1460, 
1450, 1411, 1362, 1310, 1238, 1178, 1113, 1083, 1063, 1031, 1018, 1002, 919, 880, 789, 728, 
708. 
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4-(3-Fluorobenzoyl)piperazin-1-yl benzoate (5l) 
 
According to TP11 3-(4-(3-fluorobenzoyl)piperazin-1-yl)propanenitrile (17d, 261 mg, 
1.00 mmol, 1.00 equiv) was dissolved in dry CH2Cl2 (2 mL) and cooled to −78 °C. Then, 
mCPBA (190 mg, 1.10 mmol, 1.10 equiv) was slowly added as a solution in dry CH2Cl2 (2 mL) 
and the resulting mixture was stirred at −78 °C for 1 h. Following, the cooling bath was 
removed and the mixture stirred at 25 °C overnight. The solvent was removed and the acid by-
product removed by filtration through a silica plug. After solvent removal, the resulting 
N-hydroxylamine was dissolved in CH2Cl2 (4 mL) followed by the addition of triethylamine 
(0.21 mL, 1.50 mmol, 1.50 equiv), DMAP (1 mg, 0.01 mmol, 1.00 mol%) and benzoyl 
chloride (168 mg, 1.20 mmol, 1.20 equiv) at 0 °C. The resulting solution was stirred at 0 °C 
for 1 h and quenched with sat. aqueous NH4Cl solution (2 mL). The mixture was extracted with 
EtOAc (3 x 5 mL) and the combined organic phases were washed with saturated NaHCO3 
solution (2 mL), brine (2 mL), and dried over Na2SO4. The crude mixture was purified with 
flash column chromatography (hexane:EtOAc 6:1) to afford the desired product a pale white 
solid (213 mg, 0.65 mmol, 65%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.96 (d, J = 7.6 Hz, 2H), 7.54 (t, J = 7.4 Hz, 1H), 
7.45–7.32 (m, 3H), 7.17 (d, J = 7.6 Hz, 1H), 7.15–7.05 (m, 2H), 4.54 (s, 1H), 3.74 (s, 1H), 3.47 
(s, 4H), 2.95 (s, 2H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 168.8 (d, J = 2.3 Hz), 164.4, 162.5 (d, J = 248.6 Hz), 
137.1 (d, J = 6.9 Hz), 133.4, 130.5 (d, J = 8.0 Hz), 129.4, 128.8, 128.5, 122.7 (d, J = 3.2 Hz), 
117.1 (d, J = 21.1 Hz), 114.40 (d, J = 22.8 Hz), 56.0, 55.7, 45.8, 40.5. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2982, 1614, 1573, 1496, 1451, 1421, 1416, 1372, 1351, 
1304, 1288, 1261, 1215, 1126, 1121, 1096, 1020, 1005, 942, 935, 881, 710, 687. 
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3,4-Dihydroisoquinolin-2(1H)-yl benzoate (5m) 
 
According to TP11 3-(3,4-dihydroisoquinolin-2(1H)-yl)propanenitrile (17e, 186 mg, 
1.00 mmol, 1.00 equiv) was dissolved in dry CH2Cl2 (2 mL) and cooled to −78 °C. Then, 
mCPBA (190 mg, 1.10 mmol, 1.10 equiv) was slowly added as a solution in dry CH2Cl2 (2 mL) 
and the resulting mixture was stirred at −78 °C for 1 h. Following, the cooling bath was 
removed and the mixture stirred at 25 °C overnight. The solvent was removed and the acid by-
product removed by filtration through a silica plug. After solvent removal, the resulting 
N-hydroxylamine was dissolved in CH2Cl2 (4 mL) followed by the addition of triethylamine 
(0.21 mL, 1.50 mmol, 1.50 equiv), DMAP (1 mg, 0.01 mmol, 1.00 mol%) and benzoyl 
chloride (168 mg, 1.20 mmol, 1.20 equiv) at 0 °C. The resulting solution was stirred at 0 °C 
for 1 h and quenched with sat. aqueous NH4Cl solution (2 mL). The mixture was extracted with 
EtOAc (3 x 5 mL) and the combined organic phases were washed with saturated NaHCO3 
solution (2 mL), brine (2 mL), and dried over Na2SO4. The crude mixture was purified with 
flash column chromatography (hexane:EtOAc 4:1) to afford the desired product a pale white 
solid (220 mg, 0.78 mmol, 78%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.00 (d, J = 7.1 Hz, 2H), 7.55 (t, J = 7.4 Hz, 1H), 7.42 
(t, J = 7.7 Hz, 2H), 7.23–7.12 (m, 3H), 7.06 (d, J = 6.4 Hz, 1H), 4.43 (s, 0H), 3.55 (s, 2H), 3.12 
(t, J = 6.0 Hz, 2H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 164.9, 133.2, 132.9, 132.3, 129.5 (2C), 129.3, 128.5 
(2C), 128.4, 126.9, 126.8, 126.3, 58.1, 53.4, 26.7. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3059, 2953, 2854, 1733, 1703, 1699, 1682, 1632, 1626, 
1598, 1580, 1490, 1448, 1427, 1364, 1313, 1249, 1232, 1191, 1173, 1159, 1117, 1100, 1083, 
1068, 1059, 1037, 1022, 1010, 1002, 996, 983, 961, 942, 923, 888, 878, 865, 841, 811, 795, 
765, 759, 740, 705, 685, 680, 673, 660. 
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4,7-Dihydrothieno[2,3-c]pyridin-6(5H)-yl benzoate (5n) 
 
According to TP11, 3-(4,7-dihydrothieno[2,3-c]pyridin-6(5H)-yl)propanenitrile (17f, 192 mg, 
1.00 mmol, 1.00 equiv) was dissolved in dry CH2Cl2 (2 mL) and cooled to −78 °C. Then, 
mCPBA (190 mg, 1.10 mmol, 1.10 equiv) was slowly added as a solution in dry CH2Cl2 (2 mL) 
and the resulting mixture was stirred at −78 °C for 1 h. Following, the cooling bath was 
removed and the mixture stirred at 25 °C overnight. The solvent was removed and the acid by-
product removed by filtration through a silica plug. After solvent removal, the resulting 
N-hydroxylamine was dissolved in CH2Cl2 (4 mL) followed by the addition of triethylamine 
(0.21 mL, 1.50 mmol, 1.50 equiv), DMAP (1 mg, 0.01 mmol, 1.00 mol%) and benzoyl 
chloride (168 mg, 1.20 mmol, 1.20 equiv) at 0 °C. The resulting solution was stirred at 0 °C 
for 1 h and quenched with sat. aqueous NH4Cl solution (2 mL). The mixture was extracted with 
EtOAc (3 x 5 mL) and the combined organic phases were washed with saturated NaHCO3 
solution (2 mL), brine (2 mL), and dried over Na2SO4. The crude mixture was purified with 
flash column chromatography (hexane:EtOAc 9:1) to afford the desired product a pale white 
solid (220 mg, 0.85 mmol, 85%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.00–7.97 (m, 2H), 7.59–7.53 (m, 1H), 7.43 (dd, J = 
8.4, 7.1 Hz, 2H), 7.15 (d, J = 5.1 Hz, 1H), 6.76 (d, J = 5.1 Hz, 1H), 4.60–4.10 (m, 0H), 3.57 (t, 
J = 6.0 Hz, 2H), 3.11 (t, J = 6.0 Hz, 2H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 13C NMR (101 MHz, CDCl3) δ 165.0, 133.2, 132.3, 
131.1, 129.5, 129.2, 128.5, 125.3, 123.5, 55.6, 53.1, 22.9. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2927, 2924, 2847, 1736, 1450, 1434, 1315, 1285, 1241, 
1213, 1176, 1164, 1088, 1065, 1046, 1019, 996, 833, 804, 744, 706, 686, 678, 665. 
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3-(Cyclopropanecarboxamido)piperidin-1-yl benzoate (5o) 
 
According to TP11 N-(1-(2-cyanoethyl)piperidin-3-yl)cyclopropanecarboxamide (17g, 
286 mg, 1.00 mmol, 1.00 equiv) was dissolved in dry CH2Cl2 (2 mL) and cooled to −78 °C. 
Then, mCPBA (190 mg, 1.10 mmol, 1.10 equiv) was slowly added as a solution in dry CH2Cl2 
(2 mL) and the resulting mixture was stirred at −78 °C for 1 h. Following, the cooling bath was 
removed and the mixture stirred at 25 °C overnight. The solvent was removed and the acid by-
product removed by filtration through a silica plug. After solvent removal, the resulting 
N-hydroxylamine was dissolved in CH2Cl2 (4 mL) followed by the addition of triethylamine 
(0.21 mL, 1.50 mmol, 1.50 equiv), DMAP (1 mg, 0.01 mmol, 1.00 mol%) and benzoyl 
chloride (168 mg, 1.20 mmol, 1.20 equiv) at 0 °C. The resulting solution was stirred at 0 °C 
for 1 h and quenched with sat. aqueous NH4Cl solution (2 mL). The mixture was extracted with 
EtOAc (3 x 5 mL) and the combined organic phases were washed with saturated NaHCO3 
solution (2 mL), brine (2 mL), and dried over Na2SO4. The crude mixture was purified with 
flash column chromatography (pure EtOAc 1:1) to afford the desired product a pale white solid 
(161 mg, 0.56 mmol, 56%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.00–7.92 (m, 2H), 7.55 (t, J = 7.4 Hz, 1H), 7.42 (t, 
J = 7.7 Hz, 2H), 6.97 (s, 1H), 4.39 (d, J = 32.0 Hz, 1H), 3.41 (d, J = 43.0 Hz, 1H), 3.09–2.66 
(m, 2H), 2.06–1.90 (m, 1H), 1.78 (tt, J = 16.1, 12.0, 4.5 Hz, 1H), 1.61–1.36 (m, 1H), 1.24 (d, 
J = 5.5 Hz, 1H), 0.96–0.90 (m, 2H), 0.75–0.67 (m, 2H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 173.0, 165.0, 133.3, 129.4 (2C), 129.0, 128.5 (2C), 
60.7, 56.8, 45.9, 29.4, 28.1, 21.0, 14.7, 7.2. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3290, 2947, 1736, 1639, 1545, 1451, 1402, 1249, 1232, 
1201, 1176, 1100, 1083, 1065, 1034, 1024, 984, 948, 923, 904, 853, 828, 709, 686, 676, 659. 
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(S)-2-(Pyridin-3-yl)piperidin-1-yl benzoate (5p) 
 
According to TP11 (S)-3-(2-(pyridin-3-yl)piperidin-1-yl)propanenitrile (17h, 215 mg, 
1.00 mmol, 1.00 equiv) was dissolved in dry CH2Cl2 (2 mL) and cooled to −78 °C. Then, 
mCPBA (190 mg, 1.10 mmol, 1.10 equiv) was slowly added as a solution in dry CH2Cl2 (2 mL) 
and the resulting mixture was stirred at −78 °C for 1 h. Following, the cooling bath was 
removed and the mixture stirred at 25 °C overnight. The solvent was removed and the acid by-
product removed by filtration through a silica plug. After solvent removal, the resulting 
N-hydroxylamine was dissolved in CH2Cl2 (4 mL) followed by the addition of triethylamine 
(0.21 mL, 1.50 mmol, 1.50 equiv), DMAP (1 mg, 0.01 mmol, 1.00 mol%) and benzoyl 
chloride (168 mg, 1.20 mmol, 1.20 equiv) at 0 °C. The resulting solution was stirred at 0 °C 
for 1 h and quenched with sat. aqueous NH4Cl solution (2 mL). The mixture was extracted with 
EtOAc (3 x 5 mL) and the combined organic phases were washed with saturated NaHCO3 
solution (2 mL), brine (2 mL), and dried over Na2SO4. The crude mixture was purified with 
flash column chromatography (hexane:EtOAc 1:1) to afford the desired product a pale white 
solid (423 mg, 0.86 mmol, 86%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.61 (d, J = 1.9 Hz, 1H), 8.42 (dd, J = 4.8, 1.7 Hz, 
1H), 7.87 (dt, J = 7.9, 2.0 Hz, 1H), 7.66 (d, J = 7.3 Hz, 2H), 7.44 (t, J = 7.5 Hz, 1H), 7.29 (t, J 
= 7.8 Hz, 2H), 7.20 (dd, J = 7.9, 4.8 Hz, 1H), 3.91 (d, J = 10.7 Hz, 1H), 3.81–3.72 (m, 1H), 
2.88 (t, J = 10.0 Hz, 1H), 2.10–1.78 (m, 5H), 1.56–1.40 (m, 1H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 164.7, 148.7, 148.6, 138.0, 134.5, 132.9, 129.1 (2C), 
129.0, 128.3 (2C), 123.7, 69.5, 58.1, 35.6, 25.4, 24.0. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2941, 2856, 1735, 1600, 1593, 1577, 1480, 1450, 1442, 
1426, 1365, 1321, 1313, 1268, 1242, 1176, 1081, 1059, 1025, 1006, 933, 869, 804, 781, 707, 
687, 674. 
MS (EI, 70 eV): m/z (%) = 282 (9), 160 (16), 105 (100). 
HRMS (EI): m/z calc. for [C17H18N2O2]: 282.1368; found 282.1370. 
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2-(2-Methoxy-2-oxo-1-phenylethyl)piperidin-1-yl benzoate (5q) 
 
According to TP11 methyl 2-(1-(2-cyanoethyl)piperidin-2-yl)-2-phenylacetate (17i, 286 mg, 
1.00 mmol, 1.00 equiv) was dissolved in dry CH2Cl2 (2 mL) and cooled to −78 °C. Then, 
mCPBA (190 mg, 1.10 mmol, 1.10 equiv) was slowly added as a solution in dry CH2Cl2 (2 mL) 
and the resulting mixture was stirred at −78 °C for 1 h. Following, the cooling bath was 
removed and the mixture stirred at 25 °C overnight. The solvent was removed and the acid by-
product removed by filtration through a silica plug. After solvent removal, the resulting 
N-hydroxylamine was dissolved in CH2Cl2 (4 mL) followed by the addition of triethylamine 
(0.21 mL, 1.50 mmol, 1.50 equiv), DMAP (1 mg, 0.01 mmol, 1.00 mol%) and benzoyl 
chloride (168 mg, 1.20 mmol, 1.20 equiv) at 0 °C. The resulting solution was stirred at 0 °C 
for 1 h and quenched with sat. aqueous NH4Cl solution (2 mL). The mixture was extracted with 
EtOAc (3 x 5 mL) and the combined organic phases were washed with saturated NaHCO3 
solution (2 mL), brine (2 mL), and dried over Na2SO4. The crude mixture was purified with 
flash column chromatography (hexane:EtOAc 4:1) to afford the desired product a pale white 
solid (216 mg, 0.61 mmol, 61%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.06 (d, J = 8.2 Hz, 2H), 7.57 (t, J = 7.4 Hz, 1H), 7.47 
(t, J = 7.6 Hz, 2H), 7.39–7.22 (m, 5H), 3.83–2.78 (m, 7H), 1.93–1.51 (m, 3H), 1.45–1.13 (m, 
3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 174.1, 164.6, 136.0, 133.1, 129.6 (3C), 128.9 (2C), 
128.6 (2C), 128.4 (2C), 127.6, 67.5, 58.0, 55.8, 51.6, 29.5, 25.2, 23.5. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2946, 2856, 1734, 1713, 1600, 1583, 1496, 1491, 1450, 
1433, 1350, 1314, 1289, 1264, 1242, 1218, 1198, 1176, 1169, 1152, 1128, 1080, 1055, 1023, 
1006, 1001, 973, 966, 940, 919, 897, 875, 864, 842, 791, 776, 731, 707, 699, 687, 674. 
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(3S,4R)-3-((Benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidin-1-yl 
benzoate (5r)  
 
According to TP11 3-((3S,4R)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-
fluorophenyl)piperidin-1-yl)propanenitrile (17j, 382 mg, 1.00 mmol, 1.00 equiv) was 
dissolved in dry CH2Cl2 (2 mL) and cooled to −78 °C. Then, mCPBA (190 mg, 1.10 mmol, 
1.10 equiv) was slowly added as a solution in dry CH2Cl2 (2 mL) and the resulting mixture was 
stirred at −78 °C for 1 h. Following, the cooling bath was removed and the mixture stirred at 
25 °C overnight. The solvent was removed and the acid by-product removed by filtration 
through a silica plug. After solvent removal, the resulting N-hydroxylamine was dissolved in 
CH2Cl2 (4 mL) followed by the addition of triethylamine (0.21 mL, 1.50 mmol, 1.50 equiv), 
DMAP (1 mg, 0.01 mmol, 1.00 mol%) and benzoyl chloride (168 mg, 1.20 mmol, 1.20 equiv) 
at 0 °C. The resulting solution was stirred at 0 °C for 1 h and quenched with sat. aqueous NH4Cl 
solution (2 mL). The mixture was extracted with EtOAc (3 x 5 mL) and the combined organic 
phases were washed with saturated NaHCO3 solution (2 mL), brine (2 mL), and dried over 
Na2SO4. The crude mixture was purified with flash column chromatography (hexane:EtOAc 
2:1) to afford the desired product a pale white solid (400 mg, 0.89 mmol, 89%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.04 (d, J = 7.7 Hz, 2H), 7.58 (t, J = 7.3 Hz, 1H), 7.45 
(t, J = 7.7 Hz, 2H), 7.22–7.14 (m, 2H), 6.99 (t, J = 8.5 Hz, 2H), 6.62 (d, J = 8.5 Hz, 1H), 6.36 
(d, J = 2.4 Hz, 1H), 6.14 (dd, J = 8.5, 2.5 Hz, 1H), 5.88 (s, 2H), 3.86 (dd, J = 10.4, 1.9 Hz, 1H), 
3.71 (d, J = 9.5 Hz, 1H), 3.61 (dd, J = 9.4, 2.8 Hz, 1H), 3.51 (dd, J = 9.4, 5.9 Hz, 1H), 2.95 (dt, 
J = 35.3, 11.0 Hz, 2H), 2.68 (t, J = 11.8 Hz, 1H), 2.51 (s, 1H), 2.20 (q, J = 12.8 Hz, 1H), 2.00 
(d, J = 13.9 Hz, 1H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 164.8, 161.7 (d, J = 244.9 Hz), 154.2, 148.2, 141.7, 
138.4, 133.1, 129.5 (4C), 128.86 (d, J = 7.3 Hz), 128.4, 115.6 (d, J = 21.1 Hz), 107.9, 107.8, 
105.5 (d, J = 6.5 Hz), 101.1 (d, J = 4.8 Hz), 101.1, 98.0 (d, J = 6.3 Hz), 68.9, 60.2, 57.3, 42.9, 
42.1, 32.9. 
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IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2923, 1735, 1509, 1502, 1487, 1468, 1450, 1261, 1240, 
1224, 1183, 1159, 1086, 1059, 1037, 1025, 936, 908, 830, 783, 732, 729, 709. 
MS (EI, 70 eV): m/z (%) = 449 (3), 327 (28), 188 (32), 147 (10), 138 (69), 105 (100), 77 (48), 
44 (51). 
HRMS (EI): m/z calc. for [C26H24FNO5]: 449.1639; found 49.1631. 
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4-((5,6-dimethoxy-1-oxo-2,3-dihydro-1H-inden-2-yl)methyl)piperidin-1-yl benzoate (5s) 
 
According to TP11, 3-(4-((5,6-dimethoxy-1-oxo-2,3-dihydro-1H-inden-2-
yl)methyl)piperidin-1-yl)propanenitrile (17k, 342 mg, 1.00 mmol, 1.00 equiv) was dissolved 
in dry CH2Cl2 (2 mL) and cooled to −78 °C. Then, mCPBA (190 mg, 1.10 mmol, 1.10 equiv) 
was slowly added as a solution in dry CH2Cl2 (2 mL) and the resulting mixture was stirred at 
−78 °C for 1 h. Following, the cooling bath was removed and the mixture stirred at 25 °C 
overnight. The solvent was removed and the acid by-product removed by filtration through a 
silica plug. After solvent removal, the resulting N-hydroxylamine was dissolved in CH2Cl2 
(4 mL) followed by the addition of triethylamine (0.21 mL, 1.50 mmol, 1.50 equiv), DMAP 
(1 mg, 0.01 mmol, 1.00 mol%) and benzoyl chloride (168 mg, 1.20 mmol, 1.20 equiv) at 0 °C. 
The resulting solution was stirred at 0 °C for 1 h and quenched with sat. aqueous NH4Cl 
solution (2 mL). The mixture was extracted with EtOAc (3 x 5 mL) and the combined organic 
phases were washed with saturated NaHCO3 solution (2 mL), brine (2 mL), and dried over 
Na2SO4. The crude mixture was purified with flash column chromatography (hexane:EtOAc 
1:1) to afford the desired product a pale white solid (287 mg, 0.70 mmol, 70%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.07–7.91 (m, 2H), 7.55–7.46 (m, 1H), 7.42–7.33 (m, 
2H), 7.11 (s, 1H), 6.80 (s, 1H), 3.90 (s, 3H), 3.84 (s, 3H), 3.53 (d, J = 9.1 Hz, 2H), 3.21 (dd, J 
= 17.5, 8.1 Hz, 1H), 2.77–2.61 (m, 4H), 1.89–1.78 (m, 2H), 1.66–1.55 (m, 3H), 1.35–1.17 (m, 
2H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 207.5, 164.8, 155.6, 149.5, 148.7, 133.4, 129.5, 
129.4, 129.2, 128.4, 107.3, 104.4, 57.1, 56.3, 56.1, 45.4, 38.2, 33.6, 33.5, 31.9, 31.3, 29.7. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2911, 1626, 1639, 1616, 1591, 1515, 1509, 1502, 1487, 
1432, 1269, 1246, 1224, 1121, 1038, 869. 
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(R)-8-Chloro-1-methyl-1,2,4,5-tetrahydro-3H-benzo[d]azepin-3-yl benzoate (5t) 
 
According to TP11 (R)-3-(8-chloro-1-methyl-1,2,4,5-tetrahydro-3H-benzo[d]azepin-3-
yl)propanenitrile (17l, 249 mg, 1.00 mmol, 1.00 equiv) was dissolved in dry CH2Cl2 (2 mL) 
and cooled to −78 °C. Then, mCPBA (190 mg, 1.10 mmol, 1.10 equiv) was slowly added as a 
solution in dry CH2Cl2 (2 mL) and the resulting mixture was stirred at −78 °C for 1 h. 
Following, the cooling bath was removed and the mixture stirred at 25 °C overnight. The 
solvent was removed and the acid by-product removed by filtration through a silica plug. After 
solvent removal, the resulting N-hydroxylamine was dissolved in CH2Cl2 (4 mL) followed by 
the addition of triethylamine (0.21 mL, 1.50 mmol, 1.50 equiv), DMAP (1 mg, 0.01 mmol, 
1.00 mol%) and benzoyl chloride (168 mg, 1.20 mmol, 1.20 equiv) at 0 °C. The resulting 
solution was stirred at 0 °C for 1 h and quenched with sat. aqueous NH4Cl solution (2 mL). 
The mixture was extracted with EtOAc (3 x 5 mL) and the combined organic phases were 
washed with saturated NaHCO3 solution (2 mL), brine (2 mL), and dried over Na2SO4. The 
crude mixture was purified with flash column chromatography (hexane:EtOAc 7:1) to afford 
the desired product a pale white solid (268 mg, 0.85 mmol, 85%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.02 (d, J = 7.6 Hz, 2H), 7.57 (t, J = 7.4 Hz, 1H), 7.45 
(t, J = 7.8 Hz, 2H), 7.19 (s, 1H), 7.13 (dd, J = 8.0, 1.9 Hz, 1H), 7.06 (d, J = 8.0 Hz, 1H), 3.85–
3.15 (m, 2H), 2.85 (s, 1H), 1.43 (d, J = 7.3 Hz, 2H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 164.4, 146.3, 138.9, 133.1, 132.5, 130.6, 129.4 (4C), 
129.4, 128.5 (2C), 126.3, 57.8, 31.6 (2C), 18.3. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2963, 2841, 1736, 1597, 1569, 1450, 1404, 1382, 1370, 
1314, 1241, 1176, 1083, 1065, 1058, 1049, 1024, 1009, 947, 878, 819, 707. 
MS (EI, 70 eV): m/z (%) = 315 (1), 122 (10), 105 (100), 77 (19). 
HRMS (EI): m/z calc. for [C18H18ClNO2]: 315.1026; found 315.1024. 
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O-Benzoyl-N-(3-(10,11-dihydro-5H-dibenzo[a,d][7]annulen-5-ylidene)propyl)-N-
methylhydroxylamine (5u) 
 
According to TP11 3-((3-(10,11-dihydro-5H-dibenzo[a,d][7]annulen-5-ylidene)propyl) 
(methyl)amino)propanenitrile (17m, 316 mg, 1.00 mmol, 1.00 equiv) was dissolved in dry 
CH2Cl2 (2 mL) and cooled to −78 °C. Then, mCPBA (190 mg, 1.10 mmol, 1.10 equiv) was 
slowly added as a solution in dry CH2Cl2 (2 mL) and the resulting mixture was stirred at −78 °C 
for 1 h. Following, the cooling bath was removed and the mixture stirred at 25 °C overnight. 
The solvent was removed and the acid by-product removed by filtration through a silica plug. 
After solvent removal, the resulting N-hydroxylamine was dissolved in CH2Cl2 (4 mL) 
followed by the addition of triethylamine (0.21 mL, 1.50 mmol, 1.50 equiv), DMAP (1 mg, 
0.01 mmol, 1.00 mol%) and benzoyl chloride (168 mg, 1.20 mmol, 1.20 equiv) at 0 °C. The 
resulting solution was stirred at 0 °C for 1 h and quenched with sat. aqueous NH4Cl solution 
(2 mL). The mixture was extracted with EtOAc (3 x 5 mL) and the combined organic phases 
were washed with saturated NaHCO3 solution (2 mL), brine (2 mL), and dried over Na2SO4. 
The crude mixture was purified with flash column chromatography (hexane:EtOAc 4:1) to 
afford the desired product a pale white solid (345 mg, 0.90 mmol, 90%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.93 (d, J = 8.4 Hz, 2H), 7.58 (t, J = 7.4 Hz, 1H), 7.42 
(t, J = 7.8 Hz, 2H), 7.32–7.28 (m, 1H), 7.20–7.09 (m, 6H), 7.05 (dd, J = 6.9, 2.1 Hz, 1H), 5.98 
(t, J = 7.5 Hz, 1H), 3.47–3.23 (m, 2H), 3.17–2.95 (m, 3H), 2.91 (s, 3H), 2.75 (d, J = 14.1 Hz, 
1H), 2.53 (q, J = 6.5 Hz, 2H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 165.1, 144.4, 141.0, 139.9, 139.3, 137.1, 133.0, 
130.0, 129.4 (2C), 129.3, 128.6, 128.4 (2C), 128.1, 128.1, 127.5, 127.1, 126.0, 125.8, 60.8, 
47.0, 33.8, 32.0, 27.4. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2918, 2236, 1731, 1601, 1485, 1450, 1441, 1429, 1362, 
1314, 1258, 1246, 1195, 1175, 1160, 1080, 1060, 1024, 1002, 907, 869, 859, 815, 801, 776, 
769, 755, 726, 706, 686, 669. 
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O-Benzoyl-N-((1S,4S)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydronaphthalen-1-yl)-N-
methylhydroxylamine (5v) 
 
According to TP11 3-(((1S,4S)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydronaphthalen-1-
yl)(methyl)amino)propanenitrile (17n, 359 mg, 1.00 mmol, 1.00 equiv) was dissolved in dry 
CH2Cl2 (2 mL) and cooled to −78 °C. Then, mCPBA (190 mg, 1.10 mmol, 1.10 equiv) was 
slowly added as a solution in dry CH2Cl2 (2 mL) and the resulting mixture was stirred at −78 °C 
for 1 h. Following, the cooling bath was removed and the mixture stirred at 25 °C overnight. 
The solvent was removed and the acid by-product removed by filtration through a silica plug. 
After solvent removal, the resulting N-hydroxylamine was dissolved in CH2Cl2 (4 mL) 
followed by the addition of triethylamine (0.21 mL, 1.50 mmol, 1.50 equiv), DMAP (1 mg, 
0.01 mmol, 1.00 mol%) and benzoyl chloride (168 mg, 1.20 mmol, 1.20 equiv) at 0 °C. The 
resulting solution was stirred at 0 °C for 1 h and quenched with sat. aqueous NH4Cl solution 
(2 mL). The mixture was extracted with EtOAc (3 x 5 mL) and the combined organic phases 
were washed with saturated NaHCO3 solution (2 mL), brine (2 mL), and dried over Na2SO4. 
The crude mixture was purified with flash column chromatography (hexane:EtOAc 9:1) to 
afford the desired product a pale white solid (307 mg, 0.72 mmol, 72%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.91 (d, J = 7.2 Hz, 2H), 7.76 (d, J = 7.8 Hz, 1H), 
7.56 (t, J = 7.4 Hz, 1H), 7.42 (t, J = 7.8 Hz, 2H), 7.28 (d, J = 2.0 Hz, 1H), 7.27 (d, J = 0.8 Hz, 
1H), 7.20 (t, J = 7.5 Hz, 1H), 7.14 (t, J = 7.4 Hz, 1H), 6.89 (t, J = 9.4 Hz, 2H), 4.25 (t, J = 
6.0 Hz, 1H), 4.15 (t, J = 5.3 Hz, 1H), 3.00 (s, 2H), 2.32–2.25 (m, 1H), 2.22–2.15 (m, 2H), 2.06–
1.99 (m, 1H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 164.7, 147.4, 138.5, 135.8, 133.0, 132.2, 130.7, 
130.6, 130.2 (2C), 130.0, 129.5, 129.4, 129.4 (2C), 128.5, 128.4, 127.7, 126.7, 65.4, 44.1, 42.7, 
29.2, 20.0. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2951, 2948, 2944, 2861, 1739, 1601, 1584, 1489, 1467, 
1450, 1396, 1352, 1314, 1258, 1247, 1209, 1174, 1131, 1087, 1076, 1058, 1024, 908, 878, 819, 
782, 760, 740, 707, 686, 678. 
MS (EI, 70 eV): m/z (%) = 425 (1), 275 (30), 158 (21), 105 (100). 
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HRMS (EI): m/z calc. for [C24H21Cl2NO2]: 425.0949; found 425.0948. 
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O-Benzoyl-N-methyl-N-(3-phenyl-3-(4-(trifluoromethyl)phenoxy)propyl)hydroxylamine 
(5w) 
 
According to TP11 3-(methyl(3-phenyl-3-(4-(trifluoromethyl)phenoxy)propyl)amino) 
propanenitrile (17o, 362 mg, 1.00 mmol, 1.00 equiv) was dissolved in dry CH2Cl2 (2 mL) and 
cooled to −78 °C. Then, mCPBA (190 mg, 1.10 mmol, 1.10 equiv) was slowly added as a 
solution in dry CH2Cl2 (2 mL) and the resulting mixture was stirred at −78 °C for 1 h. 
Following, the cooling bath was removed and the mixture stirred at 25 °C overnight. The 
solvent was removed and the acid by-product removed by filtration through a silica plug. After 
solvent removal, the resulting N-hydroxylamine was dissolved in CH2Cl2 (4 mL) followed by 
the addition of triethylamine (0.21 mL, 1.50 mmol, 1.50 equiv), DMAP (1 mg, 0.01 mmol, 
1.00 mol%) and benzoyl chloride (168 mg, 1.20 mmol, 1.20 equiv) at 0 °C. The resulting 
solution was stirred at 0 °C for 1 h and quenched with sat. aqueous NH4Cl solution (2 mL). 
The mixture was extracted with EtOAc (3 x 5 mL) and the combined organic phases were 
washed with saturated NaHCO3 solution (2 mL), brine (2 mL), and dried over Na2SO4. The 
crude mixture was purified with flash column chromatography (hexane:EtOAc 7:1) to afford 
the desired product a pale white solid (283 mg, 0.66 mmol, 66%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.00 (d, J = 7.3 Hz, 2H), 7.57 (t, J = 7.4 Hz, 1H), 7.43 
(t, J = 7.8 Hz, 2H), 7.40 (d, J = 8.7 Hz, 2H), 7.34–7.28 (m, 3H), 7.24 (t, J = 7.0 Hz, 1H), 6.91 
(d, J = 8.5 Hz, 1H), 5.49 (d, J = 8.4 Hz, 1H), 3.22–3.16 (m, 1H), 3.14–3.06 (m, 1H), 2.90 (s, 
2H), 2.32–2.21 (m, 1H), 2.15–2.06 (m, 1H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 165.3, 160.5, 140.8, 133.2, 129.4 (4C), 129.1, 128.8 
(2C), 128.5 (2C), 127.8 , 126.7 (2C), 124.4 (q, J = 271.1 Hz), 122.8 (q, J = 32.7 Hz), 115.8 
(2C), 77.8, 57.2, 47.4, 36.2. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3063, 2964, 2851, 1738, 1614, 1585, 1516, 1494, 1451, 
1424, 1324, 1245, 1200, 1176, 1159, 1109, 1081, 1066, 1024, 1009, 962, 868, 835, 810, 757, 
708, 701, 687, 668. 
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O-Benzoyl-N-((1R,2S)-1-((tert-butyldimethylsilyl)oxy)-1-phenylpropan-2-yl)-N-
methylhydroxylamine (5x) 
 
According to TP11 3-(((1R,2S)-1-((tert-butyldimethylsilyl)oxy)-1-phenylpropan-2-
yl)(methyl)amino)propanenitrile (17p, 261 mg, 1.00 mmol, 1.00 equiv) was dissolved in dry 
CH2Cl2 (2 mL) and cooled to −78 °C. Then, mCPBA (190 mg, 1.10 mmol, 1.10 equiv) was 
slowly added as a solution in dry CH2Cl2 (2 mL) and the resulting mixture was stirred at −78 °C 
for 1 h. Following, the cooling bath was removed and the mixture stirred at 25 °C overnight. 
The solvent was removed and the acid by-product removed by filtration through a silica plug. 
After solvent removal, the resulting N-hydroxylamine was dissolved in CH2Cl2 (4 mL) 
followed by the addition of triethylamine (0.21 mL, 1.50 mmol, 1.50 equiv), DMAP (1 mg, 
0.01 mmol, 1.00 mol%) and benzoyl chloride (168 mg, 1.20 mmol, 1.20 equiv) at 0 °C. The 
resulting solution was stirred at 0 °C for 1 h and quenched with sat. aqueous NH4Cl solution 
(2 mL). The mixture was extracted with EtOAc (3 x 5 mL) and the combined organic phases 
were washed with saturated NaHCO3 solution (2 mL), brine (2 mL), and dried over Na2SO4. 
The crude mixture was purified with flash column chromatography (hexane:EtOAc 4:1) to 
afford the desired product a pale white solid (340 mg, 0.85 mmol, 85%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.47–8.39 (m, 1H), 8.07 (d, J = 7.5 Hz, 2H), 7.82 (dt, 
J = 7.7, 2.6 Hz, 1H), 7.61 (t, J = 7.4 Hz, 1H), 7.58–7.41 (m, 5H), 7.34–7.27 (m, 1H), 7.23 (d, 
J = 4.7 Hz, 1H), 7.13 (d, J = 3.2 Hz, 1H), 7.00–6.93 (m, 2H), 3.29 (hept, J = 7.3 Hz, 2H), 2.95 
(s, 3H), 2.70–2.58 (m, 1H), 2.46–2.35 (m, 1H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 165.3, 153.3, 144.9, 134.6, 133.2, 129.5 (2C), 129.2, 
128.5 (2C), 127.6, 126.7, 126.4, 126.1, 125.9, 125.3, 124.9, 124.9, 122.1, 120.7, 107.2, 74.1, 
57.4, 47.5, 36.5. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3057, 1735, 1595, 1578, 1506, 1461, 1449, 1396, 1315, 
1260, 1235, 1176, 1092, 1080, 1057, 1024, 1018, 907, 790, 770, 728, 722, 707, 702, 686, 665. 
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Ethyl 1-(benzoyloxy)piperidine-3-carboxylate (5y) 
 
Then, according to TP11, ethyl 1-(2-cyanoethyl)piperidine-3-carboxylate (17q, 210 mg, 
1.00 mmol, 1.00 equiv) was dissolved in dry CH2Cl2 (2 mL) and cooled to −78 °C. Then, 
mCPBA (190 mg, 1.10 mmol, 1.10 equiv) was slowly added as a solution in dry CH2Cl2 (2 mL) 
and the resulting mixture was stirred at −78 °C for 1 h. Following, the cooling bath was 
removed and the mixture stirred at 25 °C overnight. The solvent was removed and the acid by-
product removed by filtration through a silica plug. After solvent removal, the resulting 
N-hydroxylamine was dissolved in CH2Cl2 (4 mL) followed by the addition of triethylamine 
(0.21 mL, 1.50 mmol, 1.50 equiv), DMAP (1 mg, 0.01 mmol, 1.00 mol%) and benzoyl 
chloride (168 mg, 1.20 mmol, 1.20 equiv) at 0 °C. The resulting solution was stirred at 0 °C 
for 1 h and quenched with sat. aqueous NH4Cl solution (2 mL). The mixture was extracted with 
EtOAc (3 x 5 mL) and the combined organic phases were washed with saturated NaHCO3 
solution (2 mL), brine (2 mL), and dried over Na2SO4. The crude mixture was purified with 
flash column chromatography (hexane:EtOAc 4:1) to afford the desired product a yellowish 
oil (175 mg, 0.63 mmol, 63%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.04–7.86 (m, 2H), 7.59–7.51 (m, 1H), 7.48–7.35 (m, 
2H), 4.14 (q, J = 7.3 Hz, 2H), 3.84–2.64 (m, 5H), 2.09–1.37 (m, 4H), 1.24 (t, J = 7.1 Hz, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 172.7, 164.6, 133.1, 129.4 (2C), 128.4 (2C), 127.6, 
60.7, 58.3, 56.7, 41.5, 26.2, 23.6, 14.2. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2952, 2839, 1728, 1601, 1476, 1450, 1378, 1313, 1244, 
1234, 1177, 1147, 1133, 1084, 1063, 1044, 1025, 1012, 911, 854, 802, 794, 729, 707, 687, 674. 
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3-((3,5-dimethylphenyl)carbamoyl)azetidin-1-yl benzoate (5z) 
 
According to TP11 1-(2-cyanoethyl)-N-(3,5-dimethylphenyl)azetidine-3-carboxamide (17r, 
257 mg, 1.00 mmol, 1.00 equiv) and K2CO3 (207 mg, 1.5 mmol, 1.50 equiv) was suspended in 
dry CH2Cl2 (2 mL) and cooled to −78 °C. Then, mCPBA (190 mg, 1.10 mmol, 1.10 equiv) was 
slowly added as a solution in dry CH2Cl2 (2 mL) and the resulting mixture was stirred at −78 °C 
for 1 h. Following, the cooling bath was removed and the mixture stirred at 25 °C overnight. 
The solvent was removed and the acid by-product removed by filtration through a silica plug. 
After solvent removal, the resulting N-hydroxylamine was dissolved in CH2Cl2 (4 mL) 
followed by the addition of triethylamine (0.21 mL, 1.50 mmol, 1.50 equiv), DMAP (1 mg, 
0.01 mmol, 1.00 mol%) and benzoyl chloride (168 mg, 1.20 mmol, 1.20 equiv) at 0 °C. The 
resulting solution was stirred at 0 °C for 1 h and quenched with sat. aqueous NH4Cl solution 
(2 mL). The mixture was extracted with EtOAc (3 x 5 mL) and the combined organic phases 
were washed with saturated NaHCO3 solution (2 mL), brine (2 mL), and dried over Na2SO4. 
The crude mixture was purified with flash column chromatography (hexane:EtOAc 4:1) to 
afford the desired product a pale white solid (169 mg, 0.52 mmol, 52%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.16 (s, 1H), 7.96–7.90 (m, 2H), 7.53–7.47 (m, 1H), 
7.40–7.34 (m, 2H), 7.16 (s, 2H), 6.68 (s, 1H), 4.09 (d, J = 7.9 Hz, 4H), 3.36 (p, J = 8.1 Hz, 
1H), 2.19 (d, J = 3.7 Hz, 6H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 168.2, 165.3, 138.7 (2C), 133.4, 129.7, 129.5 (2C), 
128.5 (2C), 128.0, 126.3, 117.7 (2C), 61.8 (2C), 45.0, 21.4 (2C). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3309, 2917, 1732, 1686, 1612, 1600, 1546, 1461, 1450, 
1433, 1315, 1246, 1177, 1082, 1061, 1025, 842, 708, 689. 
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(S)-2-(((S)-1-Methoxy-1-oxo-3-phenylpropan-2-yl)carbamoyl)pyrrolidin-1-yl benzoate 
(5aa) 
 
According to TP11 methyl N2-(tert-butoxycarbonyl)-N6-(2-cyanoethyl)-N6-ethyl-L-
lysylglycinate (17s, 399 mg, 1.00 mmol, 1.00 equiv) and K2CO3 (207 mg, 1.5 mmol, 
1.50 equiv) was suspended in dry CH2Cl2 (2 mL) and cooled to −78 °C. Then, mCPBA 
(190 mg, 1.10 mmol, 1.10 equiv) was slowly added as a solution in dry CH2Cl2 (2 mL) and the 
resulting mixture was stirred at −78 °C for 1 h. Following, the cooling bath was removed and 
the mixture stirred at 25 °C overnight. The solvent was removed and the acid by-product 
removed by filtration through a silica plug. After solvent removal, the resulting 
N-hydroxylamine was dissolved in CH2Cl2 (4 mL) followed by the addition of triethylamine 
(0.21 mL, 1.50 mmol, 1.50 equiv), DMAP (1 mg, 0.01 mmol, 1.00 mol%) and benzoyl 
chloride (168 mg, 1.20 mmol, 1.20 equiv) at 0 °C. The resulting solution was stirred at 0 °C 
for 1 h and quenched with sat. aqueous NH4Cl solution (2 mL). The mixture was extracted with 
EtOAc (3 x 5 mL) and the combined organic phases were washed with saturated NaHCO3 
solution (2 mL), brine (2 mL), and dried over Na2SO4. The crude mixture was purified with 
flash column chromatography (hexane:EtOAc 1:1) to afford the desired product a pale white 
solid (273 mg, 0.69 mmol, 69%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.17 (d, J = 8.3 Hz, 1H), 8.14–7.94 (m, 2H), 7.65–
7.55 (m, 1H), 7.46 (dtd, J = 14.1, 7.6, 7.1, 1.7 Hz, 2H), 7.32–7.18 (m, 4H), 7.18–7.13 (m, 1H), 
4.95–4.76 (m, 1H), 4.07–3.97 (m, 1H), 3.87 (dd, J = 9.9, 6.6 Hz, 0.5H), 3.62 (d, J = 66.4 Hz, 
3H), 3.45–2.96 (m, 3H), 2.81 (tt, J = 8.6, 2.5 Hz, 1H), 2.35–2.24 (m, 0.5H), 2.03–1.67 (m, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 171.5, 171.3, 165.7, 135.9, 133.4, 130.2, 129.6 (2C), 
129.2 (2C), 128.6 (2C), 128.5 (2C), 127.1, 69.9, 61.9, 53.2, 52.4, 38.1, 34.0, 22.1. 
NMR spectroscopy indicated the presence of rotamers. Therefore, 2 sets of proton and carbon 
signals are observed. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2948, 1738, 1677, 1626, 1602, 1519, 1497, 1450, 1436, 
1315, 1248, 1217, 1176, 1157, 1083, 1064, 1025, 711, 703, 688. 
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4.6 Preparation of Amination Products of Type 2 
(4-(4-Chlorophenyl)piperazin-1-yl)(morpholino)methanone (2w) 
 
According to TP13 4-(morpholine-4-carbonyl)piperazin-1-yl benzoate (5k, 160 mg, 
0.50 mmol, 1.00 equiv) was dissolved in dry THF (2 mL). Predried CoCl2·(3 mg, 25 µmol, 
5.00 mol%) was added and subsequent (4-chlorophenyl)zinc chloride ( , 2.6 mL, 0.29 M, 
0.75 mmol, 1.50 equiv) was added dropwise and the resulting mixture was stirred for 2 h at rt. 
Purification of the crude product by flash chromatography (hexane:EtOAc 9:1) afforded the 
title compound as a colourless oil (138mg, 0.45 mmol, 89%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.21 (d, J = 8.9 Hz, 2H), 6.84 (d, J = 8.9 Hz, 2H), 
3.75–3.65 (m, 4H), 3.46–3.38 (m, 4H), 3.31 (t, J = 4.7 Hz, 4H), 3.17–3.08 (m, 4H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 163.7, 149.8, 129.1 (2C), 125.2, 117.7 (2C), 66.7 
(2C), 49.3 (2C), 47.3 (2C), 46.6 (2C). 
Analytical data according to literature89 
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(4-(benzo[b]thiophen-2-yl)piperazin-1-yl)(3-fluorophenyl)methanone (2x) 
 
According to TP13 4-(3-fluorobenzoyl)piperazin-1-yl benzoate (5l, 164 mg, 0.50 mmol, 
1.00 equiv) was dissolved in dry THF (2 mL). Predried CoCl2·(3 mg, 25 µmol, 5.00 mol%) 
was added and subsequent benzo[b]thiophen-2-ylzinc chloride (1o, 2.8 mL, 0.27 M, 
0.75 mmol, 1.50 equiv) was added dropwise and the resulting mixture was stirred for 2 h at rt. 
Purification of the crude product by flash chromatography (hexane:EtOAc 1:1) afforded the 
title compound as a colourless oil (47 mg, 0.46 mmol, 92%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.64 (d, J = 7.9 Hz, 1H), 7.51 (d, J = 7.8 Hz, 1H), 
7.48–7.41 (m, 1H), 7.31–7.26 (m, 1H), 7.24 (dt, J = 7.6, 1.1 Hz, 1H), 7.22–7.13 (m, 3H), 6.30 
(s, 1H), 4.12–3.11 (m, 8H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 169.0, 162.6 (d, J = 248.6 Hz), 156.8, 140.1, 137.3 
(d, J = 6.9 Hz), 133.0, 130.5 (d, J = 8.0 Hz), 124.7, 122.8 (d, J = 3.2 Hz), 122.0, 121.7, 121.3, 
117.1 (d, J = 21.1 Hz), 114.48 (d, J = 22.8 Hz), 101.0, 51.1 (2C), 46.9, 41.6. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3066, 1713, 1637, 1634, 1613, 1583, 1566, 1535, 1489, 
1458, 1439, 1384, 1304, 1285, 1266, 1254, 1231, 1210, 1199, 1157, 1130, 1067, 1010, 941, 
821, 793, 777, 747, 724. 
MS (EI, 70 eV): m/z (%) = 340 (90), 215 (69), 160 (100), 95 (57). 
HRMS (EI): m/z calc. for [C19H17FN2OS]: 340.1064; found 340.1073. 
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4-(3,4-Dihydroisoquinolin-2(1H)-yl)-2-fluorobenzonitrile (2y) 
 
According to TP13 3,4-dihydroisoquinolin-2(1H)-yl benzoate (5k, 127 mg, 0.50 mmol, 
1.00 equiv) was dissolved in dry THF (2 mL). Predried CoCl2·(3 mg, 25 µmol, 5.00 mol%) 
was added and subsequent (4-cyano-3-fluorophenyl)zinc chloride (1p, 2.6 mL, 0.29 M, 
0.75 mmol, 1.50 equiv) was added dropwise and the resulting mixture was stirred for 2 h at rt. 
Purification of the crude product by flash chromatography (hexane:EtOAc 9:1) afforded the 
title compound as a colourless oil (108 mg, 0.43 mmol, 86%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.42 (dd, J = 8.9, 7.7 Hz, 1H), 7.26–7.16 (m, 3H), 
6.64 (dd, J = 8.9, 2.5 Hz, 1H), 6.56 (dd, J = 13.1, 2.5 Hz, 1H), 4.49 (s, 2H), 3.62 (t, J = 5.9 Hz, 
2H), 3.00 (t, J = 5.9 Hz, 2H). 
13C-NMR (101 MHz, CDCl3): δ / ppm =164.91 (d, J = 253.9 Hz), 154.08 (d, J = 11.1 Hz), 
134.8, 133.9, 132.9, 128.1, 127.2, 126.60 (d, J = 26.0 Hz), 115.7, 108.5, 99.32 (d, J = 3.9 Hz), 
99.08 (d, J = 3.7 Hz), 87.32 (d, J = 16.2 Hz), 48.7, 44.7, 28.9. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3073, 2234, 1708, 1655, 1651, 1602, 1584, 1578, 1498, 
1473, 1460, 1422, 1406, 1331, 1310, 1296, 1257, 1225, 1168, 1159, 1117, 1063, 879, 831, 818, 
775, 746, 702. 
MS (EI, 70 eV): m/z (%) = 252 (76), 147 (10), 120 (15), 104 (100), 78 (21). 
HRMS (EI): m/z calc. for [C16H13FN2]: 252.1063; found 252.1061. 
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6-(2,6-Dimethoxypyrimidin-4-yl)-4,5,6,7-tetrahydrothieno[2,3-c]pyridine (2z) 
 
According to TP13 4,7-dihydrothieno[2,3-c]pyridin-6(5H)-yl benzoate (5n, 130 mg, 
0.50 mmol, 1.00 equiv) was dissolved in dry THF (2 mL). Predried CoCl2·(3 mg, 25 µmol, 
5.00 mol%) was added and subsequent (2,6-dimethoxypyrimidin-4-yl)zinc chloride (1q, 
2.7 mL, 0.28 M, 0.75 mmol, 1.50 equiv) was added dropwise and the resulting mixture was 
stirred for 2 h at rt. Purification of the crude product by flash chromatography (hexane:EtOAc 
9:1) afforded the title compound as a colourless oil (98 mg, 0.35 mmol, 71%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.86 (s, 1H), 7.13 (d, J = 5.1 Hz, 1H), 6.79 (d, J = 5.1 
Hz, 1H), 4.17 (d, J = 1.7 Hz, 2H), 4.06 (s, 3H), 3.96 (s, 3H), 3.41 (t, J = 5.7 Hz, 2H), 2.94 (t, J 
= 5.8 Hz, 2H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 164.9, 160.7, 146.5, 133.3, 132.9, 128.2, 124.9, 
123.1, 54.8, 54.3, 50.5, 48.6, 25.0. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2924, 1740, 1595, 1562, 1479, 1468, 1456, 1409, 1380, 
1278, 1243, 1211, 1080, 1055, 1014, 790, 699. 
MS (EI, 70 eV): m/z (%) =277 (80), 247 (71), 138 (57), 109 (100), 81 (31), 56 (25). 
HRMS (EI): m/z calc. for [C13H15N3O2S]: 277.0885; found 277.0882. 
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N-(1-(3-Methoxyphenyl)piperidin-3-yl)cyclopropanecarboxamide (2aa) 
 
According to TP13 3-(cyclopropanecarboxamido)piperidin-1-yl benzoate (5o, 144 mg, 
0.50 mmol, 1.00 equiv) was dissolved in dry THF (2 mL). Predried CoCl2·(3 mg, 25 µmol, 
5.00 mol%) was added and subsequent (3-methoxyphenyl)zinc chloride (1r, 2.6 mL, 0.29 M, 
0.75 mmol, 1.50 equiv) was added dropwise and the resulting mixture was stirred for 2 h at rt. 
Purification of the crude product by flash chromatography (hexane:EtOAc 2:1) afforded the 
title compound as a colourless oil (106 mg, 0.39 mmol, 77%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.16 (t, J = 8.2 Hz, 1H), 6.60–6.54 (m, 1H), 6.49 (t, 
J = 2.2 Hz, 1H), 6.43 (dd, J = 8.1, 2.2 Hz, 1H), 6.13 (d, J = 7.5 Hz, 1H), 4.25–4.16 (m, 1H), 
3.79 (s, 3H), 3.30–3.19 (m, 2H), 3.12–2.99 (m, 2H), 1.88–1.59 (m, 4H), 1.40–1.30 (m, 1H), 
1.00–0.94 (m, 2H), 0.72 (dq, J = 7.2, 3.9 Hz, 2H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 172.8, 160.6, 153.2, 129.8, 109.9, 104.8, 103.5, 55.2, 
55.2, 50.3, 45.0, 29.4, 22.3, 14.9, 7.2 (2C). 
Analytical data according to literature90 
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(S)-3-(1-(4-Fluoro-3-methylphenyl)piperidin-2-yl)pyridine (2bb) 
 
According to TP13 (S)-2-(pyridin-3-yl)piperidin-1-yl benzoate (5p, 141 mg, 0.50 mmol, 
1.00 equiv) was dissolved in dry THF (2 mL). Predried CoCl2·(3 mg, 25 µmol, 5.00 mol%) 
was added and subsequent (4-fluoro-3-methylphenyl)zinc chloride (1s, 2.7 mL, 0.28 M, 
0.75 mmol, 1.50 equiv) was added dropwise and the resulting mixture was stirred for 2 h at rt. 
Purification of the crude product by flash chromatography (hexane:EtOAc:CH2Cl2 1:1:1) 
afforded the title compound as a colourless oil (105 mg, 0.39 mmol, 78%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.47 (d, J = 2.3 Hz, 1H), 8.33 (dd, J = 4.8, 1.7 Hz, 
1H), 7.54 (dt, J = 7.9, 2.0 Hz, 1H), 7.09 (dd, J = 7.9, 4.8 Hz, 1H), 6.77 (dd, J = 7.0, 2.6 Hz, 
1H), 6.73–6.65 (m, 2H), 4.07 (dd, J = 9.6, 3.4 Hz, 1H), 3.33 (dtd, J = 12.0, 3.9, 1.5 Hz, 1H), 
2.91–2.82 (m, 1H), 2.11 (d, J = 2.0 Hz, 3H), 1.96–1.88 (m, 1H), 1.86–1.66 (m, 4H), 1.59–1.45 
(m, 1H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 157.0 (d, J = 240.2 Hz), 149.2, 148.0 (d, J = 2.9 Hz), 
147.8, 139.8, 135.0, 126.0 (d, J = 5.0 Hz), 124.8 (d, J = 18.1 Hz), 123.3, 121.3 (d, J = 7.8 Hz), 
114.8 (d, J = 23.0 Hz), 61.9, 56.2, 35.9, 26.3, 23.9, 14.7. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2932, 2856, 1576, 1499, 1479, 1449, 1441, 1423, 1372, 
1326, 1284, 1264, 1252, 1224, 1203, 1184, 1173, 1147, 1120, 1103, 1063, 1057, 1023, 995, 
956, 893, 880, 845, 838, 809, 758, 715. 
MS (EI, 70 eV): m/z (%) = 270 (48), 193 (12), 192 (100), 136 (14), 109 (22), 83 (18), 57 (36), 
43 (54). 
HRMS (EI): m/z calc. for [C17H19FN2]: 270.1532; found 270.1530. 
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Methyl 2-(1-(3,4-Difluorophenyl)piperidin-2-yl)-2-phenylacetate (2cc) 
 
According to TP13 2-(2-methoxy-2-oxo-1-phenylethyl)piperidin-1-yl benzoate (5q, 177 mg, 
0.50 mmol, 1.00 equiv) was dissolved in dry THF (2 mL). Predried CoCl2·(3 mg, 25 µmol, 
5.00 mol%) was added and subsequent (3,4-difluorophenyl)zinc chloride (1t, 2.9 mL, 0.26 M, 
0.75 mmol, 1.50 equiv) was added dropwise and the resulting mixture was stirred for 2 h at rt. 
Purification of the crude product by flash chromatography (hexane:EtOAc 4:1) afforded the 
title compound as a colourless oil (140 mg, 0.41 mmol, 81%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.41–7.37 (m, 2H), 7.31–7.25 (m, 2H), 7.25–7.22 (m, 
1H), 6.93 (q, J = 9.3 Hz, 1H), 6.75 (ddd, J = 13.8, 6.9, 3.0 Hz, 1H), 6.66–6.60 (m, 1H), 4.36 
(dd, J = 11.5, 3.9 Hz, 1H), 4.26 (d, J = 11.5 Hz, 1H), 3.39 (s, 3H), 3.38–3.27 (m, 2H), 1.71–
1.31 (m, 6H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 173.2, 150.5 (dd, J = 244.3, 13.2 Hz), 147.8 (dd, J = 
8.0, 2.1 Hz), 143.2 (dd, J = 238.5, 13.0 Hz), 136.3, 128.9 (2C), 128.6 (2C), 127.8, 117.0 (dd, J 
= 17.5, 1.8 Hz), 111.7 (dd, J = 5.3, 2.9 Hz), 105.4 (d, J = 20.2 Hz), 60.8, 51.9, 51.2, 42.7, 24.0, 
23.3, 19.1. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2946, 2939, 1732, 1628, 1598, 1514, 1497, 1454, 1445, 
1434, 1392, 1354, 1317, 1274, 1223, 1210, 1195, 1186, 1156, 1126, 1109, 1022, 1010, 964, 
873, 832, 824, 799, 775, 733, 703, 696. 
MS (EI, 70 eV): m/z (%) = 345 (1), 225 (11), 196 (100), 178 (95), 91 (90). 
HRMS (EI): m/z calc. for [C20H21F2NO2]: 345.1540; found 345.1547. 
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4-((3S,4R)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidin-1-yl)-
3,5-dimethylisoxazole (2dd) 
 
According to TP13 (3S,4R)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl) 
piperidin-1-yl benzoate (5r, 225 mg, 0.50 mmol, 1.00 equiv) was dissolved in dry THF (2 mL). 
Predried CoCl2·(3 mg, 25 µmol, 5.00 mol%) was added and subsequent (3,5-dimethylisoxazol-
4-yl)zinc chloride (1u, 2.9 mL, 0.26 M, 0.75 mmol, 1.50 equiv) was added dropwise and the 
resulting mixture was stirred for 2 h at rt. Purification of the crude product by flash 
chromatography (hexane:EtOAc 3:1) afforded the title compound as a colourless oil (136 mg, 
0.32 mmol, 64%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.23–7.19 (m, 2H), 7.00 (t, J = 8.7 Hz, 2H), 6.62 (d, 
J = 8.5 Hz, 1H), 6.33 (d, J = 2.5 Hz, 1H), 6.12 (dd, J = 8.5, 2.5 Hz, 1H), 5.87 (s, 2H), 3.59 (dd, 
J = 9.5, 3.0 Hz, 1H), 3.49–3.45 (m, 1H), 3.35 (dd, J = 11.3, 3.1 Hz, 2H), 3.10–3.00 (m, 2H), 
2.96 (t, J = 11.0 Hz, 1H), 2.53 (td, J = 11.6, 4.3 Hz, 1H), 2.41 (s, 3H), 2.28 (s, 3H), 1.96–1.85 
(m, 2H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 161.6 (d, J = 244.6 Hz), 160.7, 158.3, 154.2, 148.2, 
141.6, 139.4 (d, J = 3.1 Hz), 128.8, 128.0, 115.5 (d, J = 21.1 Hz, 2C), 107.9, 107.8, 105.5 (d, 
J = 9.2 Hz), 101.1, 97.9 (d, J = 9.4 Hz), 69.3, 56.2, 52.9, 43.9, 42.9, 35.2, 11.7 (d, J = 5.0 Hz), 
10.6 (d, J = 3.8 Hz). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2919, 1631, 1604, 1509, 1502, 1486, 1467, 1451, 1422, 
1389, 1283, 1269, 1242, 1214, 1180, 1159, 1135, 1101, 1099, 1090, 1036, 1015, 951, 937, 922, 
911, 832, 816, 798, 784, 765, 731. 
MS (EI, 70 eV): m/z (%) = 424 (100), 383 (11), 342 (48), 287 (58), 220 (21), 190 (29), 139 
(70), 109 (60), 96 (24), 56 (39), 44 (52), 43 (79). 
HRMS (EI): m/z calc. for [C24H25FN2O4]: 424.1798; found 424.1796. 
  
C. Experimental Section 
178 
2-((1-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)piperidin-4-yl)methyl)-5,6-dimethoxy-2,3-
dihydro-1H-inden-1-one (2ee) 
 
According to TP13 4-((5,6-dimethoxy-1-oxo-2,3-dihydro-1H-inden-2-yl)methyl)piperidin-1-
yl benzoate (5s, 205 mg, 0.50 mmol, 1.00 equiv) was dissolved in dry THF (2 mL). Predried 
CoCl2·(3 mg, 25 µmol, 5.00 mol%) was added and subsequent (2,3-
dihydrobenzo[b][1,4]dioxin-6-yl)zinc chloride (1v, 2.9 mL, 0.26 M, 0.75 mmol, 1.50 equiv) 
was added dropwise and the resulting mixture was stirred for 2 h at rt. Purification of the crude 
product by flash chromatography (hexane:EtOAc 1:1) afforded the title compound as a 
colourless oil (157 mg, 0.37 mmol, 74%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.12 (s, 1H), 6.80 (s, 1H), 6.73–6.68 (m, 1H), 6.49–
6.44 (m, 2H), 4.19–4.15 (m, 2H), 4.15–4.12 (m, 2H), 3.90 (s, 3H), 3.84 (s, 3H), 3.51–3.41 (m, 
2H), 3.25–3.15 (m, 1H), 2.72–2.63 (m, 2H), 2.62–2.52 (m, 2H), 1.93–1.84 (m, 1H), 1.82–1.70 
(m, 2H), 1.61–1.19 (m, 4H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 207.9, 155.5, 149.5, 148.9, 143.6, 133.5, 130.1, 
128.4, 117.3, 111.3, 107.4, 106.4, 104.4, 64.6, 64.3, 56.2, 56.1, 51.4, 45.3, 38.7, 34.2, 33.4, 
32.9, 31.7, 29.7. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2921, 2851, 2360, 2335, 1697, 1691, 1598, 1578, 1502, 
1496, 1453, 1313, 1283, 1264, 1244, 1222, 1211, 1173, 1153, 1123, 1068, 1038, 961, 912, 890, 
854, 794, 715. 
MS (EI, 70 eV): m/z (%) = 423 (15), 288 (47), 191 (100), 135 (31), 97 (21), 55 (16).  
HRMS (EI): m/z calc. for [C25H29NO5]: 423.2046; found 423.2046. 
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(R)-8-Chloro-3-(3,5-dimethylphenyl)-1-methyl-2,3,4,5-tetrahydro-1H-benzo[d]azepine 
(2ff) 
 
According to TP13 (R)-8-chloro-1-methyl-1,2,4,5-tetrahydro-3H-benzo[d]azepin-3-yl 
benzoate (5t, 158 mg, 0.50 mmol, 1.00 equiv) was dissolved in dry THF (2 mL). Predried 
CoCl2·(3 mg, 25 µmol, 5.00 mol%) was added and subsequent (3,5-dimethylphenyl)zinc 
chloride (1w, 2.6 mL, 0.29 M, 0.75 mmol, 1.50 equiv) was added dropwise and the resulting 
mixture was stirred for 2 h at rt. Purification of the crude product by flash chromatography 
(hexane:EtOAc 4:1) afforded the title compound as a colourless oil (118 mg, 0.40 mmol, 79%). 
1H-NMR (400 MHz, CDCl3): δ / ppm =7.15 (d, J = 1.9 Hz, 1H), 7.07 (dd, J = 8.0, 2.0 Hz, 
1H), 7.02 (d, J = 8.0 Hz, 1H), 6.47 (s, 2H), 6.42 (s, 1H), 3.74–3.61 (m, 1H), 3.36–3.26 (m, 2H), 
3.09–2.94 (m, 1H), 2.28 (s, 4H), 1.36 (d, J = 6.5 Hz, 2H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 149.9, 146.9, 138.9 (2C), 138.6, 132.0, 131.1, 127.2, 
125.9, 119.4, 112.1 (2C), 55.8, 49.9, 39.2, 35.1, 21.8, 18.9 (2C). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2960, 2916, 1593, 1568, 1478, 1475, 1463, 1389, 1372, 
1360, 1265, 1194, 1175, 1155, 1101, 1038, 1000, 953, 931, 909, 886, 813, 730, 688, 662. 
MS (EI, 70 eV): m/z (%) = 229 (100), 234 (60), 115 (49). 
HRMS (EI): m/z calc. for [C19H22ClN]: 299.1441; found 229.1434. 
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N-(3-(10,11-Dihydro-5H-dibenzo[a,d][7]annulen-5-ylidene)propyl)-N-
methylnaphthalen-1-amine (2gg) 
 
According to TP13 O-benzoyl-N-(3-(10,11-dihydro-5H-dibenzo[a,d][7]annulen-5-
ylidene)propyl)-N-methylhydroxylamine (5u, 192 mg, 0.50 mmol, 1.00 equiv) was dissolved 
in dry THF (2 mL). Predried CoCl2·(3 mg, 25 µmol, 5.00 mol%) was added and subsequent 
naphthalen-1-ylzinc chloride (1x, 2.8 mL, 0.27 M, 0.75 mmol, 1.50 equiv) was added dropwise 
and the resulting mixture was stirred for 2 h at rt. Purification of the crude product by flash 
chromatography (hexane:EtOAc 9:1) afforded the title compound as a yellowish oil (175 mg, 
0.45 mmol, 90%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.27 (d, J = 7.7 Hz, 1H), 7.89–7.80 (m, 1H), 7.60–
7.45 (m, 3H), 7.39 (t, J = 7.8 Hz, 1H), 7.32–7.27 (m, 1H), 7.23 (d, J = 4.2 Hz, 2H), 7.20–7.03 
(m, 6H), 5.98 (t, J = 7.6 Hz, 1H), 3.48–3.17 (m, 4H), 2.99 (s, 1H), 2.85 (s, 3H), 2.80 (s, 1H), 
2.50 (q, J = 7.5 Hz, 2H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 150.1, 143.9, 141.3, 140.1, 139.4, 137.1, 134.9, 
130.0, 129.5, 129.1, 128.6, 128.3, 128.2, 128.0, 127.4, 127.0, 126.0, 125.8, 125.7, 125.2, 124.0, 
123.2, 123.1, 115.6, 57.0, 42.2, 33.8, 32.0, 27.8. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3432, 1725, 1481, 1451, 1368, 1316, 1284, 1258, 1212, 
1178, 1132, 1114, 1088, 1066, 1046, 1034, 1019, 976, 908, 831, 731, 709, 664. 
MS (EI, 70 eV): m/z (%) = 389 (1), 170 (100). 
HRMS (EI): m/z calc. for [C29H27N]: 389.2143; found 389.2144. 
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N-((1S,4R)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydronaphthalen-1-yl)-N,1-dimethyl-1H-
indol-5-amine (2hh) 
 
According to TP13 O-benzoyl-N-((1S,4R)-4-(3,4-dichlorophenyl)-1,2,3,4-
tetrahydronaphthalen -1-yl)-N-methylhydroxylamine (5v, 213 mg, 0.50 mmol, 1.00 equiv) 
was dissolved in dry THF (2 mL). Predried CoCl2·(3 mg, 25 µmol, 5.00 mol%) was added and 
subsequent (1-methyl-1H-indol-5-yl)zinc chloride (1y, 2.9 mL, 0.26 M, 0.75 mmol, 
1.50 equiv) was added dropwise and the resulting mixture was stirred for 2 h at rt. Purification 
of the crude product by flash chromatography (hexane:EtOAc 10:1) afforded the title 
compound as a white solid (139 mg, 0.32 mmol, 64%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.70 (d, J = 7.8 Hz, 1H), 7.37 (d, J = 8.3 Hz, 1H), 
7.33–7.25 (m, 2H), 7.22 (t, J = 7.4 Hz, 1H), 7.17 (dd, J = 13.4, 1.6 Hz, 2H), 7.08–7.00 (m, 2H), 
6.99 (d, J = 7.6 Hz, 1H), 6.90 (dd, J = 8.3, 1.8 Hz, 1H), 6.39 (d, J = 2.9 Hz, 1H), 5.07 (dd, J = 
10.3, 5.8 Hz, 1H), 4.25–4.19 (m, 1H), 3.79 (s, 3H), 2.76 (s, 3H), 2.27 (tdd, J = 12.9, 5.7, 2.8 Hz, 
1H), 2.06–1.97 (m, 1H), 1.95–1.83 (m, 1H), 1.81–1.70 (m, 1H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 147.6, 145.1, 139.3, 138.2, 132.2, 131.3, 130.8, 
130.5, 130.0, 129.9, 129.3, 129.1, 128.2, 128.1, 127.2, 127.1, 112.7, 109.7, 105.6, 100.0, 61.0, 
43.6, 33.7, 32.9, 30.6, 19.8. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2936, 2865, 1621, 1569, 1489, 1466, 1448, 1420, 1386, 
1316, 1268, 1247, 1217, 1131, 1113, 1085, 1029, 975, 907, 881, 826, 784, 729, 678. 
MS (EI, 70 eV): m/z (%) = 343 (18), 159 (100), 131 (13), 43 (20). 
HRMS (EI): m/z calc. for [C26H24Cl2N2]: 434.1317; found 434.1308. 
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N-Methyl-N-(3-phenyl-3-(4-(trifluoromethyl)phenoxy)propyl)-6-(8-((trimethylsilyl)oxy)-
1,4-dioxaspiro[4.5]decan-8-yl)pyridin-3-amine (2ii) 
 
According to TP13 O-benzoyl-N-methyl-N-(3-phenyl-3-(4-(trifluoromethyl)phenoxy) 
propyl)hydroxylamine (5w, 215 mg, 0.50 mmol, 1.00 equiv) was dissolved in dry THF (2 mL). 
Predried CoCl2·(3 mg, 25 µmol, 5.00 mol%) was added and subsequent (6-(8-
((trimethylsilyl)oxy)-1,4-dioxaspiro[4.5]decan-8-yl)pyridin-3-yl)zinc chloride (1z, 3.3 mL, 
0.23 M, 0.75 mmol, 1.50 equiv) was added dropwise and the resulting mixture was stirred for 
2 h at rt. Purification of the crude product by flash chromatography (hexane:EtOAc 3:1) 
afforded the title compound as a colourless oil (188 mg, 0.31 mmol, 61%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.06 (d, J = 3.0 Hz, 1H), 7.43 (d, J = 8.8 Hz, 2H), 
7.35–7.31 (m, 2H), 7.30–7.25 (m, 4H), 6.92 (dd, J = 8.8, 3.1 Hz, 1H), 6.89 (d, J = 8.7 Hz, 2H), 
5.18 (dd, J = 8.9, 3.9 Hz, 1H), 4.00–3.92 (m, 4H), 3.61–3.54 (m, 2H), 2.94 (s, 3H), 2.25–2.10 
(m, 4H), 2.10–2.03 (m, 2H), 1.99 (t, J = 11.8 Hz, 2H), 1.69–1.63 (m, 2H), -0.11 (s, 9H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 160.3–160.2 (m), 152.6, 143.5, 140.5, 132.4, 129.0–
128.8 (m), 128.0, 126.8 (q, J = 3.4 Hz), 124.3 (q, J = 271.2 Hz), 123.0 (q, J = 32.7 Hz), 120.8 
(d, J = 6.1 Hz, 2C), 119.1, 115.7 (4C), 108.9, 77.9, 77.8, 75.7, 64.2, 64.1, 48.7, 38.2, 38.2, 35.7, 
35.7, 35.6, 31.0, 1.9 (3C). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2953, 2880, 1614, 1591, 1555, 1516, 1497, 1452, 1371, 
1323, 1246, 1210, 1177, 1158, 1107, 1067, 1052, 1037, 1010, 944, 937, 908, 862, 834, 753, 
701. 
MS (EI, 70 eV): m/z (%) = 614 (1), 600 (11), 525 (12), 438 (20), 362 (21), 297 (15), 276 (43), 
173 (17), 162 (44), 101 (29), 75 (100). 
HRMS (EI): m/z calc. for [C33H41F3N2O4Si]: 614.2788; found 614.2796. 
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(S)-4-Chloro-N-methyl-N-(3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propyl)aniline (2jj) 
 
According to TP13 (S)-O-benzoyl-N-methyl-N-(3-(naphthalen-1-yloxy)-3-(thiophen-2-
yl)propyl)hydroxylamine (5x, 209 mg, 0.50 mmol, 1.00 equiv) was dissolved in dry THF 
(2 mL). Predried CoCl2·(3 mg, 25 µmol, 5.00 mol%) was added and subsequent 4-
chlorophenylzinc chloride (1aa, 2.6 mL, 0.29 M, 0.75 mmol, 1.50 equiv) was added dropwise 
and the resulting mixture was stirred for 2 h at rt. Purification of the crude product by flash 
chromatography (hexane:EtOAc 1:1) afforded the title compound as a white solid (149 mg, 
0.44 mmol, 87%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.45–8.39 (m, 1H), 7.89 (d, J = 8.9 Hz, 2H), 7.87–
7.81 (m, 1H), 7.60–7.51 (m, 2H), 7.44 (d, J = 8.2 Hz, 1H), 7.28 (t, J = 8.0 Hz, 1H), 7.24 (dd, J 
= 5.0, 1.2 Hz, 1H), 7.08 (d, J = 3.5 Hz, 1H), 6.96 (dd, J = 5.0, 3.5 Hz, 1H), 6.83 (d, J = 7.7 Hz, 
1H), 6.68 (d, J = 9.0 Hz, 2H), 5.72 (d, J = 3.8 Hz, 1H), 4.35 (q, J = 7.1 Hz, 2H), 3.73 (t, J = 
7.2 Hz, 2H), 3.01 (s, 3H), 2.58–2.37 (m, 2H), 1.39 (t, J = 7.1 Hz, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 167.0, 153.0, 152.0, 144.5, 134.7, 131.4 (2C), 127.7, 
126.7, 126.5, 126.0 (2C), 125.7, 125.5, 125.0, 124.8, 121.9, 120.9, 117.6, 110.8, 106.9, 73.9, 
60.2, 48.9, 38.7, 36.2, 14.5. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2973, 1697, 1605, 1523, 1462, 1366, 1279, 1236, 1184, 
1106, 1094, 1017, 830, 790, 770. 
MS (EI, 70 eV): m/z (%) = 445 (5), 301 (8), 192 (100), 164 (13). 
HRMS (EI): m/z calc. for [C27H27NO3S]: 445.1712; found 448.1700. 
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Ethyl 1-(3-fluoro-[1,1'-biphenyl]-4-yl)piperidine-3-carboxylate (2kk) 
 
According to TP13 ethyl 1-(benzoyloxy)piperidine-3-carboxylate (5y, 139 mg, 0.50 mmol, 
1.00 equiv) was dissolved in dry THF (2 mL). Predried CoCl2·(3 mg, 25 µmol, 5.00 mol%) 
was added and subsequent (3-fluoro-[1,1'-biphenyl]-4-yl)zinc chloride (1cc, 2.6 mL, 0.29 M, 
0.75 mmol, 1.50 equiv) was added dropwise and the resulting mixture was stirred for 2 h at rt. 
Purification of the crude product by flash chromatography (hexane:EtOAc 4:1) afforded the 
title compound as a colourless oil (102 mg, 0.31 mmol, 62%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.57 (dt, J = 8.1, 1.5 Hz, 2H), 7.45 (t, J = 7.6 Hz, 2H), 
7.39–7.32 (m, 2H), 6.82 (dd, J = 8.6, 2.5 Hz, 1H), 6.75 (dd, J = 14.1, 2.5 Hz, 1H), 4.22 (q, J = 
7.2 Hz, 2H), 3.81 (ddd, J = 12.6, 3.6, 1.7 Hz, 1H), 3.62–3.53 (m, 1H), 3.17 (dd, J = 12.6, 9.8 
Hz, 1H), 3.00–2.90 (m, 1H), 2.76–2.67 (m, 1H), 2.13–2.06 (m, 1H), 1.90–1.80 (m, 1H), 1.80–
1.68 (m, 2H), 1.33 (t, J = 7.2 Hz, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 173.7, 160.61 (d, J = 245.9 Hz), 151.96 (d, J = 10.1 
Hz), 136.06 (d, J = 1.5 Hz), 130.90 (d, J = 5.5 Hz), 128.67 (d, J = 3.0 Hz), 128.4, 126.8, 119.17 
(d, J = 13.8 Hz), 111.9, 103.43 (d, J = 26.8 Hz), 60.7, 51.4, 49.1, 41.1, 26.9, 23.9, 14.3. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2939, 2819, 2354, 2335, 1723, 1623, 1555, 1517, 1487, 
1387, 1308, 1237, 1170, 1136, 1112, 1036, 978, 857, 829, 762, 697. 
MS (EI, 70 eV): m/z (%) = 327 (100), 298 (99), 282 (15), 254 (61), 26 (59), 214 (42), 199 (98), 
170 (90), 151 (14), 99 (10), 55 (12). 
HRMS (EI): m/z calc. for [C20H22FNO2]: 327.1635; found 327.1630. 
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N,1-bis(3,5-dimethylphenyl)azetidine-3-carboxamide (2ll) 
 
According to TP13 3-((3,5-dimethylphenyl)carbamoyl)azetidin-1-yl benzoate (5aa, 162 mg, 
0.50 mmol, 1.00 equiv) was dissolved in dry THF (2 mL). Predried CoCl2·(3 mg, 25 µmol, 
5.00 mol%) was added and subsequent (3,5-dimethylphenyl)zinc chloride (1w, 2.6 mL, 0.29 M, 
0.75 mmol, 1.50 equiv) was added dropwise and the resulting mixture was stirred for 2 h at rt. 
Purification of the crude product by flash chromatography (hexane:EtOAc 4:1) afforded the 
title compound as a colourless oil (103 mg, 0.34 mmol, 67%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.77 (s, 1H), 7.10 (s, 2H), 6.69 (s, 1H), 6.41 (s, 1H), 
6.09 (s, 2H), 3.97 (dd, J = 6.5, 2.1 Hz, 4H), 3.32 (ddd, J = 7.5, 5.5, 1.8 Hz, 1H), 2.21 (s, 6H), 
2.20 (s, 6H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 170.9, 151.7, 138.8 (2C), 137.6 (2C), 126.2, 120.7, 
117.7 (2C), 110.0 (2C), 55.1 (2C), 37.1, 29.7, 21.5 (2C), 21.4 (2C). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3262, 2920, 2850, 1650, 1615, 1599, 1540, 1482, 1463, 
1444, 1438, 1432, 1397, 1377, 1361, 1302, 1218, 1152, 1038, 908, 843, 817, 730, 724, 717, 
712, 704, 686. 
MS (EI, 70 eV): m/z (%) = 308 (13), 203 (61), 120 (100), 105 (43), 83 (66). 
HRMS (EI): m/z calc. for [C20H24N2O]: 308.1889; found 308.1882. 
  
C. Experimental Section 
186 
Methyl (4-chlorophenyl)-L-prolyl-L-phenylalaninate (2mm) 
 
According to TP13 (S)-2-(((S)-1-methoxy-1-oxo-3-phenylpropan-2-yl)carbamoyl)pyrrolidin-
1-yl benzoate (5aa, 185 mg, 0.50 mmol, 1.00 equiv) was dissolved in dry THF (2 mL). 
Predried CoCl2·(3 mg, 25 µmol, 5.00 mol%) was added and subsequent 4-chlorophenylzinc 
chloride ( , 2.6 mL, 0.29 M, 0.75 mmol, 1.50 equiv) was added dropwise and the resulting 
mixture was stirred for 2 h at rt. Purification of the crude product by flash chromatography 
(hexane:EtOAc 4:1) afforded the title compound as a colourless oil (153 mg, 0.40 mmol, 79%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.31–7.23 (m, 3H), 7.21–7.15 (m, 2H), 7.11–7.05 (m, 
2H), 6.77 (d, J = 8.1 Hz, 1H), 6.55–6.49 (m, 2H), 4.86 (td, J = 7.9, 5.4 Hz, 1H), 3.91 (dd, J = 
9.7, 2.1 Hz, 1H), 3.69 (s, 3H), 3.45 (t, J = 8.0 Hz, 1H), 3.26 (dd, J = 14.0, 5.5 Hz, 1H), 3.12 
(ddd, J = 10.9, 8.9, 6.1 Hz, 1H), 2.99 (dd, J = 14.0, 7.8 Hz, 1H), 2.24–2.12 (m, 1H), 2.10–2.02 
(m, 1H), 1.96–1.87 (m, 1H), 1.66–1.52 (m, 1H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 173.4, 171.5, 145.9, 135.9, 129.0 (2C), 129.0 (2C), 
128.6 (2C), 127.2, 123.2, 114.3 (2C), 64.5, 52.6, 52.4, 49.6, 37.5, 31.3, 23.9. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2950, 1738, 1657, 1598, 1493, 1435, 1357, 1337, 1213, 
1175, 1157, 1124, 1095, 1031, 977, 907, 809, 729, 699. 
MS (EI, 70 eV): m/z (%) = 386 (13), 180 (100), 138 (34), 111 (23), 91 (16). 
HRMS (EI): m/z calc. for [C21H23ClN2O3]: 386.1397; found 386.1392. 
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4.7 Synthesis of Gepirone (3p) 
1-(4-Iodobutyl)-4,4-dimethylpiperidine-2,6-dione 
 
1-(4-iodobutyl)-4,4-dimethylpiperidine-2,6-dione was prepared according to a literature 
procedure.127 
1H-NMR (400 MHz, CDCl3): δ / ppm = 3.80 (d, J = 7.4 Hz, 2H), 3.20 (t, J = 6.9 Hz, 2H), 2.51 
(s, 4H), 1.88–1.78 (m, 2H), 1.64 (p, J = 7.3 Hz, 2H), 1.09 (s, 6H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 171.9, 46.4, 38.2, 31.0, 29.2, 29.0, 27.7, 5.8. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2956, 2929, 2870, 1722, 1666, 1468, 1453, 1432, 1392, 
1349, 1332, 1275, 1268, 1256, 1214, 1181, 1122, 1020, 933, 818, 734. 
MS (EI, 70 eV): m/z (%) = 323 (1), 196 (100), 154 (23), 126 (24), 83 (60), 55 (40). 
HRMS (EI): m/z calc. for [C11H18INO2]: 163.0997; found 163.0992. 
 
(4-(4,4-Dimethyl-2,6-dioxopiperidin-1-yl)butyl)zinc chloride (1bb) 
 
According to TP5, 1-(4-Iodobutyl)-4,4-dimethylpiperidine-2,6-dione (618 mg, 2.50 mmol, 
1.00 equiv) was added to a suspension of anhydrous LiCl (159 mg, 3.75 mmol, 1.50 equiv), 
anhydrous ZnCl2 (409 mg, 3.00 mmol, 1.20 equiv) and magnesium turnings (122 mg, 
5.00 mmol, 2.00 equiv) in dry THF (5 mL). The mixture was stirred at 25 °C overnight. 
Titration with iodine gave a concentration of 0.24 mmol/mL active zinc species, corresponding 
to 82% yield. 
 
                                                          
127  E. Ofori, X. Y. Zhu, J. R. Etukala, B. A. Bricker, S. Y. Ablordeppey 2016, 24, 5730–5740. 
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4,4-Dimethyl-1-(4-(4-(pyrimidin-2-yl)piperazin-1-yl)butyl)piperidine-2,6-dione 
(Gepirone) (2v) 
 
According to TP13 4-(pyrimidin-2-yl)piperazin-1-yl benzoate (5j, 142 mg, 0.50 mmol, 
1.00 equiv) was dissolved in dry THF (2 mL). Predried CoCl2·(6 mg, 50 µmol, 10.0 mol%) 
was added and subsequent (4-(4,4-dimethyl-2,6-dioxopiperidin-1-yl)butyl)zinc chloride (1o, 
3.13 mL, 0.24 M, 0.75 mmol, 1.50 equiv) was added dropwise and the resulting mixture was 
stirred for 2 h at rt. Purification of the crude product by flash chromatography (pure EtOAc) 
afforded the title compound as a yellowish liquid (147 mg, 0.41 mmol, 82%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.20 (d, J = 4.7 Hz, 2H), 6.42 (t, J = 4.7 Hz, 1H), 3.91 
(s, 4H), 3.69 (t, J = 7.1 Hz, 2H), 2.68–2.47 (m, 6H), 2.42 (s, 4H), 1.64–1.41 (m, 4H), 0.97 (s, 
6H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 172.1, 161.4, 157.8, 110.4, 58.0, 52.6, 46.4, 38.7, 
29.2, 27.7, 25.7, 23.0. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2953, 2931, 2870, 1722, 1668, 1584, 1547, 1511, 1495, 
1469, 1446, 1392, 1357, 1307, 1290, 1273, 1260, 1219, 1208, 1130, 983, 955, 798, 731. 
MS (EI, 70 eV): m/z (%) = 359 (30), 21 (61), 177 (100), 122 (65). 
HRMS (EI): m/z calc. for [C19H29N5O2]: 359.2321; found 359.2326. 
 
4.8 Synthesis of Penfluridol 
4,4'-(4-Iodobutane-1,1-diyl)bis(fluorobenzene) 
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4,4'-(4-Iodobutane-1,1-diyl)bis(fluorobenzene) was prepared according to a literature 
procedure. The analytical data was consistent with the literature.128  
 
(4,4-Bis(4-fluorophenyl)butyl)zinc chloride (22) 
 
According to TP5, 4,4'-(4-iodobutane-1,1-diyl)bis(fluorobenzene) (931 mg, 2.50 mmol, 
1.00 equiv) was added to a suspension of anhydrous LiCl (159 mg, 3.75 mmol, 1.50 equiv), 
anhydrous ZnCl2 (409 mg, 3.00 mmol, 1.20 equiv) and magnesium turnings (122 mg, 
5.00 mmol, 2.00 equiv) in dry THF (5 mL). The mixture was stirred at 25 °C overnight. 
Titration with iodine gave a concentration of 0.27 mmol/mL active zinc species, corresponding 
to 92% yield. 
 
3-(4-Oxopiperidin-1-yl)propanenitrile (17a) 
 
According to TP10, piperidin-4-one hydrochloride (272 mg, 2.00 mmol, 1.00 equiv) was 
dissolved in dry MeOH (5 mL) and added to a solution of sodium metal (46 mg, 2.00 mmol, 
1.00 equiv). Then, acrylonitrile (0.66 mL, 530 mg, 10.0 mmol, 5.00 equiv) was added and the 
resulting mixture was stirred at 55 °C overnight. The solvent was removed and the crude 
product purified by flash column chromatography (hexane:EtOAc 1:1) to afford the title 
compound as a colourless oil (332 mg, 1.52 mmol, 76%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 2.82 (td, J = 6.5, 2.9 Hz, 6H), 2.56 (t, J = 6.8 Hz, 2H), 
2.48 (t, J = 6.2 Hz, 4H). 
                                                          
128  M. Saito, N. Tsuji, Y. Kobayashi, Y. Takemoto Org. Lett. 2015, 17, 3000–3003. 
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13C-NMR (101 MHz, CDCl3): δ / ppm = 208.0, 118.5, 52.7, 52.5, 41.1, 16.6. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2960, 2817, 2246, 1715, 1475, 1418, 1378, 1355, 1336, 
1280, 1234, 1195, 1135, 1093, 1049, 1013, 748. 
MS (EI, 70 eV): m/z (%) = 112 (100), 84 (16). 
HRMS (EI): m/z calc. for [C8H12N2O]: 152.0950; found 112.0757 [M-CH2CN]. 
 
(3-Chloro-4-(trifluoromethyl)phenyl)magnsium Chloride (19) 
 
According to TP4 (without the last step of transmetalation using ZnCl2), 4-bromo-2-chloro-1-
(trifluoromethyl)benzene (649 mg, 2.50 mmol, 1.00 equiv) was added to a suspension of 
anhydrous LiCl (159 mg, 3.75 mmol, 1.50 equiv) and magnesium turnings (122 mg, 
5.00 mmol, 2.00 equiv) in dry THF (5 mL). The mixture was stirred at 25 °C overnight. 
Titration with iodine gave a concentration of 0.47 mmol/mL active magnesium species, 
corresponding to 96% yield. 
 
3-(4-(4-Chloro-3-(trifluoromethyl)phenyl)-4-hydroxypiperidin-1-yl)propanenitrile (20) 
 
A dry and argon flushed Schlenk-flask equipped with a septum and a magnetic stirring bar was 
charged with LaCl3·2LiCl (0.33 M; 6.10 mL, 2.00 mmol, 1.00 equiv) as a solution in dry THF. 
3-(4-oxopiperidin-1-yl)propanenitrile (437 mg, 2.00 mmol, 1.00 equiv) was added and the 
resulting mixture was stirred for 1 h at rt. The reaction mixture was cooled to 0 °C and (3-
chloro-4-(trifluoromethyl)phenyl)magnesium chloride (19, 0.56 M, 3.8 mL, 2.10 mmol, 
1.05 equiv) was added dropwise. The reaction mixture was stirred at 25 °C for 1.5 h and then 
quenched with sat. aqueous NH4Cl (2 mL). The aqueous layer was extracted with EtOAc 
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(3×10 mL), the combined organic layers were dried over Na2SO4 and concentrated in vacuo. 
The crude residue was purified by flash column chromatography (hexane:EtOAc 1:2) to afford 
the titel compound as white solid (346 mg, 1.04 mmol, 52%) 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.85 (d, J = 2.3 Hz, 1H), 7.59 (dd, J = 8.4, 2.3 Hz, 
1H), 7.48 (d, J = 8.4 Hz, 1H), 2.84–2.79 (m, 2H), 2.77 (t, J = 7.0 Hz, 2H), 2.61–2.53 (m, 4H), 
2.12 (td, J = 13.2, 4.6 Hz, 2H), 1.73 (dq, J = 14.4, 2.9 Hz, 2H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 147.3, 131.4, 130.9, 129.2, 128.22 (q, J = 31.1 Hz), 
124.07 (q, J = 5.3 Hz, 2C), 122.89 (q, J = 273.3 Hz), 118.8, 70.9, 53.4, 48.8 (2C), 38.3, 16.0. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3436, 2946, 2827, 2824, 2249, 1481, 1471, 1409, 1377, 
1349, 1315, 1269, 1257, 1215, 1175, 1124, 1113, 1047, 1032, 1009, 969, 940, 908, 833, 771, 
730, 664, 654. 
MS (EI, 70 eV): m/z (%) = 332 (4), 292 (100), 274 (43), 201 (22), 179 (18), 109 (12), 56 (17), 
42 (64). 
HRMS (EI): m/z calc. for [C15H16ClF3N2O]: 332.0903; found 332.0911. 
 
4-(4-Chloro-3-(trifluoromethyl)phenyl)-4-hydroxypiperidin-1-yl benzoate (21) 
 
According to TP11 3-(4-(4-chloro-3-(trifluoromethyl)phenyl)-4-hydroxypiperidin-1-
yl)propanenitrile (20, 333 mg, 1.00 mmol, 1.00 equiv) was dissolved in dry CH2Cl2 (2 mL) and 
cooled to −78 °C. Then, mCPBA (190 mg, 1.10 mmol, 1.10 equiv) was slowly added as a 
solution in dry CH2Cl2 (2 mL) and the resulting mixture was stirred at −78 °C for 1 h. 
Following, the cooling bath was removed and the mixture stirred at 25 °C overnight. The 
solvent was removed and the acid by-product removed by filtration through a silica plug. After 
solvent removal, the resulting N-hydroxylamine was dissolved in CH2Cl2 (4 mL) followed by 
the addition of triethylamine (0.21 mL, 1.50 mmol, 1.50 equiv), DMAP (1 mg, 0.01 mmol, 
1.00 mol%) and benzoyl chloride (168 mg, 1.20 mmol, 1.20 equiv) at 0 °C. The resulting 
solution was stirred at 0 °C for 1 h and quenched with sat. aqueous NH4Cl solution (2 mL). 
The mixture was extracted with EtOAc (3 x 5 mL) and the combined organic phases were 
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washed with saturated NaHCO3 solution (2 mL), brine (2 mL), and dried over Na2SO4. The 
crude mixture was purified with flash column chromatography (hexane:EtOAc 1:1) to afford 
the desired product a pale white solid (148 mg, 0.74 mmol, 74%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.03 (dd, J = 8.1, 1.5 Hz, 2H), 7.89 (d, J = 2.3 Hz, 
1H), 7.63 (d, J = 7.9 Hz, 1H), 7.59 (t, J = 7.4 Hz, 1H), 7.51 (d, J = 8.3 Hz, 1H), 7.46 (t, J = 
7.7 Hz, 2H), 3.59–3.25 (m, 3H), 2.53–2.42 (m, 2H), 1.96–1.59 (m, 4H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 164.8, 146.4, 133.2, 131.6, 131.2, 129.4 (2C), 129.2, 
129.0, 128.5 (2C), 128.2 (d, J = 31.1 Hz, 2C), 124.1 (q, J = 5.4 Hz, 2C), 122.8 (d, J = 273.4 Hz), 
70.2, 52.3, 38.0. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3436, 1725, 1605, 1481, 1451, 1410, 1368, 1316, 1284, 
1258, 1212, 1178, 1132, 1114, 1088, 1066, 1046, 1034, 1019, 975, 908, 831, 731, 709, 664. 
MS (EI, 70 eV): m/z (%) =382 (1), 257 (100), 202 (26), 153 (14). 
HRMS (EI): m/z calc. for [C19H17ClF3NO3]: 399.0849; found 382.0818 [M-OH]. 
 
1-(4,4-Bis(4-fluorophenyl)butyl)-4-(4-chloro-3-(trifluoromethyl)phenyl)piperidin-4-ol 
(Penfluridol) (15) 
 
In a dry and argon flushed flask, 4-(4-chloro-3-(trifluoromethyl)phenyl)-4-hydroxypiperidin-
1-yl benzoate (21, 200 mg, 0.50 mmol, 1.00 equiv) was dissolved in dry CH2Cl2 (2 mL) 
followed by the addition of triethylamine (0.11 mL, 0.75 mmol, 1.50 equiv), DMAP (1 mg, 
0.01 mmol, 2.0 mol%) and trimethylsilyl chloride (65 mg, 0.60 mmol, 1.20 equiv) at 0 °C. The 
mixture was stirred for 2 h at 0 °C and quenched with sat. aqueous NH4Cl solution (2 mL). The 
mixture was extracted with EtOAc (3 x 5 mL) and the combined organic phases were washed 
with saturated NaHCO3 solution (2 mL), brine (2 mL), and dried over Na2SO4. Evaporation of 
the solvent afforded the crude 4-(4-chloro-3-(trifluoromethyl)phenyl)-4-((trimethylsilyl) 
oxy)piperidin-1-yl benzoate. 
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1H-NMR (400 MHz, CDCl3): δ / ppm = 8.09–7.95 (m, 2H), 7.82 (d, J = 2.1 Hz, 1H), 7.60–
7.41 (m, 5H), 3.48 (dd, J = 8.5, 5.0 Hz, 2H), 3.28 (t, J = 11.2 Hz, 2H), 2.32 (td, J = 13.1, 4.0 
Hz, 2H), 2.09 (d, J = 13.5 Hz, 2H), -0.02 (s, 9H). 
Then, according to TP13, the 4-(4-chloro-3-(trifluoromethyl)phenyl)-4-((trimethylsilyl) 
oxy)piperidin-1-yl benzoate was dissolved in dry THF (2 mL). Predried CoCl2·(3 mg, 
25 µmol, 5.00 mol%) was added and subsequent (4,4-bis(4-fluorophenyl)butyl)zinc chloride 
(12, 2.78 mL, 0.27 M, 0.75 mmol, 1.50 equiv) was added dropwise and the resulting mixture 
was stirred for 2 h at rt. The crude 1-(4,4-Bis(4-fluorophenyl)butyl)-4-(4-chloro-3-
(trifluoromethyl)phenyl)-4-((trimethylsilyl)oxy)piperidine was dissolved in dry THF and 
aqueous 1 M hCl (2 mL) was added. The mixture was stirred for 1 h at rt. The mixture was 
extracted with EtOAc (3 x 5 mL) and the combined organic phases were washed with saturated 
NaHCO3 solution (2 mL), brine (2 mL), and dried over Na2SO4. Purification of the crude 
product by flash chromatography (hexane:EtOAc 1:1) afforded the title compound as a 
colourless oil (233 mg, 0.45 mmol, 89%) 
Analytical data according to literature129 
  
                                                          
129  G. Chen, h. Xia, Y. Cai, D. Ma, J. Yuan, C. Yuan Bioorg. Med. Chem Lett. 2011, 21, 234–239. 
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5. Preparation of Tertiary Amines by Triple Functionalization of 
Tris-(2-cyanoethyl)amine Using a Cobalt-Catalyzed 
Electrophilic Amination of Organozinc Halides 
5.1 Preparation of Organozinc Chlorides 
Cyclopentylzinc chloride (1dd) 
 
According to TP4, bromocyclopentan (373 mg, 2.50 mmol, 1.00 equiv) was added to a 
suspension of anhydrous LiCl (159 mg, 3.75 mmol, 1.50 equiv) and magnesium turnings 
(122 mg, 5.00 mmol, 2.00 equiv) in dry THF (5 mL). The mixture was stirred at 25 °C 
overnight and then ZnCl2 (1 M in THF, 3.0 mL, 3.00 mmol, 1.20 equiv) was added as a solution 
in THF at 0 °C. Titration with iodine gave a concentration of 0.29 mmol/mL active zinc 
species, corresponding to 98% yield. 
 
Cyclohexylzinc chloride (1ee) 
 
According to TP4, bromocyclohexyl (408 mg, 2.50 mmol, 1.00 equiv) was added to a 
suspension of anhydrous LiCl (159 mg, 3.75 mmol, 1.50 equiv) and magnesium turnings 
(122 mg, 5.00 mmol, 2.00 equiv) in dry THF (5 mL). The mixture was stirred at 25 °C 
overnight and then ZnCl2 (1 M in THF, 3.0 mL, 3.00 mmol, 1.20 equiv) was added as a solution 
in THF at 0 °C. Titration with iodine gave a concentration of 0.27 mmol/mL active zinc 
species, corresponding to 88% yield. 
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Phenethylzinc chloride (1ff) 
 
According to TP4, (2-bromoethyl)benzene (463 mg, 2.50 mmol, 1.00 equiv) was added to a 
suspension of anhydrous LiCl (159 mg, 3.75 mmol, 1.50 equiv) and magnesium turnings 
(122 mg, 5.00 mmol, 2.00 equiv) in dry THF (5 mL). The mixture was stirred at 25 °C 
overnight and then ZnCl2 (1 M in THF, 3.0 mL, 3.00 mmol, 1.20 equiv) was added as a solution 
in THF at 0 °C. Titration with iodine gave a concentration of 0.28 mmol/mL active zinc 
species, corresponding to 92% yield. 
 
(((1S,2S,3S,5R)-2,6,6-Trimethylbicyclo[3.1.1]heptan-3-yl)methyl)zinc chloride (1hh) 
 
According to TP6, (1S,2S,3S,5R)-3-(bromomethyl)-2,6,6-trimethylbicyclo[3.1.1]heptane 
(578 mg, 2.50 mmol, 1.00 equiv) was added to a suspension of anhydrous LiCl (159 mg, 
3.75 mmol, 1.50 equiv) and activated zinc dust (245 mg, 3.75 mmol, 1.50 equiv) in dry THF 
(5 mL). The mixture was stirred at 50 °C overnight. Titration with iodine gave a concentration 
of 0.32 mmol/mL active zinc species, corresponding to 67% yield. 
 
(4-((4-Chlorobenzyl)oxy)-4-oxobutyl)zinc chloride (1ii) 
 
According to TP6, 4-chlorobenzyl 4-bromobutanoate (738 mg, 2.50 mmol, 1.00 equiv) was 
added to a suspension of anhydrous LiCl (159 mg, 3.75 mmol, 1.50 equiv) and activated zinc 
dust (245 mg, 3.75 mmol, 1.50 equiv) in dry THF (5 mL). The mixture was stirred at 50 °C 
overnight. Titration with iodine gave a concentration of 0.40 mmol/mL active zinc species, 
corresponding to 84% yield. 
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(2-(1,3-Dioxan-2-yl)ethyl) (1jj) 
 
According to TP6, 2-(2-bromoethyl)-1,3-dioxane (488 mg, 2.50 mmol, 1.00 equiv) was added 
to a suspension of anhydrous LiCl (159 mg, 3.75 mmol, 1.50 equiv) and activated zinc dust 
(245 mg, 3.75 mmol, 1.50 equiv) in dry THF (5 mL). The mixture was stirred at 50 °C 
overnight. Titration with iodine gave a concentration of 0.45 mmol/mL active zinc species, 
corresponding to 95% yield. 
 
(3-(4-(2,6-Difluorobenzoyl)phenyl)propyl)zinc chloride (1kk) 
 
According to TP6, (4-(3-bromopropyl)phenyl)(2,6-difluorophenyl)methanone (848 mg, 
2.50 mmol, 1.00 equiv) was added to a suspension of anhydrous LiCl (159 mg, 3.75 mmol, 
1.50 equiv) and activated zinc dust (245 mg, 3.75 mmol, 1.50 equiv) in dry THF (5 mL). The 
mixture was stirred at 50 °C overnight. Titration with iodine gave a concentration of 
0.41 mmol/mL active zinc species, corresponding to 86% yield. 
(4-(((1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl)oxy)-4-oxobutyl)zinc chloride (1mm) 
 
According to TP6, (1R,2S,5R)-2-isopropyl-5-methylcyclohexyl 4-bromobutanoate (763 mg, 
2.50 mmol, 1.00 equiv) was added to a suspension of anhydrous LiCl (159 mg, 3.75 mmol, 
1.50 equiv) and activated zinc dust (245 mg, 3.75 mmol, 1.50 equiv) in dry THF (5 mL). The 
mixture was stirred at 50 °C overnight. Titration with iodine gave a concentration of 
0.43 mmol/mL active zinc species, corresponding to 90% yield. 
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(3-Chloro-5-fluorophenyl)zinc chloride (1nn) 
 
According to TP4, 1-bromo-3-chloro-5-fluorobenzene (524 mg, 2.50 mmol, 1.00 equiv) was 
added to a suspension of anhydrous LiCl (159 mg, 3.75 mmol, 1.50 equiv) and magnesium 
turnings (122 mg, 5.00 mmol, 2.00 equiv) in dry THF (5 mL). The mixture was stirred at 25 °C 
overnight and then ZnCl2 (1 M in THF, 3.0 mL, 3.00 mmol, 1.20 equiv) was added as a solution 
in THF at 0 °C. Titration with iodine gave a concentration of 0.27 mmol/mL active zinc 
species, corresponding to 92% yield. 
 
(4-(Trifluoromethyl)phenyl)zinc chloride (1oo) 
 
According to TP2, 1-bromo-4-(trifluoromethyl)benzene (563 mg, 2.50 mmol) was dissolved 
in dry THF (7.5 mL) and iPrMgCl·LiCl (2.15 mL, 1.28 M, 2.75 mmol) was added. After 
stirring for 4 h at 25 °C ZnCl2 (1 M in THF, 3.0 mL, 3.00 mmol, 1.20 equiv) was added as a 
solution in THF at 0 °C. Titration with iodine gave a concentration of 0.29 mmol/mL active 
zinc species, corresponding to 96% yield. 
 
(4-Cyanophenyl)zinc chloride (1pp) 
 
According to TP2, 4-iodobenzonitrile (1.15 g, 5.00 mmol, 1.00 equiv) was dissolved in dry 
THF (5 mL) and iPrMgCl·LiCl (4.30 mL, 1.28 M, 5.50 mmol, 1.10 equiv) was added. After 
stirring for 2 h at 0 °C ZnCl2 (1 M in THF, 6.0 mL, 6.00 mmol) was added. Titration with iodine 
gave a concentration of 0.25 mmol/mL active zinc species, corresponding to 81% yield. 
(3-((tert-Butyldimethylsilyl)oxy)phenyl)zinc chloride (1qq) 
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According to TP4, (3-bromophenoxy)(tert-butyl)dimethylsilane (718 mg, 2.50 mmol, 
1.00 equiv) was added to a suspension of anhydrous LiCl (159 mg, 3.75 mmol, 1.50 equiv) and 
magnesium turnings (122 mg, 5.00 mmol, 2.00 equiv) in dry THF (5 mL). The mixture was 
stirred at 25 °C overnight and then ZnCl2 (1 M in THF, 3.0 mL, 3.00 mmol, 1.20 equiv) was 
added as a solution in THF at 0 °C. Titration with iodine gave a concentration of 0.26 mmol/mL 
active zinc species, corresponding to 88% yield.  
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5.2 Preparation of N-Hydroxylamine Derivatives 
3,3'-((Benzoyloxy)azanediyl)dipropanenitrile (5bb) 
 
According to TP11 3,3',3''-nitrilotripropanenitrile (23, 217 mg, 1.00 mmol, 1.00 equiv) was 
dissolved in dry CH2Cl2 (2 mL) and cooled to −78 °C. Then, mCPBA (190 mg, 1.10 mmol, 
1.10 equiv) was slowly added as a solution in dry CH2Cl2 (2 mL) and the resulting mixture was 
stirred at −78 °C for 1 h. Following, the cooling bath was removed and the mixture stirred at 
25 °C overnight. The solvent was removed and the acid by-product removed by filtration 
through a silica plug. After solvent removal, the resulting N-hydroxylamine was dissolved in 
CH2Cl2 (4 mL) followed by the addition of triethylamine (0.21 mL, 1.50 mmol, 1.50 equiv), 
DMAP (1 mg, 0.01 mmol, 1.00 mol%) and benzoyl chloride (168 mg, 1.20 mmol, 1.20 equiv) 
at 0 °C. The resulting solution was stirred at 0 °C for 1 h and quenched with sat. aqueous NH4Cl 
solution (2 mL). The mixture was extracted with EtOAc (3 x 5 mL) and the combined organic 
phases were washed with saturated NaHCO3 solution (2 mL), brine (2 mL), and dried over 
Na2SO4. The crude mixture was purified with flash column chromatography (hexane:EtOAc 
2:1) to afford the desired product a pale white solid (139 mg, 0.57 mmol, 57%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.99–7.83 (m, 2H), 7.58–7.48 (m, 1H), 7.39 (dt, J = 
20.7, 7.9 Hz, 2H), 3.32 (t, J = 6.7 Hz, 4H), 2.62 (td, J = 6.8, 1.9 Hz, 4H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 164.1, 134.0, 129.8 (2C), 128.8 (2C), 128.0, 117.6 
(2C), 54.6 (2C), 16.1 (2C). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 1771, 1600, 1493, 1454, 1316, 1294, 1229, 1204, 1151, 
1075, 1038, 1016, 1002, 977, 933, 914, 797, 781, 767, 700, 691. 
HRMS (EI): m/z calc. for [C13H15N3O2]: 243.1008; found 243.1001. 
  
C. Experimental Section 
200 
3-((Benzoyloxy)(cyclopentyl)amino)propanenitrile (5cc) 
 
According to TP11 3,3'-(cyclopentylazanediyl)dipropanenitrile (26a, 191 mg, 1.00 mmol, 
1.00 equiv) was dissolved in dry CH2Cl2 (2 mL) and cooled to −78 °C. Then, mCPBA (190 mg, 
1.10 mmol, 1.10 equiv) was slowly added as a solution in dry CH2Cl2 (2 mL) and the resulting 
mixture was stirred at −78 °C for 1 h. Following, the cooling bath was removed and the mixture 
stirred at 25 °C overnight. The solvent was removed and the acid by-product removed by 
filtration through a silica plug. After solvent removal, the resulting N-hydroxylamine was 
dissolved in CH2Cl2 (4 mL) followed by the addition of triethylamine (0.21 mL, 1.50 mmol, 
1.50 equiv), DMAP (1 mg, 0.01 mmol, 1.00 mol%) and benzoyl chloride (168 mg, 1.20 mmol, 
1.20 equiv) at 0 °C. The resulting solution was stirred at 0 °C for 1 h and quenched with sat. 
aqueous NH4Cl solution (2 mL). The mixture was extracted with EtOAc (3 x 5 mL) and the 
combined organic phases were washed with saturated NaHCO3 solution (2 mL), brine (2 mL), 
and dried over Na2SO4. The crude mixture was purified with flash column chromatography 
(hexane:EtOAc 3:1) to afford the desired product a pale white solid (189 mg, 0.73 mmol, 73%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.06–7.86 (m, 2H), 7.67–7.52 (m, 1H), 7.50–7.35 (m, 
2H), 3.48 (p, J = 7.3 Hz, 1H), 3.30 (t, J = 7.2 Hz, 2H), 2.65 (td, J = 7.2, 4.1 Hz, 2H), 1.85 (tdd, 
J = 9.3, 4.2, 2.5 Hz, 2H), 1.79–1.51 (m, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 165.8, 133.5, 129.7 (2C), 128.6 (2C), 127.8, 118.1, 
69.1, 53.4, 29.9 (2C), 24.5 (2C), 16.1. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2961, 2871, 2251, 1742, 1601, 1575, 1473, 1451, 1423, 
1358, 1315, 1282, 1276, 1238, 1177, 1103, 1080, 1061, 1024, 1002, 903, 885, 862, 804, 744, 
709, 687, 674. 
HRMS (EI): m/z calc. for [C15H16N2O2]: 258.1368; found 258.1362. 
  
C. Experimental Section 
201 
3-((Benzoyloxy)(cyclohexyl)amino)propanenitrile (5dd) 
 
According to TP11 3,3'-(cyclohexylazanediyl)dipropanenitrile (26b, 205 mg, 1.00 mmol, 
1.00 equiv) was dissolved in dry CH2Cl2 (2 mL) and cooled to −78 °C. Then, mCPBA (190 mg, 
1.10 mmol, 1.10 equiv) was slowly added as a solution in dry CH2Cl2 (2 mL) and the resulting 
mixture was stirred at −78 °C for 1 h. Following, the cooling bath was removed and the mixture 
stirred at 25 °C overnight. The solvent was removed and the acid by-product removed by 
filtration through a silica plug. After solvent removal, the resulting N-hydroxylamine was 
dissolved in CH2Cl2 (4 mL) followed by the addition of triethylamine (0.21 mL, 1.50 mmol, 
1.50 equiv), DMAP (1 mg, 0.01 mmol, 1.00 mol%) and benzoyl chloride (168 mg, 1.20 mmol, 
1.20 equiv) at 0 °C. The resulting solution was stirred at 0 °C for 1 h and quenched with sat. 
aqueous NH4Cl solution (2 mL). The mixture was extracted with EtOAc (3 x 5 mL) and the 
combined organic phases were washed with saturated NaHCO3 solution (2 mL), brine (2 mL), 
and dried over Na2SO4. The crude mixture was purified with flash column chromatography 
(hexane:EtOAc 3:1) to afford the desired product a pale white solid (193 mg, 0.71 mmol, 71%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.05–7.89 (m, 2H), 7.59 (dddd, J = 14.2, 8.0, 2.5, 1.2 
Hz, 1H), 7.50–7.38 (m, 2H), 3.36 (t, J = 7.2 Hz, 2H), 2.94 (tt, J = 10.8, 3.6 Hz, 1H), 2.64 (td, 
J = 7.2, 4.5 Hz, 2H), 2.03–1.92 (m, 2H), 1.86–1.77 (m, 2H), 1.70–1.59 (m, 1H), 1.42–1.06 (m, 
5H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 164.6, 133.5, 129.7 (2C), 128.6 (2C), 127.8, 118.1, 
66.0, 50.6, 29.0, 25.7 (2C), 25.0 (2C), 16.3. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2934, 2857, 2251, 1742, 1601, 1451, 1422, 1372, 1349, 
1315, 1238, 1194, 1177, 1159, 1079, 1063, 1022, 1002, 913, 895, 866, 852, 826, 802, 780, 731, 
707, 687, 674. 
HRMS (EI): m/z calc. for [C16H20N2O2]: 272.1525; found 272.1529. 
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202 
3-((Benzoyloxy)(phenethyl)amino)propanenitrile (5ee) 
 
According to TP11 3,3'-(phenethylazanediyl)dipropanenitrile (26c, 227 mg, 1.00 mmol, 
1.00 equiv) was dissolved in dry CH2Cl2 (2 mL) and cooled to −78 °C. Then, mCPBA (190 mg, 
1.10 mmol, 1.10 equiv) was slowly added as a solution in dry CH2Cl2 (2 mL) and the resulting 
mixture was stirred at −78 °C for 1 h. Following, the cooling bath was removed and the mixture 
stirred at 25 °C overnight. The solvent was removed and the acid by-product removed by 
filtration through a silica plug. After solvent removal, the resulting N-hydroxylamine was 
dissolved in CH2Cl2 (4 mL) followed by the addition of triethylamine (0.21 mL, 1.50 mmol, 
1.50 equiv), DMAP (1 mg, 0.01 mmol, 1.00 mol%) and benzoyl chloride (168 mg, 1.20 mmol, 
1.20 equiv) at 0 °C. The resulting solution was stirred at 0 °C for 1 h and quenched with sat. 
aqueous NH4Cl solution (2 mL). The mixture was extracted with EtOAc (3 x 5 mL) and the 
combined organic phases were washed with saturated NaHCO3 solution (2 mL), brine (2 mL), 
and dried over Na2SO4. The crude mixture was purified with flash column chromatography 
(hexane:EtOAc 3:1) to afford the desired product a pale white solid (185 mg, 0.63 mmol, 63%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.05–7.86 (m, 2H), 7.64–7.55 (m, 1H), 7.52–7.38 (m, 
2H), 7.30–7.24 (m, 2H), 7.23–7.15 (m, 3H), 3.43–3.23 (m, 4H), 3.01–2.87 (m, 2H), 2.69 (td, J 
= 7.1, 5.7 Hz, 2H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 164.4, 138.4, 134.8, 133.7 (2C), 129.9 (2C), 129.7 
(2C), 128.6 (2C), 127.8, 126.6, 117.8, 61.0, 54.6, 33.4, 16.0 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3028, 2923, 2851, 1742, 1602, 1575, 1496, 1452, 1424, 
1362, 1315, 1283, 1238, 1178, 1117, 1100, 1088, 1079, 1060, 1044, 1022, 1002, 883, 802, 743, 
708, 699, 673. 
HRMS (EI): m/z calc. for [C18H18N2O2]: 294.1368; found 294.1363. 
  
C. Experimental Section 
203 
3-(((3s,5s,7s)-adamantan-1-yl)(benzoyloxy)amino)propanenitrile (5ff) 
 
According to TP11, 3,3'-(((3s,5s,7s)-adamantan-1-yl)azanediyl)dipropanenitrile (26d, 
257 mg, 1.00 mmol, 1.00 equiv) was dissolved in dry CH2Cl2 (2 mL) and cooled to −78 °C. 
Then, mCPBA (190 mg, 1.10 mmol, 1.10 equiv) was slowly added as a solution in dry CH2Cl2 
(2 mL) and the resulting mixture was stirred at −78 °C for 1 h. Following, the cooling bath was 
removed and the mixture stirred at 25 °C overnight. The solvent was removed and the acid by-
product removed by filtration through a silica plug. After solvent removal, the resulting 
N-hydroxylamine was dissolved in CH2Cl2 (4 mL) followed by the addition of triethylamine 
(0.21 mL, 1.50 mmol, 1.50 equiv), DMAP (1 mg, 0.01 mmol, 1.00 mol%) and benzoyl 
chloride (168 mg, 1.20 mmol, 1.20 equiv) at 0 °C. The resulting solution was stirred at 0 °C 
for 1 h and quenched with sat. aqueous NH4Cl solution (2 mL). The mixture was extracted with 
EtOAc (3 x 5 mL) and the combined organic phases were washed with saturated NaHCO3 
solution (2 mL), brine (2 mL), and dried over Na2SO4. The crude mixture was purified with 
flash column chromatography (hexane:EtOAc 3:1) to afford the desired product a pale white 
solid (172 mg, 0.53 mmol, 53%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.11–8.01 (m, 2H), 7.66–7.55 (m, 1H), 7.48 (t, J = 
7.7 Hz, 2H), 3.35 (t, J = 7.3 Hz, 2H), 2.61 (t, J = 7.3 Hz, 2H), 2.19–2.08 (m, 3H), 1.84 (d, J = 
3.0 Hz, 6H), 1.76–1.57 (m, 6H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 166.1, 133.5, 129.7 (2C), 128.7 (2C), 128.5, 118.4, 
61.2, 46.3, 38.2 (3C), 36.4 (3C), 29.2 (3C), 17.2. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3018, 1642, 1622, 1595, 1482, 1476, 1434, 1395, 1301, 
1261, 1221, 1189, 1135, 1122, 1050, 1060, 1021, 1001, 879, 812, 734, 718, 694, 667. 
HRMS (EI): m/z calc. for [C20H24N2O2]: 324.1838; found 324.1830. 
  
C. Experimental Section 
204 
3-((Benzoyloxy)(((1S,2S,3S,5R)-2,6,6-trimethylbicyclo[3.1.1]heptan-3-
yl)methyl)amino)propanenitrile (5gg) 
 
According to TP11 3,3'-((((1S,2S,3S,5R)-2,6,6-trimethylbicyclo[3.1.1]heptan-3-
yl)methyl)azanediyl)dipropanenitrile (26e, 273 mg, 1.00 mmol, 1.00 equiv) was dissolved in 
dry CH2Cl2 (2 mL) and cooled to −78 °C. Then, mCPBA (190 mg, 1.10 mmol, 1.10 equiv) was 
slowly added as a solution in dry CH2Cl2 (2 mL) and the resulting mixture was stirred at −78 °C 
for 1 h. Following, the cooling bath was removed and the mixture stirred at 25 °C overnight. 
The solvent was removed and the acid by-product removed by filtration through a silica plug. 
After solvent removal, the resulting N-hydroxylamine was dissolved in CH2Cl2 (4 mL) 
followed by the addition of triethylamine (0.21 mL, 1.50 mmol, 1.50 equiv), DMAP (1 mg, 
0.01 mmol, 1.00 mol%) and benzoyl chloride (168 mg, 1.20 mmol, 1.20 equiv) at 0 °C. The 
resulting solution was stirred at 0 °C for 1 h and quenched with sat. aqueous NH4Cl solution 
(2 mL). The mixture was extracted with EtOAc (3 x 5 mL) and the combined organic phases 
were washed with saturated NaHCO3 solution (2 mL), brine (2 mL), and dried over Na2SO4. 
The crude mixture was purified with flash column chromatography (pure EtOAc 2:1) to afford 
the desired product a pale white solid (238 mg, 0.670 mmol, 70%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.04–7.88 (m, 2H), 7.62–7.54 (m, 1H), 7.49–7.40 (m, 
2H), 3.41–3.27 (m, 2H), 3.10 (dd, J = 12.4, 4.8 Hz, 1H), 2.87 (dd, J = 12.4, 9.7 Hz, 1H), 2.73–
2.65 (m, 2H), 2.30 (dtd, J = 9.8, 6.2, 2.1 Hz, 1H), 2.19 (dddd, J = 12.1, 10.0, 3.6, 1.9 Hz, 1H), 
1.94–1.82 (m, 2H), 1.81–1.67 (m, 3H), 1.16 (s, 3H), 1.04 (d, J = 7.1 Hz, 3H), 0.91 (s, 3H), 0.72 
(d, J = 9.7 Hz, 1H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 165.2, 133.5, 129.6 (2C), 128.6 (2C), 127.7, 118.1, 
69.1, 54.6, 47.8, 41.5, 41.4, 38.8, 34.4, 33.9, 33.5, 27.9, 23.0, 21.7, 15.9. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2903, 2870, 1744, 1472, 1451, 1423, 1385, 1374, 1367, 
1315, 1239, 1177, 1101, 1084, 1056, 1024, 1002, 906, 862, 801, 735, 707, 687, 673, 657. 
HRMS (EI): m/z calc. for [C21H28N2O2]: 340.2151; found 340.2155. 
  
C. Experimental Section 
205 
4-Chlorobenzyl 4-((benzoyloxy)(cyclopentyl)amino)butanoate (5hh) 
 
According to TP11 4-chlorobenzyl 4-((2-cyanoethyl)(cyclopentyl)amino)butanoate (27a, 
349 mg, 1.00 mmol, 1.00 equiv) was dissolved in dry CH2Cl2 (2 mL) and cooled to −78 °C. 
Then, mCPBA (190 mg, 1.10 mmol, 1.10 equiv) was slowly added as a solution in dry CH2Cl2 
(2 mL) and the resulting mixture was stirred at −78 °C for 1 h. Following, the cooling bath was 
removed and the mixture stirred at 25 °C overnight. The solvent was removed and the acid by-
product removed by filtration through a silica plug. After solvent removal, the resulting 
N-hydroxylamine was dissolved in CH2Cl2 (4 mL) followed by the addition of triethylamine 
(0.21 mL, 1.50 mmol, 1.50 equiv), DMAP (1 mg, 0.01 mmol, 1.00 mol%) and benzoyl 
chloride (168 mg, 1.20 mmol, 1.20 equiv) at 0 °C. The resulting solution was stirred at 0 °C 
for 1 h and quenched with sat. aqueous NH4Cl solution (2 mL). The mixture was extracted with 
EtOAc (3 x 5 mL) and the combined organic phases were washed with saturated NaHCO3 
solution (2 mL), brine (2 mL), and dried over Na2SO4. The crude mixture was purified with 
flash column chromatography (hexane:EtOAc 4:1) to afford the desired product a pale white 
solid (345 mg, 0.83 mmol, 83%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.05–7.88 (m, 2H), 7.61–7.52 (m, 1H), 7.48–7.37 (m, 
2H), 7.32–7.24 (m, 4H), 5.06 (d, J = 2.0 Hz, 2H), 3.82–3.71 (m, 1H), 3.41 (td, J = 7.4, 2.4 Hz, 
1H), 3.01 (t, J = 7.0 Hz, 2H), 2.55 (t, J = 7.2 Hz, 2H), 1.94–1.76 (m, 5H), 1.74–1.52 (m, 4H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 173.2, 165.9, 133.1, 129.8, 129.6, 129.6, 129.2, 
128.7, 128.5, 127.7, 69.2, 68.0, 65.3, 57.0, 31.6, 29.9, 25.6, 24.5, 22.2. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2959, 2869, 1740, 1682, 1601, 1574, 1450, 1425, 1412, 
1355, 1314, 1282, 1239, 1176, 1116, 1101, 1080, 1061, 1023, 1002, 861, 850, 833, 775, 744, 
708, 686, 674. 
HRMS (EI): m/z calc. for [C23H26ClNO4]: 415.1550; found 415.1559. 
  
C. Experimental Section 
206 
N-(2-(1,3-dioxan-2-yl)ethyl)-O-benzoyl-N-cyclohexylhydroxylamine (5ii) 
 
According to TP11 3-((2-(1,3-dioxan-2-yl)ethyl)(cyclohexyl)amino)propanenitrile (27b, 
266 mg, 1.00 mmol, 1.00 equiv) was dissolved in dry CH2Cl2 (2 mL) and cooled to −78 °C. 
Then, mCPBA (190 mg, 1.10 mmol, 1.10 equiv) was slowly added as a solution in dry CH2Cl2 
(2 mL) and the resulting mixture was stirred at −78 °C for 1 h. Following, the cooling bath was 
removed and the mixture stirred at 25 °C overnight. The solvent was removed and the acid by-
product removed by filtration through a silica plug. After solvent removal, the resulting 
N-hydroxylamine was dissolved in CH2Cl2 (4 mL) followed by the addition of triethylamine 
(0.21 mL, 1.50 mmol, 1.50 equiv), DMAP (1 mg, 0.01 mmol, 1.00 mol%) and benzoyl 
chloride (168 mg, 1.20 mmol, 1.20 equiv) at 0 °C. The resulting solution was stirred at 0 °C 
for 1 h and quenched with sat. aqueous NH4Cl solution (2 mL). The mixture was extracted with 
EtOAc (3 x 5 mL) and the combined organic phases were washed with saturated NaHCO3 
solution (2 mL), brine (2 mL), and dried over Na2SO4. The crude mixture was purified with 
flash column chromatography (hexane:EtOAc 3:1) to afford the desired product a pale white 
solid (263 mg, 0.79 mmol, 79%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.02–7.86 (m, 2H), 7.56–7.48 (m, 1H), 7.44–7.30 (m, 
2H), 4.67 (t, J = 5.1 Hz, 1H), 4.05–3.98 (m, 2H), 3.70 (ddt, J = 12.3, 10.3, 2.4 Hz, 2H), 3.13 
(dd, J = 8.5, 6.4 Hz, 2H), 2.85 (tt, J = 11.0, 3.5 Hz, 1H), 2.08–1.88 (m, 3H), 1.84 (ddd, J = 9.9, 
7.9, 4.0 Hz, 2H), 1.75 (dt, J = 12.6, 3.2 Hz, 2H), 1.65–1.53 (m, 1H), 1.42–1.05 (m, 6H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 165.9, 133.1, 129.6 (2C), 129.2, 128.5 (2C), 100.7, 
66.9 (2C), 65.8, 50.0, 32.5, 29.1 (2C), 25.9, 25.8, 25.2 (2C). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2933, 2854, 1742, 1602, 1575, 1469, 1451, 1428, 1407, 
1377, 1315, 1284, 1239, 1195, 1177, 1140, 1081, 1059, 1024, 998, 974, 967, 938, 927, 907, 
893, 856, 824, 745, 734, 709, 688, 674. 
HRMS (EI): m/z calc. for [C19H27NO4]: 333.1940; found 333.1947. 
  
C. Experimental Section 
207 
N-(2-(1,3-Dioxan-2-yl)ethyl)-O-benzoyl-N-phenethylhydroxylamine (5jj) 
 
According to TP11 3-((2-(1,3-dioxan-2-yl)ethyl)(phenethyl)amino)propanenitrile (27c, 
288 mg, 1.00 mmol, 1.00 equiv) was dissolved in dry CH2Cl2 (2 mL) and cooled to −78 °C. 
Then, mCPBA (190 mg, 1.10 mmol, 1.10 equiv) was slowly added as a solution in dry CH2Cl2 
(2 mL) and the resulting mixture was stirred at −78 °C for 1 h. Following, the cooling bath was 
removed and the mixture stirred at 25 °C overnight. The solvent was removed and the acid by-
product removed by filtration through a silica plug. After solvent removal, the resulting 
N-hydroxylamine was dissolved in CH2Cl2 (4 mL) followed by the addition of triethylamine 
(0.21 mL, 1.50 mmol, 1.50 equiv), DMAP (1 mg, 0.01 mmol, 1.00 mol%) and benzoyl 
chloride (168 mg, 1.20 mmol, 1.20 equiv) at 0 °C. The resulting solution was stirred at 0 °C 
for 1 h and quenched with sat. aqueous NH4Cl solution (2 mL). The mixture was extracted with 
EtOAc (3 x 5 mL) and the combined organic phases were washed with saturated NaHCO3 
solution (2 mL), brine (2 mL), and dried over Na2SO4. The crude mixture was purified with 
flash column chromatography (hexane:EtOAc 3:1) to afford the desired product a pale white 
solid (263 mg, 0.74 mmol, 74%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.04–7.98 (m, 2H), 7.60–7.54 (m, 1H), 7.47–7.41 (m, 
2H), 7.25–7.14 (m, 5H), 4.71 (t, J = 5.1 Hz, 1H), 4.11–4.02 (m, 2H), 3.81–3.70 (m, 2H), 3.30–
3.22 (m, 2H), 3.16 (dd, J = 8.2, 6.6 Hz, 2H), 2.96–2.88 (m, 2H), 2.10–1.97 (m, 2H), 1.91 (ddd, 
J = 10.2, 7.9, 4.1 Hz, 2H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 165.6, 139.3, 133.1, 129.6 (2C), 128.7 (2C), 128.5 
(2C), 128.4 (2C), 126.2, 100.4, 66.9 (2C), 61.2, 54.4, 33.4, 32.4, 25.8, 14.2. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3062, 3028, 2961, 2854, 1740, 1602, 1584, 1496, 1470, 
1451, 1429, 1409, 1378, 1315, 1241, 1176, 1139, 1092, 1080, 1058, 1024, 1001, 972, 940, 926, 
893, 854, 747, 709, 700, 673. 
HRMS (EI): m/z calc. for [C21H25NO4]: 355.1784; found 355.1795. 
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(4-(3-((Benzoyloxy)(phenethyl)amino)propyl)phenyl)(2,6-difluorophenyl)methanone 
(5kk) 
 
According to TP11 3-((3-(4-(2,6-difluorobenzoyl)phenyl)propyl)(phenethyl)amino) 
propanenitrile (27d, 433 mg, 1.00 mmol, 1.00 equiv) was dissolved in dry CH2Cl2 (2 mL) and 
cooled to −78 °C. Then, mCPBA (190 mg, 1.10 mmol, 1.10 equiv) was slowly added as a 
solution in dry CH2Cl2 (2 mL) and the resulting mixture was stirred at −78 °C for 1 h. 
Following, the cooling bath was removed and the mixture stirred at 25 °C overnight. The 
solvent was removed and the acid by-product removed by filtration through a silica plug. After 
solvent removal, the resulting N-hydroxylamine was dissolved in CH2Cl2 (4 mL) followed by 
the addition of triethylamine (0.21 mL, 1.50 mmol, 1.50 equiv), DMAP (1 mg, 0.01 mmol, 
1.00 mol%) and benzoyl chloride (168 mg, 1.20 mmol, 1.20 equiv) at 0 °C. The resulting 
solution was stirred at 0 °C for 1 h and quenched with sat. aqueous NH4Cl solution (2 mL). 
The mixture was extracted with EtOAc (3 x 5 mL) and the combined organic phases were 
washed with saturated NaHCO3 solution (2 mL), brine (2 mL), and dried over Na2SO4. The 
crude mixture was purified with flash column chromatography (hexane:EtOAc 4:1) to afford 
the desired product a pale white solid (435 mg, 0.87 mmol, 87%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.04–8.00 (m, 2H), 7.76 (d, J = 8.1 Hz, 2H), 7.61–
7.56 (m, 1H), 7.49–7.39 (m, 3H), 7.29–7.23 (m, 4H), 7.23–7.14 (m, 3H), 7.03–6.95 (m, 2H), 
3.28–3.19 (m, 2H), 3.03 (t, J = 7.1 Hz, 2H), 2.97–2.89 (m, 2H), 2.82 (t, J = 7.7 Hz, 2H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 188.6, 165.8, 159.8 (dd, J = 251.5, 7.7 Hz), 149.1, 
139.3, 134.9, 133.3, 131.9 (t, J = 9.8 Hz),130.1, 129.7, 129.1, 129.0, 128.8, 128.6, 128.6, 126.4, 
117.27 (t, J = 22.0 Hz), 112.2–111.8 (m), 61.5, 59.0, 33.7, 28.3, 21.2. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3063, 3030, 2955, 2866, 1739, 1713, 1672, 1622, 1604, 
1589, 1496, 1464, 1452, 1416, 1361, 1312, 1277, 1243, 1235, 1222, 1177, 1146, 1090, 1063, 
1024, 1005, 930, 911, 853, 791, 750, 729, 708, 700, 670. 
HRMS (EI): m/z calc. for [C31H27FNO3]: 499.1959; found 499.1967. 
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209 
N-((3s,5s,7s)-adamantan-1-yl)-O-benzoyl-N-isopropylhydroxylamine (5ll) 
 
According to TP11 3-(((3s,5s,7s)-adamantan-1-yl)(isopropyl)amino)propanenitrile (27e, 
246 mg, 1.00 mmol, 1.00 equiv) was dissolved in dry CH2Cl2 (2 mL) and cooled to −78 °C. 
Then, mCPBA (190 mg, 1.10 mmol, 1.10 equiv) was slowly added as a solution in dry CH2Cl2 
(2 mL) and the resulting mixture was stirred at −78 °C for 1 h. Following, the cooling bath was 
removed and the mixture stirred at 25 °C overnight. The solvent was removed and the acid by-
product removed by filtration through a silica plug. After solvent removal, the resulting 
N-hydroxylamine was dissolved in CH2Cl2 (4 mL) followed by the addition of triethylamine 
(0.21 mL, 1.50 mmol, 1.50 equiv), DMAP (1 mg, 0.01 mmol, 1.00 mol%) and benzoyl 
chloride (168 mg, 1.20 mmol, 1.20 equiv) at 0 °C. The resulting solution was stirred at 0 °C 
for 1 h and quenched with sat. aqueous NH4Cl solution (2 mL). The mixture was extracted with 
EtOAc (3 x 5 mL) and the combined organic phases were washed with saturated NaHCO3 
solution (2 mL), brine (2 mL), and dried over Na2SO4. The crude mixture was purified with 
flash column chromatography (hexane:EtOAc 4:1) to afford the desired product a pale white 
solid (210 mg, 0.67 mmol, 67%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.11–8.06 (m, 2H), 7.67–7.53 (m, 1H), 7.50–7.44 (m, 
2H), 3.67 (p, J = 6.5 Hz, 1H), 2.15–2.06 (m, 3H), 1.96–1.83 (m, 6H), 1.70–1.59 (m, 6H), 1.26–
1.14 (m, 6H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 166.6, 132.9, 129.6, 129.6 (2C), 128.5 (2C), 61.2, 
50.7, 39.7 (3C), 36.6 (3C), 29.5 (3C), 24.2, 19.0. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2980, 2906, 2846, 1739, 1699, 1600, 1583, 1448, 1381, 
1361, 1344, 1311, 1274, 1259, 1240, 1190, 1177, 1130, 1120, 1081, 1061, 1044, 1020, 977, 
970, 939, 906, 876, 860, 819, 801, 707, 686, 672. 
HRMS (EI): m/z calc. for [C20H27NO2]: 313.2042; found 313.2050. 
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(1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl 4-((benzoyloxy)(((1S,2S,3S,5R)-2,6,6-
trimethylbicyclo[3.1.1]heptan-3-yl)methyl)amino)butanoate (5mm) 
 
According to TP11 (1R,2S,5R)-2-isopropyl-5-methylcyclohexyl 4-((2-
cyanoethyl)(((1S,2S,3S,5R)-2,6,6-trimethylbicyclo[3.1.1]heptan-3-
yl)methyl)amino)butanoate (27f, 445 mg, 1.00 mmol, 1.00 equiv) was dissolved in dry CH2Cl2 
(2 mL) and cooled to −78 °C. Then, mCPBA (190 mg, 1.10 mmol, 1.10 equiv) was slowly 
added as a solution in dry CH2Cl2 (2 mL) and the resulting mixture was stirred at −78 °C for 
1 h. Following, the cooling bath was removed and the mixture stirred at 25 °C overnight. The 
solvent was removed and the acid by-product removed by filtration through a silica plug. After 
solvent removal, the resulting N-hydroxylamine was dissolved in CH2Cl2 (4 mL) followed by 
the addition of triethylamine (0.21 mL, 1.50 mmol, 1.50 equiv), DMAP (1 mg, 0.01 mmol, 
1.00 mol%) and benzoyl chloride (168 mg, 1.20 mmol, 1.20 equiv) at 0 °C. The resulting 
solution was stirred at 0 °C for 1 h and quenched with sat. aqueous NH4Cl solution (2 mL). 
The mixture was extracted with EtOAc (3 x 5 mL) and the combined organic phases were 
washed with saturated NaHCO3 solution (2 mL), brine (2 mL), and dried over Na2SO4. The 
crude mixture was purified with flash column chromatography (hexane:EtOAc 4:1) to afford 
the desired product a pale white solid (363 mg, 0.71 mmol, 71%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.05–7.86 (m, 2H), 7.61–7.50 (m, 1H), 7.49–7.35 (m, 
2H), 4.66 (td, J = 10.9, 4.3 Hz, 1H), 3.12–2.95 (m, 4H), 2.81 (t, J = 11.3 Hz, 1H), 2.53–2.43 
(m, 2H), 2.34–2.14 (m, 2H), 2.00–1.80 (m, 8H), 1.79–1.70 (m, 2H), 1.65 (ddd, J = 13.0, 6.1, 
2.3 Hz, 4H), 1.54–1.39 (m, 1H), 1.33 (ddt, J = 12.2, 10.7, 3.1 Hz, 1H), 1.16 (s, 3H), 1.04 (d, J 
= 7.1 Hz, 3H), 0.92 (s, 3H), 0.88 (d, J = 6.6 Hz, 3H), 0.85 (d, J = 7.0 Hz, 3H), 0.72 (d, J = 7.0 
Hz, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 173.1, 165.3, 133.0, 129.4 (2C), 128.5 (2C), 127.6, 
74.1, 69.3, 58.4, 47.9, 46.9, 41.6, 41.5, 40.9, 38.9, 34.4, 34.2, 33.9, 33.5, 31.9, 31.4, 28.0, 26.2, 
23.4, 23.1, 22.2, 22.0, 21.7, 20.8, 16.3. 
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IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2951, 2926, 2869, 1744, 1727, 1602, 1576, 1469, 1451, 
1385, 1370, 1345, 1314, 1239, 1176, 1152, 1134, 1099, 1083, 1057, 1039, 1024, 1010, 985, 
966, 935, 912, 843, 824, 802, 744, 707, 687, 673. 
  
C. Experimental Section 
212 
5.3 Preparation of Amination Products 
3,3'-(Cyclopentylazanediyl)dipropanenitrile (26a) 
 
According to TP13 3,3'-((benzoyloxy)azanediyl)dipropanenitrile (5bb, 122 mg, 0.50 mmol, 
1.00 equiv) was dissolved in dry THF (2 mL). Predried CoCl2·(3 mg, 25 µmol, 5.00 mol%) 
was added and subsequent cyclopentylzinczinc chloride (1dd, 2.6 mL, 0.29 M, 0.75 mmol, 
1.50 equiv) was added dropwise and the resulting mixture was stirred for 2 h at rt. Purification 
of the crude product by flash chromatography (hexane:EtOAc 1:3) afforded the title compound 
as a colourless oil (62 mg, 0.33 mmol, 65%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 3.06 (p, J = 8.6, 8.1 Hz, 1H), 2.89 (t, J = 6.9 Hz, 4H), 
2.46 (t, J = 6.9 Hz, 3H), 1.87–1.76 (m, 2H), 1.74–1.62 (m, 1H), 1.61–1.48 (m, 1H), 1.44–1.30 
(m, 2H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 118.9 (2C), 63.4, 47.9 (2C), 29.9 (2C), 23.8 (2C). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2955, 2868, 2247, 1463, 1453, 1421, 1362, 1338, 1312, 
1265, 1238, 1130, 1085, 1040, 1023, 966, 945, 757. 
HRMS (EI): m/z calc. for [C11H17N3]: 191.1422; found 191.1425. 
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3,3'-(Cyclohexylazanediyl)dipropanenitrile (26b) 
 
According to TP13 3,3'-((benzoyloxy)azanediyl)dipropanenitrile (5bb, 122 mg, 0.50 mmol, 
1.00 equiv) was dissolved in dry THF (2 mL). Predried CoCl2·(3 mg, 25 µmol, 5.00 mol%) 
was added and subsequent cyclohexylzinc chloride (1ee, 2.8 mL, 0.27 M, 0.75 mmol, 
1.50 equiv) was added dropwise and the resulting mixture was stirred for 2 h at rt. Purification 
of the crude product by flash chromatography (hexane:EtOAc 1:3) afforded the title compound 
as a colourless oil (75 mg, 0.37 mmol, 73%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 2.81 (t, J = 6.8 Hz, 4H), 2.42 (t, J = 6.8 Hz, 4H), 
2.40–2.35 (m, 1H), 1.76 (ddt, J = 10.7, 8.1, 4.9 Hz, 4H), 1.64–1.57 (m, 1H), 1.27–0.98 (m, 
5H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 118.9 (2C), 60.4, 46.8 (2C), 29.4 (2C), 26.0, 25.9 
(2C), 19.2 (2C). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2995, 2247, 1432, 1442, 2, 1355, 1321, 1305, 1287, 
1230, 1070, 1065, 955, 760. 
HRMS (EI): m/z calc. for [C12H19N3]: 205.1579; found 205.1586. 
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3,3'-(Phenethylazanediyl)dipropanenitrile (26c) 
 
According to TP13 3,3'-((benzoyloxy)azanediyl)dipropanenitrile (5bb, 122 mg, 0.50 mmol, 
1.00 equiv) was dissolved in dry THF (2 mL). Predried CoCl2·(3 mg, 25 µmol, 5.00 mol%) 
was added and subsequent phenethylzinc chloride (1ff, 2.7 mL, 0.28 M, 0.75 mmol, 1.50 equiv) 
was added dropwise and the resulting mixture was stirred for 2 h at rt. Purification of the crude 
product by flash chromatography (hexane:EtOAc 1:3) afforded the title compound as a 
colourless oil (69 mg, 0.31 mmol, 61%). 
1H-NMR (400 MHz, CDCl3): δ / ppm =7.33–7.27 (m, 2H), 7.25–7.18 (m, 3H), 2.90 (t, J = 6.8 
Hz, 4H), 2.85–2.73 (m, 4H), 2.41 (t, J = 6.8 Hz, 4H). 
13C-NMR (101 MHz, CDCl3): δ / ppm =139.4, 128.8 (2C), 128.6 (2C), 126.5, 118.7 (2C), 
55.7, 49.9 (2C), 34.3, 17.2 (2C). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3062, 3028, 2930, 2849, 2248, 1626, 1602, 1584, 1495, 
1465, 1454, 1420, 1362, 1336, 1242, 1180, 1128, 1080, 1030, 966, 910, 825, 748, 700. 
HRMS (EI): m/z calc. for [C14H17N3]: 227.1422; found 227.1422. 
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3,3'-(((3s,5s,7s)-adamantan-1-yl)azanediyl)dipropanenitrile (26d) 
 
According to TP13 3,3'-((benzoyloxy)azanediyl)dipropanenitrile (5bb, 122 mg, 0.50 mmol, 
1.00 equiv) was dissolved in dry THF (2 mL). Predried CoCl2·(3 mg, 25 µmol, 5.00 mol%) 
was added and subsequent ((3s,5s,7s)-adamantan-1-yl)zinc chloride (1gg, 2.7 mL, 0.28 M, 
0.75 mmol, 1.50 equiv) was added dropwise and the resulting mixture was stirred for 2 h at rt. 
Purification of the crude product by flash chromatography (hexane:EtOAc 1:3) afforded the 
title compound as a white solid (66 mg, 0.26 mmol, 51%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 2.88 (t, J = 7.1 Hz, 4H), 2.39 (t, J = 7.1 Hz, 4H), 
2.07–2.00 (m, 3H), 1.59 (t, J = 3.7 Hz, 9H), 1.57–1.48 (m, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 118.9 (2C), 55.7, 45.4 (2C), 40.0 (3C), 36.4 (3C), 
29.4 (3C), 20.8 (2C)l. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2980, 2906, 2847, 1740, 1600, 1583, 1448, 1381, 1361, 
1344, 1311, 1273, 1257, 1240, 1190, 1176, 1130, 1120, 1081, 1061, 1044, 1020, 977, 954, 939, 
907, 876, 860, 818, 801, 771, 747, 707, 686, 672. 
HRMS (EI): m/z calc. for [C16H23N3]: 257.1892; found 257.1899. 
m.p.: 46 °C 
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3,3'-((((1S,2S,3S,5R)-2,6,6-trimethylbicyclo[3.1.1]heptan-3-
yl)methyl)azanediyl)dipropanenitrile (26e) 
 
According to TP13 3,3'-((benzoyloxy)azanediyl)dipropanenitrile (5bb, 122 mg, 0.50 mmol, 
1.00 equiv) was dissolved in dry THF (2 mL). Predried CoCl2·(3 mg, 25 µmol, 5.00 mol%) 
was added and subsequent (((1S,2S,3S,5R)-2,6,6-trimethylbicyclo[3.1.1]heptan-3-
yl)methyl)zinc chloride (1hh, 2.3 mL, 0.32 M, 0.75 mmol, 1.50 equiv) was added dropwise and 
the resulting mixture was stirred for 2 h at rt. Purification of the crude product by flash 
chromatography (hexane:EtOAc 1:3) afforded the title compound as a colourless oil (90 mg, 
0.33 mmol, 66%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 2.89–2.75 (m, 4H), 2.51–2.35 (m, 5H), 2.29–2.19 (m, 
2H), 2.14–2.04 (m, 1H), 1.92–1.84 (m, 1H), 1.78–1.66 (m, 2H), 1.54–1.39 (m, 2H), 1.13 (s, 
3H), 0.99 (d, J = 7.2 Hz, 3H), 0.94 (s, 3H), 0.62 (d, J = 9.7 Hz, 1H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 118.6 (2C), 64.1, 49.7 (2C), 47.9, 41.6, 41.6, 38.9, 
34.3, 33.8, 33.2, 27.9, 23.1, 22.0, 16.7 (2C). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2932, 2856, 2249, 2197, 1742, 1621, 1601, 1584, 1464, 
1450, 1421, 1372, 1350, 1315, 1239, 1194, 1177, 1162, 1137, 1080, 1063, 1023, 1002, 894, 
866, 825, 802, 780, 746, 709, 687, 674. 
HRMS (EI): m/z calc. for [C17H27N3]: 273.2205; found 273.2212. 
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4-Chlorobenzyl 4-((2-cyanoethyl)(cyclopentyl)amino)butanoate (27a) 
 
According to TP13 3-((benzoyloxy)(cyclopentyl)amino)propanenitrile (5cc, 129 mg, 
0.50 mmol, 1.00 equiv) was dissolved in dry THF (2 mL). Predried CoCl2·(3 mg, 25 µmol, 
5.00 mol%) was added and subsequent (4-((4-chlorobenzyl)oxy)-4-oxobutyl)zinc bromide (1ii, 
1.9 mL, 0.40 M, 0.75 mmol, 1.50 equiv) was added dropwise and the resulting mixture was 
stirred for 2 h at rt. Purification of the crude product by flash chromatography (hexane:EtOAc 
2:1) afforded the title compound as a colourless oil (152 mg, 0.44 mmol, 81%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.35–7.27 (m, 4H), 5.07 (s, 2H), 3.04–2.93 (m, 1H), 
2.82 (t, J = 7.1 Hz, 2H), 2.50 (dd, J = 7.9, 6.4 Hz, 2H), 2.39 (td, J = 7.1, 3.6 Hz, 4H), 1.79–
1.70 (m, 2H), 1.69–1.58 (m, 2H), 1.56–1.45 (m, 2H), 1.37–1.24 (m, 2H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 173.3, 134.5, 134.2, 129.8 (2C), 128.8 (2C), 119.2, 
65.4, 63.1, 50.5, 47.3, 31.6, 29.7 (2C), 23.9 (2C), 22.6, 16.5. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2953, 2868, 2247, 1732, 1695, 1621, 1600, 1493, 1463, 
1452, 1417, 1412, 1378, 1355, 1316, 1255, 1212, 1161, 1122, 1091, 1015, 971, 944, 838, 805. 
HRMS (EI): m/z calc. for [C19H25ClN2O2]: 348.1605; found 348.1613. 
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3-((2-(1,3-Dioxan-2-yl)ethyl)(cyclohexyl)amino)propanenitrile (27b) 
 
According to TP13 3-((benzoyloxy)(cyclohexyl)amino)propanenitrile (5dd, 136 mg, 
0.50 mmol, 1.00 equiv) was dissolved in dry THF (2 mL). Predried CoCl2·(3 mg, 25 µmol, 
5.00 mol%) was added and subsequent (2-(1,3-dioxan-2-yl)ethyl)zinc chloride (1jj, 1.7 mL, 
0.45 M, 0.75 mmol, 1.50 equiv) was added dropwise and the resulting mixture was stirred for 
2 h at rt. Purification of the crude product by flash chromatography (hexane:EtOAc 1:1) 
afforded the title compound as a colourless oil (125 mg, 0.47 mmol, 94%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 4.66 (t, J = 5.3 Hz, 1H), 4.03 (ddt, J = 10.5, 5.0, 1.4 
Hz, 2H), 3.78–3.70 (m, 2H), 2.66 (t, J = 6.7 Hz, 2H), 2.52 (t, J = 6.9 Hz, 2H), 2.35 (t, J = 6.7 
Hz, 2H), 2.01 (dtt, J = 15.8, 12.5, 5.0 Hz, 1H), 1.79–1.68 (m, 4H), 1.63 (td, J = 6.9, 5.3 Hz, 
2H), 1.59–1.50 (m, 1H), 1.37–1.25 (m, 2H), 1.20–1.09 (m, 4H), 1.08–0.93 (m, 1H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 119.4, 100.4, 66.8, 59.4, 46.2, 44.8, 34.3, 29.0, 26.2, 
26.1, 25.9, 18.6. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2963, 2926, 2850, 1469, 1458, 1451, 1432, 1405, 1380, 
1336, 1290, 1283, 1273, 1251, 1240, 1222, 1169, 1155, 1132, 1108, 1090, 1073, 1046, 1025, 
1007, 994, 973, 958, 925, 902, 894, 888, 859, 845, 826, 752. 
HRMS (EI): m/z calc. for [C15H26N2O2]: 266.1994; found 266.1999. 
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3-((2-(1,3-Dioxan-2-yl)ethyl)(phenethyl)amino)propanenitrile (27c) 
 
According to TP13 3-((benzoyloxy)(phenethyl)amino)propanenitrile (5ee, 147 mg, 
0.50 mmol, 1.00 equiv) was dissolved in dry THF (2 mL). Predried CoCl2·(3 mg, 25 µmol, 
5.00 mol%) was added and subsequent (2-(1,3-dioxan-2-yl)ethyl)zinc bromide (1jj, 1,7 mL, 
0.45 M, 0.75 mmol, 1.50 equiv) was added dropwise and the resulting mixture was stirred for 
2 h at rt. Purification of the crude product by flash chromatography (hexane:EtOAc 1:1) 
afforded the title compound as a colourless oil (108 mg, 0.38 mmol, 75%). 
1H-NMR (400 MHz, CDCl3): δ / ppm =7.31–7.26 (m, 2H), 7.23–7.17 (m, 3H), 4.56 (t, J = 5.3 
Hz, 1H), 4.07 (ddt, J = 10.5, 5.1, 1.4 Hz, 2H), 3.74 (ddt, J = 12.3, 10.3, 2.0 Hz, 2H), 2.79 (t, J 
= 6.9 Hz, 2H), 2.76–2.67 (m, 4H), 2.61 (t, J = 7.0 Hz, 2H), 2.40 (t, J = 6.8 Hz, 2H), 2.12–1.98 
(m, 1H), 1.70 (td, J = 7.0, 5.3 Hz, 2H), 1.36–1.24 (m, 1H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 140.2, 128.9 (2C), 128.4 (2C), 126.1, 119.2, 100.4, 
66.9 (2C), 55.8, 49.9, 48.1, 34.0, 32.9, 25.9, 16.7. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2957, 2851, 2247, 1624, 1604, 1496, 1462, 1454, 1429, 
1407, 1379, 1286, 1238, 1218, 1202, 1135, 1088, 1048, 1031, 1006, 974, 961, 930, 892, 853, 
748, 700. 
HRMS (EI): m/z calc. for [C17H24N2O2]: 288.1838; found 288.1842. 
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3-((3-(4-(2,6-Difluorobenzoyl)phenyl)propyl)(phenethyl)amino)propanenitrile (27d) 
 
According to TP13 3-((benzoyloxy)(phenethyl)amino)propanenitrile (5ee, 147 mg, 
0.50 mmol, 1.00 equiv) was dissolved in dry THF (2 mL). Predried CoCl2·(3 mg, 25 µmol, 
5.00 mol%) was added and (3-(4-(2,6-difluorobenzoyl)phenyl)propyl)zinc bromide (1kk, 
1.8 mL, 0.41 M, 0.75 mmol, 1.50 equiv) was added dropwise and the resulting mixture was 
stirred for 2 h at rt. Purification of the crude product by flash chromatography (hexane:EtOAc 
2:1) afforded the title compound as a yellowish oil(160 mg, 0.37 mmol, 74%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.71 (d, J = 8.1 Hz, 2H), 7.36 (tt, J = 8.5, 6.4 Hz, 1H), 
7.24–7.16 (m, 4H), 7.15–7.08 (m, 3H), 6.96–6.89 (m, 2H), 2.75 (t, J = 6.8 Hz, 2H), 2.65 (s, 
4H), 2.61 (dd, J = 8.6, 6.8 Hz, 2H), 2.46 (t, J = 7.0 Hz, 2H), 2.29 (t, J = 6.8 Hz, 2H), 1.76–1.66 
(m, 2H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 188.6, 159.8 (dd, J = 251.4, 7.7 Hz, 2C), 149.5, 
140.1, 134.8, 131.8 (t, J = 9.8 Hz), 130.0 (2C), 128.9 (2C), 128.8 (2C), 128.5 (2C), 126.2, 
119.1, 117.2 (t, J = 22.0 Hz), 112.3–111.5 (m, 2C), 55.6, 53.0, 49.6, 33.9, 33.4, 28.7, 16.5. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2938, 1712, 1670, 1622, 1604, 1589, 1496, 1464, 1416, 
1362, 1311, 1277, 1234, 1183, 1145, 1080, 1030, 1004, 930, 852, 790, 748, 724, 699. 
HRMS (EI): m/z calc. for [C27H26F2N2O]: 432.2013; found 432.2018. 
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3-(((3s,5s,7s)-adamantan-1-yl)(isopropyl)amino)propanenitrile (27e) 
 
According to TP13 3-(((3s,5s,7s)-adamantan-1-yl)(benzoyloxy)amino)propanenitrile (5ff, 
162 mg, 0.50 mmol, 1.00 equiv) was dissolved in dry THF (2 mL). Predried CoCl2·(3 mg, 
25 µmol, 5.00 mol%) was added and subsequent isopropylzinc chloride (1ll, 1.4 mL, 0.52 M, 
0.75 mmol, 1.50 equiv) was added dropwise and the resulting mixture was stirred for 2 h at rt. 
Purification of the crude product by flash chromatography (hexane:EtOAc 1:1) afforded the 
title compound as a colourless oil (89 mg, 0.36 mmol, 72%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 3.44–3.33 (m, 1H), 2.91–2.83 (m, 2H), 2.31–2.24 (m, 
2H), 2.00 (s, 3H), 1.64–1.48 (m, 12H), 0.94 (d, J = 6.6 Hz, 6H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 119.3, 55.7, 44.7, 41.5 (3C), 37.4, 36.6 (3C), 29.7 
(3C), 23.2 (2C), 22.9. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2951, 2924, 2869, 1729, 1596, 1557, 1466, 1456, 1402, 
1384, 1370, 1333, 1314, 1284, 1265, 1241, 1175, 1153, 1134, 1123, 1107, 1097, 1076, 1039, 
1013, 984, 964, 938, 919, 801, 710. 
HRMS (EI): m/z calc. for [C16H26N2]: 246.2096; found 246.2101. 
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(1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl 4-((2-cyanoethyl)(((1S,2S,3S,5R)-2,6,6-
trimethylbicyclo[3.1.1]heptan-3-yl)methyl)amino)butanoate (27f) 
 
According to TP13 3-((benzoyloxy)(((1S,2S,3S,5R)-2,6,6-trimethylbicyclo[3.1.1]heptan-3-
yl)methyl)amino)propanenitrile (5gg, 170 mg, 0.50 mmol, 1.00 equiv) was dissolved in dry 
THF (2 mL). Predried CoCl2·(3 mg, 25 µmol, 5.00 mol%) was added and subsequent (4-
(((1R,2S,5R)-2-isopropyl-5-methylcyclohexyl)oxy)-4-oxobutyl)zinc bromide (1mm, 1.7 mL, 
0.43 M, 0.75 mmol, 1.50 equiv) was added dropwise and the resulting mixture was stirred for 
2 h at rt. Purification of the crude product by flash chromatography (hexane:EtOAc 2:1) 
afforded the title compound as a colourless oil (171 mg, 0.39 mmol, 77%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 4.58 (qt, J = 7.0, 2.6 Hz, 1H), 2.90–2.75 (m, 2H), 
2.73–2.65 (m, 4H), 2.53–2.42 (m, 2H), 2.39 (t, J = 7.1 Hz, 2H), 2.08–1.73 (m, 8H), 1.72–1.38 
(m, 9H), 1.38–1.26 (m, 2H), 1.00 (d, J = 6.8 Hz, 6H), 0.94 (s, 3H), 0.91 (dd, J = 6.8, 1.5 Hz, 
3H), 0.89–0.85 (m, 6H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 173.7, 118.0, 76.2, 57.0, 53.7, 52.3, 47.0, 45.1, 40.3, 
40.0, 39.5, 39.4, 38.3, 34.3, 33.0, 31.3, 31.3, 30.4, 26.3, 24.7, 24.6, 24.4, 24.3, 22.0, 19.1, 19.0, 
17.6, 15.7. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2953, 2870, 1727, 1456, 1420, 1385, 1370, 1345, 1328, 
1298, 1252, 1178, 1151, 1133, 1119, 1097, 1081, 1059, 1039, 1010, 984, 966, 939, 914, 844. 
HRMS (EI): m/z calc. for [C28H48N2O2]: 444.3716; found 444.3722. 
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Ethyl 4-((4-((4-chlorobenzyl)oxy)-4-oxobutyl)(cyclopentyl)amino)benzoate (2nn) 
 
According to TP13 4-chlorobenzyl 4-((benzoyloxy)(cyclopentyl)amino)butanoate (5hh, 
208 mg, 0.50 mmol, 1.00 equiv) was dissolved in dry THF (2 mL). Predried CoCl2·(3 mg, 
25 µmol, 5.00 mol%) was added and subsequent (4-(ethoxycarbonyl)phenyl)zinc chloride 
(1aa, 2.5 mL, 0.30 M, 0.75 mmol, 1.50 equiv) was added dropwise and the resulting mixture 
was stirred for 2 h at rt. Purification of the crude product by flash chromatography 
(hexane:EtOAc 1:1) afforded the title compound as a colourless oil (195 mg, 0.44 mmol, 88%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.87 (d, J = 9.1 Hz, 2H), 7.39–7.24 (m, 4H), 6.71 (d, 
J = 9.2 Hz, 2H), 5.10 (s, 2H), 4.31 (q, J = 7.1 Hz, 2H), 4.11 (p, J = 9.0, 8.5 Hz, 1H), 3.29–3.19 
(m, 2H), 2.42 (t, J = 7.0 Hz, 2H), 2.02–1.85 (m, 4H), 1.78–1.65 (m, 2H), 1.65–1.56 (m, 2H), 
1.36 (t, J = 7.1 Hz, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 172.8, 166.9, 152.4, 134.3, 131.3, 129.8 (2C), 128.8 
(2C), 127.2 (2C), 117.3, 111.6 (2C), 65.6, 60.1, 59.7, 44.8, 31.4, 29.2 (2C), 23.8, 23.4 (2C), 
14.5. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2926, 2854, 1736, 1688, 1667, 1462, 1453, 1417, 1371, 
1347, 1317, 1241, 1219, 1165, 1145, 1095, 1072, 1046, 1020, 987, 906, 892, 869, 844, 825, 
725, 681. 
HRMS (EI): m/z calc. for [C25H30ClNO4]: 443.1863; found 443.1869. 
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N-(2-(1,3-Dioxan-2-yl)ethyl)-3-chloro-N-cyclohexyl-5-fluoroaniline (2oo) 
 
According to TP13 N-(2-(1,3-dioxan-2-yl)ethyl)-O-benzoyl-N-cyclohexylhydroxylamine (5ii, 
167 mg, 0.50 mmol, 1.00 equiv) was dissolved in dry THF (2 mL). Predried CoCl2·(3 mg, 
25 µmol, 5.00 mol%) was added and subsequent (3-chloro-5-fluorophenyl)zinc chloride (1nn, 
2.8 mL, 0.27 M, 0.75 mmol, 1.50 equiv) was added dropwise and the resulting mixture was 
stirred for 2 h at rt. Purification of the crude product by flash chromatography (hexane:EtOAc 
1:1) afforded the title compound as a white solid (179 mg, 0.43 mmol, 86%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 6.49 (t, J = 2.2 Hz, 1H), 6.38–6.26 (m, 2H), 4.59 (t, 
J = 4.8 Hz, 1H), 4.12 (ddd, J = 12.0, 5.0, 1.4 Hz, 2H), 3.76 (ddt, J = 12.3, 10.4, 2.4 Hz, 2H), 
3.44 (tt, J = 11.4, 3.4 Hz, 1H), 3.38–3.24 (m, 2H), 2.22–2.02 (m, 1H), 1.93–1.78 (m, 6H), 1.78–
1.60 (m, 1H), 1.54–1.25 (m, 5H), 1.21–1.07 (m, 1H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 164.1 (d, J = 243.1 Hz), 150.6 (d, J = 12.0 Hz), 135.5 
(d, J = 14.4 Hz), 108.2 (d, J = 2.3 Hz), 102.9 (d, J = 25.8 Hz), 100.5, 97.7 (d, J = 26.3 Hz), 
67.0 (2C), 57.8, 39.6, 34.6, 30.6 (2C), 26.2(2C), 25.8, 25.7. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2967, 2927, 2860, 2843, 1611, 1594, 1574, 1564, 1486, 
1474, 1455, 1448, 1434, 1406, 1364, 1340, 1274, 1257, 1240, 1200, 1172, 1142, 1131, 1100 , 
1033, 1003, 995, 978, 951, 922, 888, 861, 848, 834, 813, 778, 760, 734, 677. 
HRMS (EI): m/z calc. for [C18H25ClFNO2]: 341.1558; found 341.1563. 
m.p.: 62.5 °C 
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N-(2-(1,3-Dioxan-2-yl)ethyl)-N-phenethyl-4-(trifluoromethyl)aniline (2pp) 
 
According to TP13 N-(2-(1,3-dioxan-2-yl)ethyl)-O-benzoyl-N-phenethylhydroxylamine (5jj, 
178 mg, 0.50 mmol, 1.00 equiv) was dissolved in dry THF (2 mL). Predried CoCl2·(3 mg, 
25 µmol, 5.00 mol%) was added and subsequent (4-(trifluoromethyl)phenyl)zinc chloride 
(1oo, 2.6 mL, 0.29 M, 0.75 mmol, 1.50 equiv) was added dropwise and the resulting mixture 
was stirred for 2 h at rt. Purification of the crude product by flash chromatography 
(hexane:EtOAc 2:1) afforded the title compound as a colourless oil (154 mg, 0.41 mmol, 81%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.37 (d, J = 8.8 Hz, 2H), 7.27–7.20 (m, 2H), 7.18–
7.10 (m, 3H), 6.69–6.62 (m, 2H), 4.46 (t, J = 4.9 Hz, 1H), 4.03 (ddt, J = 10.5, 5.0, 1.4 Hz, 2H), 
3.65 (ddt, J = 12.3, 10.5, 2.4 Hz, 2H), 3.50–3.41 (m, 2H), 3.34 (t, J = 7.4 Hz, 2H), 2.78 (dd, J 
= 9.0, 6.7 Hz, 2H), 2.09–1.93 (m, 1H), 1.82–1.74 (m, 2H), 1.26 (dtt, J = 13.5, 2.7, 1.4 Hz, 1H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 149.7, 139.1, 129.3, 128.8, 128.7, 126.7 (d, J = 3.7 
Hz), 126.5, 125.2 (d, J = 270.1 Hz), 117.1 (q, J = 32.7 Hz), 110.8, 100.2, 66.9, 52.5, 45.7, 33.2, 
32.6, 25.7. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2956, 2872, 1733, 1697, 1601, 1519, 1493, 1479, 1462, 
1452, 1432, 1403, 1386, 1365, 1314, 1271, 1170, 1104, 1016, 958, 829, 805, 769, 746, 700, 
674, 653. 
HRMS (EI): m/z calc. for [C21H24F3NO2]: 379.1759; found 379.1768. 
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4-((3-(4-(2,6-Difluorobenzoyl)phenyl)propyl)(phenethyl)amino)benzonitrile (2qq) 
 
According to TP13 (4-(3-((benzoyloxy)(phenethyl)amino)propyl)phenyl)(2,6-
difluorophenyl)methanone (5kk, 250 mg, 0.50 mmol, 1.00 equiv) was dissolved in dry THF 
(2 mL). Predried CoCl2·(3 mg, 25 µmol, 5.00 mol%) was added and subsequent (4-
cyanophenyl)zinc chloride (1vv, 3.0 mL, 0.25 M, 0.75 mmol, 1.50 equiv) was added dropwise 
and the resulting mixture was stirred for 2 h at rt. Purification of the crude product by flash 
chromatography (hexane:EtOAc 3:1) afforded the title compound as a colourless oil (190 mg, 
0.40 mmol, 79%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.90 (d, J = 8.2 Hz, 2H), 7.59–7.51 (m, 3H), 7.37 
(ddt, J = 11.5, 8.8, 7.0 Hz, 5H), 7.26–7.21 (m, 2H), 7.15–7.07 (m, 2H), 6.70–6.65 (m, 2H), 
3.72–3.54 (m, 2H), 3.41–3.25 (m, 2H), 2.94 (t, J = 7.5 Hz, 2H), 2.78 (t, J = 7.6 Hz, 2H), 2.04–
1.88 (m, 2H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 188.5, 159.8 (dd, J = 251.5, 7.6 Hz, 2C), 150.1, 
148.2, 138.6, 135.1, 133.8 (2C), 132.9, 131.9 (t, J = 9.9 Hz), 130.1 (2C), 128.8 (2C), 128.7 
(2C), 128.7 (2C), 126.7, 117.1 (t, J = 21.9 Hz), 112.1–111.8 (m, 2C), 111.2 (2C), 97.2, 52.7, 
50.4, 33.3, 33.2, 27.9. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2932, 2211, 1670, 1622, 1602, 1519, 1496, 1463, 1405, 
1360, 1311, 1294, 1277, 1234, 1202, 1174, 1145, 1117, 1004, 967, 930, 815, 790, 748, 724, 
699. 
HRMS (EI): m/z calc. for [C31H26F2N2O]: 480.2013; found 480.2023. 
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(3s,5s,7s)-N-(4-chlorophenyl)-N-isopropyladamantan-1-amine (2rr) 
 
According to TP13 N-((3s,5s,7s)-adamantan-1-yl)-O-benzoyl-N-isopropylhydroxylamine (5ll, 
157 mg, 0.50 mmol, 1.00 equiv) was dissolved in dry THF (2 mL). Predried CoCl2·(3 mg, 
25 µmol, 5.00 mol%) was added and subsequent naphthalen-1-ylzinc chloride ( , 2.8 mL, 
0.27 M, 0.75 mmol, 1.50 equiv) was added dropwise and the resulting mixture was stirred for 
2 h at rt. Purification of the crude product by flash chromatography (hexane:EtOAc 9:1) 
afforded the title compound as a colourless oil (94 mg, 0.31 mmol, 62%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.33–7.17 (m, 2H), 6.90–6.79 (m, 2H), 3.84 (p, J = 
6.8 Hz, 1H), 2.17–1.97 (m, 9H), 1.73–1.62 (m, 6H), 1.24 (d, J = 6.8 Hz, 6H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 142.9, 129.4 (2C), 127.6, 119.3 (2C), 60.5, 47.3, 
40.7 (3C), 36.3 (3C), 29.7 (3C), 22.4 (2C). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2950, 1738, 1657, 1598, 1493, 1435, 1357, 1337, 1213, 
1175, 1157, 1124, 1095, 1031, 977, 907, 809, 729, 699. 
HRMS (EI): m/z calc. for [C19H26ClN]: 303.1754; found 303.1749. 
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(1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl 4-((2,6-dimethoxypyrimidin-4-yl) 
(((1S,2S,3S,5R)-2,6,6-trimethylbicyclo[3.1.1]heptan-3-yl)methyl)amino)butanoate (2ss) 
 
According to TP13 (1R,2S,5R)-2-isopropyl-5-methylcyclohexyl 4-((benzoyloxy) 
(((1S,2S,3S,5R)-2,6,6-trimethylbicyclo[3.1.1]heptan-3-yl)methyl)amino)butanoate (5mm, 
256 mg, 0.50 mmol, 1.00 equiv) was dissolved in dry THF (2 mL). Predried CoCl2·(3 mg, 
25 µmol, 5.00 mol%) was added and subsequent (2,6-dimethoxypyrimidin-4-yl)zinczinc 
chloride (1q, 2.7 mL, 0.28 M, 0.75 mmol, 1.50 equiv) was added dropwise and the resulting 
mixture was stirred for 2 h at rt. Purification of the crude product by flash chromatography 
(hexane:EtOAc 4:1) afforded the title compound as a colourless oil (215 mg, 0.41 mmol, 81%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.89 (s, 1H), 4.64 (td, J = 10.8, 4.3 Hz, 1H), 3.98 (s, 
3H), 3.94 (s, 3H), 3.10 (dd, J = 12.5, 5.3 Hz, 1H), 2.96 (dd, J = 7.9, 6.4 Hz, 2H), 2.66 (dd, J = 
12.5, 9.6 Hz, 1H), 2.32 (t, J = 7.4 Hz, 2H), 2.28–2.20 (m, 1H), 2.01–1.89 (m, 2H), 1.89–1.76 
(m, 2H), 1.74–1.57 (m, 7H), 1.58–1.40 (m, 2H), 1.37–1.28 (m, 1H), 1.14 (s, 3H), 0.93 (d, J = 
7.0 Hz, 3H), 0.89–0.84 (m, 12H), 0.72 (d, J = 6.8 Hz, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 173.1, 167.1, 161.2, 152.7, 126.1, 74.0, 62.9, 54.7, 
53.8, 53.0, 48.0, 47.0, 41.6, 41.4, 40.9, 38.9, 34.2, 34.1, 33.6, 32.9, 31.9, 31.4, 27.9, 26.3, 23.4, 
23.1, 23.0, 22.0, 21.8, 20.8, 16.3. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2951, 2924, 2869, 1729, 1596, 1557, 1466, 1456, 1402, 
1384, 1370, 1333, 1314, 1284, 1265, 1241, 1175, 1153, 1134, 1123, 1107, 1097, 1076, 1039, 
1013, 984, 964, 938, 919, 844, 801, 764, 733, 710. 
HRMS (EI): m/z calc. for [C31H51N3O4]: 529.3880; found 529.3888. 
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(1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl 4-((3-((tert-butyldimethylsilyl)oxy)phenyl) 
(((1S,2S,3S,5R)-2,6,6-trimethylbicyclo[3.1.1]heptan-3-yl)methyl)amino)butanoate (2tt) 
 
According to TP13 (1R,2S,5R)-2-isopropyl-5-methylcyclohexyl 4-((benzoyloxy) 
(((1S,2S,3S,5R)-2,6,6-trimethylbicyclo[3.1.1]heptan-3-yl)methyl)amino)butanoate (5mm, 
256 mg, 0.50 mmol, 1.00 equiv) was dissolved in dry THF (2 mL). Predried CoCl2·(3 mg, 
25 µmol, 5.00 mol%) was added and subsequent (3-((tert-butyldimethylsilyl)oxy)phenyl)zinc 
chloride (1qq, 2.9 mL, 0.26 M, 0.75 mmol, 1.50 equiv) was added dropwise and the resulting 
mixture was stirred for 2 h at rt. Purification of the crude product by flash chromatography 
(hexane:EtOAc 4:1) afforded the title compound as a colourless oil (257 mg, 0.43 mmol, 86%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 6.84 (t, J = 8.1 Hz, 1H), 6.03 (t, J = 2.3 Hz, 1H), 5.97 
(ddd, J = 7.9, 2.2, 0.7 Hz, 1H), 4.51 (d, J = 4.4 Hz, 1H), 3.27–3.13 (m, 2H), 3.08 (dd, J = 14.3, 
6.8 Hz, 1H), 2.94 (dt, J = 14.2, 7.2 Hz, 1H), 2.17–2.07 (m, 4H), 2.06–1.95 (m, 1H), 1.87 (dddd, 
J = 13.1, 9.7, 3.3, 1.9 Hz, 1H), 1.79 (dtd, J = 11.9, 3.8, 1.7 Hz, 1H), 1.75–1.43 (m, 10H), 1.29 
(dddd, J = 11.8, 9.2, 6.2, 3.8 Hz, 3H), 1.18 (ddt, J = 12.5, 10.9, 3.2 Hz, 1H), 0.98 (s, 3H), 0.89–
0.81(m, 1H), 0.83 (d, J = 7.1 Hz, 3H), 0.78 (s, 9H), 0.77 (s, 3H), 0.70 (dd, J = 6.8, 3.6 Hz, 6H), 
0.56 (d, J = 7.0 Hz, 3H), -0.00 (d, J = 1.7 Hz, 6H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 172.8, 156.7, 149.4, 129.7, 107.9, 106.3, 104.8, 74.2, 
61.0, 51.5, 48.3, 47.0, 41.7, 41.6, 41.0, 38.8, 34.3, 34.0, 33.9, 32.4, 32.0, 31.4, 28.0, 26.3, 25.8 
(3C), 23.4, 23.0, 22.1, 22.1, 22.0, 20.8, 18.3, 16.3, -4.3, -4.3. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 2953, 2928, 2859, 1729, 1601, 1573, 1496, 1471, 1462, 
1456, 1386, 1368, 1252, 1231, 1193, 1172, 1159, 1126, 1096, 1081, 1037, 1004, 984, 963, 953, 
909, 834, 780, 757, 732, 690, 664. 
HRMS (EI): m/z calc. for [C37H63NO3Si]: 597.4577; found 597.4588. 
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6. Iron-Mediated Electrophilic Amination of Organozinc Halides 
using Organic Azides Detailed Reaction Optimization 
6.1 Reaction Optimization 
The optimization of the conditions was performed according to the described procedure for 
amine 3b, altering the conditions as described in the following (Table 12). 
Table 12. Detailed reaction optimization. 
 
Entry Catalyst (loading) Other alteration GC-yield [%] 
1 - - 0 
2 CuCN·2LiCl (20 mol%) - < 5 
3 CuCl2 (20 mol%) - < 5 
4 NiCl2 (20 mol%) - < 5 
5 CoCl2 (20 mol%) - < 5 
6 CrCl2 (20 mol%) - < 5 
7 CrCl3 (20 mol%) - < 5 
8 MnCl2 (20 mol%) - < 5 
9 PdCl2 (20 mol%) - < 5 
10 FeCl2 (20 mol%) - 48 
11 FeBr2 (20 mol%) - 45 
12 Fe(acac)2 (20 mol%) - 38 
13 Fe(OAc)2 (20 mol%) - 46 
14 Fe(acac)3 (20 mol%) - 47 
15 Fe(DBM)3 (20 mol%) - 48 
16 Fe(OTf)3 (20 mol%) - 40 
17 FeBr3 (20 mol%) - 46 
18 FeCl3 (20 mol%) - 49 
19 FeCl3 (15 mol%) - 39 
20 FeCl3 (10 mol%) - 32 
21 FeCl3 (5 mol%) - 16 
22 FeCl3 (20 mol%) Azide:AnZnCl = 1.5:1.0 27 
23 FeCl3 (20 mol%) Inverse addition (Organozinc/Azide) 46 
24 FeCl3 (20 mol%) Inverse addition (Organozinc/Azide) + 45 °C, 1 h 50 
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25 FeCl3 (20 mol%) 45 °C, 1 h 59 
26 FeCl3 (33 mol%) 45 °C, 1 h 60 
27 FeCl3 (50 mol%) 45 °C, 1 h 69 
28 FeCl3 (75 mol%) 45 °C, 1 h 27 
29 FeCl3 (1.0 equiv) 45 °C, 1 h 25 
30 FeCl3 (20 mol%) AnZnCl (1.1 equiv); 45 °C, 1 h 61 
31 FeCl3 (50 mol%) AnZnCl (1.75 equiv); 45 °C, 1 h 79 
32 FeCl3 (50 mol%) AnZnCl (2.0 equiv); 45 °C, 1 h 80 
33 FeCl3 (42 mol%) AnZnCl (1.25 equiv); 45 °C, 1 h 54 
34 FeCl3 (35 mol%) AnZnCl (1.05 equiv); 45 °C, 1 h 37 
35 FeCl3 (75 mol%) AnZnCl (2.25 equiv); 45 °C, 1 h 59 
36 FeCl3 (1.00 equiv) AnZnCl (3.0 equiv); 45 °C, 1 h 58 
 
Furthermore, solvent mixture of type THF/solvent 1:1 have been tested (solvent = DMF, 
DMSO, DCE, DMPU, NMP, DME, toluene). However, all mixture led to decreased amounts 
of product yield. 
Higher amounts of FeCl2 (e.g. 50%) also always provided less good yields than equal amounts 
of FeCl3. Over 50% the same decrease in yield as for FeCl3 was observed. 
We assume, that the decrease of product formation with higher amounts of iron originates from 
the concurring dimerization reaction. The described reaction is very fast (usually done within 
5 min) and is in most cases faster than the transition metal catalyzed homo-dimerization of the 
organozinc reagent. However, if the amount of FeCl3 is too high, dimerization overpowers the 
desired transformation. We also assume that higher amounts of FeCl3 lead to decomposition of 
the azide. 
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6.2 Preparation of the Organozinc Chlorides 
(4-Methoxyphenyl)zinc chloride (1rr) 
 
According to TP4, 1-bromo-4-methoxybenzene (468 mg, 2.50 mmol, 1.00 equiv) was added 
to a suspension of anhydrous LiCl (159 mg, 3.75 mmol, 1.50 equiv) and magnesium turnings 
(122 mg, 5.00 mmol, 2.00 equiv) in dry THF (5 mL). The reaction mixture was stirred at 25 °C 
overnight and then a solution of ZnCl2 (1.00 M, 3.00 mL, 3.00 mmol, 1.20 equiv) in dry THF 
was added at 0 °C. After warming up slowly and stirring at 25 °C for 15 min, the titration using 
iodine gave a concentration of 0.29 mmol/mL active zinc species, corresponding to 98% yield. 
 
(4-Fluorophenyl)zinc chloride (1ss) 
 
According to TP4, 1-bromo-4-fluorobenzene (438 mg, 2.50 mmol, 1.00 equiv) was added to a 
suspension of anhydrous LiCl (159 mg, 3.75 mmol, 1.50 equiv) and magnesium turnings 
(122 mg, 5.00 mmol, 2.00 equiv) in dry THF (5 mL). The reaction mixture was stirred at 25 °C 
overnight and then a solution of ZnCl2 (1.00 M, 3.00 mL, 3.00 mmol, 1.20 equiv) in dry THF 
was added at 0 °C. After warming up slowly and stirring at 25 °C for 15 min, the titration using 
iodine gave a concentration of 0.27 mmol/mL active zinc species, corresponding to 92% yield. 
 
(4-Cyanophenyl)zinc chloride (1tt) 
 
According to TP2, 4-iodobenzonitrile (1.15 g, 5.00 mmol, 1.00 equiv) was dissolved in dry 
THF (10 mL) and iPrMgCl·LiCl (1.28 M, 4.30 mL, 5.50 mmol, 1.10 equiv) was added 
dropwise at 0 °C. The reaction mixture was stirred at the set temperature for 1 h and then a 
solution of ZnCl2 (1.00 M, 6.00 mL, 6.00 mmol, 1.20 equiv) in dry THF was added at 0 °C. After 
C. Experimental Section 
233 
warming up slowly and stirring at 25 °C for 15 min, the titration using iodine gave a 
concentration of 0.20 mmol/mL active zinc species, corresponding to 81% yield. 
(4-(Morpholine-4-carbonyl)phenyl)zinc chloride (1uu) 
 
According to TP2, (4-iodophenyl)(morpholino)methanone (1.59 g, 5.00 mmol, 1.00 equiv) 
was dissolved in dry THF (5 mL) and iPrMgCl·LiCl (1.28 M, 4.30 mL, 5.50 mmol, 1.10 equiv) 
was added dropwise at 0 °C. The reaction mixture was stirred at the set temperature for 2 h and 
then a solution of ZnCl2 (1.00 M, 6.00 mL, 6.00 mmol, 1.20 equiv) in dry THF was added at 
0 °C. After warming up slowly and stirring at 25 °C for 15 min, the titration using iodine gave a 
concentration of 0.20 mmol/mL active zinc species, corresponding to 81% yield. 
 
(4-(Dimethylamino)phenyl)zinc chloride (1vv) 
 
According to TP4, 4-bromo-N,N-dimethylaniline (553 mg, 2.50 mmol, 1.00 equiv) was added 
to a suspension of anhydrous LiCl (159 mg, 3.75 mmol, 1.50 equiv) and magnesium turnings 
(122 mg, 5.00 mmol, 2.00 equiv) in dry THF (5 mL). The reaction mixture was stirred at 25 °C 
overnight and then a solution of ZnCl2 (1.00 M, 3.00 mL, 3.00 mmol, 1.20 equiv) in dry THF 
was added at 0 °C. After warming up slowly and stirring at 25 °C for 15 min, the titration using 
iodine gave a concentration of 0.26 mmol/mL active zinc species, corresponding to 88% yield. 
 
(3-Fluoro-4-methoxyphenyl)zinc chloride (1ww) 
 
According to TP4, 4-bromo-2-fluoro-1-methoxybenzene (512 mg, 2.50 mmol, 1.00 equiv) 
was added to a suspension of anhydrous LiCl (159 mg, 3.75 mmol, 1.50 equiv) and magnesium 
turnings (122 mg, 5.00 mmol, 2.00 equiv) in dry THF (5 mL). The reaction mixture was stirred 
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at 25 °C overnight and then a solution of ZnCl2 (1.00 M, 3.00 mL, 3.00 mmol, 1.20 equiv) in 
dry THF was added at 0 °C. After warming up slowly and stirring at 25 °C for 15 min, the 
titration using iodine gave a concentration of 0.27 mmol/mL active zinc species, corresponding 
to 92% yield. 
 
(4-(t-Butyl)phenyl)zinc chloride (1xx) 
 
According to TP4, 1-bromo-4-(t-butyl)benzene (585 mg, 2.50 mmol, 1.00 equiv) was added to 
a suspension of anhydrous LiCl (159 mg, 3.75 mmol, 1.50 equiv) and magnesium turnings 
(122 mg, 5.00 mmol, 2.00 equiv) in dry THF (5 mL). The reaction mixture was stirred at 25 °C 
overnight and then a solution of ZnCl2 (1.00 M, 3.00 mL, 3.00 mmol, 1.20 equiv) in dry THF 
was added at 0 °C. After warming up slowly and stirring at 25 °C for 15 min, the titration using 
iodine gave a concentration of 0.28 mmol/mL active zinc species, corresponding to 95% yield. 
 
(4-(Trifluoromethoxy)phenyl)zinc chloride (1yy) 
 
According to TP4, 1-bromo-4-(trifluoromethoxy)benzene (603 mg, 2.50 mmol, 1.00 equiv) 
was added to a suspension of anhydrous LiCl (159 mg, 3.75 mmol, 1.50 equiv) and magnesium 
turnings (122 mg, 5.00 mmol, 2.00 equiv) in dry THF (5 mL). The reaction mixture was stirred 
at 25 °C overnight and then a solution of ZnCl2 (1.00 M, 3.00 mL, 3.00 mmol, 1.20 equiv) in 
dry THF was added at 0 °C. After warming up slowly and stirring at 25 °C for 15 min, the 
titration using iodine gave a concentration of 0.26 mmol/mL active zinc species, corresponding 
to 88% yield. 
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Cyclopropylzinc chloride (1zz) 
 
According to TP4, bromocyclopropane (302 mg, 2.50 mmol, 1.00 equiv) was added to a 
suspension of anhydrous LiCl (159 mg, 3.75 mmol, 1.50 equiv) and magnesium turnings 
(122 mg, 5.00 mmol, 2.00 equiv) in dry THF (5 mL). The reaction mixture was stirred at 25 °C 
overnight and then a solution of ZnCl2 (1.00 M, 3.00 mL, 3.00 mmol, 1.20 equiv) in dry THF 
was added at 0 °C. After warming up slowly and stirring at 25 °C for 15 min, the titration using 
iodine gave a concentration of 0.28 mmol/mL active zinc species, corresponding to 95% yield. 
 
(3,6-Dichloropyridazin-4-yl)zinc chloride (1aaa)  
 
In a dry and argon flushed Schlenk-flask equipped with a magnetic stirring bar and a septum 
3,6-dichloropyridazine (447 mg, 3.00 mmol, 1.00 equiv) was dissolved in dry THF (6 mL) and 
then a solution of TMPZnCl·LiCl (0.50 M, 6.6 mL, 3.30 mmol, 1.10 equiv) in dry THF was 
added dropwise. The reaction mixture was stirred at 25 °C for 30 min. the titration using iodine 
gave a concentration of 0.18 mmol/mL active zinc species, corresponding to 76% yield.31 
 
(3-Fluorophenyl)zinc chloride (1bbb) 
 
According to TP4, 1-bromo-3-fluorobenzene (438 mg, 2.50 mmol, 1.00 equiv) was added to a 
suspension of anhydrous LiCl (159 mg, 3.75 mmol, 1.50 equiv) and magnesium turnings 
(122 mg, 5.00 mmol, 2.00 equiv) in dry THF (5 mL). The reaction mixture was stirred at 25 °C 
overnight and then a solution of ZnCl2 (1.00 M, 3.00 mL, 3.00 mmol, 1.20 equiv) in dry THF 
was added at 0 °C. After warming up slowly and stirring at 25 °C for 15 min, the titration using 
iodine gave a concentration of 0.27 mmol/mL active zinc species, corresponding to 92% yield.  
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6.3 Preparation of the Azides 
1-Azido-3,5-dimethylbenzene (28a) 
 
1-Azido-3,5-dimethylbenzene was prepared according to a literature known procedure.130 
1H MR (400 MHz, CDCl3): δ / ppm = 6.79 (s, 1H), 6.66 (s, 2H), 2.32 (s, 6H). 
Analytical data equivalent to literature.131 
 
(4-Azidophenyl)(methyl)sulfane (28b) 
 
(4-Azidophenyl)(methyl)sulfane was prepared according to a literature known procedure.130 
1H NMR (400 MHz, CDCl3): δ / ppm = 7.31–7.25 (m, 1H), 7.01–6.95 (m, 1H), 2.50 (s, 1H). 
Analytical data equivalent to literature.131 
 
1-Azido-2-bromo-4-(trifluoromethyl)benzene (28c) 
 
1-Azido-2-bromo-4-(trifluoromethyl)benzene was prepared according to a literature known 
procedure.130 
1H NMR (400 MHz, CDCl3): δ / ppm = 7.64–7.58 (m, 1H), 7.31 (d, J = 1.9 Hz, 1H), 7.22–
7.15 (m, 1H). 
  
                                                          
130  B.-Y. Ryu, T. Emrick, Angew. Chem. Int Ed. 2010, 49, 9644–9647. 
131  F. Shi, J. P. Waldo, Y. Chen, R. C. Larock, Org. Lett. 2008, 10, 2409–2412. 
C. Experimental Section 
237 
1-Azido-4-methoxybenzene (28d) 
 
1-Azido-4-methoxybenzene was prepared according to a literature known procedure.130 
1H NMR (400 MHz, CDCl3): δ / ppm = 6.99–6.94 (m, 2H), 6.94–6.84 (m, 2H), 3.80 (s, 3H). 
Analytical data equivalent to literature.132 
 
1-Azido-3,5-dichlorobenzene (28e) 
 
1-Azido-3,5-dichlorobenzene was prepared according to a literature known procedure.130 
1H MR (400 MHz, CDCl3): δ / ppm = 7.13 (t, J = 1.8 Hz, 1H), 6.92 (d, J = 1.8 Hz, 2H). 
Analytical data equivalent to literature.133 
 
4-Azidobenzamide (28f) 
 
4-Azidobenzamide was prepared according to a literature known procedure.130 
1H NMR (400 MHz, Chloroform-d) δ 7.88–7.77 (m, 2H), 7.14–7.05 (m, 2H), 5.98 (s, 1H), 5.62 
(s, 1H). 
Analytical data equivalent to literature.134 
  
                                                          
132  Y. Li, L.-X. Gao, F.-S Han, Chem. Eur. J. 2010, 16, 7969–7972. 
133  T. Meguro, N. Terashima, H. Ito, Y. Koike, I. Kii, S. Yoshida, T. Hosoya, Chem. Commun. 2018, 54, 7904–
7907. 
134  K. D. Grimes, A. Gupte, C. C. Aldrich, Synthesis 2010, 9, 1441–1448. 
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Ethyl 4-azido-3-bromobenzoate (28g) 
 
Ethyl 4-azido-3-bromobenzoate was prepared according to a literature known procedure.130 
1H MR (400 MHz, CDCl3): δ / ppm = 8.23 (d, J = 1.9 Hz, 1H), 8.02 (dd, J = 8.4, 1.9 Hz, 1H), 
7.21 (d, J = 8.3 Hz, 1H), 4.37 (q, J = 7.1 Hz, 2H), 1.39 (t, J = 7.1 Hz, 3H). 
Analytical data equivalent to literature.135 
 
4-Azidobenzaldehyde (28h) 
 
4-Azidobenzaldehyde was prepared according to a literature known procedure.130 
1H NMR (400 MHz, CDCl3): δ / ppm = 9.94 (s, 1H), 7.91–7.84 (m, 2H), 7.19–7.11 (m, 2H). 
Analytical data equivalent to literature.131 
 
4-Azidobenzonitrile (28i) 
 
4-Azidobenzonitrile was prepared according to a literature known procedure.130 
1H NMR (400 MHz, CDCl3): δ / ppm = 7.69–7.60 (m, 2H), 7.13–7.08 (m, 2H). 
Analytical data equivalent to literature.131 
  
                                                          
135  C.-Y. Liu, P. Knochel, J. Org. Chem. 2007, 72, 7106–7115. 
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2-Azido-1,3-diisopropylbenzene (28j) 
 
2-Azido-1,3-diisopropylbenzene was prepared according to a literature known procedure.130 
1H NMR (400 MHz, CDCl3): δ / ppm = 7.21 (dd, J = 8.8, 6.3 Hz, 1H), 7.15 (d, J = 6.8 Hz, 
2H), 3.43–3.32 (m, 2H), 1.28 (d, J = 6.9 Hz, 12H). 
Analytical data equivalent to literature.136 
 
1-(4-Azidophenyl)ethan-1-one (28k) 
 
1-(4-Azidophenyl)ethan-1-one was prepared according to a literature known procedure.130 
1H NMR (400 MHz, CDCl3): δ / ppm = 7.92 (d, J = 8.2 Hz, 2H), 7.04 (d, J = 8.3 Hz, 2H), 
2.54 (s, 3H). 
Analytical data equivalent to literature.131 
 
1-Azido-4-nitrobenzene (28l) 
 
1-Azido-4-nitrobenzene was prepared according to a literature known procedure.130 
1H NMR (400 MHz, CDCl3): δ / ppm = 8.29–8.19 (m, 2H), 7.18–7.07 (m, 2H). 
Analytical data equivalent to literature.131 
  
                                                          
136  G. Guisado-Barrios, J. Bouffard, B. Donnadieu, G. Bertrand, Angew. Chem. Int. Ed. 2010, 49, 4759–4762. 
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1-Azido-2-fluorobenzene (28m) 
 
1-Azido-2-fluorobenzene was prepared according to a literature known procedure.130 
1H NMR (400 MHz, CDCl3): δ / ppm = 7.16–7.03 (m, 4H). 
Analytical data equivalent to literature 137 
 
5-Azido-2-chloropyridine (28n) 
 
5-Azido-2-chloropyridine was prepared according to a literature known procedure.130 
1H MR (400 MHz, CDCl3): δ / ppm = 8.13 (t, J = 1.8 Hz, 1H), 7.32 (d, J = 1.9 Hz, 2H). 
Analytical data equivalent to literature.138 
 
3-Azidoquinoline (28o) 
 
3-Azidoquinoline was prepared according to a literature known procedure.130 
1H MR (400 MHz, CDCl3): δ / ppm = 8.62 (d, J = 2.6 Hz, 1H), 8.09 (dd, J = 8.5, 1.2 Hz, 1H), 
7.80–7.73 (m, 2H), 7.67 (ddd, J = 8.5, 6.9, 1.5 Hz, 1H), 7.57 (ddd, J = 8.2, 6.9, 1.2 Hz, 1H). 
Analytical data equivalent to literature.139 
  
                                                          
137  I. Birkenfelder, J. Gurke, L. Grubert, S. Hecht, B. M. Schmidt, Chem. Asian J. 2017, 12, 3156–3161. 
138  T. L. Seidl, D. R. Stuart, J. Org. Chem. 2017, 82, 11765–11771. 
139  F. R. Bou-Hamdan, F. Levesque, A. G. O'Brien, P. H. Seeberger, Beilstein J. Org. Chem. 2011, 7, 1124–1129. 
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5-Azido-4-chloro-2,6-dimethoxypyrimidine (28p) 
 
5-Azido-4-chloro-2,6-dimethoxypyrimidine was prepared according to a literature known 
procedure.108 
1H NMR (400 MHz, CDCl3): δ / ppm = 4.09 (s, 3H), 3.98 (s, 3H). 
Analytical data equivalent to literature.140 
 
2-Azido-1-methyl-1H-benzo[d]imidazole (28q) 
 
2-Azido-1-methyl-1H-benzo[d]imidazole was prepared according to a literature known 
procedure. 
1H NMR (400 MHz, CDCl3): δ / ppm = 7.71–7.51 (m, 1H), 7.32–7.13 (m, 3H), 3.59 (s, 3H). 
Analytical data equivalent to literature.141 
  
                                                          
140  N. Ple, A. Turck, K. Couture, G. Queguiner, Synthesis 1996, 7, 838–842. 
141  D. Zornik, R. M. Meudtner, T. El Malah, C. M. Thiele, S. Hecht, Chem. Eur. J. 2011, 17, 1473–1484. 
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1-Adamantylazide (28r) 
 
1-Adamantylazide was prepared according to a literature known procedure.130 
1H NMR (400 MHz, CDCl3): δ / ppm = 2.15 (p, J = 3.3 Hz, 3H), 1.80 (d, J = 2.9 Hz, 6H), 
1.72–1.59 (m, 6H). 
Analytical Data equivalent to literature142 
 
Methyl (S)-2-azido-3-phenylpropanoate (28s) 
 
Methyl (S)-2-azido-3-phenylpropanoate was prepared according to a literature known 
procedure.143 
1H NMR (400 MHz, CDCl3): δ / ppm = 7.40–7.23 (m, 5H), 4.10 (dd, J = 8.8, 5.4 Hz, 1H), 
3.81 (s, 3H), 3.21 (dd, J = 14.0, 5.4 Hz, 1H), 3.04 (dd, J = 13.9, 8.8 Hz, 1H). 
13C NMR (101 MHz, CDCl3) δ / ppm = 170.5, 135.9, 129.2 (2C), 128.7 (2C), 127.3, 63.3, 
52.7, 37.7. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3031, 2955, 2106, 1741, 1604, 1497, 1455, 1436, 1356, 
1259, 1203, 1172, 1112, 1081, 1015, 928, 905, 828, 748, 698, 672. 
e.r. (determined by chiral-HPLC) = 92:8. 
  
                                                          
142  S.-K. Chen, W-Q. Ma, Z.-B. Yan, F.-M. Zhang, S.-H. Wang, Y.-Q. Tu, X.-M. Zhang, J.-M. Tian, J. Am. Chem. 
Soc. 2018, 140, 10099–10103. 
143  E. D. Goddard-Borger, R. V. Stick, Org. Lett. 2007, 9, 3797–3800. 
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Methyl ((S)-2-azido-3-methylbutanoyl)-D-phenylalaninate (28t) 
 
Methyl ((S)-2-azido-3-methylbutanoyl)-D-phenylalaninate was prepared according to a 
literature known procedure.143 
1H NMR (400 MHz, CDCl3): δ / ppm = 7.26–7.14 (m, 3H), 7.10–6.98 (m, 2H), 6.64 (d, J = 
8.3 Hz, 1H), 4.83 (ddd, J = 8.4, 7.1, 5.6 Hz, 1H), 3.72 (d, J = 4.3 Hz, 1H), 3.67 (s, 3H), 3.12–
2.95 (m, 2H), 2.21 (td, J = 6.8, 4.3 Hz, 1H), 0.93 (d, J = 6.9 Hz, 3H), 0.70 (d, J = 6.7 Hz, 3H). 
13C NMR (101 MHz, CDCl3) δ / ppm = 171.65, 168.62, 135.57, 129.11 (2C), 128.68 (2C), 
127.24, 70.47, 52.92, 52.47, 38.10, 31.95, 19.53, 16.68. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3352, 2971, 2092, 1736, 1650, 1525, 1493, 1461, 1452, 
1443, 1431, 1383, 1372, 1352, 1323, 1288, 1256, 1240, 1223, 1202, 1181, 1160, 1141, 1118, 
1105, 1077, 1030, 994, 966, 949, 937, 892, 849, 816, 793, 763, 756, 740, 700, 682. 
d.r. (determined by NMR) = 95:5. 
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Methyl ((S)-2-azido-3-phenylpropanoyl)-D-methioninate (28u) 
 
Methyl ((S)-2-azido-3-phenylpropanoyl)-D-methioninate was prepared according to a 
literature known procedure.143 
1H NMR (400 MHz, CDCl3): δ / ppm = 7.32–7.16 (m, 5H), 6.80 (d, J = 8.1 Hz, 1H), 4.60 (td, 
J = 7.7, 4.9 Hz, 1H), 4.22 (dd, J = 7.3, 4.2 Hz, 1H), 3.68 (s, 3H), 3.24 (dd, J = 14.1, 4.2 Hz, 
1H), 3.04 (dd, J = 14.1, 7.3 Hz, 1H), 2.18 (dt, J = 7.8, 6.3 Hz, 2H), 2.04–1.98 (m, 1H), 1.98 (d, 
J = 1.9 Hz, 3H), 1.83 (dd, J = 8.4, 7.2 Hz, 1H). 
13C NMR (101 MHz, CDCl3) δ / ppm = 171.8, 168.2, 135.7, 129.6 (2C), 128.7 (2C), 127.4, 
65.2, 52.7, 51.4, 38.2, 31.3, 29.6, 15.4. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3410, 3336, 3005, 2958, 2920, 2851, 2115, 1746, 1710, 
1537, 1526, 1498, 1436, 1422, 1360, 1220, 1092, 1031, 991, 902, 786, 748, 702. 
d.r. (determined by NMR) = 96:4. 
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6.4 Electrophilic Amination Reactions using Organic Azides 
N-(4-Methoxyphenyl)-3,5-dimethylaniline (3b) 
 
According to TP14, 1-azido-3,5-dimethylbenzene (28a, 74 mg, 0.50 mmol, 1.00 equiv) was 
dissolved in dry THF (1 mL). First anhydrous FeCl3 (41 mg, 0.25 mmol, 0.50 equiv) and then 
(4-methoxyphenyl)zinc chloride (1rr, 0.29 M, 3.0 mL, 0.875 mmol, 1.75 equiv) in dry THF 
were added in one portion, respectively. The reaction was stirred at 50 °C for 1 h and 
subsequently quenched with sat. aqueous NH4Cl solution (5 mL). The mixture was extracted 
with EtOAc (3 × 10 mL). The combined org. layers were washed with sat. NaHCO3 solution 
(5 mL), brine (5 mL), and dried over Na2SO4. The crude product was purified by flash column 
chromatography (hexanes:EtOAc 9:1) to yield the titel compound as brownish solid (84 mg, 
0.37 mmol, 74%). 
1H NMR (400 MHz, CDCl3): δ / ppm = 7.18–7.06 (m, 2H), 6.98–6.86 (m, 2H), 6.63–6.59 (m, 
2H), 6.57 (dt, J = 1.8, 1.0 Hz, 1H), 5.47 (s, 1H), 3.86 (s, 3H), 2.31 (d, J = 0.8 Hz, 6H). 
13C NMR (101 MHz, CDCl3): δ / ppm = 155.1, 145.2, 139.1, 135.9, 122.3 (2C), 121.5 (2C), 
114.6 (2C), 113.5 (2C), 55.6, 21.5 (2C). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3614, 3526, 3004, 2919, 2364, 1748, 1710, 1601, 1540, 
1510, 1420, 1359, 1220, 1092, 902. 
HRMS (EI): m/z calc. for [C15H17NO]: 227.1310; found 227.1304. 
m.p.: 74.1 - 75.6 °C 
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4-Fluoro-N-(4-(methylthio)phenyl)aniline (3c) 
 
According to TP14, (4-azidophenyl)(methyl)sulfane (28b, 83 mg, 0.50 mmol, 1.00 equiv) was 
dissolved in dry THF (1 mL). First anhydrous FeCl3 (41 mg, 0.25 mmol, 0.50 equiv) and then 
(4-fluorophenyl)zinc chloride (1ss, 0.27 M, 3.2 mL, 0.875 mmol, 1.75 equiv) in dry THF were 
added in one portion, respectively. The reaction was stirred at 50 °C for 1 h and subsequently 
quenched with sat. aqueous NH4Cl solution (5 mL). The mixture was extracted with EtOAc (3 
× 10 mL). The combined org. layers were washed with sat. NaHCO3 solution (5 mL), brine 
(5 mL), and dried over Na2SO4. The crude product was purified by flash column 
chromatography (hexanes:EtOAc 9.5:0.5) to yield the titel compound as yellowish oil (108 mg, 
0.465 mmol, 93%). 
1H NMR (400 MHz, CDCl3): δ / ppm = 7.31–7.23 (m, 2H), 7.08–6.99 (m, 4H), 6.97–6.91 (m, 
2H), 5.61 (s, 1H), 2.49 (s, 3H). 
13C NMR (101 MHz, CDCl3): δ / ppm = 158.1 (d, J = 240.2 Hz), 142.2, 138.8 (d, J = 2.4 Hz), 
130.1, 128.6, 120.5 (d, J = 7.8 Hz), 117.6, 116.0 (d, J = 22.5 Hz), 18.0. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3357, 3003, 2922, 1748, 1708, 1652, 1595, 1508, 1493, 
1436, 1421, 1359, 1316, 1219, 1184, 1156, 1092, 969, 902, 819, 776, 709 
HRMS (EI): m/z calc. for [C13H12FNS]: 233.0674; found 233.0667. 
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2-Bromo-N-(4-fluorophenyl)-4-(trifluoromethyl)aniline (3d) 
 
According to TP14, 1-azido-2-bromo-4-(trifluoromethyl)benzene (28c, 133 mg, 0.50 mmol, 
1.00 equiv) was dissolved in dry THF (1 mL). First anhydrous FeCl3 (41 mg, 0.25 mmol, 
0.50 equiv) and then ((4-fluoro)phenyl)zinc chloride (1ss, 0.27 M, 3.2 mL, 0.875 mmol, 
1.75 equiv) in dry THF were added in one portion, respectively. The reaction was stirred at 
50 °C for 1 h and subsequently quenched with sat. aqueous NH4Cl solution (5 mL). The mixture 
was extracted with EtOAc (3 × 10 mL). The combined org. layers were washed with sat. 
NaHCO3 solution (5 mL), brine (5 mL), and dried over Na2SO4. The crude product was 
purified by flash column chromatography (hexanes:EtOAc 9.5:0.5) to yield the titel compound 
as yellowish oil (124 mg, 0.370 mmol, 74%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.6 (dd, J = 8.2, 1.0 Hz, 1H), 7.2–7.1 (m, 3H), 7.1–
7.1 (m, 2H), 6.9 (dd, J = 8.3, 2.1 Hz, 1H), 6.2 (s, 1H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 159.8 (d, J = 244.1 Hz), 143.0, 136.0, 133.3, 130.8 
(q, J = 32.5 Hz), 124.6 (d, J = 8.2 Hz, 2C), 123.7 (q, J = 272.5 Hz), 116.6 (d, J = 22.7 Hz, 2C), 
116.3 (q, J = 3.8 Hz), 114.0, 110.2 (q, J = 3.9 Hz). 
19F NMR (377 MHz, CDCl3): δ / ppm = -62.90, -117.50 (tt, J = 8.6, 4.8 Hz). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3404, 1714, 1583, 1506, 1430, 1398, 1331, 1299, 1275, 
1224, 1210, 1167, 1120, 1078, 1023, 937, 909, 867, 830, 806, 787, 754, 734, 712, 685. 
HRMS (EI): m/z calc. for [C13H8BrF4N]: 332.9776; found 332.9769. 
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Ethyl 4-((4'-methoxyphenyl)amino)benzoate (3e) 
 
According to TP14, 1-azido-4-methoxybenzene (28d, 75 mg, 0.50 mmol, 1.00 equiv) was 
dissolved in dry THF (1 mL). First anhydrous FeCl3 (41 mg, 0.25 mmol, 0.50 equiv) and then 
(4-(ethoxycarbonyl)phenyl)zinc chloride (1aa, 0.22 M, 4.0 mL, 0.875 mmol, 1.75 equiv) in dry 
THF were added in one portion, respectively. The reaction was stirred at 50 °C for 1 h and 
subsequently quenched with sat. aqueous NH4Cl solution (5 mL). The mixture was extracted 
with EtOAc (3 × 10 mL). The combined org. layers were washed with sat. NaHCO3 solution 
(5 mL), brine (5 mL), and dried over Na2SO4. The crude product was purified by flash column 
chromatography (hexanes:EtOAc 9:1) to yield the titel compound as yellowish oil (119 mg, 
0.440 mmol, 88%). 
1H NMR (400 MHz, CDCl3): δ / ppm = 7.91–7.84 (m, 2H), 7.17–7.09 (m, 2H), 6.93–6.86 (m, 
2H), 6.85–6.76 (m, 2H), 5.94 (s, 1H), 4.32 (q, J = 7.1 Hz, 2H), 3.81 (s, 3H), 1.36 (t, J = 7.1 Hz, 
3H). 
13C NMR (101 MHz, CDCl3): δ / ppm = 166.7, 156.4, 149.7, 133.5, 131.5 (2C), 124.3 (2C), 
120.3, 114.7 (2C), 113.2 (2C), 60.4, 55.6, 14.5. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3349, 3002, 1705, 1602, 1510, 1464, 1456, 1442, 1429, 
1362, 1310, 1275, 1252, 1221, 1172, 1104, 1033, 837, 814, 772, 699. 
HRMS (EI): m/z calc. for [C16H17NO3]: 271.1208; found 271.1203. 
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Ethyl 4-((3,5-dichlorophenyl)amino)benzoate (3f) 
 
According to TP14, 1-azido-3,5-dichlorobenzene (28e, 94 mg, 0.50 mmol, 1.00 equiv) was 
dissolved in dry THF (1 mL). First anhydrous FeCl3 (41 mg, 0.25 mmol, 0.50 equiv) and then 
(4-(ethoxycarbonyl)phenyl)zinc chloride (1aa, 0.22 M, 4.0 mL, 0.875 mmol, 1.75 equiv) in dry 
THF were added in one portion, respectively. The reaction was stirred at 50 °C for 1 h and 
subsequently quenched with sat. aqueous NH4Cl solution (5 mL). The mixture was extracted 
with EtOAc (3 × 10 mL). The combined org. layers were washed with sat. NaHCO3 solution 
(5 mL), brine (5 mL), and dried over Na2SO4. The crude product was purified by flash column 
chromatography (hexanes:EtOAc 9:1) to yield the titel compound as yellowish oil (109 mg, 
0.35 mmol, 70%). 
1H NMR (400 MHz, CDCl3): δ / ppm = 8.03–7.93 (m, 2H), 7.08–7.02 (m, 2H), 7.00 (d, J = 
1.8 Hz, 2H), 6.97 (t, J = 1.8 Hz, 1H), 6.05 (s, 1H), 4.35 (q, J = 7.1 Hz, 2H), 1.38 (t, J = 7.1 Hz, 
3H). 
13C NMR (101 MHz, CDCl3): δ / ppm = 166.2, 145.7, 143.6, 135.8 (2C), 131.5 (2C), 122.0, 
116.7 (2C), 116.6 (2C), 113.2, 60.8, 14.4. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3004, 2919, 1748, 1710, 1584, 1539, 1434, 1419, 1359, 
1276, 1220, 1177, 1092, 957, 902, 786, 772. 
HRMS (EI): m/z calc. for [C15H13Cl2NO2]: 309.0323; found 309.0317. 
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4-((2-Bromo-4-(trifluoromethyl)phenyl)amino)benzonitrile (3g) 
 
According to TP14, 1-azido-2-bromo-4-(trifluoromethyl)benzene (28c, 133 mg, 0.50 mmol, 
1.00 equiv) was dissolved in dry THF (1 mL). First anhydrous FeCl3 (41 mg, 0.25 mmol, 
0.50 equiv) and then (4-cyanophenyl)zinc chloride (1tt, 0.2 M, 4.4 mL, 0.875 mmol, 
1.75 equiv) in dry THF were added in one portion, respectively. The reaction was stirred at 
50 °C for 1 h and subsequently quenched with sat. aqueous NH4Cl solution (5 mL). The mixture 
was extracted with EtOAc (3 × 10 mL). The combined org. layers were washed with sat. 
NaHCO3 solution (5 mL), brine (5 mL), and dried over Na2SO4. The crude product was 
purified by flash column chromatography (hexanes:EtOAc 9:1) to yield the titel compound as 
white solid (159 mg, 0.465 mmol, 93%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.71 (dd, J = 8.3, 0.9 Hz, 1H), 7.63–7.55 (m, 3H), 
7.13 (dq, J = 9.2, 2.3 Hz, 3H), 6.43 (s, 1H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 145.4, 139.4, 134.1, 134.0 (2C), 131.4, 130.9 (q, J 
= 33.0 Hz), 123.5 (d, J = 272.6 Hz), 119.9 (q, J = 3.8 Hz), 119.2, 118.1, 117.5 (2C), 115.1 (q, 
J = 3.8 Hz), 104.7. 
19F NMR (377 MHz, CDCl3): δ / ppm = -62.82. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3342, 2222, 1610, 1591, 1525, 1504, 1429, 1407, 1331, 
1320, 1301, 1279, 1244, 1223, 1176, 1137, 1116, 1079, 1027, 974, 935, 890, 854, 838, 811, 
758, 710, 687. 
HRMS (EI): m/z calc. for [C14H8BrF3N2]: 339.9823; found 339.9816. 
m.p.: 128.7-130.1 °C 
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(4-((4-Methoxyphenyl)amino)phenyl)(morpholino)methanone (3h) 
 
According to TP14, 1-azido-4-methoxybenzene (28d, 75 mg, 0.50 mmol, 1.00 equiv) was 
dissolved in dry THF (1 mL). First anhydrous FeCl3 (41 mg, 0.25 mmol, 0.50 equiv) and then 
(4-(morpholine-4-carbonyl)phenyl)zinc chloride (1uu, 0.20 M, 4.4 mL, 0.875 mmol, 
1.75 equiv) in dry THF were added in one portion, respectively. The reaction was stirred at 
50 °C for 1 h and subsequently quenched with sat. aqueous NH4Cl solution (5 mL). The mixture 
was extracted with EtOAc (3 × 10 mL). The combined org. layers were washed with sat. 
NaHCO3 solution (5 mL), brine (5 mL), and dried over Na2SO4. The crude product was 
purified by flash column chromatography (hexanes:EtOAc 4:1) to yield the titel compound as 
brownish solid (102 mg, 0.325 mmol, 65%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.3 (dd, J = 9.1, 2.4 Hz, 2H), 7.1–7.1 (m, 2H), 6.9–
6.8 (m, 4H), 5.9 (s, 1H), 3.8 (s, 3H), 3.8–3.6 (m, 8H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 170.9, 156.1, 147.5, 134.3, 129.4 (2C), 124.9, 123.6 
(2C), 114.8 (2C), 114.0 (2C), 67.0 (4C), 55.6. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3293, 3190, 3095, 3030, 3002, 2953, 2929, 2848, 2832, 
1643, 1627, 1613, 1602, 1578, 1521, 1505, 1456, 1439, 1421, 1371, 1364, 1328, 1304, 1296, 
1271, 1252, 1219, 1174, 1157, 1104, 1065, 1030, 1014, 1004, 959, 946, 933, 895, 846, 828, 
811, 768, 759, 728, 710, 694. 
HRMS (EI): m/z calc. for [C18H20N2O3]: 312.1474; found 312.1467. 
m.p.: 125.1-127.3 °C 
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4-((4-Fluorophenyl)amino)benzamide (3i) 
 
According to TP14, 4-azidobenzamide (28f, 81 mg, 0.50 mmol, 1.00 equiv) was dissolved in 
dry THF (1 mL). First anhydrous FeCl3 (41 mg, 0.25 mmol, 0.50 equiv) and then (4-
fluorophenyl)zinc chloride (1ss, 0,27 M, 3.2 mL, 0.875 mmol, 1.75 equiv) in dry THF were 
added in one portion, respectively. The reaction was stirred at 50 °C for 1 h and subsequently 
quenched with sat. aqueous NH4Cl solution (5 mL). The mixture was extracted with EtOAc (3 
× 10 mL). The combined org. layers were washed with sat. NaHCO3 solution (5 mL), brine 
(5 mL), and dried over Na2SO4. The crude product was purified by flash column 
chromatography (hexanes:EtOAc 9.5:0.5) to yield the titel compound as white solid (93 mg, 
0.41 mmol, 81%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.7–7.7 (m, 2H), 7.1 (ddt, J = 8.2, 5.7, 2.8 Hz, 2H), 
7.1–7.0 (m, 2H), 6.9–6.9 (m, 2H), 5.9 (s, 1H), 5.7 (s, 2H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 168.8, 159.1 (d, J = 242.7 Hz), 148.0, 136.8, 129.3, 
123.9, 123.1 (d, J = 8.0 Hz), 116.3 (d, J = 22.6 Hz), 114.3. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3416, 3333, 3163, 2919, 1698, 1645, 1607, 1597, 1574, 
1521, 1506, 1456, 1429, 1391, 1336, 1312, 1298, 1240, 1211, 1193, 1156, 1149, 1132, 1126, 
1099, 1010, 970, 850, 820, 802, 780, 684. 
HRMS (EI): m/z calc. for [C13H11FN2O]: 230.0855; found 230.0848. 
m.p.: 167.1-168.4 °C 
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3,5-Dichloro-N-(4-methoxyphenyl)aniline (3j) 
 
According to TP14, 1-azido-3,5-dichlorobenzene (28e, 94 mg, 0.50 mmol, 1.00 equiv) was 
dissolved in dry THF (1 mL). First anhydrous FeCl3 (41 mg, 0.25 mmol, 0.50 equiv) and then 
(4-methoxyphenyl)zinc chloride (1rr, 0.29 M, 3.0 mL, 0.875 mmol, 1.75 equiv) in dry THF 
were added in one portion, respectively. The reaction was stirred at 50 °C for 1 h and 
subsequently quenched with sat. aqueous NH4Cl solution (5 mL). The mixture was extracted 
with EtOAc (3 × 10 mL). The combined org. layers were washed with sat. NaHCO3 solution 
(5 mL), brine (5 mL), and dried over Na2SO4. The crude product was purified by flash column 
chromatography (hexanes:EtOAc 9:1) to yield the titel compound as yellowish oil (111 mg, 
0.415 mmol, 83%). 
1H NMR (400 MHz, CDCl3): δ / ppm = 7.08 (d, J = 8.4 Hz, 2H), 6.94–6.88 (m, 2H), 6.76 (s, 
1H), 6.69 (d, J = 1.9 Hz, 2H), 3.82 (s, 3H). 
13C NMR (101 MHz, CDCl3): δ / ppm = 156.7, 147.7, 135.6 (2C), 133.2, 124.5 (C), 118.8 
(2C), 114.9 (2C), 112.8, 55.6. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3396, 3366, 1706, 1588, 1572, 1510, 1449, 1361, 1316, 
1298, 1281, 1245, 1224, 1180, 1110, 1094, 1034, 987, 955, 824, 800, 765, 672, 660. 
HRMS (EI): m/z calc. for [C13H11Cl2NO]: 267.0218; found 267.0212. 
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N1,N1-Dimethyl-N4-(4-(methylthio)phenyl)benzene-1,4-diamine (3k) 
 
According to TP14, (4-azidophenyl)(methyl)sulfane (28b, 83 mg, 0.50 mmol, 1.00 equiv) was 
dissolved in dry THF (1 mL). First anhydrous FeCl3 (41 mg, 0.25 mmol, 0.50 equiv) and then 
(4-(dimethylamino)phenyl)zinc chloride (1vv, 0.26 M, 3.4 mL, 0.875 mmol, 1.75 equiv) in dry 
THF were added in one portion, respectively. The reaction was stirred at 50 °C for 1 h and 
subsequently quenched with sat. aqueous NH4Cl solution (5 mL). The mixture was extracted 
with EtOAc (3 × 10 mL). The combined org. layers were washed with sat. NaHCO3 solution 
(5 mL), brine (5 mL), and dried over Na2SO4. The crude product was purified by flash column 
chromatography (hexanes:EtOAc 9:1) to yield the titel compound as yellowish oil (99 mg, 
0.39 mmol, 77%). 
1H-NMR (400 MHz, Acetone-d6): δ / ppm = 7.2–7.1 (m, 2H), 7.1–7.0 (m, 2H), 7.0 (s, 1H), 
6.9–6.8 (m, 2H), 6.8–6.7 (m, 2H), 2.9 (s, 6H), 2.4 (s, 3H). 
13C-NMR (101 MHz, Acetone-d6): δ / ppm = 147.1, 145.4, 132.5 (2C), 125.0, 122.4 (2C), 
115.0 (2C), 113.8 (2C), 40.4 (2C), 17.7. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3407, 3004, 2962, 2918, 1749, 1709, 1597, 1519, 1495, 
1421, 1359, 1311, 1220, 1165, 1092, 946, 903, 819. 
HRMS (EI): m/z calc. for [C15H18N2S]: 258.1191; found 258.1187. 
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Ethyl 3-bromo-4-((3-fluoro-4-methoxyphenyl)amino)benzoate (3l) 
 
According to TP14, ethyl 4-azido-3-bromobenzoate (28g, 135 mg, 0.50 mmol, 1.00 equiv) 
was dissolved in dry THF (1 mL). First anhydrous FeCl3 (41 mg, 0.25 mmol, 0.50 equiv) and 
then (3-fluoro-4-methoxyphenyl)zinc chloride (1ww, 0.27 M, 3.2 mL, 0.875 mmol, 
1.75 equiv) in dry THF were added in one portion, respectively. The reaction was stirred at 
50 °C for 1 h and subsequently quenched with sat. aqueous NH4Cl solution (5 mL). The mixture 
was extracted with EtOAc (3 × 10 mL). The combined org. layers were washed with sat. 
NaHCO3 solution (5 mL), brine (5 mL), and dried over Na2SO4. The crude product was 
purified by flash column chromatography (hexanes:EtOAc 9:1) to yield the titel compound as 
yellowish oil (118 mg, 0.325 mmol, 65%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.2 (d, J = 2.0 Hz, 1H), 7.8 (dd, J = 8.6, 2.0 Hz, 1H), 
7.0–6.9 (m, 4H), 6.3 (s, 1H), 4.3 (q, J = 7.1 Hz, 2H), 3.9 (s, 3H), 1.4 (t, J = 7.1 Hz, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 165.4, 152.6 (d, J = 247.5 Hz), 146.2, 145.2 (d, J = 
10.7 Hz), 134.5, 132.8 (d, J = 8.6 Hz), 130.2, 121.6, 119.7 (d, J = 3.4 Hz), 114.2 (d, J = 2.9 
Hz), 112.5 (d, J = 19.9 Hz), 112.2, 109.3, 60.8, 56.6, 14.4. 
19F NMR (377 MHz, CDCl3): δ / ppm = -132.42 (dd, J = 12.0, 7.3 Hz). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3388, 2979, 2936, 2840, 1702, 1699, 1596, 1564, 1510, 
1463, 1442, 1391, 1366, 1298, 1263, 1217, 1184, 1174, 1159, 1107, 1024, 972, 873, 828, 808, 
760, 718, 703, 654. 
HRMS (EI): m/z calc. for [C16H14BrNO4]: 367.2024; found 367.0212. 
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4-((4-(tert-Butyl)phenyl)amino)benzaldehyde (3m) 
 
According to TP14, 4-azidobenzaldehyde (28h, 74 mg, 0.50 mmol, 1.00 equiv) was dissolved 
in dry THF (1 mL). First anhydrous FeCl3 (41 mg, 0.25 mmol, 0.50 equiv) and then 
(4-(t-butyl)phenyl)zinc chloride (1xx, 0.28 M, 3.1 mL, 0.875 mmol, 1.75 equiv) in dry THF 
were added in one portion, respectively. The reaction was stirred at 50 °C for 1 h and 
subsequently quenched with sat. aqueous NH4Cl solution (5 mL). The mixture was extracted 
with EtOAc (3 × 10 mL). The combined org. layers were washed with sat. NaHCO3 solution 
(5 mL), brine (5 mL), and dried over Na2SO4. The crude product was purified by flash column 
chromatography (hexanes:EtOAc 9.5:0.5) to yield the titel compound as brownish solid 
(60 mg, 0.24 mmol, 47%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 9.8 (s, 1H), 7.8–7.7 (m, 2H), 7.4 (dd, J = 9.0, 2.5 Hz, 
2H), 7.2–7.1 (m, 2H), 7.0–7.0 (m, 2H), 6.3 (s, 1H), 1.3 (s, 9H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 190.5, 150.4, 147.2, 137.3, 132.2 (2C), 128.1, 126.4 
(2C), 121.5 (2C), 114.1, 34.5, 31.4 (3C). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3523, 3410, 3351, 3005, 2965, 1748, 1708, 1652, 1592, 
1525, 1421, 1360, 1308, 1270, 1221, 1164, 1110, 1092, 903, 829, 788. 
HRMS (EI): m/z calc. for [C17H19NO]: 253.1467; found 253.1461. 
m.p.: 129.6-132.4 °C 
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4-((2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)amino)benzonitrile (3n) 
 
According to TP14, 4-azidobenzonitrile (28i, 72 mg, 0.50 mmol, 1.00 equiv) was dissolved in 
dry THF (1 mL). First anhydrous FeCl3 (41 mg, 0.25 mmol, 0.50 equiv) and then (2,3-
dihydrobenzo[b][1,4]dioxin-6-yl)zinc chloride (1v, 0.28 M, 3.1 mL, 0.875 mmol, 1.75 equiv) 
in dry THF were added in one portion, respectively. The reaction was stirred at 50 °C for 1 h and 
subsequently quenched with sat. aqueous NH4Cl solution (5 mL). The mixture was extracted 
with EtOAc (3 × 10 mL). The combined org. layers were washed with sat. NaHCO3 solution 
(5 mL), brine (5 mL), and dried over Na2SO4. The crude product was purified by flash column 
chromatography (hexanes:EtOAc 9:1) to yield the titel compound as yellowish oil (106 mg, 
0.420 mmol, 84%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.45–7.40 (m, 2H), 6.87–6.80 (m, 3H), 6.72 (d, J = 
2.5 Hz, 1H), 6.65 (dd, J = 8.6, 2.6 Hz, 1H), 5.98 (s, 1H), 4.26 (s, 4H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 149.2, 144.1, 140.9, 133.8, 133.4, 120.3, 118.0, 
116.4, 114.1, 112.1, 100.5, 64.6, 64.4. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3337, 2980, 2930, 2876, 2212, 1705, 1599, 1504, 1458, 
1440, 1408, 1382, 1339, 1297, 1278, 1258, 1240, 1204, 1171, 1121, 1105, 1065, 1049, 962, 
923, 887, 826, 782, 736, 666. 
HRMS (EI): m/z calc. for [C15H12N2O2]: 252.0899; found 252.0892. 
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2,6-Diisopropyl-N-(4-(trifluoromethoxy)phenyl)aniline (3o) 
 
According to TP14, 2-azido-1,3-diisopropylbenzene (28j, 102 mg, 0.50 mmol, 1.00 equiv) 
was dissolved in dry THF (1 mL). First anhydrous FeCl3 (41 mg, 0.25 mmol, 0.50 equiv) and 
then ((4-trifluoromethoxy)phenyl)zinc chloride (1yy, 0.26 M, 3.4 mL, 0.875 mmol, 1.75 equiv) 
in dry THF were added in one portion, respectively. The reaction was stirred at 50 °C for 1 h and 
subsequently quenched with sat. aqueous NH4Cl solution (5 mL). The mixture was extracted 
with EtOAc (3 × 10 mL). The combined org. layers were washed with sat. NaHCO3 solution 
(5 mL), brine (5 mL), and dried over Na2SO4. The crude product was purified by flash column 
chromatography (hexanes:EtOAc 9.5:0.5) to yield the titel compound as yellowish oil (137 mg, 
0.405 mmol, 81%). 
1H NMR (400 MHz, CDCl3): δ / ppm = 7.34–7.27 (m, 1H), 7.24–7.20 (m, 2H), 6.98 (dt, J = 
8.0, 1.0 Hz, 2H), 6.45–6.40 (m, 2H), 5.16 (s, 1H), 3.15 (p, J = 6.9 Hz, 2H), 1.14 (d, J = 6.9 Hz, 
12H). 
13C NMR (101 MHz, CDCl3): δ / ppm = 147.6 (2C), 146.9, 140.7, 134.7, 127.6, 124.0 (2C), 
122.4 (2C), 120.7 (q, J = 255.3 Hz), 113.2 (2C), 28.2 (2C), 23.9 (4C). 
19F NMR (377 MHz, , CDCl3): δ / ppm = -58.40. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3004, 2966, 2926, 1748, 1711, 1510, 1421, 1359, 1259, 
1220, 1092, 902, 837, 787, 669. 
HRMS (EI): m/z calc. for [C19H22F3NO]: 337.1653; found 337.1645. 
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1-(4-(Naphthalen-1-ylamino)phenyl)ethan-1-one (3p) 
 
According to TP14, 1-(4-azidophenyl)ethan-1-one (28k, 81 mg, 0.50 mmol, 1.00 equiv) was 
dissolved in dry THF (1 mL). First anhydrous FeCl3 (41 mg, 0.25 mmol, 0.50 equiv) and then 
naphthalen-1-ylzinc chloride (1x, 0.27 M, 3.2 mL, 0.875 mmol, 1.75 equiv) in dry THF were 
added in one portion, respectively. The reaction was stirred at 50 °C for 1 h and subsequently 
quenched with sat. aqueous NH4Cl solution (5 mL). The mixture was extracted with EtOAc (3 
× 10 mL). The combined org. layers were washed with sat. NaHCO3 solution (5 mL), brine 
(5 mL), and dried over Na2SO4. The crude product was purified by flash column 
chromatography (hexanes:EtOAc 9:1) to yield the titel compound as yellowish oil (89 mg, 
0.34 mmol, 68%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.0–7.9 (m, 1H), 7.9–7.9 (m, 1H), 7.9–7.8 (m, 2H), 
7.8–7.7 (m, 1H), 7.6–7.4 (m, 4H), 6.9–6.8 (m, 2H), 6.3 (s, 1H), 2.5 (s, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 196.5, 150.4, 136.2, 134.7, 130.7 (2C), 128.6, 126.5, 
126.3, 126.3, 125.9, 125.8, 125.7, 122.3, 120.7, 114.1 (2C), 26.2. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3349, 3055, 2924, 1659, 1626, 1595, 1574, 1523, 1437, 
1417, 1397, 1359, 1324, 1308, 1276, 1178, 1075, 1018, 957, 832, 778. 
HRMS (EI): m/z calc. for [C18H15NO]: 261.1154; found 261.1136. 
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N-Cyclopropyl-4-nitroaniline (3q) 
 
According to TP14, 1-azido-4-nitrobenzene (28l, 82 mg, 0.50 mmol, 1.00 equiv) was 
dissolved in dry THF (1 mL). First anhydrous FeCl3 (41 mg, 0.25 mmol, 0.50 equiv) and then 
cyclopropylzinc chloride (1zz, 0.28 M, 3.1 mL, 0.875 mmol, 1.75 equiv) in dry THF were 
added in one portion, respectively. The reaction was stirred at 50 °C for 1 h and subsequently 
quenched with sat. aqueous NH4Cl solution (5 mL). The mixture was extracted with EtOAc (3 
× 10 mL). The combined org. layers were washed with sat. NaHCO3 solution (5 mL), brine 
(5 mL), and dried over Na2SO4. The crude product was purified by flash column 
chromatography (hexanes:EtOAc 9.5:0.5) to yield the titel compound as yellowish solid 
(57 mg, 0.32 mmol, 64%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.1–8.0 (m, 2H), 6.8–6.7 (m, 2H), 4.9 (s, 1H), 2.5 
(ttd, J = 6.7, 3.6, 1.5 Hz, 1H), 0.9–0.8 (m, 2H), 0.6–0.5 (m, 2H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 154.0 (2C), 138.5, 126.2 (2C), 111.7, 24.8, 7.8 (2C). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3389, 2921, 1698, 1595, 1558, 1516, 1506, 1494, 1466, 
1343, 1319, 1298, 1283, 1260, 1194, 1180, 1172, 1109, 1058, 1048, 1028, 994, 978, 950, 902, 
864, 852, 834, 812, 751, 696. 
HRMS (EI): m/z calc. for [C9H10N2O2]: 178.0742; found 178.0735. 
m.p.: 121.8-123.0 °C 
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N-(2-Fluorophenyl)-2,6-dimethoxypyrimidin-4-amine (3r) 
 
According to TP14, 1-azido-2-fluorobenzene (28m, 69 mg, 0.50 mmol, 1.00 equiv) was 
dissolved in dry THF (1 mL). First anhydrous FeCl3 (41 mg, 0.25 mmol, 0.50 equiv) and then 
(2,6-dimethoxypyrimidin-4-yl)zinc chloride (1q, 0.22 M, 4.0 mL, 0.875 mmol, 1.75 equiv) in 
dry THF were added in one portion, respectively. The reaction was stirred at 50 °C for 1 h and 
subsequently quenched with sat. aqueous NH4Cl solution (5 mL). The mixture was extracted 
with EtOAc (3 × 10 mL). The combined org. layers were washed with sat. NaHCO3 solution 
(5 mL), brine (5 mL), and dried over Na2SO4. The crude product was purified by flash column 
chromatography (hexanes:EtOAc 4:1) to yield the titel compound as yellowish oil (107 mg, 
0.430 mmol, 86%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.21 (s, 1H), 7.12–6.96 (m, 3H), 6.88–6.78 (m, 1H), 
5.53 (d, J = 2.9 Hz, 1H), 4.04 (s, 3H), 3.98 (s, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 163.7, 160.4, 152.7 (d, J = 241.2 Hz), 146.8, 131.9 
(d, J = 11.0 Hz), 124.5 (d, J = 3.6 Hz), 120.5 (d, J = 7.2 Hz), 119.1, 115.6 (d, J = 3.4 Hz), 115.5 
(d, J = 24.5 Hz), 54.9, 54.4. 
19F NMR (377 MHz, CDCl3): δ / ppm = -124.44 (dq, J = 8.5, 4.2 Hz). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3422, 2991, 2953, 1619, 1606, 1574, 1510, 1478, 1457, 
1398, 1375, 1308, 1286, 1246, 1207, 1185, 1154, 1099, 1072, 1054, 1034, 1011, 961, 937, 878, 
801, 779, 743, 712. 
HRMS (EI): m/z calc. for [C12H12FN3O2]: 249.0914; found 249.0907. 
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3,6-Dichloro-N-(2-fluorophenyl)pyridazin-4-amine (3s) 
 
According to TP14, 1-azido-2-fluorobenzene (28m, 69 mg, 0.50 mmol, 1.00 equiv) was 
dissolved in dry THF (1 mL). First anhydrous FeCl3 (41 mg, 0.25 mmol, 0.50 equiv) and then 
(3,6-dichloropyridazin-4-yl)zinc chloride (1aaa, 0.18 M, 4.9 mL, 0.875 mmol, 1.75 equiv) in 
dry THF were added in one portion, respectively. The reaction was stirred at 50 °C for 1 h and 
subsequently quenched with sat. aqueous NH4Cl solution (5 mL). The mixture was extracted 
with EtOAc (3 × 10 mL). The combined org. layers were washed with sat. NaHCO3 solution 
(5 mL), brine (5 mL), and dried over Na2SO4. The crude product was purified by flash column 
chromatography (hexanes:EtOAc 4:1) to yield the titel compound as yellowish oil (107 mg, 
0.415 mmol, 83%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.4–7.2 (m, 4H), 6.8 (d, J = 1.6 Hz, 1H), 6.6 (s, 1H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 156.3 (d, J = 249.4 Hz), 155.8, 144.6, 141.8, 128.7 
(d, J = 7.7 Hz), 125.6, 125.3 (d, J = 4.0 Hz), 124.0 (d, J = 12.0 Hz), 117.2 (d, J = 19.3 Hz), 
107.6 (d, J = 1.5 Hz). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3196, 3059, 1568, 1531, 1501, 1449, 1376, 1350, 1304, 
1262, 1204, 1131, 1113, 1103, 1080, 1054, 1030, 969, 948, 879, 859, 780, 750, 733, 707, 654. 
HRMS (EI): m/z calc. for [C10H6Cl2FN3]: 256.9923; found 256.9917. 
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3,6-Dichloro-N-(4-(methylthio)phenyl)pyridazin-4-amine (3t) 
 
According to TP14, (4-azidophenyl)(methyl)sulfane (28b, 83 mg, 0.50 mmol, 1.00 equiv) was 
dissolved in dry THF (1 mL). First anhydrous FeCl3 (41 mg, 0.25 mmol, 0.50 equiv) and then 
(3,6-dichloropyridazin-4-yl)zinc chloride (1aaa, 0.18 M, 4.9 mL, 0.875 mmol, 1.75 equiv) in 
dry THF were added in one portion, respectively. The reaction was stirred at 50 °C for 1 h and 
subsequently quenched with sat. aqueous NH4Cl solution (5 mL). The mixture was extracted 
with EtOAc (3 × 10 mL). The combined org. layers were washed with sat. NaHCO3 solution 
(5 mL), brine (5 mL), and dried over Na2SO4. The crude product was purified by flash column 
chromatography (hexanes:EtOAc 4:1) to yield the titel compound as yellowish oil (112 mg, 
0.390 mmol, 78%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.4–7.3 (m, 2H), 7.2–7.1 (m, 2H), 6.8 (s, 1H), 6.7 (s, 
1H), 2.5 (s, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 155.8, 144.4, 142.6, 138.3, 132.8, 127.9 (2C), 125.0 
(2C), 106.9, 15.8. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3524, 3004, 1748, 1708, 1652, 1646, 1558, 1498, 1421, 
1359, 1293, 1221, 1126, 1109, 1092, 966, 903, 825. 
HRMS (EI): m/z calc. for [C11H9Cl2N3S]: 284.9894; found 284.9888. 
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6-Chloro-N-(4-fluorophenyl)pyridin-3-amine (3u) 
 
According to TP14, 5-azido-2-chloropyridine (28n, 77 mg, 0.50 mmol, 1.00 equiv) was 
dissolved in dry THF (1 mL). First anhydrous FeCl3 (41 mg, 0.25 mmol, 0.50 equiv) and then 
(4-fluorophenyl)zinc chloride (1ss, 0.27 M, 3.2 mL, 0.875 mmol, 1.75 equiv) in dry THF were 
added in one portion, respectively. The reaction was stirred at 50 °C for 1 h and subsequently 
quenched with sat. aqueous NH4Cl solution (5 mL). The mixture was extracted with EtOAc (3 
× 10 mL). The combined org. layers were washed with sat. NaHCO3 solution (5 mL), brine 
(5 mL), and dried over Na2SO4. The crude product was purified by flash column 
chromatography (hexanes:EtOAc 4:1) to yield the titel compound as brownish soild (59 mg, 
0.27 mmol, 53%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.0 (d, J = 2.9 Hz, 1H), 7.2 (dd, J = 8.6, 3.0 Hz, 1H), 
7.1 (d, J = 8.6 Hz, 1H), 7.0–6.9 (m, 4H), 5.8 (s, 1H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 158.8 (d, J = 242.3 Hz), 141.6, 140.0, 138.0, 137.2, 
125.5, 124.3, 121.7 (d, J = 8.0 Hz, 2C), 116.4 (d, J = 22.6 Hz, 2C). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3273, 3218, 3180, 3050, 1614, 1584, 1529, 1504, 1476, 
1463, 1429, 1416, 1365, 1337, 1294, 1283, 1229, 1208, 1158, 1145, 1107, 1099, 1015, 899, 
816, 801, 774, 724, 715, 686. 
HRMS (EI): m/z calc. for [C11H8ClFN2]: 222.0360; found 222.0353. 
m.p.: 124.1-126.3 °C 
 
  
C. Experimental Section 
265 
Ethyl 4-((6-chloropyridin-3-yl)amino)benzoate (3v) 
 
According to TP14, 5-azido-2-chloropyridine (28n, 77 mg, 0.50 mmol, 1.00 equiv) was 
dissolved in dry THF (1 mL). First anhydrous FeCl3 (41 mg, 0.25 mmol, 0.50 equiv) and then 
(4-(ethoxycarbonyl)phenyl)zinc chloride (1aa, 0.22 M, 4.0 mL, 0.875 mmol, 1.75 equiv) in dry 
THF were added in one portion, respectively. The reaction was stirred at 50 °C for 1 h and 
subsequently quenched with sat. aqueous NH4Cl solution (5 mL). The mixture was extracted 
with EtOAc (3 × 10 mL). The combined org. layers were washed with sat. NaHCO3 solution 
(5 mL), brine (5 mL), and dried over Na2SO4. The crude product was purified by flash column 
chromatography (hexanes:EtOAc 4:1) to yield the titel compound as yellowish oil (89 mg, 
0.32 mmol, 64%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.2 (d, J = 2.8 Hz, 1H), 8.0–7.9 (m, 2H), 7.5 (dd, J = 
8.6, 2.9 Hz, 1H), 7.3 (d, J = 8.6 Hz, 1H), 7.1–7.0 (m, 2H), 6.6 (s, 1H), 4.4 (q, J = 7.1 Hz, 2H), 
1.4 (t, J = 7.1 Hz, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 166.4, 146.5, 144.0, 141.1, 137.3, 131.6 (2C), 129.2, 
124.5, 122.9, 115.3 (2C), 60.8, 14.4. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3342, 3003, 2917, 1748, 1708, 1609, 1581, 1523, 1463, 
1421, 1392, 1360, 1334, 1311, 1274, 1220, 1176, 1142, 1106, 1018, 903, 838, 770, 734, 711, 
694. 
HRMS (EI): m/z calc. for [C14H13ClN2O2]: 276.0666; found 276.0659. 
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N-(4-Fluorophenyl)quinolin-3-amine (3w) 
 
According to TP14, 3-azidoquinoline (28o, 85 mg, 0.50 mmol, 1.00 equiv) was dissolved in 
dry THF (1 mL). First anhydrous FeCl3 (41 mg, 0.25 mmol, 0.50 equiv) and then (4-
fluorophenyl)zinc chloride (1ss, 0.27 M, 3.2 mL, 0.875 mmol, 1.75 equiv) in dry THF were 
added in one portion, respectively. The reaction was stirred at 50 °C for 1 h and subsequently 
quenched with sat. aqueous NH4Cl solution (5 mL). The mixture was extracted with EtOAc (3 
× 10 mL). The combined org. layers were washed with sat. NaHCO3 solution (5 mL), brine 
(5 mL), and dried over Na2SO4. The crude product was purified by flash column 
chromatography (hexanes:EtOAc 4:1) to yield the titel compound as yellowish oil (85 mg, 
0.36 mmol, 71%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.64 (d, J = 2.8 Hz, 1H), 8.02–7.97 (m, 1H), 7.61 (dd, 
J = 8.0, 1.6 Hz, 1H), 7.58–7.54 (m, 1H), 7.48–7.42 (m, 2H), 7.19–7.13 (m, 2H), 7.09–7.04 (m, 
2H), 6.08 (s, 1H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 158.8 (d, J = 241.9 Hz), 144.6, 143.9, 143.5, 130.2, 
129.1, 129.0, 127.3, 126.9, 126.5 (d, J = 2.9 Hz), 123.2, 121.5 (d, J = 8.0 Hz, 2C), 116.5 (d, J 
= 22.6 Hz, 2C). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3005, 2918, 1748, 1711, 1607, 1599, 1576, 1542, 1490, 
1418, 1358, 1334, 1286, 1220, 1166, 1127, 1092, 1070, 901, 786, 755, 701. 
HRMS (EI): m/z calc. for [C15H11FN2]: 238.0906; found 238.0898. 
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N-(4-(Trifluoromethyl)phenyl)quinolin-3-amine (3x) 
 
According to TP14, 3-azidoquinoline (28o, 85 mg, 0.50 mmol, 1.00 equiv) was dissolved in 
dry THF (1 mL). First anhydrous FeCl3 (41 mg, 0.25 mmol, 0.50 equiv) and then (4-
(trifluoromethyl)phenyl)zinc chloride (1oo, 0.23 M, 3.8 mL, 0.875 mmol, 1.75 equiv) in dry 
THF were added in one portion, respectively. The reaction was stirred at 50 °C for 1 h and 
subsequently quenched with sat. aqueous NH4Cl solution (5 mL). The mixture was extracted 
with EtOAc (3 × 10 mL). The combined org. layers were washed with sat. NaHCO3 solution 
(5 mL), brine (5 mL), and dried over Na2SO4. The crude product was purified by flash column 
chromatography (hexanes:EtOAc 4:1) to yield the titel compound as yellowish solid (94 mg, 
0.33 mmol, 65%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.9 (dd, J = 8.3, 1.2 Hz, 1H), 7.7 (d, J = 2.6 Hz, 1H), 
7.6 (dd, J = 8.0, 1.6 Hz, 1H), 7.4 (dddd, J = 23.1, 8.2, 6.9, 1.5 Hz, 2H), 7.3 (t, J = 7.9 Hz, 1H), 
7.3 (d, J = 2.0 Hz, 1H), 7.2 (dd, J = 8.1, 2.3 Hz, 1H), 7.2–7.1 (m, 1H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 145.3, 142.9, 135.9, 132.1 (q, J = 32.2 Hz), 130.2, 
129.0, 127.4, 127.3, 126.7, 124.0 (q, J = 272.5 Hz), 120.4, 119.0, 118.2 (q, J = 3.9 Hz, 2C), 
114.1 (q, J = 3.9 Hz, 2C). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3207, 3140, 3111, 3044, 3008, 2921, 2852, 1615, 1600, 
1567, 1543, 1497, 1468, 1426, 1397, 1380, 1367, 1352, 1327, 1304, 1280, 1250, 1220, 1185, 
1160, 1153, 1140, 1122, 1104, 1097, 1009, 978, 952, 916, 885, 853, 828, 805, 781, 772, 750, 
710, 682. 
HRMS (EI): m/z calc. for [C16H11F3N2]: 288.0874; found 288.0865. 
m.p.: 124.2-125.9 °C 
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4-Chloro-N-(4-chlorophenyl)-2,6-dimethoxypyrimidin-5-amine (3y) 
 
According to TP14, 5-azido-4-chloro-2,6-dimethoxypyrimidine (28p, 108 mg, 0.50 mmol, 
1.00 equiv) was dissolved in dry THF (1 mL). First anhydrous FeCl3 (41 mg, 0.25 mmol, 
0.50 equiv) and then (4-chlorophenyl)zinc chloride ( , 0.29 M, 3.0 mL, 0.875 mmol, 
1.75 equiv) in dry THF were added in one portion, respectively. The reaction was stirred at 
50 °C for 1 h and subsequently quenched with sat. aqueous NH4Cl solution (5 mL). The mixture 
was extracted with EtOAc (3 × 10 mL). The combined org. layers were washed with sat. 
NaHCO3 solution (5 mL), brine (5 mL), and dried over Na2SO4. The crude product was 
purified by flash column chromatography (hexanes:EtOAc 4:1) to yield the titel compound as 
yellowish oil (137 mg, 0.455 mmol, 91%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.2–7.1 (m, 2H), 6.6–6.5 (m, 2H), 5.2 (s, 1H), 4.0 (s, 
3H), 4.0 (s, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 13C NMR (101 MHz, CDCl3) δ 167.4, 160.8, 156.8, 
142.8, 129.0 (2C), 124.7, 115.9 (2C), 114.5, 55.6, 55.2. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3379, 2953, 1709, 1599, 1542, 1493, 1484, 1466, 1394, 
1376, 1336, 1301, 1287, 1246, 1222, 1188, 1118, 1086, 1029, 1007, 963, 943, 861, 817, 779, 
721, 667. 
HRMS (EI): m/z calc. for [C12H11Cl2N3O2]: 299.0228; found 299.0221. 
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4-Chloro-N-(4-fluorophenyl)-2,6-dimethoxypyrimidin-5-amine (3z) 
 
According to TP14, 5-azido-4-chloro-2,6-dimethoxypyrimidine (28p, 108 mg, 0.50 mmol, 
1.00 equiv) was dissolved in dry THF (1 mL). First anhydrous FeCl3 (41 mg, 0.25 mmol, 
0.50 equiv) and then (4-fluorophenyl)zinc chloride (1ss, 0.27 M, 3.2 mL, 0.875 mmol, 
1.75 equiv) in dry THF were added in one portion, respectively. The reaction was stirred at 
50 °C for 1 h and subsequently quenched with sat. aqueous NH4Cl solution (5 mL). The mixture 
was extracted with EtOAc (3 × 10 mL). The combined org. layers were washed with sat. 
NaHCO3 solution (5 mL), brine (5 mL), and dried over Na2SO4. The crude product was 
purified by flash column chromatography (hexanes:EtOAc 4:1) to yield the titel compound as 
yellowish solid (126 mg, 0.445 mmol, 89%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.0–6.8 (m, 2H), 6.6–6.5 (m, 2H), 5.2 (s, 1H), 4.0 (s, 
3H), 4.0 (s, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 167.2, 160.5, 157.3 (d, J = 238.1 Hz), 156.1, 140.2, 
116.2 (d, J = 7.7 Hz, 2C), 115.7 (d, J = 22.7 Hz, 2C), 115.4, 55.6, 55.2. 
19F NMR (377 MHz, CDCl3): δ / ppm = -133.11 (tt, J = 7.6, 3.4 Hz). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3408, 2957, 2919, 1590, 1543, 1506, 1490, 1478, 1462, 
1404, 1370, 1331, 1298, 1286, 1263, 1246, 1223, 1206, 1190, 1153, 1102, 1083, 1021, 940, 
874, 860, 834, 825, 806, 791, 764, 748, 727, 706, 698. 
HRMS (EI): m/z calc. for [C12H11ClFN3O2]: 283.0524; found 283.0517. 
m.p.: 173.9-175.2 °C 
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N-(3,6-Dichloropyridazin-4-yl)quinolin-3-amine (3aa) 
 
According to TP14, 3-azidoquinoline (28o, 85 mg, 0.50 mmol, 1.00 equiv) was dissolved in 
dry THF (1 mL). First anhydrous FeCl3 (41 mg, 0.25 mmol, 0.50 equiv) and then (3,6-
dichloropyridazin-4-yl)zinc chloride (1aaa, 0.18 M, 4.9 mL, 0.875 mmol, 1.75 equiv) in dry 
THF were added in one portion, respectively. The reaction was stirred at 50 °C for 1 h and 
subsequently quenched with sat. aqueous NH4Cl solution (5 mL). The mixture was extracted 
with EtOAc (3 × 10 mL). The combined org. layers were washed with sat. NaHCO3 solution 
(5 mL), brine (5 mL), and dried over Na2SO4. The crude product was purified by flash column 
chromatography (hexanes:EtOAc 4:1) to yield the titel compound as yellowish oil (79 mg, 
0.27 mmol, 54%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.8 (d, J = 2.6 Hz, 1H), 8.1–8.1 (m, 2H), 7.8 (dd, J = 
8.2, 1.4 Hz, 1H), 7.7 (ddd, J = 8.4, 6.9, 1.5 Hz, 1H), 7.6 (ddd, J = 8.2, 7.0, 1.2 Hz, 1H), 7.6 (s, 
1H), 6.9 (s, 1H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 155.8, 147.5, 146.6, 144.8, 142.6, 130.1, 130.0, 
130.0, 129.4, 128.0, 127.9, 127.6, 107.2. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3325, 3276, 3064, 3043, 1712, 1602, 1574, 1557, 1496, 
1481, 1470, 1456, 1424, 1393, 1371, 1348, 1332, 1288, 1230, 1216, 1210, 1200, 1144, 1124, 
1105, 1075, 1048, 1017, 987, 959, 924, 914, 906, 863, 846, 786, 776, 764, 750, 734. 
HRMS (EI): m/z calc. for [C13H8Cl2N4]: 290.0126; found 290.0120. 
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N-(4-Fluorophenyl)-1-methyl-1H-benzo[d]imidazol-2-amine (3bb) 
 
According to TP14, 2-azido-1-methyl-1H-benzo[d]imidazole (28q, 87 mg, 0.50 mmol, 
1.00 equiv) was dissolved in dry THF (1 mL). First anhydrous FeCl3 (41 mg, 0.25 mmol, 
0.50 equiv) and then (4-fluorophenyl)zinc chloride (1ss, 0.27 M, 3.2 mL, 0.875 mmol, 
1.75 equiv) in dry THF were added in one portion, respectively. The reaction was stirred at 
50 °C for 1 h and subsequently quenched with sat. aqueous NH4Cl solution (5 mL). The mixture 
was extracted with EtOAc (3 × 10 mL). The combined org. layers were washed with sat. 
NaHCO3 solution (5 mL), brine (5 mL), and dried over Na2SO4. The crude product was 
purified by flash column chromatography (hexanes:EtOAc 2:1) to yield the titel compound as 
white solid (62 mg, 0.255 mmol, 51%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.51–7.44 (m, 1H), 7.38–7.30 (m, 2H), 7.14–7.04 (m, 
3H), 6.98–6.89 (m, 2H), 3.49 (s, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 158.6 (d, J = 241.4 Hz), 150.4, 134.4, 121.8 (2C), 
120.8 (2C), 120.36 (d, J = 7.7 Hz, 2C), 117.3, 115.91 (d, J = 22.6 Hz, 2C), 107.8, 29.1. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3422, 2992, 2953, 1619, 1606, 1574, 1510, 1478, 1456, 
1398, 1374, 1308, 1285, 1246, 1207, 1185, 1154, 1099, 1072, 1054, 1034, 1011, 961, 937, 920, 
878, 801, 779, 742, 712. 
HRMS (EI): m/z calc. for [C14H12FN3]: 241.1015; found 241.1021. 
m.p.: 90.1-93.5 °C 
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(1s,3s)-N-(3-Fluorophenyl)adamantan-1-amine (3cc) 
 
According to TP14, (1s,3s)-1-azidoadamantane (28r, 89 mg, 0.50 mmol, 1.00 equiv) was 
dissolved in dry THF (1 mL). First anhydrous FeCl3 (41 mg, 0.25 mmol, 0.50 equiv) and then 
(3-fluorophenyl)zinc chloride (1bbb, 0.27 M, 3.2 mL, 0.875 mmol, 1.75 equiv) in dry THF 
were added in one portion, respectively. The reaction wxas stirred at 50 °C for 1 h and 
subsequently quenched with sat. aqueous NH4Cl solution (5 mL). The mixture was extracted 
with EtOAc (3 × 10 mL). The combined org. layers were washed with sat. NaHCO3 solution 
(5 mL), brine (5 mL), and dried over Na2SO4. The crude product was purified by flash column 
chromatography (hexanes:EtOAc 9.5:0.5) to yield the titel compound as brownish solid 
(98 mg, 0.40 mmol, 80%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.10–7.00 (m, 1H), 6.53–6.46 (m, 2H), 6.46–6.36 (m, 
1H), 2.12 (p, J = 3.3 Hz, 4H), 1.90 (d, J = 2.9 Hz, 6H), 1.76–1.62 (m, 7H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 163.5 (d, J = 242.4 Hz), 129.8 (d, J = 10.2 Hz, 2C), 
113.4, 104.6 (d, J = 20.2 Hz), 104.2 (d, J = 25.0 Hz), 52.3, 43.1 (3C), 36.4 (3C), 29.7 (3C). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3418, 2904, 2849, 2088, 1618, 1582, 1509, 1490, 1480, 
1450, 1436, 1422, 1412, 1356, 1340, 1305, 1286, 1273, 1259, 1240, 1210, 1186, 1174, 1146, 
1125, 1096, 1059, 1040, 1006, 987, 980, 965, 935, 919, 906, 864, 826, 812, 779, 752, 681. 
HRMS (EI): m/z calc. for [C16H20FN]: 245.1580; found 245.1573. 
m.p.: 83.9-85.7 °C 
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Methyl naphthalen-1-yl-L-phenylalaninate (3dd) 
 
According to TP14, methyl 2-azido-3-phenylpropanoate (28s, 103 mg, 0.50 mmol, 1.00 equiv) 
was dissolved in dry THF (1 mL). First anhydrous FeCl3 (41 mg, 0.25 mmol, 0.50 equiv) and 
then naphthalen-1-ylzinc chloride (1x, 0.27 M, 3.2 mL, 0.875 mmol, 1.75 equiv) in dry THF 
were added in one portion, respectively. The reaction was stirred at 50 °C for 1 h and 
subsequently quenched with sat. aqueous NH4Cl solution (5 mL). The mixture was extracted 
with EtOAc (3 × 10 mL). The combined org. layers were washed with sat. NaHCO3 solution 
(5 mL), brine (5 mL), and dried over Na2SO4. The crude product was purified by flash column 
chromatography (hexanes:EtOAc 3:1) to yield the titel compound as colourless oil (90 mg, 
0.30 mmol, 59%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = .8–7.6 (m, 2H), 7.4–7.2 (m, 7H), 7.1–7.1 (m, 2H), 6.5 
(dd, J = 7.3, 1.4 Hz, 1H), 4.5 (t, J = 6.1 Hz, 1H), 3.6 (s, 3H), 3.2 (qd, J = 13.6, 6.0 Hz, 2H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 173.7, 141.5, 136.3, 134.4, 129.4 (2C), 128.6, 128.6 
(2C), 127.1, 126.4, 125.9, 125.0, 123.8, 120.1, 118.5, 105.2, 57.7, 52.2, 38.5. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3397, 2920, 1595, 1576, 1506, 1438, 1423, 1386, 1313, 
1216, 1183, 1155, 1094, 968, 816, 777, 708. 
HRMS (EI): m/z calc. for [C20H19NO2]: 305.1416; found 305.1418. 
e.r. = 93:7 (determined by chiral HPLC) 
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Ethyl 4-(((S)-1-(((R)-1-methoxy-1-oxo-3-phenylpropan-2-yl)amino)-3-methyl-1-
oxobutan-2-yl)amino)benzoate (3ee) 
 
According to TP14, methyl (2-azido-3-methylbutanoyl)-D-phenylalaninate (28t, 152 mg, 
0.50 mmol, 1.00 equiv) was dissolved in dry THF (1 mL). First anhydrous FeCl3 (41 mg, 
0.25 mmol, 0.50 equiv) and then (4-(ethoxycarbonyl)phenyl)zinc chloride (1aa, 0.22 M, 
4.0 mL, 0.875 mmol, 1.75 equiv) in dry THF were added in one portion, respectively. The 
reaction was stirred at 50 °C for 1 h and subsequently quenched with sat. aqueous NH4Cl solution 
(5 mL). The mixture was extracted with EtOAc (3 × 10 mL). The combined org. layers were 
washed with sat. NaHCO3 solution (5 mL), brine (5 mL), and dried over Na2SO4. The crude 
product was purified by flash column chromatography (hexanes:EtOAc 3:1) to yield the titel 
compound as colourless oil (160 mg, 0.375 mmol, 75%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.9–7.8 (m, 2H), 7.2–7.2 (m, 3H), 7.1–7.0 (m, 2H), 
6.8 (d, J = 8.1 Hz, 1H), 6.6–6.5 (m, 2H), 4.9 (td, J = 7.8, 5.5 Hz, 1H), 4.5 (d, J = 5.8 Hz, 1H), 
4.3 (q, J = 7.1 Hz, 2H), 3.6–3.6 (m, 1H), 3.6 (s, 3H), 3.2 (dd, J = 14.1, 5.5 Hz, 1H), 3.0 (dd, J 
= 14.0, 7.6 Hz, 1H), 2.2 (d, J = 5.1 Hz, 0H), 1.3 (t, J = 7.1 Hz, 3H), 1.0–0.9 (m, 3H), 0.9 (d, J 
= 6.9 Hz, 3H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 172.1, 171.6, 166.7, 151.1, 135.9, 131.4 (2C), 129.1 
(2C), 128.6 (2C), 127.1, 120.3, 112.7 (2C), 64.1, 60.4, 53.0, 52.4, 37.8, 31.2, 19.4, 17.8, 14.5. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3329, 3065, 3031, 2962, 2874, 1742, 1681, 1658, 1652, 
1604, 1523, 1498, 1465, 1456, 1444, 1437, 1422, 1391, 1367, 1336, 1314, 1271, 1213, 1173, 
1105, 1043, 1020, 910, 839, 771, 730, 698. 
HRMS (EI): m/z calc. for [C24H30N2O5]: 426.2155; found 426.2161. 
d.r. = 95:5 (determined by NMR) 
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Methyl (3-fluorophenyl)-L-phenylalanyl-D-methioninate (3ff) 
 
According to TP14, methyl (2-azido-3-phenylpropanoyl)-D-methioninate (28u, 168 mg, 
0.50 mmol, 1.00 equiv) was dissolved in dry THF (1 mL). First anhydrous FeCl3 (41 mg, 
0.25 mmol, 0.50 equiv) and then (3-fluorophenyl)zinc chloride (1bbb, 0.27 M, 3.2 mL, 
0.875 mmol, 1.75 equiv) in dry THF were added in one portion, respectively. The reaction was 
stirred at 50 °C for 1 h and subsequently quenched with sat. aqueous NH4Cl solution (5 mL). 
The mixture was extracted with EtOAc (3 × 10 mL). The combined org. layers were washed 
with sat. NaHCO3 solution (5 mL), brine (5 mL), and dried over Na2SO4. The crude product 
was purified by flash column chromatography (hexanes:EtOAc 3:1) to yield the titel compound 
as colourless oil (105 mg, 0.26 mmol, 52%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.4–7.3 (m, 3H), 7.2–7.2 (m, 2H), 7.1 (ddd, J = 14.8, 
8.9, 7.3 Hz, 2H), 6.5–6.4 (m, 1H), 6.3 (ddd, J = 8.1, 2.3, 0.8 Hz, 1H), 6.3 (dt, J = 11.2, 2.3 Hz, 
1H), 4.7 (td, J = 7.9, 5.0 Hz, 1H), 4.0–4.0 (m, 2H), 3.7 (s, 3H), 3.3 (dd, J = 14.1, 4.3 Hz, 1H), 
3.1 (dd, J = 14.1, 7.4 Hz, 1H), 2.4 (dd, J = 7.9, 6.9 Hz, 2H), 2.2–2.1 (m, 0H), 2.0 (s, 3H), 2.0–
1.8 (m, 1H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 172.4, 171.7, 163.8 (d, J = 244.1 Hz), 148.2 (d, J = 
10.4 Hz), 136.1, 130.4 (d, J = 10.0 Hz), 129.1 (2C), 129.0 (2C), 127.4, 110.0, 106.1 (d, J = 
21.4 Hz), 101.3 (d, J = 25.4 Hz), 60.1, 52.5, 51.4, 38.5, 31.2, 29.9, 15.4. 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3409, 3004, 1748, 1710, 1621, 1497, 1421, 1359, 1220, 
1178, 1152, 1092, 1000, 903, 832, 765, 702, 685. 
HRMS (EI): m/z calc. for [C21H25FN2O3S]: 404.1570; found 404.1578. 
d.r. = 96:4 (determined by NMR) 
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6.5 Preparation of Androgen/Estrogen Modulator 32 
(4-Azidophenoxy)(tert-butyl)dimethylsilane (28v) 
 
(4-Azidophenoxy)trimethylsilane was prepared according to a literature known procedure.144 
1H NMR (400 MHz, CDCl3): δ / ppm = 6.90 (d, J = 8.8 Hz, 1H), 6.83 (d, J = 8.9 Hz, 1H), 
0.99 (s, 6H), 0.20 (s, 4H). 
Analytical Data equivalent to literture145 
 
4-((tert-Butyldimethylsilyl)oxy)-N-(4-((tert-butyldimethylsilyl)oxy)phenyl)-N-(4-
methoxyphenyl)benzamide (34) 
 
According to TP14, (4-azidophenoxy)trimethylsilane (28v, 125 mg, 0.50 mmol, 1.00 equiv) 
was dissolved in dry THF (1 mL). First anhydrous FeCl3 (41 mg, 0.25 mmol, 0.50 equiv) and 
then (4-methoxyphenyl)zinc chloride (1dd, 0.29 M, 3.0 mL, 0.875 mmol, 1.75 equiv) in dry 
THF were added in one portion, respectively. The reaction was stirred at 50 °C for 10 min and 
subsequently 4-((tert-butyldimethylsilyl)oxy)benzoyl chloride (203 mg, 0.75 mmol, 
1.50 equiv) was added. After stirring for additional 50 min, the reaction mixture was quenched 
with sat. aqueous NH4Cl solution (5 mL). The mixture was extracted with EtOAc (3 × 10 mL). 
The combined org. layers were washed with sat. NaHCO3 solution (5 mL), brine (5 mL), and 
dried over Na2SO4. The crude product was purified by flash column chromatography 
(hexanes:EtOAc 4:1) to yield 34 as yellowish oil (209 mg, 0.370 mmol, 74%). 
                                                          
144  M. I. Mangione, R. A. Spanevello, M. B. Anzardi, RSC Adv. 2017, 7, 47681–47688. 
145  S. Montanari, L. Scalvini, M. Bartolini, F. Belluti, S. Gobbi, V. Andrisano, A. Ligresti, V. Di Marzo, S. Rivara, 
M. Mor, A. Bisi, A. Rampa J. Med. Chem. 2016, 59, 6387–6406. 
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1H-NMR (400 MHz, CDCl3): δ / ppm = 7.37–7.32 (m, 2H), 7.03 (dd, J = 32.0, 8.4 Hz, 4H), 
6.84–6.70 (m, 4H), 6.69–6.63 (m, 2H), 3.76 (s, 3H), 0.97 (s, 9H), 0.95 (s, 9H), 0.18 (s, 6H), 
0.16 (s, 6H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 170.3, 157.6, 157.2, 153.7, 137.9, 137.3, 131.1 (2C), 
129.1, 128.3 (4C), 120.4 (2C), 119.4 (2C), 114.3 (2C), 55.4, 25.7 (3C), 25.6 (3C), 18.2 (2C), -
4.4 (4C). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3409, 3004, 1748, 1710, 1621, 1497, 1421, 1359, 1220, 
1178, 1152, 1092, 1000, 903, 832, 765, 702, 685. 
HRMS (EI): m/z calc. for [C32 H45NO4Si4]: 563.8850; found 563.8856. 
 
4-Hydroxy-N-(4-hydroxyphenyl)-N-(4-methoxyphenyl)benzamide (32) 
 
Amide 10 (209 mg, 0.37 mmol, 1.00 equiv) was dissolved in dry CH2Cl2 (2 mL) and treated 
with TBAF (145 mg, 0.56 mmol, 1.5 equiv) for 2 h at r.t.. The reaction mixture was 
concentrated in vacuo and purified by flash column chromatography (hexanes:EtOAc 1:1) to 
give amide 32 as a yellowish oil (119 mg, 0.36 mmol, 96%). 
1H-NMR (400 MHz, DMSO-d6): δ / ppm = 8.77 (s, 1H), 8.56 (s, 1H), 7.95–7.83 (m, 2H), 
7.28–7.21 (m, 2H), 7.21–7.15 (m, 2H), 6.94 (d, J = 7.5 Hz, 2H), 6.85 (d, J = 7.6 Hz, 2H), 6.82–
6.79 (m, 2H). 2.62 (s, 3H). 
13C-NMR (101 MHz, DMSO-d6): δ / ppm = 169.9, 159.1, 157.5, 155.9, 138.0, 136.4, 131.3 
(2C), 129.1, 116.0 (2C), 114.8 (2C), 114.6 (2C), 55.7. 
Analytical Data equivalent to literature.109 
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6.6 Preparation of Antrafenine (35) 
2-(4-(3-(Trifluoromethyl)phenyl)piperazin-1-yl)ethan-1-ol (36) 
 
2-(4-(3-(Trifluoromethyl)phenyl)piperazin-1-yl)ethan-1-ol (36) was prepared according to a 
literature known procedure. (Literture/Patent: X. Zou, Y. Cai, Q. Li, H. Zhang, CN 106866582 
A, Jun 20, 2017) 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.3 (t, J = 8.0 Hz, 1H), 7.1 (t, J = 2.0 Hz, 1H), 7.1–
7.0 (m, 2H), 3.7–3.6 (m, 2H), 3.3–3.2 (m, 4H), 3.1–2.9 (m, 1H), 2.7–2.6 (m, 4H), 2.6 (t, J = 
5.4 Hz, 2H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 151.3, 131.4 (q, J = 31.7 Hz), 129.6, 124.3 (q, J = 
272.4 Hz), 118.7, 115.9 (q, J = 3.8 Hz), 112.2 (q, J = 3.9 Hz), 59.4, 57.8, 52.7 (2C), 48.7 (2C). 
 
2-(4-(3-(Trifluoromethyl)phenyl)piperazin-1-yl)ethyl 2-iodobenzoate (37) 
 
In a dry and argon flushed Schlenk-flask equipped with a magnetic stirring bar and a septum 
2-(4-(3-(trifluoromethyl)phenyl)piperazin-1-yl)ethan-1-ol (36, 686 mg, 2.50 mmol, 
1.00 equiv) was dissolved in dry CH2Cl2 (5 mL) and NEt3 (0.70 mL, 5.00 mmol, 2.00 equiv) 
and DMAP (3 mg, 0,03 mmol, 1 mol%) were added. After the dropwise addition of 2-
iodobenzoyl chloride (1.17 g, 4.38 mmol, 1.75 equiv), the reaction mixture was stirred at 25 °C 
for 12 h, quenched with H2O and extracted with CH2Cl2 (3 × 20 mL). The combined org. layers 
were washed with sat. NaHCO3, brine and dried over NaSO4. The purification by flash column 
chromatography (hexanes:EtOAc 1:3) gave 2-(4-(3-(trifluoromethyl)phenyl)piperazin-1-
yl)ethyl 2-iodobenzoate (37) as yellowish solid (1.21 g, 2.03 mmol, 81%). 
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1H-NMR (400 MHz, CDCl3): δ / ppm = 8.0 (dd, J = 8.0, 1.1 Hz, 1H), 7.8 (dd, J = 7.8, 1.7 Hz, 
1H), 7.4 (td, J = 7.6, 1.2 Hz, 1H), 7.3 (t, J = 8.0 Hz, 1H), 7.2 (td, J = 7.7, 1.8 Hz, 1H), 7.1 (d, 
J = 2.1 Hz, 1H), 7.1–7.0 (m, 2H), 4.5 (t, J = 5.8 Hz, 2H), 3.3–3.2 (m, 4H), 2.8 (t, J = 5.8 Hz, 
2H), 2.8–2.7 (m, 4H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 166.6, 151.3, 141.3, 135.2, 132.7, 131.4 (q, J = 31.7 
Hz), 130.9, 129.6, 128.0, 124.3 (q, J = 272.5 Hz), 118.7, 115.8 (q, J = 3.8 Hz), 112.1 (q, J = 
3.9 Hz), 94.1, 62.8, 56.5, 53.2 (2C), 48.7 (2C). 
IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3409, 3004, 1748, 1710, 1621, 1497, 1421, 1359, 1220, 
1178, 1152, 1092, 1000, 903, 832, 765, 702, 685. 
HRMS (EI): m/z calc. for [C20H20F3IN2O2]: 504.0522; found 504.0527. 
 
4-Azido-7-(trifluoromethyl)quinoline (28w) 
 
4-Azido-7-(trifluoromethyl)quinoline was prepared according to a literature known 
procedure.146 
1H-NMR (60 MHz, DMSO-d6): δ / ppm = 8.93 (d, J = 6 Hz, 1H), 8.38 (d, J = 2 Hz, 1H), 8.20 
(d, J = 8 Hz, 1H), 7.70 (q, J = 2 and 8 Hz, 1H), 7.23 (d, J = 6 Hz, 1H). 
Analytical Data equivalent to literture 
  
                                                          
146  S. Kamiya, S. Sueyoshi, M. Miyahara, K. Yanagimachi, T. Nakashima, Chem. Pharm. Bull. 1980, 28, 1485–
1490. 
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Antrafenine (35) 
 
According to TP2, 2-(4-(3-(trifluoromethyl)phenyl)piperazin-1-yl)ethyl 2-iodobenzoate (37) 
(504 mg, 1.00 mmol, 2.00 equiv) was dissolved in dry THF (15 mL) and iPrMgCl·LiCl 
(1.28 M, 0.98 mL, 1.25 mmol, 1.25 equiv) was added dropwise at –78 °C. Subsequently, a 
solution of ZnCl2 (1.00 M, 1.3 mL, 1.30 mmol, 1.20 equiv) in dry THF was added at −78 °C. 
Then in a separate flask (according to TP14), 4-azido-7-(trifluoromethyl)quinoline (28w), 
119 mg, 0.50 mmol, 1.00 equiv) was dissolved in dry THF (1 mL). First anhydrous FeCl3 
(41 mg, 0.25 mmol, 0.50 equiv) and then the earlier prepared organozinc reagent were added 
in one portion, respectively. The reaction was stirred at 50 °C for 1 h and subsequently quenched 
with sat. aqueous NH4Cl solution (5 mL). The mixture was extracted with EtOAc (3 × 10 mL). 
The combined org. layers were washed with sat. NaHCO3 solution (5 mL), brine (5 mL), and 
dried over Na2SO4. The final purification by flash column chromatography (hexanes:EtOAc 
1:1) gave antrafenine (11) as solid (188 mg, 0.32 mmol, 64%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 10.9 (s, 1H), 9.0 (d, J = 5.2 Hz, 1H), 8.6 (s, 1H), 8.5 
(d, J = 8.8 Hz, 1H), 8.3 (dd, J = 8.1, 1.6 Hz, 1H), 7.9 (dd, J = 8.9, 1.9 Hz, 1H), 7.9 (d, J = 8.4 
Hz, 1H), 7.7 (ddd, J = 8.5, 7.2, 1.6 Hz, 1H), 7.7 (d, J = 5.2 Hz, 1H), 7.5 (t, J = 8.0 Hz, 1H), 7.3 
(t, J = 2.1 Hz, 1H), 7.3–7.3 (m, 2H), 7.2 (dd, J = 8.3, 2.4 Hz, 1H), 4.8 (t, J = 5.7 Hz, 2H), 3.4 
(dd, J = 6.5, 3.6 Hz, 4H), 3.1 (t, J = 5.8 Hz, 2H), 3.0 (dd, J = 6.1, 3.9 Hz, 4H). 
13C-NMR (101 MHz, CDCl3): δ / ppm = 168.3, 152.0, 151.3, 148.5, 145.1, 143.9, 134.2, 
131.9, 131.3 (q, J = 31.6 Hz), 131.2 (q, J = 32.7 Hz), 129.5, 128.4, 127.7 (q, J = 4.2 Hz), 124.4 
(d, J = 272.5 Hz), 124.0 (d, J = 272.5 Hz), 123.3, 122.3, 121.5, 121.5 (q, J = 2.9 Hz), 120.3, 
119.9, 118.6, 117.5, 115.8 (q, J = 3.8 Hz), 112.0 (q, J = 3.9 Hz), 106.2, 62.8, 56.4, 53.1 (2C), 
48.6 (2C). 
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IR (Diamond-ATR, neat): 𝜈 / cm-1 = 3299, 3260, 2954, 2829, 1712, 1684, 1607, 1582, 1571, 
1530, 1498, 1452, 1421, 1380, 1360, 1319, 1269, 1245, 1222, 1198, 1182, 1157, 1118, 1090, 
1075, 992, 954, 919, 904, 877, 864, 832, 785, 750, 740, 730, 696, 683. 
HRMS (EI): m/z calc. for [C30H26F6N4O2]: 588.5544; found 588.5539. 
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7. Copper-Catalyzed Electrophilic Thiolation of Organozinc 
Halides Using N-Thiophthalimides Leading to Polyfunctional 
Thioethers 
7.1 Preparation of Organozinc Reagents 
Benzofuran-5-ylzinc chloride (1ccc) 
 
According to TP4, 5-bromobenzofuran (493 mg, 2.50 mmol, 1.00 equiv) was added to a 
suspension of anhydrous LiCl (159 mg, 3.75 mmol, 1.50 equiv) and magnesium turnings 
(122 mg, 5.00 mmol, 2.00 equiv) in dry THF (5 mL). The mixture was stirred at 25 °C 
overnight and then ZnCl2 (1 M in THF, 3.0 mL, 3.00 mmol, 1.20 equiv) was added as a solution 
in THF at 0 °C. Titration with iodine gave a concentration of 0.30 mmol/mL active zinc 
species, corresponding to 98% yield. 
 
Mesitylzinc chloride (1ddd) 
 
According to TP4, 2-bromo-1,3,5-trimethylbenzene (498 mg, 2.50 mmol, 1.00 equiv) was 
added to a suspension of anhydrous LiCl (159 mg, 3.75 mmol, 1.50 equiv) and magnesium 
turnings (122 mg, 5.00 mmol, 2.00 equiv) in dry THF (5 mL). The mixture was stirred at 25 °C 
overnight and then ZnCl2 (1 M in THF, 3.0 mL, 3.00 mmol, 1.20 equiv) was added as a solution 
in THF at 0 °C. Titration with iodine gave a concentration of 0.28 mmol/mL active zinc 
species, corresponding to 92% yield. 
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Ferrocenyl zinc chloride (1eee) 
 
According to TP4, bromoferrocene (662 g, 2.50 mmol, 1.00 equiv) was added to a suspension 
of anhydrous LiCl (159 mg, 3.75 mmol, 1.50 equiv) and magnesium turnings (122 mg, 
5.00 mmol, 2.00 equiv) in dry THF (5 mL). The mixture was stirred at 25 °C overnight and 
then ZnCl2 (1 M in THF, 3.0 mL, 3.00 mmol, 1.20 equiv) was added as a solution in THF at 
0 °C. Titration with iodine gave a concentration of 0.21 mmol/mL active zinc species, 
corresponding to 69% yield.  
 
(5-Formylfuran-2-yl)zinc iodide (1fff) 
 
According to TP6, 5-iodofuran-2-carbaldehyde (555 mg, 2.50 mmol, 1.00 equiv) was added to 
a suspension of anhydrous LiCl (127 mg, 3.00 mmol, 1.20 equiv) and activated zinc dust 
(245 mg, 3.75 mmol, 1.50 equiv) in dry THF (5 mL). The mixture reaction was stirred at 25 °C 
for 12 h. Titration with iodine gave a concentration of 0.33 mmol/mL active zinc species, 
corresponding to 69% yield. 
 
(5-Cyanothiazol-2-yl)zinc chloride (1ggg) 
 
According to TP2, 2-bromothiazole-5-carbonitrile (945 mg, 5.00 mmol, 1.00 equiv) was 
dissolved in dry THF (5 mL) and iPrMgCl·LiCl (4.30 mL, 1.28 M, 5.50 mmol, 1.10 equiv) was 
added. After stirring for 2 h at −40 °C ZnCl2 (1 M in THF, 6.0 mL, 6.00 mmol) was added. 
Titration with iodine gave a concentration of 0.33 mmol/mL active zinc species, corresponding 
to 99% yield. 
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(1,3,5-Trimethyl-1H-pyrazol-4-yl)zinc Chloride (1hhh) 
 
According to TP4, 4-bromo-1,3,5-trimethyl-1H-pyrazole (7n) (1.89 g, 10.0 mmol, 1.00 equiv) 
was added to a suspension of anhydrous LiCl (159 mg, 3.75 mmol, 1.50 equiv) and magnesium 
turnings (122 mg, 5.00 mmol, 2.00 equiv) in dry THF (5 mL). The mixture was stirred at 25 °C 
overnight and then ZnCl2 (1 M in THF, 3.0 mL, 3.00 mmol, 1.20 equiv) was added as a solution 
in THF at 0 °C. Titration with iodine gave a concentration of 0.18 mmol/mL corresponding to 
a yield of 40%. 
 
((6-Chloropyridin-3-yl)methyl)zinc chloride (1iii) 
 
According to TP6, 2‑chloro‑5‑(chloromethyl)pyridine (405 mg, 2.50 mmol, 1.00 equiv) was 
added to a suspension of anhydrous LiCl (127 mg, 3.00 mmol, 1.20 equiv) and activated zinc 
dust (245 mg, 3.75 mmol, 1.50 equiv) in dry THF (5 mL). The mixture reaction was stirred at 
25 °C for 12 h. Titration with iodine gave a concentration of 0.45 mmol/mL active zinc species, 
corresponding to 94% yield. 
 
Cholest-5-ene-3-ylzinc chloride (1jjj) 
 
According to TP4, 3α-bromocholest-5-ene (1.12 g, 2.50 mmol, 1.00 equiv) was added to a 
suspension of anhydrous LiCl (159 mg, 3.75 mmol, 1.50 equiv) and magnesium turnings 
(122 mg, 5.00 mmol, 2.00 equiv) in dry THF (5 mL). The mixture was stirred at 25 °C 
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overnight and then ZnCl2 (1 M in THF, 3.0 mL, 3.00 mmol, 1.20 equiv) was added as a solution 
in THF at 0 °C. Titration with iodine gave a concentration of 0.13 mmol/mL active zinc 
species, corresponding to 43% yield. 
 
((1S,4S)-4,7,7-Trimethyl-3-oxobicyclo[2.2.1]heptan-2-yl)zinc bromide (1kkk) 
 
According to TP6, (1S,4S)-3-bromo-1,7,7-trimethylbicyclo[2.2.1]heptan-2-one (578 mg, 
2.50 mmol, 1.00 equiv) was added to a suspension of anhydrous LiCl (127 mg, 3.00 mmol, 
1.20 equiv) and activated zinc dust (245 mg, 3.75 mmol, 1.50 equiv) in dry THF (5 mL). The 
mixture reaction was stirred at 25 °C for 12 h. Titration with iodine gave a concentration of 
0.33 mmol/mL active zinc species, corresponding to 69% yield. 
 
(2-(Trifluoromethyl)phenyl)zinc chloride (1lll) 
 
According to TP4, 1-bromo-2-(trifluoromethyl)benzene (563 mg, 2.50 mmol, 1.00 equiv) was 
added to a suspension of anhydrous LiCl (159 mg, 3.75 mmol, 1.50 equiv) and magnesium 
turnings (122 mg, 5.00 mmol, 2.00 equiv) in dry THF (5 mL). The mixture was stirred at 25 °C 
overnight and then ZnCl2 (1 M in THF, 3.0 mL, 3.00 mmol, 1.20 equiv) was added as a solution 
in THF at 0 °C. Titration with iodine gave a concentration of 0.43 mmol/mL active zinc 
species, corresponding to 99% yield. 
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(2,4,6-Trimethoxyphenyl)zinc chloride (1mmm) 
 
According to TP4, 2-bromo-1,3,5-trimethoxybenzene (618 mg, 2.50 mmol, 1.00 equiv) was 
added to a suspension of anhydrous LiCl (159 mg, 3.75 mmol, 1.50 equiv) and magnesium 
turnings (122 mg, 5.00 mmol, 2.00 equiv) in dry THF (5 mL). The mixture was stirred at 25 °C 
overnight and then ZnCl2 (1 M in THF, 3.0 mL, 3.00 mmol, 1.20 equiv) was added as a solution 
in THF at 0 °C. Titration with iodine gave a concentration of 0.26 mmol/mL active zinc 
species, corresponding to 85% yield.  
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7.2 Preparation of N-Thiophthalimides 
N-(Ethylthio)phthalimide (38c)147 
 
A dry and argon flushed reaction tube equipped with a magnetic stirring bar and a septum was 
charged with ethanethiol (311 mg, 5.00 mmol, 1.00 equiv), dry trimethylamine (76 mg, 
0.75 mmol, 0.15 equiv) and dry CH2Cl2 (5 mL). Sulfuryl chloride (675 mg, 5.00 mmol, 
1.00 equiv) in dry CH2Cl2 (1 mL) was added dropwise at 0 °C. After 15 min at 0 °C the solution 
was allowed to warm up to 25 °C while stirring for additional 30 min. The resulting solution 
was transferred dropwise via cannula to a solution of phthalimide (736 mg, 5.00 mmol, 
1.00 equiv) and dry triethylamine (657 mg, 6.50 mmol, 1.30 equiv) in dry CH2Cl2 (5 mL) at 
0 °C and subsequently stirred for 1 h at r.t.. The mixture was poured into ice cold water (20 mL) 
and the aqueous layer was extracted with CH2Cl2 (3 × 30 mL). The combined organic phases 
were dried with anhydrous mg2SO4. Evaporation of the solvents in vacuo and purification by 
recrystallization (EtOH) afforded the title compound as colourless needles (436 mg, 
2.16 mmol, 43%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.93 (dd, J = 5.5, 3.1 Hz, 2H), 7.78 (dd, J = 5.5, 
3.1 Hz, 2H), 2.92 (q, J = 7.4 Hz, 2H), 1.27 (t, J = 7.4 Hz, 3H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 168.6 (2C), 134.6 (2C), 132.0 (2C), 123.9 (2C), 32.7, 
13.2. 
IR (Diamond-ATR, neat): ṽ / cm-1 = 1783, 1736, 1711, 1606, 1465, 1456, 1448, 1407, 1366, 
1357, 1340, 1307, 1285, 1279, 1261, 1253, 1222, 1168, 1052, 1031, 1008, 895, 866, 854, 800, 
793, 755, 710, 695, 687, 669, 660. 
MS (EI, 70 eV): m/z (%) = 207 (6), 148 (100), 129 (75), 103 (37), 76 (40), 60 (25), 50(15). 
HRMS (EI): m/z calc. for [C10H9NO2S]: 207.0345; found 207.0346. 
m. p. (°C): 117.1–119.4  
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N-((4-Chlorophenyl)thio)phthalimide (38d)148 
 
A dry and argon flushed round bottom flask equipped with a magnetic stirring bar and a septum 
was charged with 4-chlorobenzenethiol (723 mg, 5.00 mmol, 1.00 equiv), 
N-chlorophthalimide (908 mg, 5.00 mmol, 1.00 equiv) and dry toluene (30 mL). Dry 
triethylamine (506 mg, 5.00 mmol, 1.00 equiv) in dry toluene (20 mL) was added dropwise 
over 30 min and the reaction mixture was stirred for 12 h. After addition of Et2O (30 mL) the 
resulting suspension was filtered and the filtrate was washed with Et2O (3 x 10 mL). After 
removal of the solvents in vacuo the crude product was purified via flash column 
chromatography on silica gel (silica-gel, iso-hexane: EtOAc = 4:1). For complete removal of 
phthalimide the resulting powder was added to pyridine (2.5 mL) and water (10 mL) and was 
slowly added at 0 °C. Filtration of the resulting suspension and washing of the filtrate with ice 
cold MeOH (3 × 5 mL) afforded title compound as a white powder (182 mg, 0.63 mmol, 
13 %). 
1H-NMR (400 MHz, CDCl3): δ / ppm =7.93 (dd, J = 5.5, 3.1 Hz, 2H), 7.79 (dd, J = 5.5, 3.1 Hz, 
2H), 7.57 (d, J = 8.5 Hz, 2H), 7.30 (d, J = 8.5 Hz, 2H) 
13C-NMR (100 MHz, CDCl3): δ / ppm = 167.6 (2C), 135.9, 134.8 (2C), 133.3 (2C), 132.9 
(2C), 131.9, 129.5 (2C), 124.1 (2C). 
IR (Diamond-ATR, neat): ṽ / cm-1 =1780, 1729, 1707, 1609, 1570, 1469, 1465, 1458, 1388, 
1361, 1345, 1286, 1277, 1264, 1223, 1170, 1166, 1108, 1091, 1077, 1051, 1045, 1012, 970, 
867, 833, 824, 801, 746, 712, 704, 695, 686.  
MS (EI, 70 eV): m/z (%) = 289 (40), 286 (40), 147 (100), 144 (60), 108 (60), 104 (61), 76 (59), 
50 (26). 
HRMS (EI): m/z calc. for [C14H8ClNO2S]: 288.9964; found 288.9960. 
m. p. (°C): 187.5–188.1. 
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C. Experimental Section 
289 
N-((4-Methoxyphenyl)thio)phthalimide (38e)149 
 
A dry and argon flushed round bottom flask equipped with a magnetic stirring bar and a septum 
was charged with 4-methoxybenzenethiol (736 mg, 5.25 mmol, 1.05 equiv), phthalimide 
(736 mg, 5.00 mmol, 1.00 equiv), dry MeCN (3.3 mL) and dry pyridine (4.2 mL). Bromine 
(675 mg, 5.00 mmol, 1.00 equiv) in dry MeCN (2.6 mL) was added dropwise at 0 °C over a 
period of 1 h and the resulting mixture was stirred for additional 30 min. Water (20 mL) was 
then added dropwise at 0 °C over 30 min and strirred for a further period of 20 min. Filtration 
of the resulting suspension and washing of the filtrate with ice cold MeOH (3 × 5 mL) afforded 
title compound as a yellow powder (1.11 g, 3.69 mmol, 74%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.89 (dd, J = 5.5, 3.1 Hz, 2H), 7.77 (d, J = 8.8 Hz, 
2H), 7.74 (dd, J = 5.5, 3.0 Hz, 2H), 6.85 (d, J = 8.8 Hz, 2H), 3.78 (s, 3H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 167.9 (2C), 161.5, 136.7 (2C), 134.5 (2C), 132.1 
(2C), 125.4, 123.9 (2C), 114.7 (2C), 55.4. 
IR (Diamond-ATR, neat): ṽ / cm-1 = 2846, 1778, 1729, 1705, 1651, 1608, 1588, 1566, 1492, 
1478, 1466, 1447, 1408, 1375, 1362, 1345, 1299, 1276, 1264, 1252, 1223, 1192, 1171, 1165, 
1104, 1089, 1047, 1026, 1007, 968, 962, 867, 848, 831, 800, 718, 712, 695, 686. 
MS (EI, 70 eV): m/z (%) = 258 (28), 147 (100), 140 (39), 104 (47), 97 (22), 76 (43), 69 (10), 
57 (15), 50 (22), 43 (22). 
HRMS (EI): m/z calc. for [C15H11NO3S]: 285.0460; found 285.0454. 
m. p. (°C): 208.3–210.8. 
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N-((4-Nitrophenyl)thio)phthalimide (38f) 
 
According to TP15, 4-nitrothiophenol (776 mg, 5.00 mmol, 1.00 equiv) was added dropwise 
at 0 °C to the solution of N-chlorophthalimide (908 mg, 5.00 mmol, 1.00 equiv). The title 
compound was obtained as a powder (1.15 g, 3.80 mmol, 76%) including 10% of phthalimide 
impurity. The reagent was used for the following reactions without further purification. 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.16 (d, J = 8.9 Hz, 2H), 8.01 (dd, J = 5.5, 3.1 Hz, 
2H), 7.87 (dd, J = 5.5, 3.1 Hz, 2H), 7.40 (d, J = 8.9 Hz, 2H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 167.0 (2C), 144.7, 135.3 (2C), 131.7 (2C), 126.4 
(2C), 125.8, 124.6 (2C), 124.5 (2C). 
IR (Diamond-ATR, neat): ṽ / cm-1 = 1787, 1744, 1716, 1599, 1578, 1511, 1475, 1468, 1359, 
1339, 1317, 1288, 1273, 1263, 1220, 1183, 1171, 1117, 1106, 1087, 1053, 1035, 1006, 949, 
866, 854, 842, 826, 816, 789, 738, 726, 709, 695, 680. 
MS (EI, 70 eV): m/z (%) = 300 (17), 323 (18), 292 (38), 279 (33), 223 (14), 147 (66), 104 (37), 
76 (40), 50 (15). 
HRMS (EI): m/z calc. for [C14H8N2O4S]: 300.0205; found 300.0208. 
m. p. (°C): 162.0–162.9. 
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N-((4-Bromophenol)thio)phthalimide (38g) 
 
According to TP15, 4-bromothiophenol (945 mg, 5.00 mmol, 1.00 equiv) was added dropwise 
at 0 °C to the solution of N-chlorophthalimide (908 mg, 5.00 mmol, 1.00 equiv). The title 
compound was obtained as a white powder (1.35 g, 4.00 mmol, 80%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.93 (dd, J = 5.5, 3.1 Hz, 2H), 7.79 (dd, J = 5.5, 
3.1 Hz, 2H), 7.52–7.42 (m, 4H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 167.6 (2C), 134.9, 134.0 (2C), 132.8 (2C), 132.5 
(2C), 131.9 (2C), 124.2 (2C), 124.0. 
IR (Diamond-ATR, neat): ṽ / cm-1 = 1782, 1739, 1731, 1706, 1605, 1563, 1466, 1383, 1359, 
1342, 1308, 1279, 1262, 1222, 1173, 1150, 1108, 1089, 1080, 1067, 1051, 1007, 867, 833, 811, 
794, 730, 711, 695, 684. 
MS (EI, 70 eV): m/z (%) = 332 (32), 254 (43), 149 (100), 140 (39), 104 (47), 97 (22), 76 (43), 
69 (10), 57 (15), 50 (22), 43 (22). 
HRMS (EI): m/z calc. for [C14H8BrNO2S]: 332.9459; found 332.9455. 
m. p. (°C): 123.6–125.3. 
  
C. Experimental Section 
292 
N-((Ethyl 4-benzoate)thio)phthalimide (38h) 
 
According to TP15, ethyl 4-mercaptobenzoate (841 mg, 4.60 mmol, 1.00 equiv) was added 
dropwise at 0 °C to the solution of N-chlorophthalimide (908 mg, 5.00 mmol, 1.00 equiv). The 
title compound was obtained as a white powder (924 mg, 2.80 mmol, 61%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.93-7.89 (m, 4H), 7.77 (dd, J = 5.5, 3.1 Hz, 2H), 
7.33 (d, J = 8.5 Hz, 2H), 4.28 (q, J = 7.1 Hz, 2H), 1.29 (t, J = 7.1 Hz, 3H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 167.4 (2C), 165.8, 141.3, 135.0 (2C), 131.9 (2C), 
130.4 (2C), 130.0 (2C), 126.6 (2C), 124.4, 61.2, 14.3. 
IR (Diamond-ATR, neat): ṽ / cm-1 = 2985, 1788, 1743, 1716, 1698, 1608, 1592, 1564, 1493, 
1476, 1465, 1444, 1402, 1367, 1345, 1309, 1292, 1273, 1238, 1184, 1175, 1167, 1126, 1120, 
1108, 1084, 1036, 1024, 1010, 978, 964, 902, 866, 851, 790, 759, 710, 686. 
MS (EI, 70 eV): m/z (%) = 327 (28), 254 (43), 149 (100), 140 (39), 104 (47), 97 (22), 76 (43), 
69 (10), 57 (15), 50 (22), 43 (22). 
HRMS (EI): m/z calc. for [C17H13NO4S]: 327.0565; found 327.0562 
m. p. (°C): 148.8–150.6. 
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4-((1,3-Dioxoisoindolin-2-yl)thio)benzonitrile (38i) 
 
According to TP15, 4-mercaptobenzonitrile (11, 676 mg, 5.00 mmol, 1.00 equiv) was added 
dropwise at 0 °C to the solution of N-chlorophthalimide (908 mg, 5.00 mmol, 1.00 equiv). The 
title compound was obtained as a beige powder (1.06 mg, 3.80 mmol, 76%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.93 (dd, J = 5.5, 3.1 Hz, 2H), 7.88–7.72 (m, 2H), 
7.59–7.45 (m, 2H), 7.39–7.26 (m, 2H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 167.1 (2C), 142.3, 135.3 (2C), 132.9 (2C), 131.7 
(2C), 126.5 (2C), 124.5 (2C), 118.2, 111.3. 
IR (Diamond-ATR, neat): ṽ / cm-1 = 2228, 1790, 1740, 1713, 1590, 1485, 1466, 1345, 1276, 
1221, 1080, 1030, 1014, 862, 822, 797, 714, 697, 686. 
MS (EI, 70 eV): m/z (%) = 280 (29), 268 (50), 146 (59), 104 (47), 76 (52), 42 (100). 
HRMS (EI): m/z calc. for [C15H8N2O2S]: 280.0306; found 280.0294. 
m. p. (°C): 151.2–151.9. 
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N-((5-(Trifluoromethyl)pyridin-2-yl)thio)phthalimide (38j) 
 
According to TP15, 5-(trifluoromethyl)pyridine-2-thiol (895 mg, 5.00 mmol, 1.00equiv), was 
added dropwise at 0 °C to the solution of N-chlorophthalimide (908 mg, 5.00 mmol, 
1.00 equiv). The title compound was obtained as a white powder (1.49 g, 4.59 mmol, 92%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.55 (s, 1H), 8.02 (dd, J = 5.5, 3.1 Hz, 2H), 7.86 (dd, 
J = 5.5, 3.1 Hz, 2H), 7.79 (dd, J = 8.5, 2.3 Hz, 1H), 7.28 (d, J = 8.5 Hz, 1H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 167.2 (2C), 161.0 (q, J = 1.4 Hz), 146.8 (q, J = 4.2 
Hz), 135.0 (2C), 133.8 (q, J = 3.4 Hz), 132.1 (2C), 124.3 (2C), 124.1 (q, J = 33.4 Hz), 123.3 
(q, J = 272.1 Hz), 117.6. 
IR (Diamond-ATR, neat): ṽ / cm-1 = 3065, 1788, 1749, 1722, 1699, 1597, 1563, 1541, 1467, 
1380, 1356, 1337, 1321, 1297, 1279, 1267, 1250, 1222, 1175, 1168, 1142, 1111, 1073, 1041, 
1007, 978, 962, 934, 891, 868, 835, 792, 743, 708, 696, 689. 
MS (EI, 70 eV): m/z (%) = 356 (100), 324 (17), 323 (18), 292 (38), 279 (33), 223 (14), 147 
(66), 104 (37), 76 (40), 50 (15). 
HRMS (EI): m/z calc. for [C14H7 F3NO2S]: 324.0180; found 324.0166 
m. p. (°C): 155.6–157.1. 
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N-((2-Pyrimidine)thio)phthalimide (38k) 
 
According to TP15, 2-mercaptopyrimidine (561 mg, 5.00 mmol, 1.00 equiv) was added 
dropwise at 0 °C to the solution of N-chlorophthalimide (908 mg, 5.00 mmol, 1.00 equiv). The 
title compound was obtained as a white powder (907 mg, 3.50 mmol, 70%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.47 (d, J = 4.8 Hz, 2H), 8.01 (dd, J = 5.5, 3.0 Hz, 
2H), 7.84 (dd, J = 5.5, 3.1 Hz, 2H), 7.02 (t, J = 4.9 Hz, 1H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 167.4 (2C), 157.9, 134.8 (2C), 132.3 (2C), 124.3 
(2C), 123.6 (2C), 118.2. 
IR (Diamond-ATR, neat): ṽ / cm-1 = 3191, 3060, 1787, 1773, 1746, 1720, 1626, 1603, 1553, 
1463, 1381, 1364, 1346, 1308, 1286, 1266, 1190, 1166, 1145, 1108, 1089, 1071, 1051, 991, 
983, 973, 903, 867, 811, 799, 769, 747, 715, 696, 689, 669. 
MS (EI, 70 eV): m/z (%) = 257 (32), 147 (100), 140 (39), 104 (47), 97 (22), 76 (43), 69 (10), 
57 (15), 50 (22), 43 (22). 
HRMS (EI): m/z calc. for [C12H7N3O2S]: 257.0259; found 257.0261 
m. p. (°C): 115.2–116.7. 
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N-2-((1-Phenyl-1H-tetrazol-5-yl)thio)phthalimide (38l) 
 
According to TP15, 1-phenyl-1H-tetrazole-5-thiol (766 mg, 4.30 mmol, 1.00 equiv) was added 
dropwise at 0 °C to the solution of N-chlorophthalimide (781 mg, 4.30 mmol, 1.00 equiv). The 
title compound was obtained as a white powder (966 mg, 3.00 mmol, 70%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.99 (dd, J = 5.5, 3.1 Hz, 2H), 7.84 (dd, J = 5.5, 3.1 
Hz, 2H), 7.64–7.52 (m, 5H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 165.9 (2C), 135.3, 131.9 (2C), 130.8 (2C), 130.3 
(2C), 130.1, 124.8 (2C), 124.4, 123.4 (2C). 
IR (Diamond-ATR, neat): ṽ / cm-1 = 1791, 1749, 1723, 1593, 1499, 1465, 1425, 1417, 1408, 
1399, 1387, 1365, 1345, 1293, 1281, 1269, 1260, 1222, 1167, 1154, 1089, 1074, 1054, 1029, 
1013, 1001, 973, 913, 865, 797, 792, 765, 760, 708, 697, 693, 684. 
MS (EI, 70 eV): m/z (%) = 147 (100), 104 (37), 76 (40), 50 (15). 
HRMS (EI): m/z calc. for [C15H9N5O2S]: 323.0477; found 323.0475 
m. p. (°C): 164.4–164.9. 
 
N-(Thiocyanato)phthalimide (38n) 
 
To a solution of N-chlorophthalimide (1.82 g, 10.0 mmol, 1.00 equiv) in dry acetonitrile 
(40 mL) under argon was added cuprous thiocyanate (1.46 g, 12.0 mmol, 1.20 equiv) in one 
portion. The dark brown reaction mixture was stirred at 25 °C for 2 h. The resulting suspension 
was concentrated in vacuo. The resulting residues were dissolved and washed with 
CH2Cl2/hexane (3:1, 2 x 40 mL) and filtered through a layer of celite. Filtrate was concentrated 
in vacuo to provide the title compound as a white solid (1.60 g, 7.80 mmol, 80%) and 20% of 
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a phthalimide impurity. The reagent was stored in the dark at -25°C, and used for the following 
reactions without further purification. 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.03 (dd, J = 5.6, 3.1 Hz, 2H), 7.89 (dd, J = 5.6, 
3.1 Hz, 2H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 164.6 (2C), 135.7 (2C), 131.5 (2C), 124.9 (2C), 
109.0. 
IR (Diamond-ATR, neat): ṽ / cm-1 = 2980, 2161, 1792, 1747, 1714, 1604, 1467, 1347, 1272, 
1258, 1167, 1031, 866, 805, 793, 711, 696, 686, 666. 
MS (EI, 70 eV): m/z (%) = 203 (38), 148 (100), 138 (60), 104 (62), 76 (55), 50 (20). 
HRMS (EI): m/z calc. for [C9H4N2O2S]: 203.9993; found 203.9990. 
m. p. (°C): 104.1–106.6. 
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7.3 Preparation of Thioethers 
Cyclohexyl(4-methoxyphenyl)sulfane (4a) 
 
According to TP16, N-(cyclohexylthio)phthalimide (38a, 131 mg, 0.50 mmol, 1.00 equiv) was 
reacted with (4-methoxyphenyl)zinc chloride (1rr, 1.53 mL, 0.36 M in THF, 0.55 mmol, 
1.10 equiv) in the presence of Cu(OAc)2·H2O. Purification by flash column chromatography 
on silica gel (hexane:EtOAc 95:5) afforded the title compound as a yellow oil (98 mg, 
0.44 mmol, 95%). (4-methoxyphenyl)zinc chloride 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.39 (d, J = 8.5 Hz, 2H), 6.84 (d, J = 8.5 Hz, 2H), 
3.79 (s, 3H), 3.09–2.72 (m, 1H), 1.98–1.88 (m, 2H), 1.82–1.69 (m, 2H), 1.66–1.51 (m, 1H), 
1.39–1.15 (m, 5H).  
13C-NMR (100 MHz, CDCl3): δ / ppm = 159.2, 135.5 (2C), 124.8, 114.2 (2C), 55.2, 47.8 (2C), 
33.3 (2C), 26.0, 25.7. 
IR (Diamond-ATR, neat): ṽ / cm-1 = 2926, 2850, 2834, 1590, 1570, 1491, 1461, 1447, 1296, 
1283, 1261, 1241, 1200, 1178, 1170, 1102, 1096, 1031, 1008, 997, 887, 825, 806, 798, 739, 
726. 
MS (EI, 70 eV): m/z (%) = 222 (21), 140 (100), 125 (32). 
HRMS (EI): m/z calc. for [C13H18OS]: 222.1078; found 222.1071. 
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(4-Methoxyphenyl)(phenyl)sulfane (4b) 
 
According to TP16, N-(phenylthio)phthalimide (38b, 128 mg, 0.50 mmol, 1.00 equiv) was 
reacted with (4-methoxyphenyl)zinc chloride (1rr, 1.53 mL, 0.36 M in THF, 0.55 mmol, 
1.10 equiv) in the presence of Cu(OAc)2·H2O. Purification by flash column chromatography 
on silica gel (hexane:EtOAc 9:1) afforded the title compound as a white powder (106 mg, 
0.49 mmol, 98%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.47 (d, J = 8.8 Hz, 2H), 7.32–7.15 (m, 5H), 6.95 (d, 
J = 8.8 Hz, 2H), 3.86 (s, 3H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 159.9, 138.7, 135.4 (2C), 129.0 (2C), 128.2 (2C), 
125.8, 124.3, 115.0 (2C), 55.4. 
IR (Diamond-ATR, neat): ṽ / cm-1 = 3060, 2996, 2969, 2944, 2840, 1588, 1580, 1570, 1491, 
1475, 1458, 1435, 1403, 1285, 1245, 1180, 1174, 1153, 1106, 1099, 1077, 1071, 1028, 1006, 
996, 982, 966, 941, 896, 835, 812, 797, 732, 689. 
MS (EI, 70 eV): m/z (%) = 216 (100), 200 (60), 171 (20), 129 (21), 96 (13), 77 (44), 51 (35). 
HRMS (EI): m/z calc. for [C13H12OS]: 216.0609; found 216.0610. 
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6-(Phenylthio)-2,3-dihydrobenzo[b][1,4]dioxine (4c) 
 
According to TP16, N-(phenylthio)phthalimide (38b, 128 mg, 0.50 mmol, 1.00 equiv) was 
reacted with (2,3-dihydrobenzo[b][1,4]dioxin-6-yl)zinc chloride (1v, 1.34 mL, 0.41 M in THF, 
0.55 mmol, 1.10 equiv) in the presence of Cu(OAc)2·H2O. Purification by flash column 
chromatography on silica gel (hexane:EtOAc 9.5:0.5) afforded the title compound as a 
colourless oil (110 mg, 0.45 mmol, 90%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.19–7.11 (m, 4H), 7.10–7.03 (m, 1H), 6.89 (d, J = 
2.1 Hz, 1H), 6.84 (dd, J = 8.4, 2.1 Hz, 1H), 6.74 (d, J = 8.4 Hz, 1H), 4.18–4.10 (m, 4H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 144.0, 143.8, 137.8, 129.1 (2C), 129.0 (2C), 126.5, 
126.2, 125.8, 122.1, 118.2, 64.4, 64.3. 
IR (Diamond-ATR, neat): ṽ / cm-1 = 3056, 2977, 2928, 2877, 1577, 1488, 1477, 1456, 1438, 
1408, 1299, 1279, 1248, 1193, 1121, 1062, 1048, 1023, 998, 931, 895, 871, 808, 737, 688. 
MS (EI, 70 eV): m/z (%) = 244 (100), 187 (30), 160 (45), 134 (14), 115 (15), 79 (20), 51 (19). 
HRMS (EI): m/z calc. for [C14H12O2S]: 244.0558; found 244.0560. 
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5-(Cyclohexylthio)benzofuran (4d) 
 
According to TP16, N-(cyclohexylthio)phthalimide (38a, 131 mg, 0.50 mmol, 1.00 equiv) was 
reacted with benzofuran‑5-ylzinc chloride (1ccc, 1.83 mL, 0.30 M in THF, 0.55 mmol, 
1.10 equiv) in the presence of Cu(OAc)2·H2O. Purification by flash column chromatography 
on silica gel (hexane:EtOAc 99:1) afforded the title compound as a colourless oil (101 mg, 
0.43 mmol, 87%).  
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.71 (d, J = 1.7 Hz, 1H), 7.62 (d, J = 2.2 Hz, 1H), 
7.46–7.35 (m, 2H), 3.00 (tt, J = 10.6, 3.6 Hz, 1H), 2.04–1.88 (m, 2H), 1.84–1.68 (m, 2H), 1.67–
1.51 (m, 1H), 1.46–1.12 (m, 5H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 154.4, 145.6, 130.2, 128.1, 127.9, 126.7, 111.6, 
106.3, 48.0, 33.3 (2C), 26.1, 25.8 (2C). 
IR (Diamond-ATR, neat): ṽ / cm-1 = 2925, 2850, 1651, 1445, 1386, 1324, 1257, 1243, 1200, 
1170, 1130, 1108, 1030, 997, 915, 885, 874, 807, 775, 764, 732, 693. 
MS (EI, 70 eV): m/z (%) = 232 (22), 150 (100), 121 (36). 
HRMS (EI): m/z calc. for [C14H16OS]: 232.0922; found 232.0916. 
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N,N-Dimethyl-4-(phenylthio)aniline (4e) 
 
According to TP16, N-(phenylthio)phthalimide (38b, 128 mg, 0.50 mmol, 1.00 equiv) was 
reacted with (4‑(dimethylamino)phenyl)zinc chloride (1vv, 1.90 mL, 0.29 M in THF, 
0.55 mmol, 1.10 equiv) in the presence of Cu(OAc)2·H2O. Purification by flash column 
chromatography on silica gel (hexane:EtOAc 9:1) afforded the title compound as a yellow 
powder (97 mg, 0.42 mmol, 85%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.48 (d, J = 8.8 Hz, 2H), 7.28 (dd, J = 8.0, 7.0 Hz, 
2H), 7.22 - 7.11 (m, 3H), 6.78 (d, J = 8.8 Hz, 2H), 3.05 (s, 6H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 150.6, 140.3, 136.1 (2C), 128.7 (2C), 126.8 (2C), 
124.9 (2C), 117.3, 112.9 (2C), 40.3 (2C). 
IR (Diamond-ATR, neat): ṽ / cm-1 = 3053, 2925, 2851, 2809, 1886, 1592, 1582, 1571, 1546, 
1508, 1477, 1443, 1436, 1425, 1367, 1328, 1315, 1298, 1290, 1257, 1228, 1194, 1183, 1171, 
1131, 1101, 1082, 1065, 1024, 996, 945, 935, 874, 834, 809, 764, 738, 712, 691. 
MS (EI, 70 eV): m/z (%) = 229 (100), 213 (32), 196 (52), 184 (43), 152 (30), 136 (27), 109 
(17), 77 (13). 
HRMS (EI): m/z calc. for [C14H15NS]: 229.0925; found 229.0919. 
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Mesityl(phenyl)sulfane (4f) 
 
According to TP16, N-(phenylthio)phthalimide (38b, 128 mg, 0.50 mmol, 1.00 equiv) was 
reacted with mesitylzinc chloride (1ddd, 1.96 mL, 0.28 M in THF, 0.55 mmol, 1.10 equiv) in 
the presence of Cu(OAc)2·H2O. Purification by flash column chromatography on silica gel 
(hexane) afforded the title compound as a colourless oil (112 mg, 0.49 mmol, 98%). 
1H-NMR (400 MHz, CDCl3): δ / ppm =7.21 (t, J = 7.7 Hz, 2H), 7.09 (t, J = 7.4 Hz, 1H), 7.06 
(s, 2H), 6.98 (d, J = 8.0 Hz, 2H), 2.44 (s, 6H), 2.37 (s, 3H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 143.7 (2C), 139.2, 138.3, 129.3 (2C), 128.8 (2C), 
126.9, 125.4 (2C), 124.4, 21.7 (2C), 21.1. 
IR (Diamond-ATR, neat): ṽ / cm-1 = 3057, 2948, 2917, 2850, 1601, 1581, 1477, 1462, 1438, 
1374, 1327, 1297, 1176, 1155, 1085, 1069, 1060, 1031, 1023, 1013, 998, 953, 895, 849, 735, 
719, 695, 688. 
MS (EI, 70 eV): m/z (%) = 228 (100), 213 (10), 198 (14), 180 (16), 165 (18), 150 (48), 135 
(14), 119 (11), 91 (16). 
HRMS (EI): m/z calc. for [C15H16S]: 228.0973; found 228.0965. 
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Ethyl 4-(phenylthio)benzoate (4g) 
 
According to TP16, N-(phenylthio)phthalimide (38b, 128 mg, 0.50 mmol, 1.00 equiv) was 
reacted with (4‑(ethoxycarbonyl)phenyl)zinc chloride (1aa, 1.83 mL, 0.30 M in THF, 
0.55 mmol, 1.10 equiv) in the presence of Cu(OAc)2·H2O. Purification by flash column 
chromatography on silica gel (hexane:EtOAc 97.5:2.5) afforded the title compound as a 
colourless oil (127 mg, 0.49 mmol, 98%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.91 (d, J = 8.5 Hz, 2H), 7.53–7.43 (m, 2H), 7.42–
7.33 (m, 3H), 7.21 (d, J = 8.6 Hz, 2H), 4.35 (q, J = 7.1 Hz, 2H), 1.37 (t, J = 7.1 Hz, 3H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 166.1, 144.0, 133.5 (2C), 132.4, 130.0 (2C), 129.5 
(2C), 128.5, 127.8, 127.5 (2C), 60.8, 14.3. 
IR (Diamond-ATR, neat): ṽ / cm-1 = 3058, 2978, 1709, 1674, 1592, 1581, 1562, 1488, 1475, 
1464, 1439, 1399, 1366, 1308, 1267, 1176, 1103, 1082, 1068, 1014, 1000, 846, 759, 746, 704, 
688. 
MS (EI, 70 eV): m/z (%) = 258 (78), 230 (40), 213 (100), 198 (14), 184 (97), 152 (20). 
HRMS (EI): m/z calc. for [C15H14O2S]: 258.0715; found 258.0707. 
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2-Fluoro-5-(phenylthio)benzonitrile (4h) 
 
According to TP16, N-(phenylthio)phthalimide (38b, 128 mg, 0.50 mmol, 1.00 equiv) was 
reacted with (4-cyano-3-fluorophenyl)zinc chloride (1p, 1.90 mL, 0.29 M in THF, 0.55 mmol, 
1.10 equiv) in the presence of Cu(OAc)2·H2O. Purification by flash column chromatography 
on silica gel (hexane:EtOAc 95:5) afforded the title compound as a white solid (105 mg, 
0.46 mmol, 92%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.51–7.43 (m, 2H), 7.41–7.34 (m, 5H), 7.13 (t, J = 
8.6 Hz, 1H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 161.7 (d, J = 259.6 Hz), 136.2 (d, J = 8.1 Hz), 134.4 
(d, J = 3.8 Hz), 133.9, 133.0, 132.4 (2C), 129.7 (2C), 128.5, 117.1 (d, J = 20.3 Hz), 113.3, 
102.3 (d, J = 16.2 Hz).  
IR (Diamond-ATR, neat): ṽ / cm-1 = 3103, 3052, 2235, 1967, 1889, 1820, 1752, 1638, 1601, 
1581, 1574, 1527, 1487, 1476, 1461, 1440, 1406, 1398, 1385, 1333, 1307, 1297, 1289, 1282, 
1268, 1244, 1192, 1177, 1171, 1156, 1119, 1104, 1092, 1076, 1067, 1023, 1000, 946, 919, 879, 
861, 847, 819, 758, 749, 704, 691, 657, 652. 
MS (EI, 70 eV): m/z (%) = 229 (100), 208 (24), 202 (22). 
HRMS (EI): m/z calc. for [C13H8FNS]: 229.0361; found 229.0355. 
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Ferrocene thiophenyl (4i) 
 
According to TP16, N-(phenylthio)phthalimide (38b, 128 mg, 0.50 mmol, 1.00 equiv) was 
reacted with ferrocenylzinc chloride (1eee, 2.62 mL, 0.21 M in THF, 0.55 mmol, 1.10 equiv) 
in the presence of Cu(OAc)2·H2O. Purification by flash column chromatography on silica gel 
(100% hexane) afforded the title compound as an orange oil (129 mg, 0.44 mmol, 88%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.22–7.14 (m, 2H), 7.10–7.02 (m, 3H), 4.41 (t, J = 
1.9 Hz, 2H), 4.35 (t, J = 1.9 Hz, 2H), 4.28 (s, 5H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 140.8, 128.6 (2C), 125.8 (2C), 124.8, 75.5, 75.0 (2C), 
70.2 (2C), 69.7 (5C). 
IR (Diamond-ATR, neat): ṽ / cm-1 = 2921, 2852, 1577, 1569, 1475, 1454, 1434, 1409, 1387, 
1362, 1347, 1195, 1170, 1152, 1106, 1071, 1060, 1053, 1023, 1016, 999, 890, 842, 826, 818, 
743, 692. 
MS (EI, 70 eV): m/z (%) = 294 (75), 228 (14), 171 (30), 141 (19), 121 (100), 95 (13), 77 (20), 
56 (42). 
HRMS (EI): m/z calc. for [C16H14FeS]: 294.0166; found 294.0162. 
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5-(Phenylthio)furan-2-carbaldehyde (4j) 
 
According to TP16, N-(phenylthio)phthalimide (38b, 128 mg, 0.50 mmol, 1.00 equiv) was 
reacted with (5‑formylfuran‑2‑yl)zinc iodide (1fff, 1.67 mL, 0.33 M in THF, 0.55 mmol, 
1.10 equiv) in the presence of Cu(OAc)2·H2O. Purification by flash column chromatography 
on silica gel (hexane:EtOAc 85:15) afforded the title compound as a yellow oil (85 mg, 
0.42 mmol, 83%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 9.43 (s, 1H), 7.30–7.23 (m, 2H), 7.23–7.14 (m, 3H), 
7.08 (d, J = 3.6 Hz, 1H), 6.44 (d, J = 3.6 Hz, 1H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 177.0, 154.5, 153.8, 131.7, 131.0 (2C), 129.5 (2C), 
128.3, 122.0, 117.1. 
IR (Diamond-ATR, neat): ṽ / cm-1 = 3136, 2819, 1668, 1614, 1581, 1561, 1475, 1450, 1440, 
1392, 1375, 1344, 1265, 1210, 1189, 1155, 1114, 1081, 1069, 1018, 999, 959, 933, 803, 760, 
737, 687, 658. 
MS (EI, 70 eV): m/z (%) = 204 (78), 175 (33), 147 (100), 115 (28), 121 (11), 115 (28), 103 
(14). 
HRMS (EI): m/z calc. for [C11H8O2S]: 204.0245; found 204.0237. 
  
C. Experimental Section 
308 
2-(Phenylthio)thiazole-5-carbonitrile (4k) 
 
According to TP16, N-(phenylthio)phthalimide (38b, 128 mg, 0.50 mmol, 1.00 equiv) was 
reacted with (5‑cyanothiazol‑2‑yl)zinc chloride (1ggg, 1.67 mL, 0.33 M in THF, 0.55 mmol, 
1.10 equiv) in the presence of Cu(OAc)2·H2O. Purification by flash column chromatography 
on silica gel (hexane:EtOAc 4:1) afforded the title compound as a yellow solid (58 mg, 
0.27 mmol, 71%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.06 (s, 1H), 7.73–7.68 (m, 2H), 7.61–7.49 (m, 3H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 177.0, 152.4, 135.4 (2C), 131.4, 130.6 (2C), 128.6, 
111.5, 105.1. 
IR (Diamond-ATR, neat): ṽ / cm-1 = 3098, 3051, 2218, 1896, 1767, 1575, 1496, 1473, 1440, 
1358, 1334, 1310, 1285, 1274, 1206, 1182, 1167, 1159, 1143, 1132, 1067, 1046, 1024, 1000, 
993, 974, 929, 886, 850, 759, 746, 702, 686, 676. 
MS (EI, 70 eV): m/z (%) = 217 (100), 140 (14), 83 (10). 
HRMS (EI): m/z calc. for [C10H5N2S2]: 216.9894; found 216.9888. 
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1,3,5-Trimethyl-4-(phenylthio)-1H-pyrazole (4l) 
 
According to TP16 N-(phenylthio)phthalimide (38b, 128 mg, 0.50 mmol, 1.00 equiv) was 
reacted with (1,3,5‑trimethyl‑1H-pyrazol-4-yl)zinc chloride (1hhh, 3.06 mL, 0.18 M in THF, 
0.55 mmol, 1.10 equiv) in the presence of Cu(OAc)2·H2O. Purification by flash column 
chromatography on silica gel (hexane:EtOAc 7:3) afforded the title compound as a yellow oil 
(103 mg, 0.47 mmol, 94%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.17 (t, J = 7.7 Hz, 2H), 7.04 (t, J = 7.4 Hz, 1H), 6.96 
(d, J = 7.1 Hz, 2H), 3.77 (s, 3H), 2.23 (s, 3H), 2.19 (s, 3H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 151.5, 143.7, 138.6, 128.6 (2C), 125.0 (2C), 124.6, 
103.4, 36.5, 11.7, 9.9. 
IR (Diamond-ATR, neat): ṽ / cm-1 = 3055, 2941, 2922, 1770, 1734, 1726, 1581, 1531, 1492, 
1477, 1438, 1423, 1411, 1382, 1365, 1327, 1300, 1274, 1193, 1155, 1106, 1082, 1069, 1037, 
1023, 997, 985, 965, 897, 833, 737, 719, 689, 674. 
MS (EI, 70 eV): m/z (%) = 218 (100), 203 (12), 190 (28), 185 (32), 170 (10), 158 (14), 144 
(12), 56 (10). 
HRMS (EI): m/z calc. for [C12H14N2S]: 218.0878; found 218.0870. 
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2-Chloro-5-((phenylthio)methyl)pyridine (4m) 
 
According to TP16, N-(phenylthio)phthalimide (38b, 128 mg, 0.50 mmol) was reacted with 
((6‑chloropyridin‑3-yl)methyl)zinc chloride (1iii, 1.00 mL, 0.55 M in THF, 0.55 mmol, 
1.10 equiv) in the presence of Cu(OAc)2·H2O. Purification by flash column chromatography 
on silica gel (hexane:EtOAc 95:5) afforded the title compound as a colourless oil (108 mg, 
0.49 mmol, 97%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.14 (d, J = 2.5 Hz, 1H), 7.49 (dd, J = 8.2, 2.5 Hz, 
1H), 7.33–7.14 (m, 6H), 3.98 (s, 2H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 150.0, 149.4, 138.9, 134.2, 132.5, 131.0 (2C), 129.0 
(2C), 127.2, 123.9, 35.7. 
IR (Diamond-ATR, neat): ṽ / cm-1 = 3073, 3050, 2923, 1583, 1563, 1480, 1458, 1438, 1378, 
1286, 1256, 1209, 1132, 1102, 1087, 1067, 1022, 1000, 930, 871, 831, 820, 737, 689, 667. 
MS (EI, 70 eV): m/z (%) = 235 (16), 126 (100), 90 (15). 
HRMS (EI): m/z calc. for [C12H10ClNS]: 235.0222; found 235.0213. 
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3-(Phenylthio)-cholest-5-ene (4n) 
 
According to TP16, N-(phenylthio)phthalimide (38b, 128 mg, 0.50 mmol, 1.00 equiv) was 
reacted with cholest‑5‑ene‑3‑ylzinc chloride (1jjj, 4.23 mL, 0.13 M in THF, 0.55 mmol, 
1.10 equiv) in the presence of Cu(OAc)2·H2O. Purification by flash column chromatography 
on silica gel (hexane) afforded the diastereomeres 3α‑(phenylthio)‑cholest‑5-ene (1nα) (49 mg, 
0.10 mmol) and 3β‑(phenylthio)-cholest-5-ene (1nβ) (185 mg, 0.39 mmol) as white powders 
which combined gives a yield of 98% (d.r. 21:79). 
3α-(Phenylthio)-cholest-5-ene (1nα) 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.38 (d, J = 7.1 Hz, 2H), 7.27 (t, J = 7.6 Hz, 2H), 7.19 
(t, J = 7.3 Hz, 1H), 5.34 (dd, J = 4.9, 2.4 Hz, 1H), 3.69–3.62 (m, 1H), 2.76 (d, J = 14.6 Hz, 
1H), 2.19 (dt, J = 14.8, 2.4 Hz, 1H), 2.07–1.78 (m, 4H), 1.80–0.93 (m, 22H), 1.02 (s, 3H), 0.92 
(d, J = 6.4 Hz, 3H), 0.88 (d, J = 6.6, 3H) 0.87 (d, J = 6.6 Hz, 3H), 0.68 (s, 3H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 138.8, 136.3, 131.4 (2C), 128.8 (2C), 126.3, 122.5, 
56.7, 56.11, 49.9, 46.6, 42.3, 39.7, 39.5, 37.2, 37.1, 36.2, 35.8, 33.8, 31.8, 31.8, 28.3, 28.0, 
26.3, 24.3, 23.9, 22.8, 22.6, 20.7, 19.3, 18.7, 11.8. 
IR (Diamond-ATR, neat): 2958, 2932, 2898, 2866, 2847, 1586, 1481, 1462, 1444, 1438, 
1374, 1363, 1322, 1156, 1093, 1026, 1008, 983, 959, 887, 823, 799, 774, 732, 700, 689. 
MS (EI, 70 eV): m/z (%) = 478 (36), 369 (100), 247 (26), 161 (27), 145 (41), 110 (37), 107 
(36), 95 (53), 81 (55), 57 (40), 43 (40). 
HRMS (EI): m/z calc. for [C33H50S]: 478.3633; found 478.3627. 
 
3β-(Phenylthio)-cholest-5-ene (1nβ) 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.39 (d, J = 7.0 Hz, 2H), 7.28 (t, J = 7.4 Hz, 2H), 7.22 
(t, J = 7.3 Hz, 1H), 5.31 (dd, J = 5.5, 2.4 Hz, 1H), 3.09–2.96 (m, 1H), 2.32 (d, J = 8.2 Hz, 2H), 
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2.09–1.73 (m, 5H), 1.69–0.93 (m, 21H), 0.99 (s, 3H), 0.92 (d, J = 6.5 Hz, 3H), 0.87 (d, J = 6.6, 
3H) 0.86 (d, J = 6.6 Hz, 3H), 0.68 (s, 3H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 141.6, 134.8, 131.7 (2C), 128.7 (2C), 126.6, 121.1, 
56.8, 56.1, 50.3, 47.3, 42.3, 39.7, 39.6, 39.5, 36.8, 36.2, 35.8, 31.8, 29.5, 28.2, 28.0, 24.2, 23.8, 
22.8, 22.5, 20.9, 19.3, 18.7, 11.8. 
IR (Diamond-ATR, neat): ṽ / cm-1 = 2958, 2933, 2900, 2866, 2847, 1586, 1481, 1462, 1438, 
1381, 1374, 1364, 1331, 1321, 1292, 1252, 1192, 1156, 1092, 1070, 1026, 1008, 983, 958, 955, 
913, 887, 823, 799, 732, 700, 689. 
MS (EI, 70 eV): m/z (%) = 478 (7), 369 (100), 161 (12), 147 (12), 109 (11), 95 (16), 81 (12), 
55 (11), 43 (11). 
HRMS (EI): m/z calc. for [C33H50S]: 478.3633; found 478.3632. 
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(1S,3S,4S)-3-(Cyclohexylthio)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-one (4o) 
 
According to TP16, N-(cyclohexylthio)phthalimide (38a, 131 mg, 0.50 mmol, 1.00 equiv) was 
reacted with ((1S,4S)‑4,7,7-trimethyl-3-oxobicyclo[2.2.1]heptan-2-yl)zinc bromide (1kkk, 
1.67 mL, 0.33 M in THF, 0.55 mmol, 1.10 equiv) in the presence of Cu(OAc)2·H2O. 
Purification by flash column chromatography on silica gel (hexane:EtOAc 99:1) afforded the 
title compound as a colourless oil (130 mg, 0.44 mmol, 97:3 d.r., 98%).  
1H-NMR (400 MHz, CDCl3): δ / ppm = 3.49 (dd, J = 4.7, 1.9 Hz, 1H), 2.88 (tt, J = 14.3, 
5.5 Hz, 1H), 2.14 (t, J = 4.4 Hz, 1H), 2.07–1.86 (m, 3H), 1.82–1.54 (m, 5H), 1.46–1.14 (m, 
6H), 1.00 (s, 3H), 0.90 (s, 3H), 0.89 (s, 3H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 217.5, 58.3, 51.1, 48.8, 46.0, 44.1, 33.9, 33.7, 30.6, 
26.0, 26.0, 25.7, 21.4, 19.6, 19.4, 9.7.  
IR (Diamond-ATR, neat): ṽ / cm-1 = 2960, 2926, 2851, 1740, 1592, 1492, 1446, 1391, 1375, 
1338, 1320, 1298, 1263, 1244, 1208, 1178, 1152, 1104, 1037, 1001, 955, 919, 885, 860,831, 
818, 780, 745. 
MS (EI, 70 eV): m/z (%) = 266 (12), 155 (94), 152 (100), 137 (30), 124 (83), 108 (64), 83 (41), 
73 (66). 
HRMS (EI): m/z calc. for [C16H26OS]: 266.1704; found 266.1697. 
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Ethyl(naphthalen-1-yl)sulfane (4p) 
 
According to TP16, N-(ethylthio)phthalimide (38c, 104 mg, 0.50 mmol, 1.00 equiv) was 
reacted with naphthalen-1-ylzinc chloride (1x, 2.04 mL, 0.27 M in THF, 0.55 mmol, 
1.10 equiv) in the presence of Cu(OAc)2·H2O. Purification by flash column chromatography 
on silica gel (hexane:EtOAc 95:5) afforded the title compound as a yellow oil (59.0 mg, 
0.32 mmol, 71%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.42 (d, J = 8.3 Hz, 1H), 7.86 (d, J = 7.4 Hz, 1H), 
7.74 (d, J = 8.2 Hz, 1H), 7.60–7.48 (m, 3H), 7.42 (t, J = 15.4 Hz, 1H), 3.02 (q, J = 7.3 Hz, 2H), 
1.34 (t, J = 7.4 Hz, 3H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 134.0, 133.9, 133.0, 128.7, 127.8, 127.1, 126.4, 
126.3, 125.7, 125.2, 28.3, 14.5. 
IR (Diamond-ATR, neat): ṽ / cm-1 = 3052, 2966, 2923, 2867, 1589, 1563, 1501, 1446, 1381, 
1331, 1258, 1202, 1163, 1142, 1068, 1052, 1023, 975, 854, 825, 798, 785, 767, 665. 
MS (EI, 70 eV): m/z (%) = 188 (100), 175 (32), 153 (52), 125 (43), 89 (40), 63 (25). 
HRMS (EI): m/z calc. for [C12H12S]: 188.0660; found 188.0658. 
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6-((4-Chlorophenyl)thio)-2,3-dihydrobenzo[b][1,4]dioxine (4q) 
 
According to TP16, N-((4-chlorophenyl)thio)phthalimide (38d, 128 mg, 0.50 mmol, 
1.00 equiv) was reacted with (2,3-dihydrobenzo[b][1,4]dioxin-6-yl)zinc chloride (1v, 1.34 mL, 
0.41 M in THF, 0.55 mmol, 1.10 equiv) in the presence of Cu(OAc)2·H2O. Purification by flash 
column chromatography on silica gel (hexane:EtOAc 95:5) afforded the title compound as a 
yellow oil (120 mg, 0.43 mmol, 94%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.24–7.19 (m, 2H), 7.16–7.11 (m, 2H), 6.97 (d, J = 
2.1 Hz, 1H), 6.93 (dd, J = 8.3, 2.2 Hz, 1H), 6.85 (d, J = 8.3 Hz, 1H), 4.30–4.23 (m, 4H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 144.1, 136.5, 132.0, 130.1 (2C), 129.1 (2C), 126.7, 
125.2, 122.2, 118.3, 64.4, 64.3. 
IR (Diamond-ATR, neat): ṽ / cm-1 = 2977, 2928, 2879, 1599, 1576, 1489, 1473, 1457, 1409, 
1389, 1362, 1300, 1279, 1248, 1194, 1144, 1122, 1091, 1082, 1063, 1049, 1009, 932, 896, 872, 
808, 767, 742, 713, 687, 664. 
MS (EI, 70 eV): m/z (%) = 278 (100), 187 (75), 159 (20), 115 (15), 79 (25), 51 (24). 
HRMS (EI): m/z calc. for [C14H11ClO2S]: 278.0168; found 278.0170. 
  
C. Experimental Section 
316 
(4-Methoxyphenyl)(2-(trifluoromethyl)phenyl)sulfane (4r) 
 
According to TP16, N-((4-methoxyphenyl)thio)phthalimide (38e, 143 mg, 0.50 mmol, 
1.00 equiv) was reacted with (2-(trifluoromethyl)phenyl)zinc chloride (1lll, 1.16 mL, 0.43 M 
in THF, 0.55 mmol, 1.10 equiv) in the presence of Cu(OAc)2·H2O. Purification by flash 
column chromatography on silica gel (hexane:EtOAc 95:5) afforded the title compound as an 
oil (138 mg, 0.49 mmol, 97%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.63 (d, J = 7.7 Hz, 1H), 7.46 (d, J = 8.7 Hz, 2H), 
7.29 (t, J = 7.6 Hz, 1H), 7.18 (t, J = 7.5 Hz, 1H), 6.98 (d, J = 8.0 Hz, 1H), 6.94 (d, J = 8.7 Hz, 
2H), 3.84 (s, 3H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 159.5, 138.1, 135.7 (2C), 130.8, 128.5, 126.4 (q, J = 
30.7 Hz), 125.5 (q, J = 5.7 Hz), 124.3, 124.0, 121.4 (d, J = 27.0 Hz), 114.3 (2C), 54.3. 
IR (Diamond-ATR, neat): ṽ / cm-1 = 2959, 2921, 2852, 1591, 1572, 1493, 1466, 1458, 1446, 
1435, 1407, 1312, 1300, 1292, 1257, 1251, 1169, 1159, 1112, 1103, 1098, 1090, 1031, 954, 
875, 822, 799, 766, 729, 714, 706, 696. 
MS (EI, 70 eV): m/z (%) = 284 (100), 268 (43), 171 (44), 139 (29), 95 (26), 69 (30). 
HRMS (EI): m/z calc. for [C14H11F3S]: 284.0483; found 284.0485. 
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5-((4-Methoxyphenyl)thio)-1-methyl-1H-indole (4s) 
 
According to TP16, N-((4-methoxyphenyl)thio)phthalimide (38e, 143 mg, 0.50 mmol, 
1.00 equiv) was reacted with (1-methyl-1H-indol-5-yl)zinc chloride (1y, 2.88 mL, 0.26 M in 
THF, 0.75 mmol, 1.50 equiv) in the presence of Cu(OAc)2·H2O. Purification by flash column 
chromatography on silica gel (hexane:EtOAc 4:1) afforded the title compound as a white 
powder (126 mg, 0.47 mmol, 96%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.63–7.60 (m, 1H), 7.28–7.13 (m, 4H), 6.94 (d, J = 3.2 
Hz, 1H), 6.74–6.67 (m, 2H), 6.33 (d, J = 3.1 Hz, 1H), 3.66 (d, J = 3.9 Hz, 6H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 158.6, 136.2, 131.8 (2C), 129.8, 129.3, 129.2, 126.2, 
125.3, 114.7 (2C), 110.2, 101.0, 55.4, 33.0. 
IR (Diamond-ATR, neat): ṽ / cm-1 = 2957, 2921, 2854, 2832, 1588, 1567, 1507, 1489, 1469, 
1447, 1437, 1421, 1403, 1375, 1328, 1296, 1286, 1273, 1269, 1239, 1199, 1180, 1170, 1149, 
1103, 1076, 1026, 910, 886, 865, 853, 832, 823, 792, 765, 756, 732, 719. 
MS (EI, 70 eV): m/z (%) = 269 (100), 253 (37), 226 (19), 210 (16), 127 (27), 102(23), 63 (52). 
HRMS (EI): m/z calc. for [C16H15NOS]: 269.0874; found 269.0878. 
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Naphthalen-1-yl(4-nitrophenyl)sulfane (4t) 
 
According to TP16, N-((4-nitrophenyl)thio)phthalimide (38f, 180 mg, 0.50 mmol, 1.00 equiv) 
was reacted with naphthalen-1-ylzinc chloride (1x, 2.78 mL, 0.27 M in THF, 0.75 mmol, 
1.50 equiv) in the presence of Cu(OAc)2·H2O. Purification by flash column chromatography 
on silica gel (hexane:EtOAc 95:5) afforded the title compound as a yellow powder (77 mg, 
0.28 mmol, 55%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.27–8.22 (m, 1H), 8.05–7.97 (m, 3H), 7.93 (m, 2H), 
7.55 (td, J = 7.8, 1.4 Hz, 3H), 7.07–7.02 (m, 2H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 148.7, 145.2, 135.9 (2C), 134.7, 134.3, 131.7, 129.1, 
128.0, 127.1, 126.8, 126.2, 126.0, 125.6, 124.2 (2C). 
IR (Diamond-ATR, neat): ṽ / cm-1 = 3102, 3054, 2921, 2851, 1732, 1590, 1573, 1500, 1474, 
1422, 1398, 1375, 1363, 1332, 1254, 1212, 1200, 1175, 1163, 1140, 1107, 1086, 1056, 1019, 
1007, 974, 954, 924, 866, 852, 840, 820, 800, 769, 738, 681, 667. 
MS (EI, 70 eV): m/z (%) = 281 (80), 234 (65), 202 (35), 159 (12), 115 (100), 76 (30), 50 (35). 
HRMS (EI): m/z calc. for [C16H11NO2S]: 281.0510; found 281.0510. 
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(4-Bromophenyl)(mesityl)sulfane (4u) 
 
According to TP16, N-((4-bromophenol)thio)phthalimide (38g, 167 mg, 0.50 mmol, 
1.00 equiv) was reacted with mesitylzinc chloride (1ccc, 1.96 mL, 0.28 M in THF, 0.55 mmol, 
1.10 equiv) in the presence of Cu(OAc)2·H2O. Purification by flash column chromatography 
on silica gel (hexane:EtOAc 99:1) afforded the title compound as a white powder (134 mg, 
0.44 mmol, 89%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.27 (d, J = 8.3 Hz, 2H), 7.01 (s, 2H), 6.77 (d, J = 
8.6 Hz, 2H), 2.36 (s, 6H), 2.32 (s, 3H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 143.8 (2C), 139.8, 137.9, 132.0 (2C), 129.6 (2C), 
127.1 (2C), 126.5, 118.0, 21.8 (2C), 21.3. 
IR (Diamond-ATR, neat): ṽ / cm-1 = 2950, 2918, 2851, 1895, 1739, 1600, 1557, 1470, 1435, 
1385, 1372, 1295, 1177, 1110, 1086, 1067, 1055, 1032, 1004, 951, 891, 856, 835, 811, 727, 
717, 693. 
MS (EI, 70 eV): m/z (%) = 306 (100), 228 (32), 212 (52), 195 (43), 179 (30), 150 (27), 119 
(17), 91 (13), 65(12). 
HRMS (EI): m/z calc. for [C15H15BrS]: 306.0078; found 306.0075. 
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Ethyl 4-((2,3-dihydrobenzo[b][1,4]dioxin-6-yl)thio)benzoate (4v) 
 
According to TP16, N-((ethyl 4-benzoate)thio)phthalimide (38h, 165 mg, 0.50 mmol, 
1.00 equiv) was reacted with (2,3-dihydrobenzo[b][1,4]dioxin-6-yl)zinc chloride (1v, 1.83 mL, 
0.41 M in THF, 0.75 mmol, 1.50 equiv) in the presence of Cu(OAc)2·H2O. Purification by flash 
column chromatography on silica gel (hexane:EtOAc 9:1) afforded the title compound as a 
colourless oil (111 mg, 0.35 mmol, 70%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.94–7.87 (m, 2H), 7.17–7.13 (m, 2H), 7.08 (d, J = 2.2 
Hz, 1H), 7.03 (dd, J = 8.3, 2.2 Hz, 1H), 6.92 (d, J = 8.3 Hz, 1H), 4.36 (q, J = 7.1 Hz, 2H), 4.33–
4.28 (m, 4H), 1.39 (t, J = 7.1 Hz, 3H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 166.3, 145.6, 144.7, 144.2, 130.0 (2C), 128.2, 127.2, 
126.3 (2C), 123.7, 122.8, 118.5, 64.4, 64.2, 60.9, 14.3. 
IR (Diamond-ATR, neat): ṽ / cm-1 = 2980, 2933, 2880, 2359, 1709, 1592, 1577, 1562, 1487, 
1460, 1409, 1399, 1366, 1301, 1270, 1250, 1196, 1177, 1121, 1105, 1081, 1064, 1050, 1015, 
932, 897, 873, 846, 811, 759, 746, 731, 689. 
MS (EI, 70 eV): m/z (%) = 316 (100), 288 (76), 215 (52), 138 (43), 76 (30). 
HRMS (EI): m/z calc. for [C17H16O4S]: 316.0769; found 316.0768. 
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4-((2,4,6-Trimethoxyphenyl)thio)benzonitrile (4w) 
 
According to TP16, 4-((1,3-dioxoisoindolin-2-yl)thio)benzonitrile (38i, 165 mg, 0.50 mmol, 
1.00 equiv) was reacted with (2,4,6-trimethoxyphenyl)zinc chloride (1mmm, 1.83 mL, 0.41 M 
in THF, 0.75 mmol, 1.50 equiv) in the presence of Cu(OAc)2·H2O. Purification by flash 
column chromatography on silica gel (hexane:EtOAc 9:1) afforded the title compound as a 
yellow oil (111 mg, 0.35 mmol, 90%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.32 (d, J = 8.5 Hz, 2H), 6.95 (d, J = 8.5 Hz, 2H), 
6.16 (s, 2H), 3.81 (s, 3H), 3.73 (s, 6H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 163.7, 162.4, 146.6, 132.0 (2C), 125.2 (2C), 119.4, 
107.1, 95.9, 91.2, 56.3, 55.5. 
IR (Diamond-ATR, neat): ṽ / cm-1 = 1577, 1492, 1458, 1322, 1301, 1282, 1247, 1126, 1069, 
1058, 930, 903, 866, 839, 809, 724. 
MS (EI, 70 eV): m/z (%) = 301 (100), 258 (32), 226 (29), 141 (40), 69 (46). 
HRMS (EI): m/z calc. for [C16H15NO3S]: 301.0773; found 301.0776. 
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2-((4-Chlorophenyl)thio)-5-(trifluoromethyl)pyridine (4x) 
 
According to TP16, N-((5-(trifluoromethyl)pyridin-2-yl)thio)phthalimide (38j, 163 mg, 
0.50 mmol, 1.00 equiv) was reacted with (4-chlorophenyl)zinc chloride ( , 1.90 mL, 0.29 M in 
THF, 0.55 mmol, 1.10 equiv) in the presence of Cu(OAc)2·H2O. Purification by flash column 
chromatography on silica gel (hexane:EtOAc 99:1) afforded the title compound as a colourless 
oil (119 mg, 0.41 mmol, 94%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.64 (s, 1H), 7.67 (dd, J = 8.6, 2.4 Hz, 1H), 7.54 (d, 
J = 8.4 Hz, 2H), 7.44 (d, J = 8.5 Hz, 2H), 6.99 (d, J = 8.5 Hz, 1H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 165.9, 146.7 (q, J = 4.2 Hz), 136.9 (2C), 136.5, 133.7 
(q, J = 3.4 Hz), 130.3 (2C), 127.8, 126.4 (q, J = 271.9 Hz), 123.0 (q, J = 33.3 Hz), 120.4. 
IR (Diamond-ATR, neat): ṽ / cm-1 = 2925, 1630, 1593, 1573, 1558, 1477, 1462, 1390, 1379, 
1322, 1245, 1164, 1125, 1112, 1091, 1073, 1013, 1008, 972, 938, 820, 790, 745, 714, 703. 
MS (EI, 70 eV): m/z (%) = 288 (100), 126 (13), 108 (15), 75 (12). 
HRMS (EI): m/z calc. for [C12H7ClF3NS]: 288.9940; found 288.9945. 
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2-((4-Chlorophenyl)thio)pyrimidine (4y) 
 
According to TP16, N-((2-pyrimidine)thio)phthalimide (38k, 129 mg, 0.50 mmol, 1.00 equiv) 
was reacted with (4-chlorophenyl)zinc chloride ( , 1.90 mL, 0.29 M in THF, 0.55 mmol, 
1.10 equiv) in the presence of Cu(OAc)2·H2O. Purification by flash column chromatography 
on silica gel (hexane:EtOAc 9:1) afforded the title compound as a colourless oil (86 mg, 
0.39 mmol, 85%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.40 (d, J = 4.8 Hz, 2H), 7.47 (d, J = 8.4 Hz, 2H), 
7.32 (d, J = 8.5 Hz, 2H), 6.90 (t, J = 4.8 Hz, 1H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 172.4, 157.7 (2C), 136.6 (2C), 135.3, 129.6, 127.9 
(2C), 117.3. 
IR (Diamond-ATR, neat): ṽ / cm-1 = 3030, 2924, 2852, 1728, 1559, 1546, 1475, 1440, 1426, 
1374, 1258, 1202, 1181, 1171, 1092, 1082, 1013, 981, 941, 818, 799, 770, 744, 702, 689. 
MS (EI, 70 eV): m/z (%) = 222 (100), 187 (15), 169 (14), 143 (25), 108 (60), 75 (27), 53 (20). 
HRMS (EI): m/z calc. for [C10H7ClN2S]: 222.0018; found 222.0015. 
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1-Methyl-5-((1-phenyl-1H-tetrazol-5-yl)thio)-1H-indole (4z) 
 
According to TP16, 2-((1-phenyl-1H-tetrazol-5-yl)thio)phthalimide (38l, 163 mg, 0.50 mmol, 
1.00 equiv) was reacted with (1-methyl-1H-indol-5-yl)zinc chloride (1y, 2.12 mL, 0.26 M in 
THF, 0.55 mmol, 1.10 equiv) in the presence of Cu(OAc)2·H2O. Purification by flash column 
chromatography on silica gel (hexane:EtOAc 4:1) afforded the title compound as a white 
powder (110 mg, 0.360 mmol, 81%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.88 (s, 1H), 7.66–7.51 (m, 5H), 7.43 (dd, J = 8.6, 
1.8 Hz, 1H), 7.36 (d, J = 8.5 Hz, 1H), 7.10 (d, J = 3.1 Hz, 1H), 6.49 (d, J = 3.0 Hz, 1H), 3.81 
(s, 3H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 137.5, 134.5, 134.0, 130.4, 130.3, 129.8 (2C), 129.6, 
128.6, 127.9, 124.5 (2C), 123.7, 115.1, 110.9, 101.8, 33.2. 
IR (Diamond-ATR, neat): ṽ / cm-1 = 2914, 1773, 1733, 1604, 1594, 1509, 1496, 1476, 1442, 
1422, 1405, 1382, 1337, 1308, 1279, 1243, 1231, 1203, 1154, 1111, 1084, 1072, 1064, 1053, 
1013, 972, 913, 908, 875, 863, 835, 802, 776, 753, 733, 715, 696, 691, 682. 
MS (EI, 70 eV): m/z (%) = 162 (100), 136 (27), 109 (17), 77 (13). 
HRMS (EI): m/z calc. for [C16H13N5S]: 307.0892; found 307.0895. 
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(Trifluoromethyl)(2,4,6-trimethoxyphenyl)sulfane (41a) 
 
According to TP16, 2-((trifluoromethyl)thio)phthalimide (124 mg, 0.50 mmol, 1.00 equiv) 
was reacted with (2,4,6-trimethoxyphenyl)zinc chloride (1mmm, 2.88 mL, 0.26 M in THF, 
0.75 mmol, 1.5 equiv) in the presence of Cu(OAc)2·H2O. Purification by flash column 
chromatography on silica gel (hexane:EtOAc 9:1) afforded the title compound as a yellow oil 
(83.2 mg, 0.310 mmol, 91%). 
1H-NMR (400 MHz, CDCl3): δ / ppm 6.15 (s, 2H), 3.80 (s, 6H), 3.78 (s, 3H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 164.6 (2C), 163.6 (2C), 160.6, 157.6, 129.6 (q, J = 
310.6 Hz), 56.4 (2C), 55.6. 
IR (Diamond-ATR, neat): ṽ / cm-1 = 2973, 2945, 2843, 1758, 1728, 1580, 1469, 1464, 1455, 
1438, 1411, 1336, 1274, 1226, 1206, 1188, 1165, 1148, 1102, 1083, 1040, 1024, 952, 915, 867, 
806, 787, 752, 713, 681, 664. 
MS (EI, 70 eV): m/z (%) = 268 (100), 199 (80), 184 (30), 171 (40), 155 (12), 141 (15), 125 
(20), 69 (60). 
HRMS (EI): m/z calc. for [C10H11F3O3S]: 268.0381; found 268.0378. 
  
C. Experimental Section 
326 
1-Methyl-5-((trifluoromethyl)thio)-1H-indole (41b) 
 
According to TP16, 2-((trifluoromethyl)thio)phthalimide (124 mg, 0.50 mmol, 1.00 equiv) 
was reacted with (1-methyl-1H-indol-5-yl)zinc chloride (1y, 2.88 mL, 0.29 M in THF, 
0.75 mmol, 1.50 equiv) in the presence of Cu(OAc)2·H2O. Purification by flash column 
chromatography on silica gel (hexane:EtOAc 4:1) afforded the title compound as a yellow 
powder (107 mg, 0.47 mmol, 93%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.97 (s, 1H), 7.49 (d, J = 8.5 Hz, 1H), 7.35 (d, J = 
8.5 Hz, 1H), 7.12 (d, J = 3.1 Hz, 1H), 6.55 (d, J = 3.0 Hz, 1H), 3.81 (s, 3H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 137.7, 130.6, 130.5, 130.1 (q, J = 308.1 Hz) 129.5, 
129.3, 113.6 (q, J = 2.0 Hz), 110.2, 101.7, 33.1. 
IR (Diamond-ATR, neat): ṽ / cm-1 = 2918, 2850, 1727, 1709, 1694, 1615, 1605, 1582, 1511, 
1474, 1441, 1423, 1376, 1361, 1331, 1279, 1244, 1146, 1123, 1110, 1091, 1063, 1009, 909, 
901, 890, 798, 777, 759, 749, 728, 718. 
MS (EI, 70 eV): m/z (%) = 231 (40), 162 (70), 118 (20), 69 (100). 
HRMS (EI): m/z calc. for [C10H8F3NS]: 231.0330; found 231.0333. 
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4-((Trifluoromethyl)thio)benzonitrile (41c) 
 
According to TP16, 2-((trifluoromethyl)thio)phthalimide (124 mg, 0.50 mmol, 1.00 equiv) 
was reacted with (4-cyanophenyl)zinc chloride (1tt, 1.53 mL, 0.25 M in THF, 0.55 mmol, 
1.10 equiv) in the presence of Cu(OAc)2·H2O. Purification by flash column chromatography 
on silica gel (hexane:EtOAc 99:1) afforded the title compound as a colourless oil (86 mg, 
0.43 mmol, 85%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.79 (d, J = 8.4 Hz, 2H), 7.74 (d, J = 8.4 Hz, 2H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 136.0 (2C), 132.9 (2C), 130.6, 129.04 (d, J = 311.7 
Hz), 117.7, 114.7. 
IR (Diamond-ATR, neat): ṽ / cm-1 = 3092, 2230, 1926, 1594, 1487, 1403, 1396, 1305, 1276, 
1259, 1187, 1160, 1119, 1084, 1018, 970, 961, 835, 780, 756, 728, 718. 
MS (EI, 70 eV): m/z (%) = 203 (52), 134 (100), 90 (23), 69 (61). 
HRMS (EI): m/z calc. for [C8H4F3NS]: 203.0017; found 203.0013. 
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6-((Trifluoromethyl)thio)-2,3-dihydrobenzo[b][1,4]dioxine (41d) 
 
According to TP16, 2-((trifluoromethyl)thio)phthalimide (124 mg, 0.50 mmol, 1.00 equiv) 
was reacted with (2,3-dihydrobenzo[b][1,4]dioxin-6-yl)zinc chloride (1v, 1.53 mL, 0.36 M in 
THF, 0.55 mmol, 1.10 equiv) in the presence of Cu(OAc)2·H2O. Purification by flash column 
chromatography on silica gel (hexane:EtOAc 99:1) afforded the title compound as a yellow 
powder (95 mg, 0.41 mmol, 85%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 6.93–6.86 (m, 2H), 6.77 (d, J = 8.2 Hz, 1H), 4.19 (s, 
4H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 143.6, 142.8, 134.1, 131.4, 127.9 (q, J = 314.8 Hz), 
119.7, 117.4, 115.4, 64.4 (2C). 
Analytical data according to literature115i 
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2-Fluoro-4-thiocyanato-1,1'-biphenyl (42a) 
 
According to TP16, N-(thiocyanato)phthalimide (141 mg, 0.50 mmol, 1.00 equiv) was reacted 
with (2-fluoro-[1,1'-biphenyl]-4-yl)zinc chloride (1cc,2.68 mL, 0.28 M in THF, 0.75 mmol, 
1.50 equiv) in the presence of Cu(OAc)2.H2O. Purification by flash column chromatography 
on silica gel (hexane:EtOAc 95:5) afforded the title compound as a yellow oil (83 mg, 
0.36 mmol, 72%).  
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.58–7.44 (m, 6H), 7.40 (ddd, J = 10.0, 6.2, 2.0 Hz, 
2H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 159.9 (d, J = 253.7 Hz), 134.1, 132.3 (d, J = 4.1 Hz), 
130.7 (d, J = 13.6 Hz), 128.9 (d, J = 3.0 Hz), 128.7 (2C), 128.6 (2C), 125.8 (d, J = 3.9 Hz), 
124.5 (d, J = 8.5 Hz), 117.8 (d, J = 26.7 Hz), 109.8. 
IR (Diamond-ATR, neat): ṽ / cm-1 = 3063, 2360, 2158, 1606, 1581, 1558, 1506, 1477, 1447, 
1400, 1285, 1267, 1212, 1132, 1083, 1076, 1009, 884, 858, 821, 764, 716, 696, 668, 662. 
MS (EI, 70 eV): m/z (%) = 229 (100), 202 (10), 170 (46). 
HRMS (EI): m/z calc. for [C13H8FNS]: 229.0361; found 229.0367. 
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1,3,5-Trimethyl-2-thiocyanatobenzene (42b) 
 
According to TP16, N-(thiocyanato)phthalimide (141 mg, 0.50 mmol, 1.00 equiv) was reacted 
with mesitylzinc chloride (1ddd, 2.68 mL, 0.28 M in THF, 0.75 mmol, 1.50 equiv) in the 
presence of Cu(OAc)2·H2O. Purification by flash column chromatography on silica gel 
(hexane:EtOAc 95:5) afforded the title compound as a yellow powder (81 mg, 0.46 mmol, 
91%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.01 (s, 2H), 2.56 (s, 6H), 2.30 (s, 3H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 142.8 (2C), 141.6, 130.2 (2C), 119.2, 111.0, 22.0 
(2C), 21.2. 
IR (Diamond-ATR, neat): ṽ / cm-1 = 2978, 2952, 2919, 2851, 2147, 1761, 1599, 1451, 1435, 
1377, 1299, 1278, 1251, 1180, 1031, 954, 867, 850, 809, 715, 676. 
MS (EI, 70 eV): m/z (%) = 177 (100), 162 (22), 144 (72), 115 (38), 91 (55), 69 (17), 51 (34). 
HRMS (EI): m/z calc. for [C10H11NS]: 177.0612; found 177.0615. 
m. p. (°C): 62. 
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1-Methoxy-4-thiocyanatobenzene (42c) 
 
According to TP16, N-(thiocyanato)phthalimide (141 mg, 0.50 mmol, 1.00 equiv) was reacted 
with (4-methoxyphenyl)zinc chloride ( , 2.08 mL, 0.36 M in THF, 0.75 mmol, 1.50 equiv) in 
the presence of Cu(OAc)2·H2O. Purification by flash column chromatography on silica gel 
(hexane:EtOAc 95:5) afforded the title compound as a yellow oil (76.8 mg, 0.465 mmol, 93%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.50 (d, J = 8.9 Hz, 2H), 6.95 (d, J = 8.9 Hz, 2H), 
3.83 (s, 3H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 161.4, 134.0 (2C), 116.0 (2C), 113.9, 111.8, 55.7. 
IR (Diamond-ATR, neat): ṽ / cm-1 = 3092, 3072, 3019, 2946, 2927, 2840, 2153, 1899, 1589, 
1571, 1493, 1460, 1443, 1407, 1295, 1275, 1249, 1181, 1174, 1107, 1087, 1021, 961, 954, 952, 
942, 824, 796, 782, 713, 676. 
MS (EI, 70 eV): m/z (%) = 165 (100), 139 (15), 122 (70), 92 (18), 69 (50), 50 (22). 
HRMS (EI): m/z calc. for [C8H7NOS]: 165.0248; found 165.0245. 
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(4-Chlorophenyl)(phenyl)selane (43) 
 
According to TP16, N-(selenophenyl)phthalimide (151 mg, 0.50 mmol, 1.00 equiv) was 
reacted with (4-chlorophenyl)zinc chloride ( , 2.08 mL, 0.36 m in THF, 0.75 mmol, 1.50 equiv) 
in the presence of Cu(OAc)2·H2O. Purification by flash column chromatography on silica gel 
(hexane:EtOAc 95:5) afforded the title compound as a white solid (76.8 mg, 0.47 mmol, 93%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.42–7.36 (m, 1H), 7.32–7.28 (m, 1H), 7.24–7.18 (m, 
2H), 7.18–7.14 (m, 1H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 134.1 (2C), 133.5, 133.2 (2C), 130.6, 129.6, 129.5 
(4C), 127.7. 
Analytical data according to literature150 
  
                                                          
150  S. Saba, J. Rafique, A. L. Braga Adv. Synth. Catal. 2015, 357, 1446–1452. 
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7.4 Synthesis of Cathepsin-D Inhibitor 9 
4-Mercaptobenzonitrile (46) 
 
In a dry and argon flushed flask, 4-bromobenzonitrile (45) (4.56 g, 25.0 mmol, 1.00 equiv) was 
dissolved in dry THF (25 mL) and cooled to 0 °C. Then, iPrMgCl·LiCl (24 mL, 27.5 mmol, 
1.10 equiv) was added dropwise to the reaction mixture. The solution was stirred for 2 h at 
0 °C and then all volatiles were removed in vacuo. After re-dissolving in dry THF, elementary 
sulphur (882 mg, 27.5 mmol, 1.10 equiv) was added in one portion and the resulting mixture 
was stirred for 1 h at 0 °C. Afterwards, 2M HCl (50 mL) were added and the organic layer 
removed. The aqueous phase was extracted with CH2Cl2 (2 x 50 mL) and the combined organic 
layers washed with brine (50 mL), dried over mgSO4 and the solvent removed in vacuo to 
afford the titel compound 11 as yellow oil (3.21 g, 23.8 mmol, 95%). The crude product was 
analytically pure (determined by NMR) and used without further purification. 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.49 (d, J = 8.4 Hz, 1H), 7.34–7.29 (m, 1H), 3.67 (s, 
1H). 
Analytical data according to literature151 
 
(6-(Trifluoromethoxy)benzo[d]thiazol-2-yl)zinc chloride (47) 
 
According to TP2, 2-bromo-6-(trifluoromethoxy)benzo[d]thiazole (745 mg, 2.50 mmol, 
1.00 equiv) was added to a suspension of anhydrous LiCl (159 mg, 3.75 mmol, 1.50 equiv) and 
magnesium turnings (122 mg, 5.00 mmol, 2.00 equiv) in dry THF (5 mL). The mixture was 
stirred at 25 °C overnight and then ZnCl2 (1 M in THF, 3.0 mL, 3.00 mmol, 1.20 equiv) was 
added as a solution in THF at 0 °C. Titration with iodine gave a concentration of 0.32 mmol/mL 
corresponding to a yield of 75%.  
                                                          
151  D. L. Orsi, B. J. Easley, A. M. R. A. Altman Org. Lett. 2017, 19, 1570–1573. 
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4-((6-(Trifluoromethoxy)benzo[d]thiazol-2-yl)thio)benzonitrile (48) 
 
According to TP16, 4-((1,3-dioxoisoindolin-2-yl)thio)benzonitrile (47, 140 mg, 0.50 mmol, 
1.00 equiv) was reacted with (6-(trifluoromethoxy)benzo[d]thiazol-2-yl)zinc chloride (12, 
1.72 mL, 0.32 M in THF, 0.55 mmol, 1.10 equiv) in the presence of Cu(OAc)2·H2O. 
Purification by flash column chromatography on silica gel (hexane:EtOAc 4:1) afforded the 
title compound as a white powder (166 mg, 0.47 mmol, 94%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.93 (d, J = 8.9 Hz, 1H), 7.82–7.69 (m, 4H), 7.63 (dd, 
J = 2.3, 1.1 Hz, 1H), 7.34 (ddd, J = 8.9, 2.5, 1.0 Hz, 1H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 165.5, 151.9, 146.5, 136.7, 133.7 (2C), 133.2 (2C), 
123.4, 120.5, 120.5 (q, J = 257.8 Hz), 117.9, 113.8, 113.8, 113.4. 
IR (Diamond-ATR, neat): ṽ / cm-1 = 2359, 2231, 1604, 1592, 1485, 1467, 1443, 1407, 1310, 
1250, 1217, 1193, 1164, 1121, 1062, 1013, 995, 944, 876, 862, 831, 814, 683, 668. 
MS (EI, 70 eV): m/z (%) = 351 (16), 102 (11), 69 (100). 
HRMS (EI): m/z calc. for [C15H7F3N2OS2]: 351.9952; found 351.9950. 
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4-((6-(Trifluoromethoxy)benzo[d]thiazol-2-yl)thio)benzamide 
 
To a 25 mL round-bottom flask equipped with stirring bar were added 4-((6-
(trifluoromethoxy)benzo[d]thiazol-2-yl)thio)benzonitrile (883 mg, 2.50 mmol, 1.00 equiv), 
acetaldoxime (296 mg, 5.00 mmol, 2.00 equiv), nickel(II) chloride hexahydrate (59 mg, 
0.25 mmol, 10.0 mol%) and H2O (10 mL). The mixture was heated to reflux for 6 h. After 
cooling to r.t., the solution was directly evaporated to dryness and the residue was purified by 
flash column chromatography on silica gel (hexane:EtOAc 4:1) to give 4-((6-
(trifluoromethoxy)benzo[d]thiazol-2-yl)thio)benzamide as a white solid (843 mg, 2.23 mmol, 
91%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.88–7.79 (m, 3H), 7.77–7.70 (m, 2H), 7.51 (dd, J = 
2.2, 1.1 Hz, 1H), 7.24 (ddd, J = 8.8, 2.4, 0.9 Hz, 1H), 5.82 (d, J = 168.6 Hz, 2H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 168.3, 167.9, 152.1, 146.1, 136.4, 134.9, 134.6 (2C), 
134.3, 128.8 (2C), 123.0, 120.4 (q, J = 257.7 Hz), 120.3, 113.7. 
19F NMR (377 MHz, CDCl3): δ / ppm = -58.1. 
IR (Diamond-ATR, neat): ṽ / cm-1 = 2359, 2231, 1604, 1592, 1485, 1467, 1443, 1407, 1310, 
1250, 1217, 1193, 1164, 1121, 1062, 1013, 995, 944, 876, 862, 831, 814, 683, 668. 
MS (EI, 70 eV): m/z (%) = 370 (100), 217 (10), 152 (11), 120 (17), 69 (80). 
HRMS (EI): m/z calc. for [C15H9F3N2O2S2]: 370.0058; found 370.0053. 
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4-((6-(Trifluoromethoxy)benzo[d]thiazol-2-yl)thio)aniline (49) 
 
To a stirred solution of KOH (126 mg, 2.25 mmol, 5.00 equiv) in H2O (2 mL) was added 
bromine (30 µL, 0.54 mmol, 1.20 equiv) at 0 °C. The mixture was stirred at 0 °C for 30 min. 
Then, 4-((6-(trifluoromethoxy)benzo[d]thiazol-2-yl)thio)benzamide (168 mg, 0.45 mmol, 
1.00 equiv) was added dropwise as a solution in THF (2 mL). The resulting mixture was stirred 
for 2.5 h at 70 °C and subsequently extracted with CH2Cl2 (3 x 10 mL), dried over mgSO4 and 
the solvent removed in vacuo. Purification by flash column chromatography on silica gel 
afforded the title compound as white solid (97 mg, 0.28 mmol, 63%). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.74 (d, J = 8.9 Hz, 1H), 7.44–7.39 (m, 3H), 7.19–
7.14 (m, 1H), 6.71–6.65 (m, 2H), 3.98 (s, 2H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 175.1, 152.9, 149.3, 145.4, 137.7, 136.1, 122.2, 120.5 
(q, J = 257.3 Hz) 119.9, 116.1, 116.0, 113.6. 
IR (Diamond-ATR, neat): ṽ / cm-1 = 3003, 2358, 2341, 1748, 1709, 1433, 1420, 1359, 1220, 
1092, 973, 902, 785, 668. 
MS (EI, 70 eV): m/z (%) = 342 (100), 217 (10), 124 (30), 92 (12), 69 (76). 
HRMS (EI): m/z calc. for [C14H9F3N2OS2]: 342.0108; found 342.0105. 
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3,5-Dichloro-2-hydroxy-N-(4-((6-(trifluoromethoxy)benzo[d]thiazol-2-
yl)thio)phenyl)benzamide (44) 
 
To a stirred solution of iodine (61 mg, 0.24 mmol, 1.20 equiv) in dry CH2Cl2 (2 mL) was added 
with one portion of PPh3 (63 mg, 0.24 mmol, 1.20 equiv) at 0 °C. 4-((6-(trifluoromethoxy) 
benzo[d]thiazol-2-yl)thio)aniline (49, 82 mg, 0.24 mmol, 1.20 equiv) was added under 
continuously stirring over 5 min. Subsequently, the resulting mixture was treated with 3,5-
dichloro-2-hydroxybenzoic acid (41 mg, 0.20 mmol, 1.00 equiv) and stirred for 5 min, 
followed by addition of triethylamine (56 µL, 0.40 mmol, 2.00 equiv). After the solution was 
allowed to warm up to 25 °C and stirred for 10 min, the crude mixture was concentrated under 
reduced pressure then purified by flash column chromatography on silica gel(hexane:EtOAc 
4:1) to give the title compound (64 mg, 0.12 mmol, 61% yield). 
1H-NMR (400 MHz, CDCl3): δ / ppm = 10.46 (s, 1H), 8.01 (d, J = 2.5 Hz, 1H), 7.74–7.68 (m, 
4H), 7.68–7.62 (m, 3H), 7.54–7.50 (m, 1H). 
13C NMR (100 MHz, CDCl3): δ / ppm = 167.6, 165.2, 155.5, 148.1, 146.6 (q, J = 257.9 Hz), 
138.0, 135.3, 132.3, 131.3, 130.1, 126.8, 123.8, 122.2 (2C), 121.5, 120.8, 119.5, 118.2 (2C), 
117.4, 113.9. 
Analytical data according to literature116 
